data_2jon_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jon _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.589 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.847 0.356 . . . . 54.03 110.876 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CE3' ' C ' ' A' ' 12' ' ' SER . 2.5 m-90 -138.08 120.86 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 74.4 110.93 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.81 102.09 14.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 63.01 110.871 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.99 152.43 26.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 73.41 111.166 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 127.78 15.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.664 2.243 . . . . 74.45 112.329 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -52.02 118.23 11.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 73.13 110.911 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 73.3 112.312 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.28 -25.61 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.748 . . . . 74.32 112.461 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HB ' ' CD1' ' A' ' 25' ' ' LEU . 13.2 t -59.1 166.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 74.11 111.104 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 24' ' ' GLN . 2.3 m -56.44 113.19 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.42 110.811 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 21' ' ' SER . 24.3 m-20 -36.57 -59.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 65.44 110.898 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -36.43 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.891 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -63.72 -48.51 76.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.458 . . . . 74.13 110.899 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.587 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.5 OUTLIER -70.98 -30.46 66.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.35 110.877 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.8 m -55.8 -30.24 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 63.4 111.14 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.13 58.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 62.11 112.532 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 4.6 m-20 -64.14 -68.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.328 . . . . 73.32 110.901 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 84.9 mt -43.82 -43.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 74.13 111.117 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -46.99 83.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 74.45 110.886 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 1.2 t80 -73.95 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 75.21 110.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' N ' ' CD2' ' A' ' 31' ' ' TYR . . . -51.15 -43.19 61.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 74.3 111.097 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 35.5 t -53.37 -14.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 65.21 110.939 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.87 14.5 19.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.901 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -46.48 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 72.42 110.94 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.65 -62.41 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 73.3 112.493 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.32 5.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 73.42 111.159 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' OD1' ' CB ' ' A' ' 32' ' ' ALA . 6.0 m-20 -82.86 -63.81 1.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 53.14 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.11 126.19 30.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 71.1 110.901 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.85 -70.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 73.24 112.471 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.616 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.82 4.85 1.98 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.694 2.263 . . . . 71.03 112.319 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.528 HD12 ' CG ' ' A' ' 57' ' ' HIS . 27.3 pt -83.35 18.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 75.33 111.113 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -74.12 129.28 84.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 74.22 110.92 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 161.24 46.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 72.1 112.352 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.87 -35.33 2.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 63.01 112.435 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.13 -26.1 5.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 75.45 112.487 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.1 -68.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 73.13 111.12 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' A' ' 49' ' ' PHE . 28.8 m -118.07 -4.36 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.45 110.866 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.7 t80 -34.28 -54.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.13 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.467 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.33 124.76 41.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 71.15 110.909 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.15 88.13 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 -1.811 . . . . 74.01 112.345 0.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.43 ' CA ' ' O ' ' A' ' 49' ' ' PHE . 13.7 p-10 -106.03 127.08 52.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.882 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 p -83.5 166.8 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 60.23 111.16 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.8 -57.84 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.41 111.123 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -78.97 13.94 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.923 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.3 -48.42 62.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.23 111.084 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.528 ' CG ' HD12 ' A' ' 42' ' ' ILE . 34.7 m170 -50.33 -50.41 51.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 73.31 110.828 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 62' ' ' MET . . . -56.66 -37.55 70.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.22 111.106 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.34 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 71.15 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 6.8 t80 -68.27 -63.11 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 70.13 110.951 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 61' ' ' VAL . 2.6 p -54.82 -33.39 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 75.34 111.147 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.457 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 1.5 mmt -45.54 -24.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 72.52 110.862 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -68.87 -58.15 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 71.51 110.905 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -50.73 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.933 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.43 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.4 t80 -46.3 -50.02 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.03 110.936 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.553 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 31.4 t80 -53.53 -36.78 62.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 73.22 110.939 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -94.09 -2.68 52.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.5 110.91 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.55 -42.62 58.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.15 110.879 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.502 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.48 -60.9 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 53.34 111.098 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.02 19.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 53.31 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.98 32.08 9.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 73.13 110.866 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.553 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 1.9 m-80 -104.75 166.38 10.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 64.32 110.857 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.428 ' CA ' HD13 ' A' ' 84' ' ' LEU . 57.8 p -68.06 -23.15 64.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 72.24 110.852 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.13 2.23 28.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.914 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -13.45 61.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 63.4 110.911 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.73 101.98 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.25 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 8.6 m-20 -118.0 7.63 12.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.868 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.411 ' CE2' ' HG2' ' A' ' 62' ' ' MET . 3.3 m-30 -59.08 -68.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.04 110.907 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -171.91 178.04 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 71.44 110.87 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -1.94 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.587 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 72.2 p -93.17 -52.52 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 72.44 111.132 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.43 102.01 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.55 111.132 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -148.94 178.06 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.117 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.428 HD13 ' CA ' ' A' ' 73' ' ' SER . 6.2 mp -66.32 126.75 29.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.947 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -106.38 169.36 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 74.13 111.121 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' THR . 33.4 m-80 -54.06 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 61.13 110.921 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -45.13 175.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 74.43 111.185 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 5.8 t-20 -51.97 105.96 0.59 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.626 0.727 . . . . 74.45 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.4 Cg_endo -69.79 -16.44 37.42 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.254 . . . . 74.44 112.31 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.403 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 29.8 t -51.97 110.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.848 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -77.2 -15.71 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 75.52 110.932 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 168.65 -122.43 1.02 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.748 -0.739 . . . . 71.24 112.501 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -40.09 -42.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 63.41 111.045 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.64 102.26 7.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 74.31 110.859 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.0 130.85 45.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 75.12 110.921 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.482 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 20.8 m-85 -83.93 144.38 44.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.659 0.742 . . . . 71.04 110.886 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 120.34 7.14 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.236 . . . . 71.41 112.369 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.476 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 52.6 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.54 110.828 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.63 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.854 0.359 . . . . 73.1 110.852 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.63 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 1.6 m-90 -134.29 111.69 10.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.118 -0.492 . . . . 74.12 110.93 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -82.42 101.99 11.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.86 152.42 26.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 72.33 111.124 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 129.17 17.15 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 75.54 112.355 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 115.93 7.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 74.34 110.883 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 54.2 Cg_endo -69.72 84.49 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 72.43 112.371 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.74 -25.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.745 -0.741 . . . . 61.33 112.457 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.1 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 75.13 111.073 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 24' ' ' GLN . 14.8 m -52.06 109.2 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.31 110.836 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 21' ' ' SER . 42.8 m-20 -33.87 -64.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 72.23 110.878 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.34 -40.53 2.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 72.43 110.883 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.9 tp60 -58.13 -51.38 69.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 73.45 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.48 ' CD1' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.68 -27.04 62.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.5 110.877 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.41 ' OG1' ' CG1' ' A' ' 54' ' ' VAL . 11.0 m -62.89 -6.88 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.44 111.14 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -25.8 45.21 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 72.41 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.39 -67.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 71.14 110.879 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 80.7 mt -39.21 -44.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 72.15 111.112 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.52 -47.6 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.24 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.53 -58.12 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.889 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.89 -41.16 61.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 72.23 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 13.3 t -56.84 -9.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 71.04 110.851 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.05 18.0 19.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 4.9 mm100 -94.46 -50.57 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.916 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.83 -81.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 72.31 112.446 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -81.6 17.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 74.34 111.128 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.476 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -89.44 -61.13 1.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 75.43 110.872 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -74.47 124.58 26.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.41 110.892 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.19 -69.77 0.42 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 65.54 112.512 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.589 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.666 2.244 . . . . 74.11 112.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.567 HD12 ' CD2' ' A' ' 57' ' ' HIS . 21.6 pt -82.53 17.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.1 111.117 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.75 138.65 62.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 75.23 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.489 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.74 145.9 58.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 71.52 112.336 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.3 -29.94 4.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 74.31 112.463 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.15 -13.1 7.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 54.45 112.536 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 -68.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 74.42 111.114 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 m -118.05 11.11 13.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.55 110.914 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.563 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 1.5 t80 -54.92 -57.39 11.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 75.31 110.909 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.563 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -100.53 127.09 33.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 74.2 110.887 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.73 153.92 93.04 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 -1.797 . . . . 71.1 112.367 -0.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -101.58 119.31 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.31 110.877 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.5 p -83.19 171.43 13.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 74.45 111.163 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' OG1' ' A' ' 26' ' ' THR . 69.1 t -65.84 -61.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 74.14 111.125 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.55 16.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.911 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.47 -47.5 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.52 111.106 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.567 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.8 m80 -50.15 -50.25 49.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.831 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.93 -33.14 68.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 74.43 111.109 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.14 86.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.083 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.589 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -68.32 -60.65 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.35 110.961 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -55.26 -34.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 73.51 111.152 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.567 ' HE3' ' CD1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -50.67 -29.99 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.846 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -65.38 -67.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 74.42 110.893 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.82 -53.35 41.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.908 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 3.3 t80 -46.94 -45.79 20.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.907 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 35.6 t80 -58.76 -26.41 63.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 72.4 110.9 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.29 -1.89 28.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 74.02 110.921 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -70.17 -42.19 72.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 73.01 110.852 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.63 -56.09 4.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 75.42 111.121 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.42 24.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 73.51 112.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 52.04 46.57 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 74.32 110.85 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -112.71 168.23 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.52 110.902 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB2' ' CD1' ' A' ' 84' ' ' LEU . 73.2 p -71.2 -24.59 62.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 73.12 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -78.87 1.35 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 74.43 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -73.68 -22.47 59.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.888 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.407 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.3 m -82.31 102.0 10.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.906 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.0 8.81 12.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 72.54 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.567 ' CD1' ' HE3' ' A' ' 62' ' ' MET . 3.5 m-30 -58.54 -68.67 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.867 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 81' ' ' THR . 3.3 t -172.07 178.01 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.819 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -65.7 -1.52 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.939 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.48 HG22 ' CD1' ' A' ' 25' ' ' LEU . 64.9 p -92.91 -52.62 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 53.42 111.157 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.34 102.33 11.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 74.33 111.092 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 t -148.78 178.01 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 73.42 111.162 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.474 ' CD1' ' HB2' ' A' ' 73' ' ' SER . 0.9 OUTLIER -66.65 112.06 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 71.43 110.958 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -89.23 168.18 12.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 71.23 111.107 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' THR . 72.1 m-20 -54.39 -167.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 73.44 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.6 t -44.46 173.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 65.35 111.138 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.8 t-20 -52.11 106.92 0.72 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 71.4 110.86 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.73 -2.77 10.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 73.35 112.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.7 t -51.99 105.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.887 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -74.6 -16.39 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 73.05 110.931 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.08 -113.25 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 51.21 112.52 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.31 79.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 72.21 111.08 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.876 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -99.36 140.16 33.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 74.24 110.894 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.518 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.07 151.14 40.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 74.52 110.841 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.623 2.215 . . . . 64.32 112.371 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.473 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 6.0 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.842 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.819 0.342 . . . . 73.22 110.891 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.4 m-90 -125.98 116.52 21.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 74.04 110.926 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -89.92 106.24 18.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 70.42 110.859 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG12 ' C ' ' A' ' 14' ' ' CYS . 2.4 m -155.4 152.43 24.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.585 0.707 . . . . 74.42 111.133 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 Cg_endo -69.75 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 73.34 112.336 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -51.97 113.55 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.601 0.715 . . . . 73.44 110.903 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 79.93 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.732 2.288 . . . . 73.42 112.325 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -26.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 71.43 112.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 25' ' ' LEU . 3.3 t -58.96 167.73 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.24 111.131 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 24' ' ' GLN . 3.6 m -53.89 111.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 64.11 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 21' ' ' SER . 23.1 m-20 -34.96 -61.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.888 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.28 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.889 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.1 tp60 -60.34 -50.25 74.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.4 110.919 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.598 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.93 -23.78 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 71.12 110.88 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 m -66.35 0.08 2.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 74.3 111.134 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -93.43 -35.64 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 73.32 112.517 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 7.9 p30 -55.15 -45.37 75.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 74.01 110.916 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 63.6 mt -59.24 -59.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 72.44 111.162 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -44.63 -40.0 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.93 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -73.94 -60.7 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 71.32 110.905 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -52.17 -26.46 11.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 60.23 111.083 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.59 1.65 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.887 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.15 9.39 32.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.851 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.03 -44.63 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 64.1 110.857 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.6 -51.95 0.84 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 74.35 112.482 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.44 ' O ' ' CG ' ' A' ' 41' ' ' PRO . 2.5 pt -82.18 8.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 75.12 111.12 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 1.1 t70 -89.1 -60.71 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.886 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.62 119.01 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 63.35 110.857 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.22 -67.86 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 50.53 112.474 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -69.72 -1.05 7.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 72.44 112.377 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.569 HD11 ' CD2' ' A' ' 57' ' ' HIS . 17.4 pt -82.87 14.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -76.75 126.54 85.72 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.637 0.732 . . . . 75.31 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.67 10.61 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 74.33 112.337 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.29 -38.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.773 -0.727 . . . . 61.34 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.92 -34.36 2.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 75.32 112.465 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.06 -68.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 74.01 111.078 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.98 15.76 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 75.15 110.876 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 50' ' ' GLU . 2.5 t80 -51.85 -66.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.837 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.1 136.66 35.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.749 . . . . 72.44 110.853 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.73 146.13 81.25 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 -1.799 . . . . 73.53 112.385 -0.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.418 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 3.1 p30 -104.8 134.04 48.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 p -95.12 169.11 10.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 64.13 111.128 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.18 -56.98 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 74.23 111.093 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -78.67 13.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.931 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.64 -46.96 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.12 111.104 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.569 ' CD2' HD11 ' A' ' 42' ' ' ILE . 38.9 m80 -50.46 -59.67 3.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 75.54 110.83 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -47.75 -38.01 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 73.12 111.106 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.84 -42.06 83.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 65.23 111.062 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.604 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 2.7 t80 -67.31 -57.78 6.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 72.33 110.934 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 58' ' ' ALA . 3.6 p -55.22 -38.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 64.2 111.153 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 78' ' ' PHE . 36.3 mtp -46.22 -25.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.24 110.91 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.41 -60.36 2.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.873 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.46 -45.69 52.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 73.23 110.936 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.4 t80 -51.4 -54.2 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 71.33 110.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 26.4 t80 -50.95 -36.15 37.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 72.45 110.924 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.49 -3.64 49.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 64.35 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.93 -42.56 60.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.13 110.83 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.492 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.2 -62.05 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.35 111.052 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.42 20.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 53.15 112.546 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.99 37.44 21.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 74.13 110.891 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -108.84 168.26 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 75.23 110.899 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.47 ' CB ' HD13 ' A' ' 84' ' ' LEU . 89.2 p -69.03 -24.93 64.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 73.22 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -80.22 1.17 29.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 71.03 110.922 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.492 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -26.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 70.24 110.9 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.5 m -82.47 102.04 11.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 63.41 110.9 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.03 14.24 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.149 -0.478 . . . . 55.33 110.873 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CE2' ' HG3' ' A' ' 62' ' ' MET . 4.3 m-30 -58.92 -67.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 74.01 110.908 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -171.64 178.02 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 73.53 110.834 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -64.88 -2.33 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 74.22 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.598 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 50.9 p -93.36 -51.77 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 75.55 111.135 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.47 ' HB3' ' CE ' ' A' ' 62' ' ' MET . . . -82.11 104.82 12.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 73.12 111.099 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 t -154.82 178.01 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.164 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.47 HD13 ' CB ' ' A' ' 73' ' ' SER . 37.6 mt -67.29 127.7 33.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.9 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -106.3 167.58 9.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 72.53 111.12 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 87' ' ' THR . 50.2 m-80 -53.85 -168.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.913 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.85 172.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 74.34 111.153 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.08 106.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 74.41 110.862 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -1.09 7.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.01 112.34 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 t -51.97 108.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.861 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -75.12 -17.11 60.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.71 -111.38 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 75.2 112.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.93 85.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 72.22 111.114 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 102.09 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 63.1 110.899 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -98.82 151.65 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 75.24 110.864 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.1 m-85 -92.41 148.93 37.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.628 0.728 . . . . 71.12 110.854 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 124.43 11.06 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.665 2.243 . . . . 74.25 112.34 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.534 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 13.1 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.909 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.607 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 36.0 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.807 0.337 . . . . 73.5 110.844 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 4.6 m-90 -133.33 116.14 15.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 74.44 110.883 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.36 101.99 14.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 74.04 110.904 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.409 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 2.9 m -148.9 153.54 38.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 70.33 111.135 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.75 126.17 13.01 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.672 2.248 . . . . 73.55 112.336 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.98 107.07 0.74 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.576 0.703 . . . . 73.31 110.909 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.81 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.717 2.278 . . . . 74.04 112.317 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.43 55.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 71.45 112.476 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 m -158.59 177.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 75.11 111.108 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -52.01 119.05 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 52.0 m-20 -52.2 -37.02 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 74.25 110.877 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -20.53 55.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 70.42 110.845 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -77.79 -48.43 16.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 65.02 110.919 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.67 -53.03 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 75.41 110.924 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.449 ' CG2' ' N ' ' A' ' 27' ' ' GLY . 14.2 t -37.49 -47.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.135 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' N ' ' CG2' ' A' ' 26' ' ' THR . . . -46.4 -41.73 12.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 73.14 112.479 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -47.18 -69.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 74.35 110.866 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 70.1 mt -40.08 -57.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 75.33 111.139 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -46.12 -42.68 14.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.1 110.869 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -73.86 -58.37 3.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.909 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -51.09 -24.78 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 74.12 111.101 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.08 2.27 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.859 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 5.73 37.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.41 110.818 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.04 -42.75 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.89 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.48 -46.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 54.1 112.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 65' ' ' TYR . 1.1 pt -82.34 5.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 72.03 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.463 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 16.4 t70 -89.36 -58.06 2.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.855 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.414 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.73 119.34 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.881 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.36 -70.84 0.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 74.13 112.465 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.5 Cg_endo -69.8 -0.84 7.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.655 2.236 . . . . 75.03 112.313 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.523 HD12 ' CG ' ' A' ' 57' ' ' HIS . 14.2 pt -83.08 17.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 75.24 111.13 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.93 137.97 69.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 64.53 110.876 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 173.92 10.3 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.221 . . . . 74.32 112.375 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.76 -35.35 1.07 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 73.14 112.462 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.13 -27.75 5.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 74.25 112.498 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 -68.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.824 0.345 . . . . 74.05 111.061 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.98 18.06 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.23 110.89 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.9 t80 -56.84 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 72.22 110.885 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -94.8 129.02 37.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 75.11 110.89 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.72 148.01 85.75 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.655 -1.81 . . . . 73.34 112.376 -0.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.39 142.27 34.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.897 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.8 p -92.39 167.32 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.11 111.163 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.61 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.081 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.19 17.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.888 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.76 -42.84 58.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 73.44 111.076 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.523 ' CG ' HD12 ' A' ' 42' ' ' ILE . 41.3 m170 -54.49 -56.59 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 71.55 110.832 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' A' ' 62' ' ' MET . . . -49.99 -36.57 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.11 111.099 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 64.3 111.068 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -67.86 -58.53 4.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.91 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 58' ' ' ALA . 3.5 p -55.06 -36.56 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 64.02 111.095 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.573 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER -46.7 -23.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.858 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -69.41 -62.35 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.896 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -45.28 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 75.22 110.928 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.436 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 2.4 t80 -53.45 -50.82 64.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.51 110.953 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 58.2 t80 -53.02 -29.13 27.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 65.32 110.892 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -99.28 -4.02 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 73.42 110.933 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -71.51 -42.2 68.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.874 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.04 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.02 111.085 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 23.19 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 55.34 112.477 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.0 39.36 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 74.33 110.903 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.609 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 4.7 m-80 -110.94 171.94 7.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.883 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.465 ' CB ' HD12 ' A' ' 84' ' ' LEU . 79.4 p -71.86 -23.56 61.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 70.42 110.85 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.78 2.48 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 73.15 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -73.74 -24.69 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 71.21 110.844 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.4 m -82.32 101.95 10.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 64.34 110.845 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -117.96 11.31 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 74.44 110.892 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CZ ' ' HE3' ' A' ' 62' ' ' MET . 4.0 m-30 -58.47 -68.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 75.53 110.867 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -171.69 177.98 3.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 53.3 110.849 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.33 -1.96 2.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.493 . . . . 72.44 110.968 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.483 HG22 ' CD1' ' A' ' 25' ' ' LEU . 61.1 p -92.53 -52.91 4.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 61.23 111.15 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.47 106.06 14.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 70.31 111.102 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -154.7 178.02 10.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 74.41 111.113 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.475 ' CD2' ' HB3' ' A' ' 12' ' ' SER . 1.4 mt -67.37 123.32 20.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 73.31 110.913 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -103.82 168.62 9.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' THR . 66.6 m-20 -54.16 -167.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 63.24 110.873 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.24 170.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 64.45 111.133 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.4 t-20 -51.97 107.03 0.73 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.624 0.726 . . . . 63.55 110.894 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.3 Cg_endo -69.82 2.55 3.46 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.653 2.235 . . . . 75.44 112.32 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.5 t -52.02 106.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 73.44 110.883 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 94' ' ' CYS . 11.2 p90 -78.62 -16.21 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 74.42 110.903 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -113.49 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 62.21 112.518 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.74 83.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 64.54 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -76.34 102.66 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 70.44 110.862 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -98.14 140.48 32.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 72.54 110.928 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.402 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.6 m-85 -92.48 158.02 39.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 74.05 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 113.82 3.51 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 74.41 112.337 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.543 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 26.1 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 74.42 110.88 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.473 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.876 0.369 . . . . 74.14 110.82 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.581 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.7 m-90 -137.52 115.75 11.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 75.33 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.01 102.05 12.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 65.15 110.867 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -152.65 152.02 27.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.731 . . . . 75.44 111.099 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.83 124.66 11.26 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.659 2.239 . . . . 73.35 112.304 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -52.0 119.57 14.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 74.33 110.863 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 80.72 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 70.23 112.308 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -25.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 72.22 112.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.401 ' CG1' ' H ' ' A' ' 21' ' ' SER . 2.5 t -59.0 173.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 64.21 111.144 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.486 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.69 115.28 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 74.33 110.857 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -40.73 -47.81 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 75.34 110.85 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -57.76 -34.38 69.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.14 110.872 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 14.1 mm100 -69.04 -46.12 68.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.959 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -70.29 -56.54 6.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.24 110.947 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 27' ' ' GLY . 11.3 t -41.05 -45.25 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.144 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 26' ' ' THR . . . -39.39 -37.8 0.84 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 72.11 112.43 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 29' ' ' ILE . 3.7 m-20 -56.14 -68.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 74.13 110.86 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 76.9 mt -35.31 -44.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.2 111.076 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -56.12 -49.18 74.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 72.35 110.89 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' ASN . 1.1 t80 -74.46 -54.43 7.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 74.52 110.912 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.92 -40.3 60.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 74.3 111.154 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.5 t -56.75 -10.04 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 73.12 110.839 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 32' ' ' ALA . 36.5 m -112.55 18.1 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 71.43 110.845 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 4.4 mm100 -93.9 -50.93 5.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.911 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.82 -85.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 70.52 112.473 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -81.38 17.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 74.11 111.115 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -85.38 -61.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 64.44 110.851 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.02 122.43 23.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 62.41 110.819 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.49 -67.42 0.51 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 71.21 112.477 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.71 1.98 3.92 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 74.44 112.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.57 HD12 ' CD2' ' A' ' 57' ' ' HIS . 24.7 pt -84.54 17.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.122 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -85.85 127.29 63.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.72 . . . . 75.41 110.912 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.454 ' CB ' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.75 156.45 63.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.717 2.278 . . . . 74.4 112.337 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.43 -47.13 1.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.457 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.04 -0.94 2.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.784 -0.722 . . . . 52.12 112.508 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.27 -68.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 73.55 111.11 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -117.94 9.86 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.925 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.564 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.5 t80 -56.21 -60.3 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.891 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.564 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 mt-10 -96.72 128.93 34.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.643 0.735 . . . . 74.4 110.89 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.81 145.09 78.59 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 -1.804 . . . . 74.44 112.372 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 1.2 p30 -107.23 151.74 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.13 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.7 p -99.92 170.87 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.24 111.172 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 26' ' ' THR . 72.0 t -65.43 -62.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 71.34 111.081 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.78 18.04 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.21 110.914 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.23 -40.91 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 71.54 111.064 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.57 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.3 m80 -53.19 -52.65 58.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 73.21 110.875 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB2' ' CE ' ' A' ' 62' ' ' MET . . . -57.47 -38.14 74.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 62.13 111.086 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.04 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 53.21 111.124 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 10.5 t80 -61.58 -65.08 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.945 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.409 ' O ' HG21 ' A' ' 61' ' ' VAL . 2.7 p -55.2 -34.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 74.03 111.088 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.551 ' HE1' ' CE2' ' A' ' 78' ' ' PHE . 2.7 mtm -44.89 -26.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.24 110.908 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -67.25 -60.74 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.31 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -52.3 18.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.91 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.434 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.7 t80 -46.46 -44.59 17.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.31 110.928 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 12.6 t80 -58.96 -28.43 66.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 70.23 110.903 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -99.56 -4.79 30.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 71.32 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -41.67 69.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.11 110.881 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.17 -58.12 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 72.01 111.094 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 23.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 75.13 112.487 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.02 43.79 30.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 74.41 110.852 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.504 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.5 m-80 -114.4 169.92 8.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 75.23 110.932 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.467 ' CB ' HD11 ' A' ' 84' ' ' LEU . 78.4 p -71.7 -23.19 61.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.873 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.06 1.89 26.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 74.53 110.907 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -73.68 -24.32 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 61.32 110.916 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -82.55 102.02 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.12 110.857 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -118.03 11.83 13.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 60.2 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.551 ' CE2' ' HE1' ' A' ' 62' ' ' MET . 3.7 m-30 -59.04 -68.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 75.11 110.895 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.46 178.02 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 43.53 110.824 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -65.9 -1.78 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 75.51 110.963 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.463 ' HB ' ' CD1' ' A' ' 25' ' ' LEU . 73.3 p -91.81 -50.01 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.22 111.118 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.14 102.01 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.23 111.076 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 t -147.37 178.47 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 73.12 111.124 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 73' ' ' SER . 35.7 mt -66.16 122.9 18.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.914 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -99.57 168.03 10.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.42 111.159 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.96 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 75.22 110.867 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.0 t -44.46 172.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.23 111.067 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.581 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.3 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 63.33 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.519 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.8 -2.37 10.09 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 75.33 112.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.0 t -52.04 108.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 72.53 110.845 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 5.9 p90 -81.57 -15.28 55.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 74.31 110.947 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.97 -115.12 0.5 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 74.35 112.566 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.96 89.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 74.1 111.142 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.568 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -76.45 102.03 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 70.22 110.867 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.5 142.84 30.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 63.2 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 10.0 m-85 -92.08 150.87 41.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.671 0.748 . . . . 72.42 110.839 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.23 11.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 72.53 112.37 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.459 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 9.1 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 71.43 110.877 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.529 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 25.2 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.915 0.388 . . . . 71.34 110.806 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.578 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.0 m-90 -137.75 119.52 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 74.54 110.927 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 101.98 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 65.3 110.884 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -151.84 152.6 30.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 75.31 111.091 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 127.76 15.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.682 2.255 . . . . 65.54 112.327 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -52.02 113.44 4.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 75.02 110.912 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 91.4 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.678 2.252 . . . . 71.02 112.393 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.13 -27.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 72.1 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.01 165.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 71.22 111.17 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -52.12 114.51 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.855 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 21' ' ' SER . 6.0 m-20 -33.65 -65.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 72.4 110.822 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.2 -39.17 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 63.44 110.872 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.7 tp-100 -58.36 -50.87 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.51 110.91 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' CD1' HG23 ' A' ' 81' ' ' THR . 0.4 OUTLIER -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.926 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 m -59.54 -31.48 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 71.5 111.154 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.77 -30.66 56.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 45.32 112.47 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' ILE . 1.1 m-20 -61.86 -68.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 74.31 110.867 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 67.6 mt -37.09 -48.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.12 111.073 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.06 -47.37 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 71.14 110.91 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.1 -53.65 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 71.5 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.479 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.12 -43.13 61.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 60.15 111.116 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -11.58 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.12 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 32' ' ' ALA . 34.7 p -109.06 18.03 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.34 110.821 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.469 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 5.1 mm100 -97.86 -49.96 4.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.42 110.887 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.65 -82.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 72.31 112.47 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 pt -80.97 17.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 73.2 111.123 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.479 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -89.56 -59.86 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 71.22 110.843 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.71 122.35 23.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.47 -71.34 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 71.4 112.463 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.601 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.77 4.24 2.31 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.684 2.256 . . . . 74.22 112.316 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.433 HD12 ' ND1' ' A' ' 57' ' ' HIS . 9.6 pt -82.87 18.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 73.31 111.136 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -80.31 148.36 66.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 72.5 110.886 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.1 Cg_endo -69.79 152.61 69.18 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.709 2.273 . . . . 71.44 112.351 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.83 -47.9 2.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 55.11 112.483 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.83 3.08 2.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 72.02 112.484 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 65.34 111.106 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.0 7.85 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.898 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -43.27 -59.0 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 74.43 110.875 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 2.4 mm-40 -96.72 131.02 28.89 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.671 0.748 . . . . 73.1 110.826 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.75 153.61 92.98 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 -1.801 . . . . 65.22 112.32 -0.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.493 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 10.4 p30 -101.73 130.55 48.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 75.43 110.876 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.432 ' OG1' ' CB ' ' A' ' 56' ' ' ALA . 41.2 p -82.97 169.99 15.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 72.31 111.163 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.1 -58.9 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.151 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -87.91 18.04 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.901 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.432 ' CB ' ' OG1' ' A' ' 53' ' ' THR . . . -49.7 -51.88 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 73.44 111.092 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' ND1' HD12 ' A' ' 42' ' ' ILE . 63.1 m170 -43.65 -58.16 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 70.25 110.841 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.22 -39.8 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 73.52 111.145 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.15 74.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 75.32 111.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 11.2 t80 -68.57 -63.45 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 72.13 110.931 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 p -54.9 -33.47 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 63.32 111.132 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.58 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 3.8 mtt -45.61 -27.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.882 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.63 -61.68 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 63.13 110.842 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -49.33 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 73.23 110.918 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.5 t80 -50.29 -47.0 55.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.3 110.926 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 30.4 t80 -55.88 -28.57 57.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 62.05 110.915 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -99.93 -4.59 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 70.52 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.11 -40.33 65.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.861 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -59.39 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.21 111.101 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.29 22.03 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 72.33 112.508 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.01 41.07 29.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 74.11 110.841 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.8 m-80 -114.11 169.12 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.863 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.5 p -70.28 -23.14 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 70.21 110.849 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -81.02 2.2 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.943 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.474 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -20.62 60.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 71.0 110.887 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.46 102.01 11.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 72.43 110.859 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.02 10.68 13.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 72.14 110.847 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CD2' ' HE2' ' A' ' 62' ' ' MET . 2.7 m-30 -58.32 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.917 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.62 178.01 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 72.1 110.897 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -2.2 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.12 110.9 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.475 HG23 ' CD1' ' A' ' 25' ' ' LEU . 65.4 p -92.15 -52.37 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.31 111.175 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.471 ' CB ' ' HE2' ' A' ' 62' ' ' MET . . . -82.52 102.15 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.13 111.114 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -148.64 178.02 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.43 111.154 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.57 127.2 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 74.52 110.874 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.04 167.76 9.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 71.22 111.179 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 87' ' ' THR . 11.3 m-80 -54.03 -168.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 74.33 110.884 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.99 173.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.23 111.17 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.7 t-20 -51.97 106.33 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.653 0.739 . . . . 73.33 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.78 -4.39 13.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 61.33 112.353 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -52.02 112.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 54.32 110.81 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 94' ' ' CYS . 1.8 p90 -79.8 -16.62 55.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.926 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.85 -123.83 0.94 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.44 112.454 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.35 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 44.33 111.08 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -76.35 104.16 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 62.14 110.882 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.0 129.24 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 74.35 110.919 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.522 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.1 m-85 -78.42 154.97 79.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.655 0.74 . . . . 72.41 110.876 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.75 108.08 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.647 2.231 . . . . 75.01 112.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.568 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 54.6 p . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 73.1 110.842 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.52 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.915 0.388 . . . . 74.33 110.836 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.595 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.0 m-90 -136.03 123.06 21.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.913 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 102.01 13.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 74.21 110.836 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -154.58 153.06 27.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 71.13 111.09 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.4 Cg_endo -69.82 129.34 17.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 71.55 112.383 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 118.12 11.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.522 0.677 . . . . 75.22 110.947 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 79.87 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.686 2.257 . . . . 74.04 112.324 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.58 -24.3 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 72.1 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -59.0 166.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.328 . . . . 71.45 111.164 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -52.01 107.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 72.13 110.849 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 21' ' ' SER . 72.9 m-20 -33.36 -63.41 0.24 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.99 -39.74 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 75.15 110.862 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -58.34 -50.93 71.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 53.34 110.875 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.49 -29.65 65.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 71.51 110.883 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.1 m -52.13 -26.53 11.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 73.55 111.129 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.36 -24.77 72.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 63.4 112.49 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.27 -51.4 63.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 65.44 110.864 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 57' ' ' HIS . 73.1 mt -62.53 -52.46 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 72.44 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -50.25 -43.63 53.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.16 -58.11 3.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.934 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -51.46 -31.65 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 63.21 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.91 -11.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.14 110.883 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 18.0 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 50.04 110.855 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -92.17 -52.1 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.22 110.887 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.38 -92.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.786 -0.721 . . . . 75.31 112.512 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.41 4.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 75.44 111.138 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' OD1' ' CG1' ' A' ' 61' ' ' VAL . 2.5 m-20 -66.66 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.84 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -76.07 134.92 39.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 52.13 110.88 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.94 -72.3 0.33 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 62.12 112.463 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.597 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.78 6.47 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.674 2.25 . . . . 73.31 112.358 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.584 HD12 ' CD2' ' A' ' 57' ' ' HIS . 22.9 pt -82.44 18.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.13 111.141 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -80.16 123.75 83.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 75.03 110.895 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.32 38.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 71.51 112.315 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.34 -32.99 1.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 73.43 112.514 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.49 -31.22 3.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 72.42 112.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.05 -68.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 73.32 111.126 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' PHE . 13.7 t -113.05 -13.77 13.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.926 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -34.46 -44.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 64.21 110.849 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.41 125.75 38.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 72.13 110.88 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.5 Cg_endo -69.75 151.89 91.82 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.726 -1.781 . . . . 74.13 112.317 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.488 ' HB2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.38 120.02 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 72.22 110.875 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.76 168.59 16.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 71.03 111.115 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -65.79 -56.79 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 75.3 111.147 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' CG ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.24 17.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 73.43 110.85 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.63 -42.29 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 74.14 111.061 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.584 ' CD2' HD12 ' A' ' 42' ' ' ILE . 67.5 m80 -52.28 -54.78 27.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.12 110.839 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 62' ' ' MET . . . -56.72 -37.74 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 62.31 111.105 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.14 -30.6 71.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 72.1 111.094 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 12.2 t80 -67.86 -66.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.902 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.497 ' CG1' ' OD1' ' A' ' 38' ' ' ASP . 7.5 p -55.24 -29.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 74.42 111.165 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.541 ' HE2' ' CE1' ' A' ' 78' ' ' PHE . 1.6 mmt -45.53 -22.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.845 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -71.95 -56.61 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.21 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -53.13 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 73.24 110.948 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.4 t80 -45.72 -48.2 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 73.12 110.953 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.606 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 33.8 t80 -58.51 -26.86 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 75.32 110.93 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -100.04 -2.78 33.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 75.32 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -40.09 52.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 74.54 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.424 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -55.41 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.21 111.082 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.35 24.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 62.43 112.496 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 49.2 31.98 3.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 72.43 110.912 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.606 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 5.2 m-80 -102.81 168.59 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 65.04 110.864 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.8 p -70.93 -21.97 62.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.827 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.437 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.08 2.03 29.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 74.31 110.902 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.424 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.57 -18.94 61.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.898 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 102.05 11.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 71.45 110.87 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 8.93 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 64.12 110.886 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.541 ' CE1' ' HE2' ' A' ' 62' ' ' MET . 3.5 m-30 -58.51 -68.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.844 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 81' ' ' THR . 8.4 t -171.93 178.06 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.45 110.875 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -65.8 -0.99 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 65.54 110.895 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.549 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 62.3 p -92.84 -52.1 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.13 111.143 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.86 106.37 13.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 71.4 111.09 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.9 t -150.64 177.98 9.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 72.14 111.162 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.03 149.85 49.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.947 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -133.77 168.55 18.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.32 111.156 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 87' ' ' THR . 14.4 m-20 -53.63 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.889 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.9 t -44.36 174.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.34 111.104 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.595 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 72.24 110.877 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -0.15 6.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.697 2.265 . . . . 74.44 112.303 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.9 t -52.04 106.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.14 110.834 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.65 -16.33 59.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.12 110.918 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.74 -115.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 64.01 112.472 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.34 69.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 62.04 111.108 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.37 102.03 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 52.22 110.886 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -99.97 137.95 37.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.903 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.26 146.52 32.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.637 0.732 . . . . 75.43 110.9 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.02 12.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 73.4 112.334 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.431 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 2.0 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.806 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.44 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 9.3 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.881 0.372 . . . . 73.13 110.898 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.2 m-90 -135.67 109.65 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 75.31 110.905 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.407 ' C ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -78.34 102.17 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.41 110.832 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.407 HG13 ' C ' ' A' ' 14' ' ' CYS . 2.7 m -155.66 152.43 24.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 73.12 111.131 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HG2' ' NZ ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.71 123.55 10.23 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.686 2.257 . . . . 72.04 112.336 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -51.98 122.42 22.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.551 0.691 . . . . 74.03 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 88.06 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 74.32 112.353 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.37 -20.79 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 60.21 112.497 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.443 HG11 ' N ' ' A' ' 21' ' ' SER . 11.0 t -63.62 158.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 75.14 111.133 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 24' ' ' GLN . 1.8 m -52.09 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 71.04 110.817 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 21' ' ' SER . 85.9 m-20 -33.5 -68.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 75.23 110.873 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.4 -39.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 73.15 110.86 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 25.4 tt0 -58.11 -51.3 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 73.01 110.938 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.602 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -70.96 -36.18 72.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 73.33 110.914 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.7 m -52.2 -15.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.162 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.98 -35.48 57.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 65.13 112.493 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -57.19 -68.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 75.32 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 73.6 mt -37.49 -47.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 72.42 111.121 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.42 -47.76 72.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 71.35 110.849 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -73.55 -56.1 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.942 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . . . -51.95 -35.7 46.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 73.12 111.102 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.5 t -56.39 -12.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.11 110.875 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.75 18.02 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.33 110.828 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -89.8 -52.82 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 72.35 110.899 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 165.19 -94.81 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 64.31 112.503 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -81.96 17.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 74.15 111.118 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -83.08 -59.95 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 64.52 110.902 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 122.31 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 71.5 110.902 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.14 -67.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 63.12 112.474 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 4.51 2.14 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.246 . . . . 73.11 112.339 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 57' ' ' HIS . 19.4 pt -82.77 17.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 72.21 111.112 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -84.48 125.15 72.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.623 0.725 . . . . 75.44 110.899 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.525 ' CB ' ' CD1' ' A' ' 49' ' ' PHE . 53.7 Cg_endo -69.74 154.58 67.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.668 2.245 . . . . 72.23 112.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.88 -40.08 1.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 62.35 112.495 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.47 -23.51 3.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.74 . . . . 72.3 112.494 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.06 -68.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 75.13 111.089 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -118.04 -11.28 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 73.22 110.873 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CD1' ' CB ' ' A' ' 44' ' ' PRO . 2.6 t80 -33.92 -52.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.897 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -99.57 127.97 32.73 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.623 0.725 . . . . 73.2 110.87 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.51 88.72 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 -1.806 . . . . 65.12 112.329 -0.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.98 152.75 24.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 63.15 110.891 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.5 p -106.69 172.38 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.22 111.153 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.21 -64.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.42 111.143 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.25 18.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.897 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.91 -38.9 52.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 51.4 111.054 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.559 ' CD2' HD13 ' A' ' 42' ' ' ILE . 60.2 m80 -54.08 -52.72 60.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.24 110.855 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.471 ' HB3' ' CE ' ' A' ' 62' ' ' MET . . . -57.27 -37.53 72.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 72.33 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.34 74.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 75.52 111.131 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 3.0 t80 -68.45 -57.96 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.891 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 1.8 p -54.57 -37.44 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 71.44 111.164 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.532 ' HE3' ' CE2' ' A' ' 78' ' ' PHE . 9.7 mtt -49.09 -20.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.22 110.912 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 44.9 t30 -69.16 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.02 110.896 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.93 -52.25 11.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 73.35 110.927 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.6 t80 -45.7 -49.55 14.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 74.11 110.87 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 2.8 t80 -58.42 -27.38 64.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.923 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.401 ' OE1' ' O ' ' A' ' 63' ' ' ASN . 29.0 mt-30 -101.11 -2.26 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.12 110.918 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -74.04 -41.43 61.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 73.01 110.864 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.15 -55.51 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 61.12 111.095 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.85 24.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.04 112.508 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 51.1 44.17 28.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 72.32 110.872 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.546 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.9 m-80 -109.89 172.44 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.4 110.913 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 84' ' ' LEU . 20.2 m -74.22 -24.78 59.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.908 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -79.67 2.0 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.91 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -73.78 -23.26 59.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.912 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.37 101.96 10.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 54.33 110.902 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.0 10.1 12.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.847 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' ' HE3' ' A' ' 62' ' ' MET . 3.0 m-30 -58.84 -68.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.84 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 t -172.0 178.01 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.4 110.836 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.51 -2.48 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.926 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.602 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 66.4 p -91.54 -50.57 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 73.31 111.149 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.71 102.09 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.108 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 t -148.81 178.01 9.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.43 111.11 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 73' ' ' SER . 44.5 mt -66.67 114.0 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 65.41 110.938 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -89.71 167.47 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 73.42 111.168 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.84 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 63.54 110.905 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.24 172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.55 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 9.5 t-20 -51.98 106.66 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 74.31 110.907 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.538 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.19 3.74 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.743 2.295 . . . . 73.04 112.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.411 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 23.0 t -52.03 106.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.783 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -17.04 61.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.01 110.941 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.44 -111.24 0.42 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.94 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 75.32 111.06 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.85 102.0 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 75.03 110.879 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -99.0 151.73 20.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 75.55 110.883 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.538 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.7 m-85 -92.35 154.07 42.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.669 0.747 . . . . 75.21 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 114.21 3.62 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 72.1 112.356 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.527 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 12.1 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 74.22 110.836 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.571 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.835 0.35 . . . . 71.21 110.846 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.5 m-90 -129.74 116.55 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 75.01 110.922 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.21 102.05 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.946 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -152.83 152.55 28.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 70.22 111.108 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 127.62 14.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.645 2.23 . . . . 73.14 112.327 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.06 118.15 11.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 74.25 110.939 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 92.12 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.673 2.248 . . . . 74.43 112.334 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.78 -26.78 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 74.51 112.488 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 t -59.0 168.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 72.14 111.174 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.5 OUTLIER -54.52 111.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 43.13 110.829 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' CG2' ' A' ' 54' ' ' VAL . 24.2 m-20 -38.94 -55.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 75.03 110.888 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.21 -33.98 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.846 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' SER . 6.6 tp60 -68.31 -46.48 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.34 110.868 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' CD2' ' O ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -70.01 -54.06 14.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.955 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 27' ' ' GLY . 16.8 m -41.14 -48.35 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.4 111.169 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' THR . . . -34.91 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 55.43 112.502 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 31' ' ' TYR . 10.3 m-20 -59.5 -64.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 72.43 110.909 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.532 HG23 ' CE1' ' A' ' 57' ' ' HIS . 72.7 mt -36.58 -41.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.33 111.163 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.59 -45.6 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' ASN . 3.4 t80 -73.55 -58.28 3.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.14 110.887 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.525 ' CB ' ' CG ' ' A' ' 38' ' ' ASP . . . -48.1 -50.05 29.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 71.32 111.072 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.79 -22.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 72.31 110.929 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -80.52 13.33 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 74.12 110.861 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.498 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -97.96 -45.79 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 75.11 110.942 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.9 -43.91 1.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 71.4 112.5 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -101.54 2.29 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.346 . . . . 70.35 111.129 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' CG ' ' CB ' ' A' ' 32' ' ' ALA . 1.4 m-20 -74.99 -70.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 74.15 110.823 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -80.4 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.41 110.862 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 42' ' ' ILE . . . 123.11 -68.78 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 74.32 112.466 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.61 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.71 6.97 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 74.05 112.36 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 57' ' ' HIS . 8.0 pt -82.14 17.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 74.41 111.136 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.25 121.69 85.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.628 0.728 . . . . 74.42 110.912 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -169.46 0.33 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 72.21 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.99 -28.74 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 73.54 112.5 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.08 -26.23 8.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 61.41 112.461 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.37 -68.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 72.5 111.138 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 13.8 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 73.4 110.843 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 10.9 t80 -47.88 -60.52 2.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.944 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 28.5 mt-10 -92.56 142.39 25.77 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.697 0.761 . . . . 74.41 110.844 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.75 146.86 83.35 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 -1.796 . . . . 73.11 112.332 -0.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -99.91 142.21 31.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 73.33 110.901 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -97.86 160.06 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 64.2 111.184 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.408 ' CG2' ' OD1' ' A' ' 22' ' ' ASP . 40.9 t -65.87 -56.43 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 74.15 111.156 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.48 17.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 72.21 110.937 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -49.64 -55.29 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.33 111.112 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.722 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -35.23 -51.34 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 71.23 110.873 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.722 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -63.97 -42.14 97.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 72.2 111.126 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.46 -49.54 77.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 70.13 111.076 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -54.21 -63.42 1.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 73.21 110.932 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 3.5 p -54.85 -35.63 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.55 111.159 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' A' ' 62' ' ' MET . 0.0 OUTLIER -44.92 -21.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.872 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 61' ' ' VAL . 33.0 t-20 -72.56 -44.25 62.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 75.25 110.942 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.71 -49.06 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 73.21 110.954 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.451 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.3 t80 -47.0 -46.26 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.937 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.9 t80 -57.14 -30.71 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.904 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -97.25 -5.14 37.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 72.31 110.911 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -40.96 62.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.847 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.51 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.38 -59.98 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.41 111.094 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.85 21.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.713 -0.756 . . . . 55.11 112.499 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 51.69 32.01 8.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 75.21 110.903 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.56 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.2 m-80 -105.55 167.1 9.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 72.3 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.8 p -68.73 -22.75 64.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 71.22 110.856 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.84 2.41 26.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.869 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.36 -16.89 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.44 110.894 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 0.8 OUTLIER -82.8 102.04 11.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 75.31 110.846 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -117.98 8.73 12.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.899 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' N ' ' HD1' ' A' ' 78' ' ' PHE . 3.4 m-30 -58.98 -69.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.858 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -172.01 177.99 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 73.0 110.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -2.56 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 72.25 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.4 p -91.62 -51.44 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 74.51 111.139 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.75 102.02 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.22 111.064 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 t -147.93 178.0 8.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.14 111.174 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.61 127.26 31.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 73.32 110.923 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -106.07 168.98 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.1 111.158 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 87' ' ' THR . 15.5 m120 -53.68 -168.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 74.33 110.894 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' ASN . 5.0 t -45.06 174.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 75.21 111.165 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.5 t-20 -51.99 107.24 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 75.45 110.882 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.75 0.89 4.97 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.714 2.276 . . . . 65.25 112.324 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.8 t -52.06 108.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 65.04 110.854 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -72.18 -16.44 61.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.909 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.407 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 174.41 -109.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 64.21 112.511 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.53 79.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 63.54 111.124 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 102.06 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.838 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 149.42 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 74.43 110.896 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.515 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -90.34 154.84 46.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 74.42 110.932 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.66 3.78 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 71.41 112.35 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.466 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 83.7 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.852 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 3.0 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.848 0.356 . . . . 74.42 110.843 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.573 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 3.8 m-90 -133.16 123.36 25.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 65.42 110.907 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.96 102.01 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 65.02 110.916 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.11 152.2 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 75.35 111.191 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD3' ' CE ' ' A' ' 62' ' ' MET . 54.1 Cg_endo -69.76 129.92 18.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.637 2.225 . . . . 74.44 112.39 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -52.0 120.94 17.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 74.4 110.879 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 80.7 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.668 2.245 . . . . 75.32 112.281 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.43 -27.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 74.21 112.516 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 21' ' ' SER . 19.7 t -59.15 164.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 65.24 111.158 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 31.3 m -55.7 114.83 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 63.11 110.885 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.52 -67.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 74.13 110.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -39.59 -42.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 61.1 110.896 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -48.7 80.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.12 110.941 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 81' ' ' THR . 0.5 OUTLIER -71.11 -27.9 63.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.88 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.6 m -60.77 -41.46 95.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 73.32 111.109 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.18 28.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 71.11 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -55.8 -44.94 78.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 64.02 110.823 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.52 HG22 ' CG ' ' A' ' 57' ' ' HIS . 90.4 mt -60.1 -64.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.01 111.093 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -37.6 -41.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 72.23 110.886 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 4.6 t80 -75.03 -68.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.33 110.946 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.483 ' N ' ' CD2' ' A' ' 31' ' ' TYR . . . -47.95 -19.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 71.22 111.107 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 4.4 t -70.52 1.59 4.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.55 110.914 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.36 17.9 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 71.52 110.862 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.451 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.72 -48.81 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.11 110.954 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.8 -61.47 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 73.24 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.459 ' CG1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.13 12.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 75.0 111.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -88.93 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.43 110.883 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -80.02 119.37 22.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 62.3 110.879 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.4 -68.84 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 72.25 112.46 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.628 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.1 Cg_endo -69.75 6.3 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.726 2.284 . . . . 74.14 112.316 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 38' ' ' ASP . 29.1 pt -82.06 17.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 72.12 111.107 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -73.94 124.6 90.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.711 . . . . 65.21 110.905 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.9 Cg_endo -69.75 -179.37 2.86 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.723 2.282 . . . . 75.44 112.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.02 -36.15 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 63.43 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.1 -27.18 5.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 75.32 112.483 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.18 -68.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 63.51 111.146 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.3 t -117.86 -5.78 11.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 64.05 110.918 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 52' ' ' ASN . 2.6 t80 -40.69 -53.07 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 72.55 110.861 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.74 130.32 28.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 70.12 110.94 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.8 151.83 91.88 Favored 'Cis proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 -1.793 . . . . 55.02 112.327 0.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 7.2 p-10 -101.69 144.32 30.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 72.45 110.907 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.9 p -94.97 160.3 14.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 72.04 111.143 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.14 -52.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 62.33 111.128 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.509 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.97 17.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.881 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.34 -56.43 11.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 73.01 111.131 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.746 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -35.55 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.53 110.818 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.746 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -65.01 -38.39 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 72.01 111.125 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.74 -53.96 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 72.02 111.101 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -54.49 -63.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 73.54 110.953 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 57' ' ' HIS . 1.6 p -53.73 -37.09 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.153 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.575 ' HE2' ' CE2' ' A' ' 78' ' ' PHE . 2.5 mtm -45.96 -21.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 71.2 110.888 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 10.3 t-20 -71.89 -54.53 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.54 110.866 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.459 HD13 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -79.0 -45.88 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.32 110.927 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.451 ' CE2' ' HG3' ' A' ' 35' ' ' GLN . 2.3 t80 -48.91 -49.63 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.883 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.6 t80 -55.32 -32.2 62.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 75.24 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -96.12 -4.91 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.883 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -74.79 -40.68 61.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 73.23 110.86 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.76 -61.57 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 63.15 111.135 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.94 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.677 -0.773 . . . . 75.21 112.484 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.94 33.3 11.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 75.31 110.94 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -106.57 167.71 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 63.41 110.878 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.482 ' CB ' HD13 ' A' ' 84' ' ' LEU . 75.4 p -69.09 -23.01 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.28 2.85 26.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 75.32 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.503 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.4 -24.37 60.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 73.05 110.881 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.95 102.0 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.2 110.901 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -118.0 11.36 13.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.3 110.848 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.575 ' CE2' ' HE2' ' A' ' 62' ' ' MET . 3.8 m-30 -57.75 -68.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 75.3 110.876 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.7 OUTLIER -171.9 178.01 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.04 110.872 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -65.61 -2.13 3.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 71.04 110.943 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.481 HG22 ' CD1' ' A' ' 25' ' ' LEU . 72.4 p -91.76 -51.77 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 63.45 111.107 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.72 107.42 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 71.44 111.146 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -152.49 177.99 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.126 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD13 ' CB ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -66.36 153.73 41.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.926 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -133.69 167.27 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 72.53 111.148 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' THR . 6.5 m120 -53.66 -168.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 73.34 110.86 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.24 174.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 73.12 111.168 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.0 t-20 -52.06 107.0 0.73 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.73 . . . . 73.5 110.895 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.51 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -0.6 7.12 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 75.21 112.369 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 5.3 t -52.0 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.827 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -79.71 -17.23 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.497 . . . . 75.41 110.914 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.421 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 177.58 -112.48 0.38 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 74.25 112.487 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.45 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 75.51 111.127 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.35 101.99 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 71.03 110.867 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.89 142.07 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.4 110.873 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.51 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.05 140.88 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.716 0.77 . . . . 74.05 110.896 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 132.05 22.43 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.635 2.224 . . . . 74.32 112.368 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 3.1 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 70.05 110.869 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.481 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 7.0 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.872 0.368 . . . . 73.34 110.839 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.573 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.1 m-90 -134.82 124.97 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 71.21 110.912 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.48 102.05 13.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 75.03 110.883 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -150.65 153.87 34.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 75.43 111.074 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.9 Cg_endo -69.74 126.3 13.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 72.35 112.376 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.08 113.42 4.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 65.34 110.868 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 79.59 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 74.01 112.351 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.14 61.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.792 -0.718 . . . . 63.1 112.487 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.466 HG23 ' CD1' ' A' ' 25' ' ' LEU . 1.7 m -157.56 178.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 72.32 111.122 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.9 m -52.04 114.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 75.05 110.827 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.56 -53.67 5.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 75.14 110.841 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -50.73 -30.09 13.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.12 110.899 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -51.35 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 71.23 110.939 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -71.42 -32.06 67.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 75.14 110.905 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 m -66.72 -1.0 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 62.34 111.121 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.29 -38.13 6.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.51 112.474 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 3.3 p30 -57.68 -56.39 22.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 72.33 110.894 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 40.6 mt -43.52 -45.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 74.23 111.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.96 -50.88 33.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.13 110.877 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -74.77 -52.43 11.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 72.5 110.906 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 35' ' ' GLN . . . -46.55 -57.15 5.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 64.02 111.108 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.41 -20.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.864 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -81.41 12.55 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 70.53 110.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -98.0 -47.16 5.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 71.31 110.901 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.38 -53.1 0.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 63.14 112.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 68' ' ' HIS . 1.2 pt -82.06 5.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 73.43 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.579 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 6.9 m-20 -87.64 -56.71 3.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 72.53 110.878 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.2 OUTLIER -78.29 120.03 22.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.33 110.88 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.19 -67.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.75 -0.738 . . . . 73.41 112.492 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.62 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.72 4.81 1.96 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.722 2.281 . . . . 62.33 112.367 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 57' ' ' HIS . 29.7 pt -82.41 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.44 111.112 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.29 125.73 90.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 74.2 110.913 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.78 7.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 75.11 112.344 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.37 -31.74 1.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 63.22 112.497 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.84 -31.91 5.17 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 61.44 112.499 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.61 -68.25 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 73.43 111.123 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.19 2.81 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 71.21 110.876 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.1 t80 -39.99 -58.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 74.45 110.914 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.57 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mm-40 -98.24 131.45 26.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 64.23 110.866 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.67 148.98 87.63 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 -1.795 . . . . 72.24 112.368 -0.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.98 134.27 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.4 110.9 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.426 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 43.3 p -79.92 155.57 27.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.3 111.152 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.07 -53.58 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 75.42 111.136 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.61 18.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.849 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.4 -55.25 11.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.45 111.105 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.766 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -33.75 -53.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 73.04 110.869 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.766 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -66.23 -38.88 88.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.3 111.118 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.11 -42.45 94.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 73.33 111.086 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.1 t80 -66.32 -60.48 2.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.886 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.507 ' CG1' ' OD1' ' A' ' 38' ' ' ASP . 2.1 p -54.11 -34.77 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 75.55 111.086 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.561 ' HE1' ' CZ ' ' A' ' 78' ' ' PHE . 1.2 mmt -45.77 -25.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 65.25 110.885 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 19.0 t-20 -65.6 -63.56 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.848 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -72.5 -53.18 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 74.4 110.961 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.448 ' HB2' ' CG2' ' A' ' 61' ' ' VAL . 2.2 t80 -39.22 -57.5 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 62.4 110.914 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.583 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 16.7 t80 -50.45 -38.1 41.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.481 . . . . 64.12 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.428 ' HA ' ' CG ' ' A' ' 71' ' ' ARG . 9.0 mt-30 -92.27 -4.22 54.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 75.1 110.929 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.492 ' CD2' HD11 ' A' ' 37' ' ' ILE . 2.3 t60 -74.88 -41.94 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 73.44 110.844 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.506 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.67 -63.17 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.34 111.099 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.03 18.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 72.25 112.538 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' CG ' ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.94 35.7 16.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 75.32 110.891 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.2 m-80 -107.31 167.84 9.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.953 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.476 ' CB ' HD11 ' A' ' 84' ' ' LEU . 72.1 p -68.98 -24.25 64.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 73.04 110.846 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -81.1 2.17 28.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 75.41 110.907 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.506 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -23.52 59.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.14 110.892 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.14 102.03 10.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 75.31 110.864 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.03 11.31 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.55 110.845 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.561 ' CZ ' ' HE1' ' A' ' 62' ' ' MET . 3.9 m-30 -57.96 -68.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.835 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -172.13 177.99 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 75.11 110.833 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -65.53 -1.61 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 72.02 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.416 ' H ' ' C ' ' A' ' 79' ' ' SER . 69.8 p -92.79 -53.16 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 75.04 111.112 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.95 103.43 11.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.35 111.05 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 t -148.45 178.02 8.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 70.02 111.096 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.481 ' CD2' ' HB3' ' A' ' 12' ' ' SER . 1.3 mt -66.69 152.4 45.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 70.01 110.872 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -133.75 167.32 20.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 87' ' ' THR . 61.8 m-80 -53.53 -168.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.867 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 86' ' ' ASN . 7.2 t -45.23 175.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.2 111.155 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.8 t-20 -51.98 108.26 1.03 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 74.31 110.911 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.74 -2.89 10.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.709 2.273 . . . . 65.53 112.368 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 t -52.0 106.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.854 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -73.15 -15.85 61.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.915 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.2 -111.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 72.4 112.499 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.44 -31.56 67.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 53.54 111.101 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 102.04 7.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 71.01 110.859 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.3 139.84 34.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.911 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.4 m-85 -85.84 157.63 57.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 71.41 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.81 106.26 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.647 2.231 . . . . 64.41 112.32 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.498 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 74.3 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 63.14 110.866 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.882 0.372 . . . . 73.32 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 5.7 m-90 -129.29 122.64 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.915 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' C ' HG11 ' A' ' 15' ' ' VAL . 1.1 t -95.47 107.56 19.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 73.43 110.897 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 3.9 m -152.64 154.81 32.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 74.55 111.136 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.74 131.37 21.13 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.701 2.267 . . . . 75.4 112.339 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 110.77 2.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.575 0.702 . . . . 74.23 110.929 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 96.79 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.252 . . . . 75.2 112.352 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.15 -32.31 2.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 53.52 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.495 ' CG1' HD23 ' A' ' 25' ' ' LEU . 3.6 p -58.67 -178.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.344 . . . . 74.34 111.127 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.49 ' H ' ' CG2' ' A' ' 20' ' ' VAL . 3.2 m -52.05 113.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 64.24 110.881 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.409 ' HA ' HD22 ' A' ' 25' ' ' LEU . 29.6 m-20 -58.22 -56.71 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.904 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.4 -15.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 72.52 110.906 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.31 -46.21 16.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 74.53 110.892 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -70.41 -50.23 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 65.21 110.906 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.442 HG21 ' N ' ' A' ' 27' ' ' GLY . 12.3 t -36.89 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.32 111.16 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . -66.34 -44.93 89.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.7 -0.762 . . . . 54.3 112.488 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' LEU . 14.5 m-20 -41.87 -48.82 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 75.42 110.883 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 57' ' ' HIS . 82.1 mt -55.63 -42.46 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 75.34 111.133 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.32 -46.05 80.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 70.32 110.886 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.15 -61.5 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.93 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.06 -46.87 53.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 74.42 111.083 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 40.4 t -50.33 -17.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 74.33 110.866 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -93.03 17.96 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.817 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -96.98 -48.95 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.935 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.7 -63.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 63.22 112.445 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.472 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.36 4.66 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 72.24 111.164 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 2.3 m-20 -78.08 -68.2 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 75.15 110.869 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.15 129.02 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.34 110.876 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 42' ' ' ILE . . . 122.57 -72.69 0.39 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 73.33 112.496 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.75 8.29 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.675 2.25 . . . . 71.22 112.364 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.474 HD13 ' HB2' ' A' ' 57' ' ' HIS . 29.8 pt -82.12 17.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 63.11 111.106 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -76.06 125.27 88.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.559 0.695 . . . . 75.12 110.91 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 161.62 45.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.24 . . . . 72.54 112.327 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.4 -40.62 1.47 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 70.42 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.71 17.34 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 74.32 112.535 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.79 -68.42 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.356 . . . . 71.11 111.099 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -117.89 11.67 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.898 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.551 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 13.0 t80 -55.32 -52.42 63.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.41 110.881 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.551 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 83.1 mt-10 -98.31 129.17 31.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.696 0.76 . . . . 61.34 110.869 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.79 153.48 93.04 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 -1.81 . . . . 64.4 112.361 -0.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -99.41 141.55 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 55.31 110.85 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.482 ' CG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -98.19 158.38 15.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 70.45 111.138 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.76 -55.17 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 74.4 111.146 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.07 18.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.903 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.9 -58.08 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 71.33 111.114 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.623 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -33.8 -48.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 62.22 110.842 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.623 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -64.53 -46.19 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 73.21 111.106 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -56.28 -46.96 79.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 74.42 111.093 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.6 t80 -59.77 -64.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 71.52 110.92 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 5.7 p -54.52 -36.21 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 75.31 111.116 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.476 ' CE ' ' SG ' ' A' ' 76' ' ' CYS . 8.6 mtp -45.49 -21.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.859 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -71.85 -52.36 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 75.3 110.84 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.472 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -81.14 -45.13 16.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 73.43 110.943 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.3 t80 -50.79 -45.93 59.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.882 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 19.3 t80 -58.9 -32.2 69.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 72.12 110.929 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -95.95 -4.92 42.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.902 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -73.42 -41.81 62.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.13 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.512 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.19 -60.73 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.117 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.15 22.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.694 -0.765 . . . . 75.34 112.457 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.03 36.42 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 73.24 110.857 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.564 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.5 m-80 -108.81 165.55 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 74.22 110.842 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -68.34 -22.67 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 74.53 110.841 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.471 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -80.78 2.16 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 73.25 110.902 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.512 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -23.69 59.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 71.05 110.867 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' CE ' ' A' ' 62' ' ' MET . 4.1 m -82.48 102.01 11.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.887 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.03 12.89 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.868 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 62' ' ' MET . 4.2 m-30 -58.8 -68.26 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -171.73 177.99 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 61.4 110.86 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -1.94 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 75.14 110.921 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.464 ' CB ' HD11 ' A' ' 25' ' ' LEU . 68.2 p -92.01 -52.03 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 73.23 111.145 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB1' ' CE ' ' A' ' 62' ' ' MET . . . -82.51 101.98 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 72.14 111.087 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -148.86 178.08 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 75.14 111.156 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mp -66.89 154.15 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.45 110.871 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -133.92 169.22 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 72.12 111.169 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.06 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 65.34 110.892 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.47 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.02 111.16 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.58 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.5 t-20 -52.04 106.55 0.67 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 74.53 110.855 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.0 Cg_endo -69.76 0.59 5.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.641 2.228 . . . . 73.51 112.357 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.428 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.01 108.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 74.44 110.86 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 1.3 p90 -80.99 -16.29 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 74.31 110.963 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.26 -119.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.54 112.444 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.63 71.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 70.23 111.118 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.2 m -78.77 101.95 7.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 75.52 110.892 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -98.79 136.56 38.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.51 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.532 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.8 m-85 -85.27 147.22 46.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.72 . . . . 74.42 110.888 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 135.77 31.42 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 73.12 112.335 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.466 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 10.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.878 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.855 0.36 . . . . 75.45 110.854 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.8 m-90 -125.41 118.37 25.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 73.25 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -94.06 102.05 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 63.31 110.879 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.9 153.34 31.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 73.33 111.095 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HA ' ' C ' ' A' ' 81' ' ' THR . 53.5 Cg_endo -69.82 127.94 15.26 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.655 2.236 . . . . 71.43 112.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -51.96 114.71 5.65 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.583 0.706 . . . . 75.44 110.952 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.76 15.3 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 73.11 112.371 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -131.65 62.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.709 -0.758 . . . . 61.04 112.499 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' A' ' 25' ' ' LEU . 2.2 m -158.49 178.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 75.51 111.077 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 m -55.84 127.45 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.826 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.55 -49.4 67.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 73.32 110.833 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -28.03 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.4 110.839 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.03 -49.57 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.905 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HB3' ' CG ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -71.05 -41.33 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 72.33 110.917 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 m -46.29 -43.39 15.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 72.35 111.131 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.62 -29.57 25.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 71.44 112.513 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -59.97 -68.15 0.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 52.05 110.946 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.52 HG23 ' CG ' ' A' ' 57' ' ' HIS . 97.2 mt -40.9 -68.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 74.41 111.123 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 29' ' ' ILE . 5.6 t30 -34.1 -44.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.838 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -75.72 -68.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.03 110.932 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -45.18 -21.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 73.41 111.082 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.96 5.16 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.01 110.876 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -110.04 15.2 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.3 110.857 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.2 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 73.04 110.866 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.19 -55.78 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 72.14 112.46 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -82.21 9.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 74.14 111.141 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.574 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 1.6 m-20 -88.1 -63.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 74.52 110.868 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 114.93 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 63.13 110.88 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 42' ' ' ILE . . . 130.77 -69.67 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 61.0 112.485 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.614 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.8 7.5 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 74.44 112.313 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 57' ' ' HIS . 29.3 pt -82.22 16.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 71.4 111.145 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -73.62 123.74 89.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 61.13 110.932 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 171.25 14.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.719 2.28 . . . . 73.42 112.316 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.83 -33.89 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 72.41 112.485 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.09 5.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 63.32 112.498 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -68.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 73.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.87 2.18 18.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 72.22 110.9 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.487 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 6.1 t80 -40.99 -60.07 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.41 110.877 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.14 134.12 22.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.731 . . . . 73.35 110.905 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.71 150.67 90.38 Favored 'Cis proline' 0 C--N 1.341 0.145 0 C-N-CA 122.7 -1.792 . . . . 62.32 112.313 -0.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -100.47 122.22 42.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.68 157.48 20.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 74.43 111.146 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.92 -49.33 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.23 111.105 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.28 18.07 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.882 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.43 -54.18 23.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 75.33 111.076 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.716 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -37.25 -50.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.21 110.861 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -65.3 -39.48 92.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 65.23 111.098 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.09 -55.85 29.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.105 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.3 t80 -52.6 -62.35 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.22 110.919 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 65' ' ' TYR . 1.5 p -54.38 -37.44 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 75.34 111.137 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.574 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -45.71 -21.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.05 110.875 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -71.37 -52.08 20.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 72.33 110.923 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.432 HD13 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -83.53 -46.39 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.34 110.899 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 2.2 t80 -46.33 -45.29 17.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.947 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CE1' ' O ' ' A' ' 72' ' ' ASN . 58.7 t80 -60.45 -34.91 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 73.13 110.939 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -93.07 -4.22 52.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 64.35 110.96 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.449 ' CE1' HG21 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -70.83 -44.58 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 60.42 110.833 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.453 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.6 -59.53 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 74.21 111.064 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.79 24.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 74.42 112.466 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.01 32.43 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 74.45 110.846 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.627 ' O ' ' CE1' ' A' ' 66' ' ' TYR . 5.9 m-80 -100.71 163.63 12.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.4 110.891 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.474 ' CB ' HD13 ' A' ' 84' ' ' LEU . 83.8 p -67.55 -21.87 65.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.42 110.885 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.489 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.71 3.5 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.875 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.453 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -76.53 -26.71 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 73.04 110.873 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.417 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 93.1 m -82.4 102.01 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 74.52 110.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -118.01 11.05 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.904 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.574 ' CZ ' ' HE3' ' A' ' 62' ' ' MET . 3.9 m-30 -57.72 -68.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 75.05 110.917 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -171.75 178.0 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.53 110.851 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -2.06 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 73.25 110.907 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.472 HG22 ' CD1' ' A' ' 25' ' ' LEU . 67.2 p -91.88 -53.58 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 64.31 111.104 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.49 102.01 11.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.34 111.107 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.3 t -152.88 178.03 10.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.21 111.141 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' CB ' ' A' ' 73' ' ' SER . 18.8 mt -65.8 123.69 20.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 73.01 110.949 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -106.17 168.63 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.05 111.132 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.8 m120 -53.88 -167.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 75.02 110.895 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.7 t -45.06 175.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 71.44 111.125 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.589 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.2 t-20 -51.95 107.09 0.75 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.701 . . . . 71.2 110.9 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.78 3.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 73.14 112.35 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.42 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 19.8 t -52.04 109.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.824 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -70.36 -16.86 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 74.21 110.967 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 175.16 -110.54 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 63.23 112.474 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.81 73.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 73.11 111.085 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.32 104.66 14.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 72.11 110.886 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -98.64 149.86 22.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 73.44 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.512 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.4 m-85 -90.71 159.87 39.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.652 0.739 . . . . 74.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 104.35 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.261 . . . . 61.52 112.334 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.578 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 40.6 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 72.23 110.89 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 58.1 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.837 0.351 . . . . 72.51 110.84 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 10.9 m-90 -145.56 113.24 6.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 75.12 110.932 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.439 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -83.64 108.45 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.896 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.517 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.4 m -158.63 153.99 22.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 73.22 111.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.51 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.77 122.85 9.52 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.707 2.272 . . . . 63.41 112.36 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 116.97 8.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 74.53 110.927 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 86.85 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 65.25 112.324 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 -27.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 70.41 112.487 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.03 170.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 74.33 111.12 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.97 118.37 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 53.24 110.826 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -42.98 -66.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 71.21 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -41.23 -40.62 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 75.22 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.01 -50.4 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 70.14 110.904 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' CD2' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -71.31 -31.17 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.947 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.2 m -64.66 -30.03 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 75.23 111.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.72 -23.3 70.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 71.13 112.466 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 57.5 m-20 -63.83 -58.64 6.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 72.24 110.912 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 95.9 mt -47.14 -47.86 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.11 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -51.65 -44.24 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.865 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.12 -56.56 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.881 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -47.85 -43.84 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 74.52 111.089 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -28.31 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.41 110.891 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -81.46 15.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.597 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.95 -46.8 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.932 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -62.43 0.64 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 61.3 112.512 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.46 ' CG1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -83.07 11.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.43 111.094 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.476 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 1.6 t70 -86.98 -56.6 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.897 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.431 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.3 m -74.85 120.59 20.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 74.33 110.873 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.33 -69.44 0.43 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 75.53 112.477 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.81 1.28 4.61 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 74.53 112.337 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.576 HD12 ' CD2' ' A' ' 57' ' ' HIS . 33.3 pt -83.2 18.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.109 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -86.75 135.69 35.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.638 0.733 . . . . 73.42 110.907 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 174.12 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.281 . . . . 73.34 112.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.09 -33.73 0.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 73.24 112.463 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.18 -21.4 6.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 72.52 112.478 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.44 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 75.14 111.078 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.2 m -117.91 -2.27 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.4 110.914 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.3 t80 -36.42 -51.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.867 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 19.1 mm-40 -99.72 129.56 28.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.59 0.71 . . . . 64.53 110.901 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.77 147.85 85.51 Favored 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.69 -1.796 . . . . 71.33 112.366 0.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 6.4 p30 -104.17 133.4 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 72.44 110.934 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.51 166.4 12.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.131 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.35 -56.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 74.45 111.095 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.51 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -80.08 14.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 75.14 110.877 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.38 53.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 73.42 111.109 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.576 ' CD2' HD12 ' A' ' 42' ' ' ILE . 64.8 m80 -51.95 -52.3 51.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.54 110.864 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.02 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.35 111.108 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.73 68.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.12 111.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -68.38 -64.71 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 70.43 110.927 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 7.1 p -55.5 -33.7 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 73.25 111.136 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.57 ' HE1' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -45.85 -27.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 65.32 110.843 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -66.16 -60.51 2.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 63.4 110.835 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -71.4 -47.85 53.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.932 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.597 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 3.0 t80 -45.55 -48.24 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.955 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.4 t80 -62.37 -31.89 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 71.23 110.943 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.64 -4.64 44.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.29 -42.89 68.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 70.53 110.869 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.45 -60.61 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 71.42 111.098 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.19 23.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 72.24 112.494 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.541 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 7.7 mtp180 52.07 43.18 30.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 74.44 110.856 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.3 m-80 -109.19 166.95 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 74.11 110.941 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 p -71.15 -24.93 62.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 51.43 110.819 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -78.52 -1.1 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 74.3 110.907 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.82 -22.07 59.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 72.55 110.879 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -82.78 102.05 11.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.51 110.855 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -117.98 6.88 12.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 73.34 110.868 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' HE1' ' A' ' 62' ' ' MET . 3.3 m-30 -58.96 -71.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.89 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.16 178.01 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.807 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -2.78 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 71.41 110.904 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.494 ' HG1' ' N ' ' A' ' 82' ' ' ALA . 29.1 p -97.99 -46.68 5.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 75.35 111.148 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.517 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -80.97 24.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 72.31 111.062 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -84.47 -178.18 6.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 62.15 111.141 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 12' ' ' SER . 1.6 mt -66.89 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.906 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -106.2 169.06 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.02 111.164 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 87' ' ' THR . 13.1 m-80 -53.25 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 71.35 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.08 173.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 75.14 111.159 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 6.6 t-20 -52.07 106.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 74.11 110.889 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.72 -13.21 34.44 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 65.44 112.378 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -52.06 105.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 65.53 110.847 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -16.7 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.31 110.908 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.56 -115.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 71.21 112.504 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.27 86.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 71.11 111.082 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 101.99 5.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.918 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.57 139.18 36.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.01 110.892 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.574 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 20.0 m-85 -93.01 141.18 23.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 74.12 110.879 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 129.02 16.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 74.31 112.331 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.556 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 36.8 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.52 110.898 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.49 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 3.7 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.854 0.359 . . . . 73.32 110.867 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.561 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 9.2 m-90 -142.85 115.16 8.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 72.23 110.893 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.441 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.79 108.62 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 62.11 110.885 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.519 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.2 m -158.56 154.16 22.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 72.52 111.124 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.52 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.78 120.75 7.48 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 75.05 112.334 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.01 117.7 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.617 0.722 . . . . 74.34 110.877 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.723 2.282 . . . . 73.11 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.06 -21.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 65.55 112.409 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 17' ' ' LYS . 2.3 t -59.07 164.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 70.04 111.155 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 24' ' ' GLN . 2.0 m -53.63 111.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 75.35 110.854 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.7 m-20 -33.78 -64.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 61.13 110.884 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.24 -40.73 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.871 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.4 tp-100 -58.33 -50.44 73.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 70.02 110.896 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.559 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.9 -29.28 65.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 74.04 110.901 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -66.53 -0.24 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.11 111.168 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.92 -38.5 5.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 62.3 112.498 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.4 p30 -53.6 -43.1 68.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 62.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 64.1 mt -59.11 -46.94 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -44.31 38.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 63.53 110.884 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.7 -49.03 27.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 64.22 110.92 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -51.7 -45.13 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 73.3 111.093 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.443 ' CA ' ' OD2' ' A' ' 38' ' ' ASP . 9.0 t -57.44 -12.16 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.863 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.13 6.69 47.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 64.02 110.831 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.468 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.96 -43.09 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.957 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.96 -47.09 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 64.23 112.428 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 pt -89.74 8.21 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 73.31 111.132 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.483 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 9.3 t70 -86.87 -61.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 70.43 110.871 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 m -75.95 124.62 27.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.812 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.28 -74.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 64.1 112.433 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 4.14 2.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 74.11 112.325 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.537 HD12 ' CG ' ' A' ' 57' ' ' HIS . 5.9 pt -82.93 17.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 74.34 111.111 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -79.16 144.33 62.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.608 0.718 . . . . 64.15 110.891 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.2 Cg_endo -69.74 148.13 64.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 74.33 112.388 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.64 -39.28 3.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 72.43 112.5 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.69 15.18 2.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.74 . . . . 72.24 112.52 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.89 -68.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 75.32 111.149 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' PHE . 21.1 t -117.93 -6.73 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 72.13 110.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 3.0 t80 -34.34 -56.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.878 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 9.7 mm-40 -99.6 125.84 39.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 61.25 110.913 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.82 150.71 90.73 Favored 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 -1.813 . . . . 72.32 112.337 0.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.47 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -111.29 133.52 53.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 72.23 110.852 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.81 176.63 6.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 64.42 111.098 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.32 -54.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.12 111.114 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.71 17.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 75.11 110.862 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.28 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 73.15 111.101 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.537 ' CG ' HD12 ' A' ' 42' ' ' ILE . 26.8 m170 -57.25 -57.77 11.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 73.2 110.893 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -50.02 -36.52 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 74.04 111.086 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.31 92.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.1 111.059 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 5.7 t80 -68.01 -59.09 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 75.14 110.904 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 58' ' ' ALA . 7.5 p -55.1 -35.97 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 111.152 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.564 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 0.3 OUTLIER -46.46 -29.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.892 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.38 -65.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.935 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -47.87 74.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 73.25 110.902 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.468 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 2.2 t80 -49.71 -47.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.929 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.1 t80 -60.6 -30.62 69.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.41 110.882 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -98.87 3.34 47.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.881 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.535 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -75.41 -48.8 21.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.878 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.535 ' N ' ' CG ' ' A' ' 68' ' ' HIS . . . -70.16 -54.55 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.24 111.065 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.67 26.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 71.11 112.489 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.97 47.96 23.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 72.41 110.847 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.563 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 4.1 m-80 -114.19 162.07 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.928 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.5 p -67.96 -24.43 65.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 74.4 110.818 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -80.04 1.19 28.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 75.4 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -19.79 55.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.35 110.919 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -83.54 102.08 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 72.11 110.833 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.04 7.56 12.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.898 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.564 ' CE2' ' HG2' ' A' ' 62' ' ' MET . 3.3 m-30 -59.27 -71.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 75.23 110.913 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -173.71 177.97 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.883 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -65.5 -1.99 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 72.45 110.931 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.559 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 26.9 p -97.92 -47.48 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 62.54 111.157 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.519 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -81.03 26.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 63.24 111.088 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.6 t -86.75 -177.83 6.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 63.33 111.158 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 mt -67.04 130.51 43.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.442 . . . . 70.51 110.899 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.5 t -106.02 169.51 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 75.02 111.139 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.0 m120 -53.15 -169.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 71.32 110.883 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.5 t -44.66 172.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 61.13 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.561 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 15.7 t-20 -52.09 106.79 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.662 0.744 . . . . 75.21 110.869 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.74 -3.7 12.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 73.44 112.353 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 1.9 t -52.02 104.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 75.11 110.889 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -17.83 25.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.899 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.08 -117.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 63.55 112.519 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.8 -26.79 65.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 72.33 111.07 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 t -76.13 102.02 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 63.02 110.87 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.77 127.94 45.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.525 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 25.6 m-85 -92.45 141.15 24.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 72.31 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.24 25.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.688 2.259 . . . . 75.53 112.361 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.3 110.859 -179.845 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.656 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.892 0.377 . . . . 71.43 110.856 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.656 ' CE3' ' C ' ' A' ' 12' ' ' SER . 8.6 m-90 -153.4 112.2 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.908 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -79.41 110.76 15.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.44 110.927 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.491 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 5.6 m -159.96 155.88 22.92 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.668 0.747 . . . . 75.55 111.078 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.77 122.9 9.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 74.44 112.331 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -52.02 114.53 5.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.525 0.678 . . . . 73.32 110.918 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 99.89 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 74.01 112.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.63 -28.28 2.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 72.53 112.474 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.431 ' CG2' ' H ' ' A' ' 21' ' ' SER . 5.8 p -58.89 173.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 52.44 111.155 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -52.0 109.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.45 110.853 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.77 -68.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.12 110.861 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -41.22 -27.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.894 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 21' ' ' SER . 6.1 tm0? -63.99 -51.49 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 73.3 110.915 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' CD1' HG23 ' A' ' 81' ' ' THR . 0.2 OUTLIER -70.24 -33.41 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 73.31 110.915 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 m -51.01 -18.84 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 74.2 111.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.97 -27.65 49.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 75.41 112.493 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 78.7 m-20 -59.81 -46.51 88.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 75.41 110.917 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 54' ' ' VAL . 65.2 mt -62.96 -53.24 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 75.11 111.117 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -52.43 -47.21 66.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.873 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -69.37 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.69 -33.36 33.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.081 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.8 t -57.27 -11.3 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 64.02 110.859 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 17.99 14.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 71.04 110.863 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.433 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -90.84 -51.83 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 73.14 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 168.02 -97.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 75.43 112.471 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.99 18.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 75.41 111.121 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -75.09 -62.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.89 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.37 126.14 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.83 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.13 -70.06 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.467 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' CG ' ' O ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.81 6.0 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.683 2.255 . . . . 65.02 112.325 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 57' ' ' HIS . 22.6 pt -82.63 18.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.01 111.135 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -79.89 129.51 70.31 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 74.33 110.922 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 170.1 17.46 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.678 2.252 . . . . 75.0 112.299 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.6 -41.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 61.44 112.48 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.35 -17.49 5.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 61.15 112.505 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.14 -68.64 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 72.21 111.132 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.05 6.29 12.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.3 110.859 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.551 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 3.7 t80 -40.87 -68.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.04 110.885 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.551 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -93.24 137.74 23.45 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.617 0.722 . . . . 73.11 110.913 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.2 Cg_endo -69.75 139.87 57.18 Favored 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.712 -1.786 . . . . 74.25 112.317 -0.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.73 133.66 52.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.437 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -86.93 174.24 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.479 . . . . 74.13 111.129 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 29' ' ' ILE . 56.4 t -65.76 -55.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 64.45 111.162 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.619 ' HZ2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -78.42 13.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 75.04 110.904 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' N ' ' HZ2' ' A' ' 55' ' ' LYS . . . -51.15 -48.89 61.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 73.11 111.112 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.585 ' CD2' HD12 ' A' ' 42' ' ' ILE . 65.5 m80 -49.04 -48.13 44.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 74.34 110.847 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB3' ' CE ' ' A' ' 62' ' ' MET . . . -57.66 -38.06 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.3 111.116 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' N ' ' HE1' ' A' ' 62' ' ' MET . . . -55.97 -37.54 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 41.13 111.119 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 3.4 t80 -68.53 -59.14 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.905 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 2.0 p -54.71 -39.19 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 73.22 111.125 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.563 ' HE3' ' CE2' ' A' ' 78' ' ' PHE . 5.0 mtm -45.96 -32.62 2.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 74.54 110.858 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 62.34 110.862 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -63.69 -59.5 4.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.911 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.436 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 4.4 t80 -39.65 -43.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.901 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.0 t80 -61.15 -41.34 96.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 63.44 110.927 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' LEU . 29.2 mt-30 -91.62 -3.82 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 64.21 110.931 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.3 t60 -75.26 -40.68 58.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 74.24 110.89 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -75.76 -60.6 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.52 111.081 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.62 20.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 72.51 112.51 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 51.96 33.91 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 73.44 110.887 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.9 m-80 -102.98 167.24 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.897 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -71.26 -24.3 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 74.2 110.858 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.436 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -78.19 0.52 24.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 75.13 110.927 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.499 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -6.17 45.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 75.24 110.925 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -94.28 102.21 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.32 110.85 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.03 5.29 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 71.31 110.819 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.563 ' CE2' ' HE3' ' A' ' 62' ' ' MET . 3.0 m-30 -59.31 -71.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 70.1 110.879 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.37 177.99 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 75.11 110.86 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.37 -2.84 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.51 110.936 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.506 ' HG1' ' N ' ' A' ' 82' ' ' ALA . 27.5 p -98.04 -47.25 5.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.14 111.103 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' N ' ' HG1' ' A' ' 81' ' ' THR . . . -81.44 24.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 64.03 111.06 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 t -85.05 -177.29 6.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 70.44 111.173 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.86 125.28 25.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 75.2 110.875 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.7 t -98.01 169.39 9.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 73.14 111.161 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 85' ' ' THR . 51.8 m-80 -52.95 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.901 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 1.6 t -44.39 170.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 63.04 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.566 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.3 t-20 -52.01 106.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.643 0.735 . . . . 73.45 110.902 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -3.09 11.28 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 73.53 112.323 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.632 ' HG ' ' ND2' ' A' ' 95' ' ' ASN . 3.5 t -51.97 107.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.45 110.857 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -17.88 45.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 75.42 110.913 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.56 -113.59 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 72.51 112.471 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.18 -38.16 90.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 65.24 111.103 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 101.99 5.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 74.35 110.905 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.632 ' ND2' ' HG ' ' A' ' 90' ' ' SER . 0.4 OUTLIER -99.51 144.97 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 60.31 110.906 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 8.6 m-85 -92.45 150.35 39.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.657 0.741 . . . . 74.01 110.924 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 115.97 4.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 72.21 112.333 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.562 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 8.5 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 53.03 110.876 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.571 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.885 0.374 . . . . 73.32 110.836 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.571 ' CE3' ' C ' ' A' ' 12' ' ' SER . 7.6 m-90 -146.7 105.24 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 74.52 110.929 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.435 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -72.28 105.34 4.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 53.43 110.867 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.505 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.2 m -158.77 153.62 21.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 75.11 111.098 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.76 120.27 7.08 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 50.25 112.371 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.0 119.37 14.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 75.24 110.904 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 85.3 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.725 2.283 . . . . 71.44 112.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.42 -22.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 70.44 112.457 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.4 t -65.81 164.13 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 73.15 111.123 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 22' ' ' ASP . 5.4 m -54.0 103.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 63.2 110.88 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 21' ' ' SER . 34.8 m-20 -34.06 -65.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 74.03 110.876 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . 35.2 m-20 -36.21 -41.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 73.31 110.895 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -62.62 -46.91 86.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.911 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.492 HD12 ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -70.27 -33.54 71.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.3 110.93 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 m -56.6 -35.0 67.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.54 111.145 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.9 -26.63 67.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 73.1 112.509 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -63.46 -43.2 98.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 73.43 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 24.9 mt -62.38 -51.63 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.01 111.102 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -54.07 -45.41 71.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.42 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -68.95 -58.07 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 75.44 110.895 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -49.94 -47.03 52.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 75.31 111.127 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.456 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -50.77 -17.43 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.863 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -88.0 13.58 10.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.897 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.45 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.03 -46.06 6.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 72.0 110.918 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 136.53 -55.57 0.7 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.714 -0.755 . . . . 71.53 112.457 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -88.13 4.1 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 64.1 111.135 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 1.9 m-20 -80.6 -58.98 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 75.51 110.857 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -75.37 127.31 32.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 75.25 110.874 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.17 -73.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 43.15 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.602 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.8 3.61 2.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.686 2.257 . . . . 73.14 112.336 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.581 HD11 ' CD2' ' A' ' 57' ' ' HIS . 12.7 pt -83.1 17.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 72.53 111.08 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.52 135.54 53.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 64.42 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 176.56 6.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.695 2.263 . . . . 72.33 112.381 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.95 -35.43 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 71.44 112.466 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.1 -25.86 9.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 61.21 112.471 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.78 -68.14 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 65.34 111.108 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.09 -8.96 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.22 110.866 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -37.49 -48.44 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.52 110.842 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.32 126.97 37.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 74.52 110.858 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.72 148.26 86.26 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 -1.789 . . . . 63.13 112.335 -0.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 8.7 t-20 -103.14 150.63 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 53.03 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.9 p -106.46 163.82 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 72.13 111.119 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.8 -56.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 73.3 111.122 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -80.49 16.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 73.41 110.864 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.24 -47.89 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.0 111.127 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.581 ' CD2' HD11 ' A' ' 42' ' ' ILE . 68.2 m80 -45.34 -58.97 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.84 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.431 ' O ' ' CG ' ' A' ' 62' ' ' MET . . . -51.46 -38.81 55.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.44 111.096 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.42 72.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.2 111.111 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.602 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 9.4 t80 -68.13 -63.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.04 110.923 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.495 ' CG1' ' OD1' ' A' ' 38' ' ' ASP . 7.4 p -55.12 -33.56 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 73.13 111.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.57 ' HE3' ' CD1' ' A' ' 78' ' ' PHE . 1.3 mmt -46.13 -29.66 1.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.885 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.37 -65.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.1 110.858 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -51.03 62.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 64.53 110.901 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 35' ' ' GLN . 2.8 t80 -44.64 -43.71 8.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 74.03 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 3.7 t80 -64.08 -30.71 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.33 110.936 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -98.21 -2.33 39.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.928 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -72.99 -48.18 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.85 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' N ' ' CG ' ' A' ' 68' ' ' HIS . . . -68.82 -57.06 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 73.43 111.136 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.7 24.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 75.13 112.482 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 52.0 35.61 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 74.24 110.839 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -103.14 166.3 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 54.04 110.846 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -71.3 -23.24 61.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 65.53 110.81 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.44 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -79.29 0.26 29.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.468 . . . . 74.34 110.936 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.463 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -23.19 59.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.3 110.891 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -84.11 102.11 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.846 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -118.08 8.44 12.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.828 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CD1' ' HE3' ' A' ' 62' ' ' MET . 3.5 m-30 -59.46 -70.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.876 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.75 177.98 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.13 110.803 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -65.33 -2.35 3.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 71.4 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.492 ' CG2' HD12 ' A' ' 25' ' ' LEU . 29.0 p -97.96 -46.46 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.13 111.17 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -81.66 25.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 75.21 111.077 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 t -86.56 -177.6 6.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 75.04 111.18 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.89 106.9 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.915 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -77.98 167.55 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 70.53 111.152 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 17.2 m-20 -53.27 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 75.21 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.65 173.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 74.4 111.099 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.558 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 21.5 t-20 -52.0 106.0 0.6 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.647 0.737 . . . . 62.14 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.2 Cg_endo -69.74 -23.03 31.33 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.272 . . . . 70.3 112.298 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.1 t -52.0 106.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 72.32 110.832 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -80.03 -15.3 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.917 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.01 -124.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 74.33 112.474 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -37.86 -43.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 73.45 111.088 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 62.22 110.852 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.84 133.83 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.12 110.907 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.521 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 23.8 m-85 -92.71 146.48 32.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.678 0.751 . . . . 74.5 110.869 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 117.13 4.89 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.674 2.249 . . . . 71.45 112.345 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.557 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 91.9 p . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 71.32 110.87 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.665 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 58.8 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.856 0.36 . . . . 71.5 110.836 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.665 ' CE3' ' C ' ' A' ' 12' ' ' SER . 9.2 m-90 -152.8 123.19 7.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.3 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.48 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -90.7 111.72 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.12 110.886 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 14' ' ' CYS . 4.2 m -160.09 154.89 20.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 72.24 111.133 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -69.75 125.59 12.33 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.717 2.278 . . . . 71.55 112.35 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 110.13 1.73 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.512 0.672 . . . . 71.3 110.882 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 97.58 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 74.31 112.29 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.83 -33.73 2.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 54.23 112.483 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.429 ' CG2' ' H ' ' A' ' 21' ' ' SER . 2.8 p -58.98 178.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 73.1 111.136 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.429 ' H ' ' CG2' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -52.0 128.46 24.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 73.21 110.838 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 24' ' ' GLN . 72.9 m-20 -58.26 -67.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.854 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.454 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 1.1 m-20 -41.81 -23.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.834 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 22' ' ' ASP . 1.0 OUTLIER -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 73.04 110.904 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' CG ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -70.89 -56.67 5.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.898 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.454 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 12.0 t -44.9 -20.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 72.32 111.108 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 25' ' ' LEU . . . -69.15 -37.93 82.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 73.2 112.48 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.88 -56.24 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.782 0.325 . . . . 74.51 110.916 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 23.4 mt -46.44 -41.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 63.44 111.128 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -56.66 -48.08 78.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.13 -56.18 5.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.1 110.967 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -51.05 -43.47 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 75.22 111.099 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 37.4 t -52.75 -15.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.51 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.32 15.87 16.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 60.02 110.886 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -97.98 -48.04 5.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 74.22 110.922 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.73 -64.14 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.748 . . . . 54.44 112.486 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 ' CD1' HD13 ' A' ' 64' ' ' LEU . 3.4 pt -82.3 14.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 71.35 111.121 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.463 ' OD1' ' CB ' ' A' ' 32' ' ' ALA . 3.2 m-20 -89.5 -65.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.846 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 m -76.08 124.49 27.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.858 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.45 -74.58 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 73.32 112.499 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.5 Cg_endo -69.78 5.73 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 71.01 112.322 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.583 HD11 ' CD2' ' A' ' 57' ' ' HIS . 5.1 pt -85.23 17.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 70.02 111.105 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -76.69 135.49 68.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.722 . . . . 75.41 110.93 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 170.66 16.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.625 2.216 . . . . 74.1 112.318 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.78 -38.83 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.444 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.57 -26.16 4.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 74.23 112.434 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.83 -68.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 63.42 111.093 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.96 14.43 14.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.897 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 3.1 t80 -56.48 -50.9 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.24 110.899 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -97.52 128.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.699 0.762 . . . . 74.44 110.853 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 150.84 90.87 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.68 -1.8 . . . . 74.54 112.37 -0.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 4.1 t30 -99.74 131.62 45.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.33 110.86 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.424 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 65.7 p -90.9 167.31 12.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 75.02 111.193 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.2 -59.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 71.4 111.141 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' CG ' ' HG3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.49 17.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 63.44 110.929 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.55 -41.12 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.4 111.043 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.583 ' CD2' HD11 ' A' ' 42' ' ' ILE . 47.2 m80 -54.76 -55.26 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 74.14 110.874 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -50.57 -41.93 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.15 111.106 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.43 -40.23 77.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 74.43 111.101 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 6.3 t80 -68.92 -57.0 6.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 73.33 110.972 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.479 ' CG1' ' HA ' ' A' ' 58' ' ' ALA . 3.3 p -54.39 -43.79 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 72.32 111.134 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.462 ' CE ' ' HD3' ' A' ' 16' ' ' PRO . 2.8 ttm -45.76 -29.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 75.4 110.863 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.502 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 32.8 t30 -59.3 -62.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.54 110.855 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.58 -46.22 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.93 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 3.4 t80 -47.43 -54.59 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.599 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.0 t80 -55.59 -30.55 61.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 74.12 110.905 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 49.4 mt-30 -95.41 -4.51 45.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 73.41 110.895 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -68.4 -44.14 75.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.494 ' N ' ' CG ' ' A' ' 68' ' ' HIS . . . -76.42 -60.23 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.52 111.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.82 23.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 33.12 112.475 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.563 ' C ' ' CE1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.02 37.24 20.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 75.23 110.858 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.599 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 2.4 m-80 -100.97 164.76 11.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.23 110.913 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 p -68.38 -25.57 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.15 110.825 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -79.55 1.78 24.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.951 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.46 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -79.92 -3.93 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.868 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -101.57 102.01 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 63.33 110.888 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -117.96 9.54 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.32 110.904 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -58.33 -70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -173.78 178.01 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 62.23 110.868 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -3.07 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 74.42 110.937 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.503 ' HG1' ' N ' ' A' ' 82' ' ' ALA . 26.5 p -97.95 -49.01 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 55.14 111.146 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.503 ' N ' ' HG1' ' A' ' 81' ' ' THR . . . -81.73 25.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.139 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -86.3 -178.5 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.33 111.16 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.9 mm? -66.91 130.89 44.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 73.42 110.899 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.05 167.85 9.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 73.02 111.149 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.9 m-20 -53.71 -168.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 71.31 110.878 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -44.53 171.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 75.43 111.163 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 13.6 t-20 -51.95 105.94 0.59 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.33 110.878 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.79 -1.27 8.21 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 72.44 112.347 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.456 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 4.9 t -51.98 110.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 72.44 110.874 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -86.98 -18.06 31.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 65.02 110.918 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.44 -120.72 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 64.43 112.452 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 74.14 111.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.98 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.35 110.854 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.03 140.32 33.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.891 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.5 m-85 -92.11 146.03 31.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 74.43 110.865 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 122.83 9.49 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 74.2 112.37 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.419 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 25.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 74.42 110.866 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.651 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 2.7 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.833 0.349 . . . . 73.4 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.651 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 6.4 m-90 -141.07 114.14 8.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.916 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.0 110.67 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 74.2 110.861 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.499 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 m -159.59 154.34 21.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.626 0.727 . . . . 75.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.507 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 54.1 Cg_endo -69.8 123.28 9.94 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 73.43 112.326 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.98 114.3 5.18 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 74.42 110.871 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 92.37 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.715 2.277 . . . . 72.14 112.37 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.74 -24.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 53.32 112.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 21' ' ' SER . 44.3 t -59.05 165.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 74.14 111.142 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 24' ' ' GLN . 3.2 m -52.08 108.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.45 110.877 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 21' ' ' SER . 5.5 m-20 -32.99 -65.27 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 70.43 110.853 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.02 -40.68 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.905 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -60.26 -49.17 78.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 73.25 110.907 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.22 -29.04 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 61.52 110.945 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.413 ' OG1' ' CG1' ' A' ' 54' ' ' VAL . 17.3 m -67.11 0.07 2.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 73.52 111.166 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -90.92 -40.34 5.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 75.41 112.506 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.3 p30 -50.47 -44.3 55.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.367 . . . . 75.21 110.883 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.506 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 61.6 mt -58.21 -49.05 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.142 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.19 -41.07 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.9 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.15 -52.68 11.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.35 110.967 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . . . -52.82 -41.6 64.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 70.3 111.099 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.42 -9.69 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 70.22 110.9 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.19 3.89 40.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.848 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.18 -36.48 6.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.923 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 -31.18 7.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 74.03 112.506 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.503 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -83.22 -11.41 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 74.43 111.168 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.498 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.65 -63.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 75.23 110.876 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 62.9 m -75.83 129.57 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 64.11 110.834 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.7 -85.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 54.31 112.51 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 7.02 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.242 . . . . 74.34 112.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.536 HD13 ' CG ' ' A' ' 57' ' ' HIS . 5.1 pt -82.62 17.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.54 111.16 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -79.53 132.85 60.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.601 0.715 . . . . 70.15 110.916 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 171.52 14.33 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.686 2.258 . . . . 64.42 112.323 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 72.24 112.492 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.36 -25.72 3.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.35 112.449 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.41 -68.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 75.21 111.12 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.95 14.88 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 65.44 110.907 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 2.9 t80 -51.66 -56.55 13.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 73.14 110.847 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 1.3 mm-40 -96.41 133.18 25.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 65.45 110.879 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 157.04 92.57 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.705 -1.79 . . . . 75.4 112.33 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -117.24 142.22 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 73.12 110.912 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.0 p -106.84 172.82 6.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.118 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.413 ' CG1' ' OG1' ' A' ' 26' ' ' THR . 43.9 t -65.73 -54.73 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.153 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -79.7 17.23 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.893 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.3 -45.44 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.34 111.115 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.536 ' CG ' HD13 ' A' ' 42' ' ' ILE . 32.9 m170 -53.79 -60.18 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 71.55 110.843 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HB3' ' CE ' ' A' ' 62' ' ' MET . . . -43.97 -47.21 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 70.3 111.1 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' N ' ' HE3' ' A' ' 62' ' ' MET . . . -50.89 -38.35 49.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 75.14 111.134 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 8.9 t80 -69.33 -65.01 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.947 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.469 ' CG2' HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -54.42 -26.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 75.02 111.127 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.473 ' CE ' ' HB3' ' A' ' 58' ' ' ALA . 1.5 mtm -52.26 -20.38 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.889 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.07 -65.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 74.4 110.877 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.46 HD11 ' CD1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -63.74 -41.77 97.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.4 110.908 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 3.4 t80 -58.51 -45.11 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.916 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 4.6 t80 -65.21 -30.43 71.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.41 110.926 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -96.21 -3.71 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 73.34 110.949 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -45.74 74.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.23 110.83 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.82 -57.75 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.071 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.11 25.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 71.4 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.545 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.04 47.09 25.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 72.01 110.897 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.6 m-80 -110.27 165.6 11.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.886 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.4 p -70.74 -25.84 63.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 65.21 110.841 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -77.74 0.3 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.946 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -14.42 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 75.53 110.886 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -91.39 102.03 14.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.24 110.864 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.06 7.75 12.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.43 110.877 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.468 ' HB3' ' CB ' ' A' ' 28' ' ' ASN . 3.3 m-30 -59.03 -70.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.853 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.85 178.03 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 75.54 110.884 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -1.84 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.33 110.908 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.58 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 37.3 p -95.0 -50.33 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.22 111.147 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -80.66 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 71.4 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 81' ' ' THR . 12.3 t -87.01 -179.52 6.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 75.22 111.148 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' A' ' 12' ' ' SER . 2.5 mt -67.36 131.51 45.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.938 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.08 168.43 9.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.129 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.25 -169.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 65.13 110.867 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -44.22 172.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 74.33 111.127 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.4 t-20 -52.01 106.78 0.7 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 74.11 110.89 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.52 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.7 -4.03 13.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.678 2.252 . . . . 74.15 112.34 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 2.5 t -51.98 110.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 65.25 110.838 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -15.69 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 72.41 110.921 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.89 -128.92 1.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 62.1 112.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.59 65.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 74.52 111.142 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.49 101.98 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.902 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -99.75 141.29 32.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 75.45 110.939 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.52 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 15.9 m-85 -93.14 147.76 34.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 75.3 110.896 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.4 4.08 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 72.24 112.289 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.448 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 27.9 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 75.31 110.878 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.662 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 70.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 75.22 110.825 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.662 ' CE3' ' C ' ' A' ' 12' ' ' SER . 7.2 m-90 -152.94 107.06 3.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.956 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -72.87 105.59 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 65.23 110.853 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.539 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.8 m -158.88 154.82 23.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.647 0.736 . . . . 74.51 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.508 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.78 118.43 5.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 72.14 112.329 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.98 110.16 1.74 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.714 . . . . 75.52 110.89 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 79.65 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.705 2.27 . . . . 71.43 112.356 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.41 58.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 41.01 112.484 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -158.26 177.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 65.34 111.105 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 2.4 m -51.97 116.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 71.55 110.878 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -40.94 -66.22 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.887 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.33 -27.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.824 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' SER . 21.8 tt0 -63.54 -52.45 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.908 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB3' ' CG ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -71.65 -51.14 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 64.42 110.903 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.41 ' OG1' ' CG1' ' A' ' 54' ' ' VAL . 25.7 m -45.5 -43.86 12.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 72.11 111.144 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.4 -30.49 2.05 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 75.25 112.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -64.37 -66.68 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 73.41 110.876 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 37.1 mt -38.21 -49.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.1 111.178 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.442 ' OD1' ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -52.14 -44.84 64.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.03 110.873 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -74.05 -54.6 7.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 74.54 110.937 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -51.57 -38.89 56.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 64.41 111.088 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -12.66 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.874 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -115.2 18.04 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.844 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 1.8 mm100 -93.02 -52.02 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.918 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 161.72 -91.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 71.22 112.482 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' C ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.55 17.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 70.42 111.132 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -85.41 -60.68 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.869 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.88 110.06 8.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 75.3 110.924 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 42' ' ' ILE . . . 138.65 -70.99 0.46 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 63.42 112.486 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.558 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.75 8.1 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.691 2.26 . . . . 74.41 112.309 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.572 HD13 ' CD2' ' A' ' 57' ' ' HIS . 20.2 pt -82.32 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 73.31 111.142 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -82.85 122.56 78.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 71.22 110.926 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 168.53 21.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 71.43 112.303 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.56 -35.45 1.08 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 51.33 112.503 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.57 -19.42 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 64.34 112.519 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 -68.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 74.21 111.089 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -117.98 12.75 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 75.21 110.914 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.524 ' CE1' ' CB ' ' A' ' 52' ' ' ASN . 2.1 t80 -56.97 -47.37 80.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.42 110.863 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.57 129.12 33.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.652 0.739 . . . . 74.24 110.909 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.76 150.54 90.33 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 -1.8 . . . . 61.3 112.367 0.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.524 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -114.5 118.2 33.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.936 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.82 170.18 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 72.41 111.156 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' OG1' ' A' ' 26' ' ' THR . 50.3 t -64.4 -52.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.23 111.134 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.73 13.63 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 65.31 110.873 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' VAL . . . -50.99 -43.06 60.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.35 111.098 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.572 ' CD2' HD13 ' A' ' 42' ' ' ILE . 61.8 m80 -55.2 -46.97 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 72.32 110.834 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.53 79.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 73.11 111.098 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.34 80.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 74.22 111.12 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.558 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -68.74 -61.19 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 74.12 110.915 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -54.79 -45.36 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 75.11 111.145 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -46.07 -21.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.876 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -69.41 -59.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.51 110.906 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -47.18 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 72.12 110.938 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t80 -46.52 -40.11 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.929 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 6.3 t80 -60.47 -31.07 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 72.31 110.956 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -96.3 -4.32 42.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.35 110.888 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -50.4 45.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.43 110.863 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.01 -57.84 5.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 65.34 111.09 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.14 25.09 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 73.45 112.501 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.01 35.82 17.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 74.15 110.888 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.476 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.2 m-80 -102.84 169.69 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.9 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.5 p -71.72 -22.49 61.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.35 110.83 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.66 0.82 32.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 74.11 110.892 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -73.71 -10.28 59.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 72.02 110.906 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -90.66 103.33 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.917 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -118.03 2.23 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 72.25 110.879 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 62' ' ' MET . 2.8 m-85 -58.94 -71.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.53 110.924 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.35 177.97 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 63.23 110.895 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -65.41 -2.48 3.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.54 110.922 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.489 ' HG1' ' N ' ' A' ' 82' ' ' ALA . 30.1 p -98.02 -48.43 5.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 64.35 111.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.539 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -80.42 23.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.21 111.137 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 81' ' ' THR . 7.4 t -84.98 -176.69 6.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 70.33 111.209 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.21 107.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 74.45 110.901 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -78.14 168.97 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.35 111.147 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' THR . 75.3 m-20 -53.54 -168.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 65.25 110.907 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 10.2 t -44.46 171.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 71.13 111.145 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.01 106.27 0.63 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.636 0.732 . . . . 73.24 110.872 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.72 -1.6 8.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.701 2.268 . . . . 75.04 112.385 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -52.01 108.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.901 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 4.1 p90 -82.82 -18.14 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.914 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 -114.48 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 65.21 112.5 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -36.92 85.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 73.35 111.049 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -79.41 101.98 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.91 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.08 147.82 25.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 65.24 110.908 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.54 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -93.1 156.41 40.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 75.34 110.904 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 125.95 12.69 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.262 . . . . 74.11 112.291 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.457 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 1.2 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.51 110.843 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.879 0.371 . . . . 71.14 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -148.4 132.31 8.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.613 0.72 . . . . 75.23 111.13 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 118.54 5.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.646 2.231 . . . . 74.54 112.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -110.39 141.59 24.27 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.63 0.728 . . . . 73.41 111.131 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.67 20.82 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.652 2.234 . . . . 64.22 112.381 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -121.23 141.9 34.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.566 0.698 . . . . 70.01 111.139 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -163.69 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 72.32 112.351 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -109.01 131.02 55.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.35 110.859 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.6 158.72 30.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.114 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.66 154.13 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 70.02 111.098 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.97 -64.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 71.41 112.487 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.589 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -152.21 158.22 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.847 0.356 . . . . 54.03 110.876 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CE3' ' C ' ' A' ' 12' ' ' SER . 2.5 m-90 -138.08 120.86 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 74.4 110.93 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.81 102.09 14.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 63.01 110.871 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.99 152.43 26.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 73.41 111.166 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 127.78 15.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.664 2.243 . . . . 74.45 112.329 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -52.02 118.23 11.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 73.13 110.911 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 73.3 112.312 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.28 -25.61 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.748 . . . . 74.32 112.461 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HB ' ' CD1' ' A' ' 25' ' ' LEU . 13.2 t -59.1 166.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 74.11 111.104 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 24' ' ' GLN . 2.3 m -56.44 113.19 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.42 110.811 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 21' ' ' SER . 24.3 m-20 -36.57 -59.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 65.44 110.898 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -36.43 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.891 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -63.72 -48.51 76.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.458 . . . . 74.13 110.899 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.587 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.5 OUTLIER -70.98 -30.46 66.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.35 110.877 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.8 m -55.8 -30.24 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 63.4 111.14 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.13 58.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 62.11 112.532 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 4.6 m-20 -64.14 -68.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.328 . . . . 73.32 110.901 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 84.9 mt -43.82 -43.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 74.13 111.117 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -46.99 83.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 74.45 110.886 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 1.2 t80 -73.95 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 75.21 110.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' N ' ' CD2' ' A' ' 31' ' ' TYR . . . -51.15 -43.19 61.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 74.3 111.097 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 35.5 t -53.37 -14.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 65.21 110.939 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.87 14.5 19.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.901 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -46.48 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 72.42 110.94 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.65 -62.41 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 73.3 112.493 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.32 5.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 73.42 111.159 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' OD1' ' CB ' ' A' ' 32' ' ' ALA . 6.0 m-20 -82.86 -63.81 1.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 53.14 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.11 126.19 30.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 71.1 110.901 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.85 -70.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 73.24 112.471 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.616 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.82 4.85 1.98 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.694 2.263 . . . . 71.03 112.319 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.528 HD12 ' CG ' ' A' ' 57' ' ' HIS . 27.3 pt -83.35 18.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 75.33 111.113 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -74.12 129.28 84.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 74.22 110.92 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 161.24 46.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 72.1 112.352 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.87 -35.33 2.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 63.01 112.435 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.13 -26.1 5.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 75.45 112.487 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.1 -68.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 73.13 111.12 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' A' ' 49' ' ' PHE . 28.8 m -118.07 -4.36 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.45 110.866 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.7 t80 -34.28 -54.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.13 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.467 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.33 124.76 41.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 71.15 110.909 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.15 88.13 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 -1.811 . . . . 74.01 112.345 0.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.43 ' CA ' ' O ' ' A' ' 49' ' ' PHE . 13.7 p-10 -106.03 127.08 52.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.882 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.1 p -83.5 166.8 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 60.23 111.16 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.8 -57.84 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.41 111.123 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -78.97 13.94 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.923 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.3 -48.42 62.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.23 111.084 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.528 ' CG ' HD12 ' A' ' 42' ' ' ILE . 34.7 m170 -50.33 -50.41 51.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 73.31 110.828 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' A' ' 62' ' ' MET . . . -56.66 -37.55 70.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.22 111.106 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.34 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 71.15 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 6.8 t80 -68.27 -63.11 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 70.13 110.951 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.405 ' O ' HG22 ' A' ' 61' ' ' VAL . 2.6 p -54.82 -33.39 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 75.34 111.147 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.457 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 1.5 mmt -45.54 -24.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 72.52 110.862 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 99' ' ' GLY . 8.4 t30 -68.87 -58.15 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 71.51 110.905 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.86 -50.73 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.933 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.43 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.4 t80 -46.3 -50.02 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.03 110.936 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.553 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 31.4 t80 -53.53 -36.78 62.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 73.22 110.939 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -94.09 -2.68 52.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.5 110.91 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.55 -42.62 58.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.15 110.879 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.502 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.48 -60.9 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 53.34 111.098 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.02 19.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 53.31 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.98 32.08 9.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 73.13 110.866 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.553 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 1.9 m-80 -104.75 166.38 10.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 64.32 110.857 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' CA ' HD13 ' A' ' 84' ' ' LEU . 57.8 p -68.06 -23.15 64.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 72.24 110.852 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.13 2.23 28.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.914 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -13.45 61.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 63.4 110.911 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.73 101.98 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 71.25 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 8.6 m-20 -118.0 7.63 12.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.868 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.411 ' CE2' ' HG2' ' A' ' 62' ' ' MET . 3.3 m-30 -59.08 -68.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.04 110.907 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -171.91 178.04 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 71.44 110.87 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -1.94 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.587 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 72.2 p -93.17 -52.52 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 72.44 111.132 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.43 102.01 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.55 111.132 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -148.94 178.06 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.117 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.428 HD13 ' CA ' ' A' ' 73' ' ' SER . 6.2 mp -66.32 126.75 29.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.947 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -106.38 169.36 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 74.13 111.121 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' THR . 33.4 m-80 -54.06 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 61.13 110.921 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -45.13 175.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 74.43 111.185 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 5.8 t-20 -51.97 105.96 0.59 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.626 0.727 . . . . 74.45 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.482 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.4 Cg_endo -69.79 -16.44 37.42 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.254 . . . . 74.44 112.31 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.403 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 29.8 t -51.97 110.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.848 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -77.2 -15.71 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 75.52 110.932 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 168.65 -122.43 1.02 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.748 -0.739 . . . . 71.24 112.501 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -40.09 -42.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 63.41 111.045 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.64 102.26 7.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 74.31 110.859 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.0 130.85 45.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 75.12 110.921 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.482 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 20.8 m-85 -83.93 144.38 44.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.659 0.742 . . . . 71.04 110.886 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 120.34 7.14 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.236 . . . . 71.41 112.369 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.476 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 52.6 p -110.23 2.96 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.54 110.828 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.47 ' O ' ' ND2' ' A' ' 63' ' ' ASN . . . 124.75 -43.42 1.39 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 71.33 112.513 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 m -77.84 141.15 39.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 61.35 110.862 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.871 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.837 0.351 . . . . 64.14 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.7 p -146.42 150.48 40.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 73.12 111.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 136.66 33.42 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.716 2.277 . . . . 75.23 112.29 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.2 p -138.41 143.46 38.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.583 0.706 . . . . 72.4 111.129 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 133.95 26.7 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 65.1 112.342 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.8 p -105.95 148.78 37.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.539 0.685 . . . . 64.21 111.137 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -173.83 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 74.14 112.349 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 115.74 14.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 72.12 110.905 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.38 166.41 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 63.52 111.12 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 163.55 7.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.13 111.125 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.634 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 58.66 105.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.749 . . . . 53.25 112.494 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.63 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.6 OUTLIER -157.95 125.87 5.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 73.1 110.852 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.634 ' CZ3' ' C ' ' A' ' 11' ' ' GLY . 1.6 m-90 -134.29 111.69 10.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.118 -0.492 . . . . 74.12 110.93 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -82.42 101.99 11.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.86 152.42 26.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 72.33 111.124 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 129.17 17.15 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 75.54 112.355 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 115.93 7.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 74.34 110.883 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 54.2 Cg_endo -69.72 84.49 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 72.43 112.371 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.74 -25.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.745 -0.741 . . . . 61.33 112.457 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.1 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 75.13 111.073 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 24' ' ' GLN . 14.8 m -52.06 109.2 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.31 110.836 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 21' ' ' SER . 42.8 m-20 -33.87 -64.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 72.23 110.878 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.34 -40.53 2.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 72.43 110.883 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.9 tp60 -58.13 -51.38 69.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 73.45 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.48 ' CD1' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.68 -27.04 62.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 75.5 110.877 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.41 ' OG1' ' CG1' ' A' ' 54' ' ' VAL . 11.0 m -62.89 -6.88 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 73.44 111.14 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -25.8 45.21 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 72.41 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.39 -67.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 71.14 110.879 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 80.7 mt -39.21 -44.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 72.15 111.112 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.52 -47.6 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.24 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.53 -58.12 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.889 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.89 -41.16 61.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 72.23 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 13.3 t -56.84 -9.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 71.04 110.851 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.05 18.0 19.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 32' ' ' ALA . 4.9 mm100 -94.46 -50.57 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.916 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.83 -81.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 72.31 112.446 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -81.6 17.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 74.34 111.128 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -89.44 -61.13 1.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 75.43 110.872 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -74.47 124.58 26.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.41 110.892 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.19 -69.77 0.42 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 65.54 112.512 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.666 2.244 . . . . 74.11 112.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.567 HD12 ' CD2' ' A' ' 57' ' ' HIS . 21.6 pt -82.53 17.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.1 111.117 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.75 138.65 62.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 75.23 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.489 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.74 145.9 58.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 71.52 112.336 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.3 -29.94 4.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 74.31 112.463 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.15 -13.1 7.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 54.45 112.536 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 -68.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 74.42 111.114 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 m -118.05 11.11 13.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.55 110.914 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.563 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 1.5 t80 -54.92 -57.39 11.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 75.31 110.909 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.563 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -100.53 127.09 33.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 74.2 110.887 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.73 153.92 93.04 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 -1.797 . . . . 71.1 112.367 -0.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -101.58 119.31 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.31 110.877 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.5 p -83.19 171.43 13.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 74.45 111.163 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' OG1' ' A' ' 26' ' ' THR . 69.1 t -65.84 -61.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 74.14 111.125 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.55 16.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 75.31 110.911 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.47 -47.5 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.52 111.106 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.567 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.8 m80 -50.15 -50.25 49.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.831 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.93 -33.14 68.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 74.43 111.109 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.14 86.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.083 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.589 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -68.32 -60.65 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.35 110.961 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -55.26 -34.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 73.51 111.152 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.567 ' HE3' ' CD1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -50.67 -29.99 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.846 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -65.38 -67.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 74.42 110.893 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.82 -53.35 41.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.908 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 3.3 t80 -46.94 -45.79 20.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.3 110.907 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 35.6 t80 -58.76 -26.41 63.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 72.4 110.9 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.469 ' NE2' ' HA2' ' A' ' 99' ' ' GLY . 41.9 mt-30 -103.29 -1.89 28.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 74.02 110.921 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -70.17 -42.19 72.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 73.01 110.852 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.63 -56.09 4.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 75.42 111.121 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.42 24.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 73.51 112.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 52.04 46.57 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 74.32 110.85 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -112.71 168.23 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.52 110.902 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HB2' ' CD1' ' A' ' 84' ' ' LEU . 73.2 p -71.2 -24.59 62.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 73.12 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -78.87 1.35 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 74.43 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -73.68 -22.47 59.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.888 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.407 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.3 m -82.31 102.0 10.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.906 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.0 8.81 12.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 72.54 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.567 ' CD1' ' HE3' ' A' ' 62' ' ' MET . 3.5 m-30 -58.54 -68.67 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.867 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 81' ' ' THR . 3.3 t -172.07 178.01 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.819 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -65.7 -1.52 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 73.21 110.939 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.48 HG22 ' CD1' ' A' ' 25' ' ' LEU . 64.9 p -92.91 -52.62 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 53.42 111.157 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.34 102.33 11.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 74.33 111.092 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 t -148.78 178.01 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 73.42 111.162 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.474 ' CD1' ' HB2' ' A' ' 73' ' ' SER . 0.9 OUTLIER -66.65 112.06 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 71.43 110.958 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -89.23 168.18 12.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 71.23 111.107 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' THR . 72.1 m-20 -54.39 -167.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 73.44 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.6 t -44.46 173.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 65.35 111.138 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.588 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.8 t-20 -52.11 106.92 0.72 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 71.4 110.86 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.518 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.73 -2.77 10.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 73.35 112.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.7 t -51.99 105.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.887 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -74.6 -16.39 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 73.05 110.931 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.08 -113.25 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 51.21 112.52 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.31 79.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 72.21 111.08 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 70.13 110.876 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -99.36 140.16 33.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 74.24 110.894 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.518 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.07 151.14 40.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 74.52 110.841 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.623 2.215 . . . . 64.32 112.371 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.473 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 6.0 p -113.35 -0.18 14.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 73.34 110.842 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.469 ' HA2' ' NE2' ' A' ' 67' ' ' GLN . . . 39.77 42.98 2.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 53.51 112.503 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.08 168.15 11.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 73.33 110.863 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 74.11 110.889 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.872 0.367 . . . . 73.53 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.478 ' CG2' ' HD2' ' A' ' 3' ' ' PRO . 4.9 m -95.87 136.44 22.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.6 0.714 . . . . 74.44 111.175 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 2' ' ' THR . 53.9 Cg_endo -69.77 99.14 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.707 2.272 . . . . 73.22 112.35 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -74.8 149.72 85.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.574 0.702 . . . . 75.11 111.147 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 154.75 67.34 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.662 2.242 . . . . 72.24 112.367 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.6 p -70.56 148.47 95.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 75.22 111.104 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -168.93 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 74.42 112.317 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -101.76 118.67 37.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.4 110.908 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.4 111.71 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 75.23 111.11 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.08 171.67 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 72.32 111.121 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . -80.12 142.75 24.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 62.03 112.522 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -153.55 126.43 8.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 73.22 110.891 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.4 m-90 -125.98 116.52 21.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 74.04 110.926 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.7 OUTLIER -89.92 106.24 18.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 70.42 110.859 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG12 ' C ' ' A' ' 14' ' ' CYS . 2.4 m -155.4 152.43 24.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.585 0.707 . . . . 74.42 111.133 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 Cg_endo -69.75 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 73.34 112.336 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -51.97 113.55 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.601 0.715 . . . . 73.44 110.903 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 79.93 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.732 2.288 . . . . 73.42 112.325 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -26.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 71.43 112.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 25' ' ' LEU . 3.3 t -58.96 167.73 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.24 111.131 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 24' ' ' GLN . 3.6 m -53.89 111.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 64.11 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 21' ' ' SER . 23.1 m-20 -34.96 -61.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.888 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.28 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.889 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.1 tp60 -60.34 -50.25 74.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.4 110.919 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.598 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.93 -23.78 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 71.12 110.88 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 m -66.35 0.08 2.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 74.3 111.134 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -93.43 -35.64 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 73.32 112.517 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 7.9 p30 -55.15 -45.37 75.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 74.01 110.916 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 63.6 mt -59.24 -59.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 72.44 111.162 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -44.63 -40.0 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 71.32 110.93 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -73.94 -60.7 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 71.32 110.905 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -52.17 -26.46 11.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 60.23 111.083 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.59 1.65 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.887 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.15 9.39 32.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 73.15 110.851 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.03 -44.63 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 64.1 110.857 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.6 -51.95 0.84 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 74.35 112.482 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.44 ' O ' ' CG ' ' A' ' 41' ' ' PRO . 2.5 pt -82.18 8.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 75.12 111.12 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 1.1 t70 -89.1 -60.71 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.886 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.62 119.01 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 63.35 110.857 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.22 -67.86 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 50.53 112.474 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -69.72 -1.05 7.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 72.44 112.377 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.569 HD11 ' CD2' ' A' ' 57' ' ' HIS . 17.4 pt -82.87 14.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -76.75 126.54 85.72 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.637 0.732 . . . . 75.31 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.67 10.61 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 74.33 112.337 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.29 -38.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.773 -0.727 . . . . 61.34 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.92 -34.36 2.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 75.32 112.465 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.06 -68.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 74.01 111.078 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.98 15.76 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 75.15 110.876 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 50' ' ' GLU . 2.5 t80 -51.85 -66.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.837 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.1 136.66 35.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.749 . . . . 72.44 110.853 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.73 146.13 81.25 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 -1.799 . . . . 73.53 112.385 -0.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.418 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 3.1 p30 -104.8 134.04 48.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 p -95.12 169.11 10.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 64.13 111.128 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.18 -56.98 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 74.23 111.093 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -78.67 13.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.42 110.931 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.64 -46.96 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.12 111.104 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.569 ' CD2' HD11 ' A' ' 42' ' ' ILE . 38.9 m80 -50.46 -59.67 3.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 75.54 110.83 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -47.75 -38.01 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 73.12 111.106 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.84 -42.06 83.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 65.23 111.062 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.604 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 2.7 t80 -67.31 -57.78 6.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 72.33 110.934 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 58' ' ' ALA . 3.6 p -55.22 -38.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 64.2 111.153 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 78' ' ' PHE . 36.3 mtp -46.22 -25.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 75.24 110.91 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.475 ' OD1' ' CA ' ' A' ' 99' ' ' GLY . 1.1 t30 -66.41 -60.36 2.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.46 -45.69 52.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 73.23 110.936 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.4 t80 -51.4 -54.2 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 71.33 110.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 26.4 t80 -50.95 -36.15 37.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 72.45 110.924 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.49 -3.64 49.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 64.35 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.93 -42.56 60.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 72.13 110.83 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.2 -62.05 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.35 111.052 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.42 20.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 53.15 112.546 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.99 37.44 21.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 74.13 110.891 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -108.84 168.26 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 75.23 110.899 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.47 ' CB ' HD13 ' A' ' 84' ' ' LEU . 89.2 p -69.03 -24.93 64.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 73.22 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -80.22 1.17 29.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 71.03 110.922 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.492 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -26.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 70.24 110.9 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.5 m -82.47 102.04 11.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 63.41 110.9 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.03 14.24 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.149 -0.478 . . . . 55.33 110.873 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CE2' ' HG3' ' A' ' 62' ' ' MET . 4.3 m-30 -58.92 -67.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 74.01 110.908 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -171.64 178.02 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 73.53 110.834 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -64.88 -2.33 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 74.22 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.598 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 50.9 p -93.36 -51.77 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 75.55 111.135 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.47 ' HB3' ' CE ' ' A' ' 62' ' ' MET . . . -82.11 104.82 12.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 73.12 111.099 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 t -154.82 178.01 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.164 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.47 HD13 ' CB ' ' A' ' 73' ' ' SER . 37.6 mt -67.29 127.7 33.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.9 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -106.3 167.58 9.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 72.53 111.12 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 87' ' ' THR . 50.2 m-80 -53.85 -168.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 71.33 110.913 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.85 172.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 74.34 111.153 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.08 106.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 74.41 110.862 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -1.09 7.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.01 112.34 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 t -51.97 108.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.43 110.861 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -75.12 -17.11 60.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.71 -111.38 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 75.2 112.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.93 85.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 72.22 111.114 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 102.09 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 63.1 110.899 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -98.82 151.65 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 75.24 110.864 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.1 m-85 -92.41 148.93 37.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.628 0.728 . . . . 71.12 110.854 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 124.43 11.06 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.665 2.243 . . . . 74.25 112.34 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.534 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 13.1 p -117.26 14.81 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.909 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.475 ' CA ' ' OD1' ' A' ' 63' ' ' ASN . . . 100.22 -22.58 39.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 62.33 112.435 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.7 p -150.67 167.36 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 74.25 110.859 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 75.23 110.862 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.91 0.386 . . . . 70.35 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -128.74 141.83 42.94 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.639 0.733 . . . . 74.21 111.109 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 112.83 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.272 . . . . 73.14 112.33 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.9 m -69.0 122.84 86.64 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.559 0.695 . . . . 74.2 111.154 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 94.75 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 73.15 112.336 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 7' ' ' PRO . 84.3 m -90.85 139.14 26.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.569 0.7 . . . . 63.53 111.156 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 6' ' ' THR . 53.8 Cg_endo -69.77 -173.76 0.78 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.672 2.248 . . . . 73.1 112.327 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 110.22 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 65.32 110.882 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 164.89 18.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 75.33 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.52 163.33 3.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.45 111.077 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.592 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 70.4 122.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 72.24 112.469 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.607 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 36.0 m -157.98 120.54 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 73.5 110.844 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 4.6 m-90 -133.33 116.14 15.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 74.44 110.883 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -87.36 101.99 14.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 74.04 110.904 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.409 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 2.9 m -148.9 153.54 38.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 70.33 111.135 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.75 126.17 13.01 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.672 2.248 . . . . 73.55 112.336 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.98 107.07 0.74 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.576 0.703 . . . . 73.31 110.909 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 79.81 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.717 2.278 . . . . 74.04 112.317 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.43 55.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 71.45 112.476 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.2 m -158.59 177.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 75.11 111.108 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -52.01 119.05 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 71.33 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 52.0 m-20 -52.2 -37.02 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 74.25 110.877 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -20.53 55.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 70.42 110.845 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -77.79 -48.43 16.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 65.02 110.919 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.67 -53.03 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 75.41 110.924 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.449 ' CG2' ' N ' ' A' ' 27' ' ' GLY . 14.2 t -37.49 -47.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.135 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' N ' ' CG2' ' A' ' 26' ' ' THR . . . -46.4 -41.73 12.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 73.14 112.479 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -47.18 -69.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 74.35 110.866 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.481 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 70.1 mt -40.08 -57.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 75.33 111.139 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -46.12 -42.68 14.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.1 110.869 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -73.86 -58.37 3.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.909 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -51.09 -24.78 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 74.12 111.101 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.08 2.27 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.859 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 5.73 37.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.41 110.818 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.04 -42.75 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.89 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.48 -46.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 54.1 112.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 65' ' ' TYR . 1.1 pt -82.34 5.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 72.03 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.463 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 16.4 t70 -89.36 -58.06 2.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 73.31 110.855 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.414 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.73 119.34 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.881 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.36 -70.84 0.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 74.13 112.465 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.5 Cg_endo -69.8 -0.84 7.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.655 2.236 . . . . 75.03 112.313 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.523 HD12 ' CG ' ' A' ' 57' ' ' HIS . 14.2 pt -83.08 17.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 75.24 111.13 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.93 137.97 69.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 64.53 110.876 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 173.92 10.3 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.221 . . . . 74.32 112.375 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.76 -35.35 1.07 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 73.14 112.462 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.13 -27.75 5.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 74.25 112.498 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 -68.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.824 0.345 . . . . 74.05 111.061 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.98 18.06 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.23 110.89 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.9 t80 -56.84 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 72.22 110.885 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -94.8 129.02 37.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 75.11 110.89 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.72 148.01 85.75 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.655 -1.81 . . . . 73.34 112.376 -0.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.39 142.27 34.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 75.14 110.897 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.8 p -92.39 167.32 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.11 111.163 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 84.5 t -65.61 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.081 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.19 17.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.888 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.76 -42.84 58.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 73.44 111.076 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.523 ' CG ' HD12 ' A' ' 42' ' ' ILE . 41.3 m170 -54.49 -56.59 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 71.55 110.832 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' A' ' 62' ' ' MET . . . -49.99 -36.57 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.11 111.099 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 64.3 111.068 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -67.86 -58.53 4.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.91 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 58' ' ' ALA . 3.5 p -55.06 -36.56 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 64.02 111.095 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.573 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER -46.7 -23.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.858 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -69.41 -62.35 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.12 110.896 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.8 -45.28 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 75.22 110.928 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.436 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 2.4 t80 -53.45 -50.82 64.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.51 110.953 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 58.2 t80 -53.02 -29.13 27.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 65.32 110.892 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.537 ' NE2' ' C ' ' A' ' 99' ' ' GLY . 23.7 mt-30 -99.28 -4.02 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 73.42 110.933 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -71.51 -42.2 68.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.874 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.04 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.02 111.085 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 23.19 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 55.34 112.477 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.0 39.36 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 74.33 110.903 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.609 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 4.7 m-80 -110.94 171.94 7.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.883 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.465 ' CB ' HD12 ' A' ' 84' ' ' LEU . 79.4 p -71.86 -23.56 61.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 70.42 110.85 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.78 2.48 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 73.15 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -73.74 -24.69 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 71.21 110.844 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.4 m -82.32 101.95 10.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 64.34 110.845 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -117.96 11.31 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 74.44 110.892 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.573 ' CZ ' ' HE3' ' A' ' 62' ' ' MET . 4.0 m-30 -58.47 -68.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 75.53 110.867 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -171.69 177.98 3.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 53.3 110.849 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.33 -1.96 2.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.493 . . . . 72.44 110.968 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.483 HG22 ' CD1' ' A' ' 25' ' ' LEU . 61.1 p -92.53 -52.91 4.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 61.23 111.15 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.47 106.06 14.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 70.31 111.102 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -154.7 178.02 10.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 74.41 111.113 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.475 ' CD2' ' HB3' ' A' ' 12' ' ' SER . 1.4 mt -67.37 123.32 20.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 73.31 110.913 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -103.82 168.62 9.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' THR . 66.6 m-20 -54.16 -167.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 63.24 110.873 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.24 170.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 64.45 111.133 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.4 t-20 -51.97 107.03 0.73 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.624 0.726 . . . . 63.55 110.894 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.3 Cg_endo -69.82 2.55 3.46 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.653 2.235 . . . . 75.44 112.32 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.5 t -52.02 106.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 73.44 110.883 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 94' ' ' CYS . 11.2 p90 -78.62 -16.21 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 74.42 110.903 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -113.49 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 62.21 112.518 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.74 83.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 64.54 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -76.34 102.66 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 70.44 110.862 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -98.14 140.48 32.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 72.54 110.928 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.402 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.6 m-85 -92.48 158.02 39.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 74.05 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 113.82 3.51 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 74.41 112.337 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.543 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 26.1 p -91.23 2.7 56.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 74.42 110.88 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.537 ' C ' ' NE2' ' A' ' 67' ' ' GLN . . . 76.97 32.82 47.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.665 -0.779 . . . . 75.42 112.484 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.9 106.87 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 74.33 110.852 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.7 t30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 70.04 110.857 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.819 0.342 . . . . 73.35 111.108 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p -100.8 152.11 37.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.57 0.7 . . . . 75.31 111.122 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -7.69 21.68 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.664 2.243 . . . . 73.22 112.395 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.8 p -82.57 153.23 67.91 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.541 0.686 . . . . 70.23 111.154 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.7 18.05 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 63.42 112.33 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.9 p -52.17 151.62 6.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 74.23 111.191 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.726 2.284 . . . . 53.33 112.333 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -108.62 110.04 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 71.3 110.917 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.68 167.48 26.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 74.13 111.112 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.16 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 64.32 111.114 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -66.29 -159.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 64.22 112.543 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.473 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -151.15 140.65 21.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 74.14 110.82 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.581 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.7 m-90 -137.52 115.75 11.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 75.33 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.01 102.05 12.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 65.15 110.867 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -152.65 152.02 27.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.731 . . . . 75.44 111.099 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.83 124.66 11.26 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.659 2.239 . . . . 73.35 112.304 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -52.0 119.57 14.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 74.33 110.863 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 80.72 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 70.23 112.308 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -25.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 72.22 112.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.401 ' CG1' ' H ' ' A' ' 21' ' ' SER . 2.5 t -59.0 173.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 64.21 111.144 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.486 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.69 115.28 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 74.33 110.857 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -40.73 -47.81 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 75.34 110.85 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -57.76 -34.38 69.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.14 110.872 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 14.1 mm100 -69.04 -46.12 68.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.959 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -70.29 -56.54 6.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.24 110.947 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 27' ' ' GLY . 11.3 t -41.05 -45.25 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.144 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 26' ' ' THR . . . -39.39 -37.8 0.84 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 72.11 112.43 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 29' ' ' ILE . 3.7 m-20 -56.14 -68.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 74.13 110.86 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 76.9 mt -35.31 -44.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.2 111.076 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -56.12 -49.18 74.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 72.35 110.89 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' ASN . 1.1 t80 -74.46 -54.43 7.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 74.52 110.912 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.92 -40.3 60.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 74.3 111.154 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.5 t -56.75 -10.04 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 73.12 110.839 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 32' ' ' ALA . 36.5 m -112.55 18.1 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 71.43 110.845 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 4.4 mm100 -93.9 -50.93 5.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 71.32 110.911 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.82 -85.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 70.52 112.473 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -81.38 17.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 74.11 111.115 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -85.38 -61.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 64.44 110.851 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.02 122.43 23.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 62.41 110.819 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.49 -67.42 0.51 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 71.21 112.477 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.71 1.98 3.92 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 74.44 112.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.57 HD12 ' CD2' ' A' ' 57' ' ' HIS . 24.7 pt -84.54 17.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 71.14 111.122 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -85.85 127.29 63.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.72 . . . . 75.41 110.912 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' CB ' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.75 156.45 63.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.717 2.278 . . . . 74.4 112.337 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.43 -47.13 1.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 74.42 112.457 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.04 -0.94 2.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.784 -0.722 . . . . 52.12 112.508 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.27 -68.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 73.55 111.11 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -117.94 9.86 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.54 110.925 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.564 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.5 t80 -56.21 -60.3 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.891 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.564 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 mt-10 -96.72 128.93 34.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.643 0.735 . . . . 74.4 110.89 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.81 145.09 78.59 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 -1.804 . . . . 74.44 112.372 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.426 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 1.2 p30 -107.23 151.74 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.13 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.7 p -99.92 170.87 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.24 111.172 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 26' ' ' THR . 72.0 t -65.43 -62.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 71.34 111.081 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.78 18.04 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.21 110.914 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.23 -40.91 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 71.54 111.064 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.57 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.3 m80 -53.19 -52.65 58.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 73.21 110.875 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB2' ' CE ' ' A' ' 62' ' ' MET . . . -57.47 -38.14 74.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 62.13 111.086 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.04 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 53.21 111.124 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 10.5 t80 -61.58 -65.08 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 75.33 110.945 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.409 ' O ' HG21 ' A' ' 61' ' ' VAL . 2.7 p -55.2 -34.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 74.03 111.088 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.551 ' HE1' ' CE2' ' A' ' 78' ' ' PHE . 2.7 mtm -44.89 -26.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.24 110.908 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -67.25 -60.74 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.31 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -52.3 18.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.91 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.434 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.7 t80 -46.46 -44.59 17.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.31 110.928 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 12.6 t80 -58.96 -28.43 66.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 70.23 110.903 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -99.56 -4.79 30.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 71.32 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -41.67 69.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.11 110.881 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.17 -58.12 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 72.01 111.094 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 23.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 75.13 112.487 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.02 43.79 30.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 74.41 110.852 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.504 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.5 m-80 -114.4 169.92 8.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 75.23 110.932 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.467 ' CB ' HD11 ' A' ' 84' ' ' LEU . 78.4 p -71.7 -23.19 61.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.873 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.06 1.89 26.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 74.53 110.907 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -73.68 -24.32 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 61.32 110.916 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -82.55 102.02 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.12 110.857 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -118.03 11.83 13.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 60.2 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.551 ' CE2' ' HE1' ' A' ' 62' ' ' MET . 3.7 m-30 -59.04 -68.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 75.11 110.895 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.46 178.02 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 43.53 110.824 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -65.9 -1.78 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 75.51 110.963 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.463 ' HB ' ' CD1' ' A' ' 25' ' ' LEU . 73.3 p -91.81 -50.01 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.22 111.118 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.14 102.01 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.23 111.076 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 t -147.37 178.47 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 73.12 111.124 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 73' ' ' SER . 35.7 mt -66.16 122.9 18.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.914 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -99.57 168.03 10.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.42 111.159 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.96 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 75.22 110.867 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.0 t -44.46 172.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.23 111.067 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.581 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.3 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 63.33 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.519 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.8 -2.37 10.09 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 75.33 112.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.0 t -52.04 108.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 72.53 110.845 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 5.9 p90 -81.57 -15.28 55.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 74.31 110.947 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.97 -115.12 0.5 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 74.35 112.566 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.96 89.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 74.1 111.142 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.568 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -76.45 102.03 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 70.22 110.867 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.5 142.84 30.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 63.2 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.519 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 10.0 m-85 -92.08 150.87 41.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.671 0.748 . . . . 72.42 110.839 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.23 11.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 72.53 112.37 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.459 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 9.1 p -106.91 -5.69 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 71.43 110.877 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.78 52.8 7.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 74.24 112.512 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.08 164.11 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.04 110.873 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 71.31 110.896 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.863 0.363 . . . . 64.1 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 t -150.61 133.69 8.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.619 0.724 . . . . 72.04 111.128 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.679 2.252 . . . . 72.45 112.352 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 p -53.53 155.22 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 73.23 111.113 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 72.31 112.375 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 p -141.85 153.19 64.1 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.566 0.698 . . . . 73.13 111.137 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -173.88 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 73.41 112.374 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.56 109.01 5.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 73.11 110.874 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.96 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 73.51 111.096 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 166.39 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 74.01 111.04 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.424 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . -38.02 157.96 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.736 -0.745 . . . . 75.52 112.513 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.529 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 25.2 m -158.0 139.73 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 71.34 110.806 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.578 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.0 m-90 -137.75 119.52 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 74.54 110.927 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 101.98 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 65.3 110.884 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -151.84 152.6 30.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 75.31 111.091 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 127.76 15.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.682 2.255 . . . . 65.54 112.327 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -52.02 113.44 4.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 75.02 110.912 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 91.4 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.678 2.252 . . . . 71.02 112.393 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.13 -27.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 72.1 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.01 165.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 71.22 111.17 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -52.12 114.51 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.855 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 21' ' ' SER . 6.0 m-20 -33.65 -65.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 72.4 110.822 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.2 -39.17 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 63.44 110.872 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.7 tp-100 -58.36 -50.87 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.51 110.91 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' CD1' HG23 ' A' ' 81' ' ' THR . 0.4 OUTLIER -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.926 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 m -59.54 -31.48 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 71.5 111.154 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.77 -30.66 56.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 45.32 112.47 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' ILE . 1.1 m-20 -61.86 -68.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 74.31 110.867 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 67.6 mt -37.09 -48.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.12 111.073 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.06 -47.37 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 71.14 110.91 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.1 -53.65 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 71.5 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.479 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.12 -43.13 61.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 60.15 111.116 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -11.58 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.12 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 32' ' ' ALA . 34.7 p -109.06 18.03 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.34 110.821 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.469 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 5.1 mm100 -97.86 -49.96 4.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.42 110.887 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.65 -82.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 72.31 112.47 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 pt -80.97 17.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 73.2 111.123 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.479 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -89.56 -59.86 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 71.22 110.843 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.71 122.35 23.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.47 -71.34 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 71.4 112.463 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.601 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.77 4.24 2.31 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.684 2.256 . . . . 74.22 112.316 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.433 HD12 ' ND1' ' A' ' 57' ' ' HIS . 9.6 pt -82.87 18.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 73.31 111.136 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -80.31 148.36 66.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 72.5 110.886 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.1 Cg_endo -69.79 152.61 69.18 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.709 2.273 . . . . 71.44 112.351 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.83 -47.9 2.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 55.11 112.483 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.83 3.08 2.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 72.02 112.484 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 65.34 111.106 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.0 7.85 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.898 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -43.27 -59.0 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 74.43 110.875 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 2.4 mm-40 -96.72 131.02 28.89 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.671 0.748 . . . . 73.1 110.826 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.75 153.61 92.98 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 -1.801 . . . . 65.22 112.32 -0.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.493 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 10.4 p30 -101.73 130.55 48.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 75.43 110.876 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.432 ' OG1' ' CB ' ' A' ' 56' ' ' ALA . 41.2 p -82.97 169.99 15.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 72.31 111.163 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.1 -58.9 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.151 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -87.91 18.04 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.901 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.432 ' CB ' ' OG1' ' A' ' 53' ' ' THR . . . -49.7 -51.88 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 73.44 111.092 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' ND1' HD12 ' A' ' 42' ' ' ILE . 63.1 m170 -43.65 -58.16 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 70.25 110.841 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.22 -39.8 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 73.52 111.145 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.15 74.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 75.32 111.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 11.2 t80 -68.57 -63.45 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 72.13 110.931 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 p -54.9 -33.47 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 63.32 111.132 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.58 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 3.8 mtt -45.61 -27.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.882 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.63 -61.68 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 63.13 110.842 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -49.33 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 73.23 110.918 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.5 t80 -50.29 -47.0 55.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.3 110.926 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 30.4 t80 -55.88 -28.57 57.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 62.05 110.915 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -99.93 -4.59 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 70.52 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.11 -40.33 65.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.861 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -59.39 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.21 111.101 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.29 22.03 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 72.33 112.508 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.01 41.07 29.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 74.11 110.841 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.8 m-80 -114.11 169.12 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.863 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.5 p -70.28 -23.14 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 70.21 110.849 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -81.02 2.2 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.943 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.474 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -20.62 60.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 71.0 110.887 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.46 102.01 11.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 72.43 110.859 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.02 10.68 13.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 72.14 110.847 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CD2' ' HE2' ' A' ' 62' ' ' MET . 2.7 m-30 -58.32 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.917 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.62 178.01 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 72.1 110.897 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -2.2 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.12 110.9 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.475 HG23 ' CD1' ' A' ' 25' ' ' LEU . 65.4 p -92.15 -52.37 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.31 111.175 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.471 ' CB ' ' HE2' ' A' ' 62' ' ' MET . . . -82.52 102.15 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.13 111.114 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -148.64 178.02 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.43 111.154 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.57 127.2 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 74.52 110.874 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.04 167.76 9.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 71.22 111.179 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 87' ' ' THR . 11.3 m-80 -54.03 -168.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 74.33 110.884 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.99 173.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 74.23 111.17 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.578 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.7 t-20 -51.97 106.33 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.653 0.739 . . . . 73.33 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.522 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.78 -4.39 13.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 61.33 112.353 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -52.02 112.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 54.32 110.81 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 94' ' ' CYS . 1.8 p90 -79.8 -16.62 55.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.926 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.85 -123.83 0.94 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.44 112.454 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.35 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 44.33 111.08 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -76.35 104.16 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 62.14 110.882 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.0 129.24 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 74.35 110.919 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.522 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.1 m-85 -78.42 154.97 79.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.655 0.74 . . . . 72.41 110.876 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.425 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.75 108.08 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.647 2.231 . . . . 75.01 112.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.568 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 54.6 p -80.55 -10.78 59.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 73.1 110.842 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.66 37.89 27.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 73.41 112.505 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -157.97 141.95 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 74.22 110.849 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 71.13 110.851 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.817 0.342 . . . . 75.2 111.066 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.9 m -103.31 121.46 48.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 74.43 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 164.52 34.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 72.23 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.1 p -111.52 113.55 53.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.633 0.73 . . . . 74.14 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -171.18 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 71.3 112.331 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.5 p -130.49 103.0 16.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.5 111.107 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -167.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.675 2.25 . . . . 70.04 112.384 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.51 128.89 50.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 73.15 110.942 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 130.92 45.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 75.12 111.076 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.1 177.96 5.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.111 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 81.43 175.21 49.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 71.12 112.465 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.52 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -148.51 138.55 22.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 74.33 110.836 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.595 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.0 m-90 -136.03 123.06 21.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.913 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 102.01 13.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 74.21 110.836 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -154.58 153.06 27.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 71.13 111.09 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.4 Cg_endo -69.82 129.34 17.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 71.55 112.383 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 118.12 11.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.522 0.677 . . . . 75.22 110.947 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 79.87 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.686 2.257 . . . . 74.04 112.324 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.58 -24.3 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 72.1 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -59.0 166.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.328 . . . . 71.45 111.164 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -52.01 107.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 72.13 110.849 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 21' ' ' SER . 72.9 m-20 -33.36 -63.41 0.24 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 73.13 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.99 -39.74 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 75.15 110.862 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -58.34 -50.93 71.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 53.34 110.875 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.49 -29.65 65.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 71.51 110.883 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.1 m -52.13 -26.53 11.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 73.55 111.129 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.36 -24.77 72.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 63.4 112.49 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.27 -51.4 63.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 65.44 110.864 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 57' ' ' HIS . 73.1 mt -62.53 -52.46 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 72.44 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -50.25 -43.63 53.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.16 -58.11 3.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.934 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -51.46 -31.65 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 63.21 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.91 -11.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.14 110.883 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 18.0 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 50.04 110.855 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -92.17 -52.1 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.22 110.887 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.38 -92.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.786 -0.721 . . . . 75.31 112.512 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.41 4.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 75.44 111.138 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' OD1' ' CG1' ' A' ' 61' ' ' VAL . 2.5 m-20 -66.66 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.84 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.428 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -76.07 134.92 39.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 52.13 110.88 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.94 -72.3 0.33 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 62.12 112.463 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.78 6.47 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.674 2.25 . . . . 73.31 112.358 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.584 HD12 ' CD2' ' A' ' 57' ' ' HIS . 22.9 pt -82.44 18.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 75.13 111.141 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -80.16 123.75 83.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 75.03 110.895 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.32 38.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 71.51 112.315 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.34 -32.99 1.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 73.43 112.514 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.49 -31.22 3.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 72.42 112.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.05 -68.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 73.32 111.126 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' PHE . 13.7 t -113.05 -13.77 13.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.926 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.488 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -34.46 -44.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 64.21 110.849 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.41 125.75 38.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 72.13 110.88 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.5 Cg_endo -69.75 151.89 91.82 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.726 -1.781 . . . . 74.13 112.317 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.488 ' HB2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.38 120.02 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 72.22 110.875 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.76 168.59 16.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 71.03 111.115 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.8 t -65.79 -56.79 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 75.3 111.147 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG3' ' CG ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.24 17.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 73.43 110.85 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.63 -42.29 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 74.14 111.061 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.584 ' CD2' HD12 ' A' ' 42' ' ' ILE . 67.5 m80 -52.28 -54.78 27.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.12 110.839 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.437 ' O ' ' CG ' ' A' ' 62' ' ' MET . . . -56.72 -37.74 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 62.31 111.105 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.14 -30.6 71.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 72.1 111.094 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 12.2 t80 -67.86 -66.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.902 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.497 ' CG1' ' OD1' ' A' ' 38' ' ' ASP . 7.5 p -55.24 -29.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 74.42 111.165 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.541 ' HE2' ' CE1' ' A' ' 78' ' ' PHE . 1.6 mmt -45.53 -22.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.845 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -71.95 -56.61 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.21 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.14 -53.13 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 73.24 110.948 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.4 t80 -45.72 -48.2 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 73.12 110.953 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.606 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 33.8 t80 -58.51 -26.86 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 75.32 110.93 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -100.04 -2.78 33.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 75.32 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -40.09 52.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 74.54 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.424 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -55.41 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 75.21 111.082 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.35 24.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 62.43 112.496 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 49.2 31.98 3.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 72.43 110.912 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.606 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 5.2 m-80 -102.81 168.59 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 65.04 110.864 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.8 p -70.93 -21.97 62.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.827 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.437 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.08 2.03 29.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 74.31 110.902 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.424 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.57 -18.94 61.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 72.14 110.898 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 102.05 11.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 71.45 110.87 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 8.93 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 64.12 110.886 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.541 ' CE1' ' HE2' ' A' ' 62' ' ' MET . 3.5 m-30 -58.51 -68.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.844 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 81' ' ' THR . 8.4 t -171.93 178.06 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.45 110.875 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -65.8 -0.99 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 65.54 110.895 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.549 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 62.3 p -92.84 -52.1 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.13 111.143 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.86 106.37 13.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 71.4 111.09 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.9 t -150.64 177.98 9.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 72.14 111.162 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.03 149.85 49.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.947 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -133.77 168.55 18.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.32 111.156 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 87' ' ' THR . 14.4 m-20 -53.63 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.889 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.9 t -44.36 174.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.34 111.104 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.595 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 72.24 110.877 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -0.15 6.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.697 2.265 . . . . 74.44 112.303 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.9 t -52.04 106.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.14 110.834 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.65 -16.33 59.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.12 110.918 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.74 -115.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 64.01 112.472 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.34 69.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 62.04 111.108 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.37 102.03 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 52.22 110.886 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -99.97 137.95 37.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.903 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.26 146.52 32.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.637 0.732 . . . . 75.43 110.9 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.02 12.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 73.4 112.334 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.431 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 2.0 p -113.7 0.25 14.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 74.41 110.806 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 62.4 -122.83 29.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 54.04 112.421 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -91.71 115.25 27.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 64.3 110.816 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 74.22 110.908 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.831 0.348 . . . . 74.32 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.5 p -144.76 148.37 39.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.558 0.694 . . . . 73.15 111.158 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 111.69 2.86 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.291 . . . . 75.12 112.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -79.7 114.33 44.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.578 0.704 . . . . 70.24 111.18 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 156.74 62.55 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 75.23 112.354 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -98.8 156.98 34.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.569 0.7 . . . . 74.35 111.147 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -173.89 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.676 2.251 . . . . 75.12 112.316 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -104.27 103.6 13.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 75.32 110.893 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 170.79 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 71.01 111.102 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.56 120.61 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.33 111.118 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.572 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . 74.42 175.92 34.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 61.15 112.502 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.44 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 9.3 m -149.16 136.31 19.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 73.13 110.898 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.572 ' CH2' ' HA3' ' A' ' 11' ' ' GLY . 4.2 m-90 -135.67 109.65 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 75.31 110.905 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.407 ' C ' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -78.34 102.17 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.41 110.832 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG13 ' C ' ' A' ' 14' ' ' CYS . 2.7 m -155.66 152.43 24.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 73.12 111.131 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HG2' ' NZ ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.71 123.55 10.23 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.686 2.257 . . . . 72.04 112.336 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -51.98 122.42 22.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.551 0.691 . . . . 74.03 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 88.06 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 74.32 112.353 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.37 -20.79 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 60.21 112.497 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.443 HG11 ' N ' ' A' ' 21' ' ' SER . 11.0 t -63.62 158.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 75.14 111.133 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 24' ' ' GLN . 1.8 m -52.09 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 71.04 110.817 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 21' ' ' SER . 85.9 m-20 -33.5 -68.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 75.23 110.873 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.4 -39.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 73.15 110.86 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 25.4 tt0 -58.11 -51.3 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 73.01 110.938 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.602 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.2 OUTLIER -70.96 -36.18 72.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 73.33 110.914 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.7 m -52.2 -15.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.162 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.98 -35.48 57.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 65.13 112.493 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -57.19 -68.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 75.32 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 73.6 mt -37.49 -47.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 72.42 111.121 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.42 -47.76 72.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 71.35 110.849 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -73.55 -56.1 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.942 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . . . -51.95 -35.7 46.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 73.12 111.102 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.5 t -56.39 -12.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.11 110.875 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.75 18.02 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.33 110.828 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -89.8 -52.82 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 72.35 110.899 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 165.19 -94.81 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 64.31 112.503 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' O ' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -81.96 17.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 74.15 111.118 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -83.08 -59.95 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 64.52 110.902 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 122.31 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 71.5 110.902 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.14 -67.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 63.12 112.474 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 4.51 2.14 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.246 . . . . 73.11 112.339 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.559 HD13 ' CD2' ' A' ' 57' ' ' HIS . 19.4 pt -82.77 17.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 72.21 111.112 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -84.48 125.15 72.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.623 0.725 . . . . 75.44 110.899 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.525 ' CB ' ' CD1' ' A' ' 49' ' ' PHE . 53.7 Cg_endo -69.74 154.58 67.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.668 2.245 . . . . 72.23 112.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.88 -40.08 1.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 62.35 112.495 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.47 -23.51 3.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.74 . . . . 72.3 112.494 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.06 -68.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 75.13 111.089 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -118.04 -11.28 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 73.22 110.873 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CD1' ' CB ' ' A' ' 44' ' ' PRO . 2.6 t80 -33.92 -52.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.897 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -99.57 127.97 32.73 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.623 0.725 . . . . 73.2 110.87 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.51 88.72 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 -1.806 . . . . 65.12 112.329 -0.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.98 152.75 24.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 63.15 110.891 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.5 p -106.69 172.38 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.22 111.153 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.0 t -66.21 -64.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.42 111.143 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.25 18.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.43 110.897 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.91 -38.9 52.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 51.4 111.054 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.559 ' CD2' HD13 ' A' ' 42' ' ' ILE . 60.2 m80 -54.08 -52.72 60.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.24 110.855 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.471 ' HB3' ' CE ' ' A' ' 62' ' ' MET . . . -57.27 -37.53 72.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 72.33 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.34 74.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 75.52 111.131 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 3.0 t80 -68.45 -57.96 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.891 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 1.8 p -54.57 -37.44 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 71.44 111.164 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.532 ' HE3' ' CE2' ' A' ' 78' ' ' PHE . 9.7 mtt -49.09 -20.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.22 110.912 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 44.9 t30 -69.16 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.02 110.896 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.93 -52.25 11.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 73.35 110.927 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.6 t80 -45.7 -49.55 14.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 74.11 110.87 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 2.8 t80 -58.42 -27.38 64.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 74.45 110.923 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.401 ' OE1' ' O ' ' A' ' 63' ' ' ASN . 29.0 mt-30 -101.11 -2.26 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.12 110.918 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -74.04 -41.43 61.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 73.01 110.864 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.15 -55.51 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 61.12 111.095 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.85 24.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.04 112.508 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 51.1 44.17 28.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 72.32 110.872 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.546 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.9 m-80 -109.89 172.44 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.4 110.913 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 84' ' ' LEU . 20.2 m -74.22 -24.78 59.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.908 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -79.67 2.0 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.91 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -73.78 -23.26 59.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.33 110.912 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.37 101.96 10.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 54.33 110.902 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.0 10.1 12.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.847 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' CE2' ' HE3' ' A' ' 62' ' ' MET . 3.0 m-30 -58.84 -68.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.84 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 t -172.0 178.01 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.4 110.836 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.51 -2.48 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.926 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.602 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 66.4 p -91.54 -50.57 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 73.31 111.149 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.71 102.09 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.108 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 t -148.81 178.01 9.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.43 111.11 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 73' ' ' SER . 44.5 mt -66.67 114.0 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 65.41 110.938 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -89.71 167.47 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 73.42 111.168 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.84 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 63.54 110.905 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.24 172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.55 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 9.5 t-20 -51.98 106.66 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 74.31 110.907 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.538 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.19 3.74 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.743 2.295 . . . . 73.04 112.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.411 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 23.0 t -52.03 106.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.783 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -17.04 61.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 75.01 110.941 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.44 -111.24 0.42 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.94 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 75.32 111.06 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.85 102.0 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 75.03 110.879 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -99.0 151.73 20.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 75.55 110.883 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.538 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.7 m-85 -92.35 154.07 42.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.669 0.747 . . . . 75.21 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 114.21 3.62 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 72.1 112.356 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.527 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 12.1 p -88.81 -11.71 44.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 74.22 110.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.71 -105.62 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 74.31 112.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.3 p -92.93 161.24 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 74.13 110.861 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.839 -179.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.881 0.372 . . . . 54.01 111.122 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.1 p -107.19 143.29 26.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.526 0.679 . . . . 64.4 111.184 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.37 60.08 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 72.52 112.338 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -119.54 111.46 36.31 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.608 0.718 . . . . 72.43 111.144 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 174.49 9.38 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.685 2.257 . . . . 74.44 112.347 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -99.16 121.34 55.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.11 111.118 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -173.6 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.688 2.259 . . . . 62.43 112.361 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.5 102.11 5.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 61.31 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.72 166.07 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 72.43 111.125 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.15 177.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 73.31 111.122 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.561 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 67.41 105.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 75.3 112.471 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.571 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -158.02 122.22 4.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 71.21 110.846 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.5 m-90 -129.74 116.55 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 75.01 110.922 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.21 102.05 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.946 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -152.83 152.55 28.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 70.22 111.108 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 127.62 14.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.645 2.23 . . . . 73.14 112.327 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.06 118.15 11.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 74.25 110.939 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 92.12 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.673 2.248 . . . . 74.43 112.334 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.78 -26.78 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 74.51 112.488 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 t -59.0 168.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 72.14 111.174 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.5 OUTLIER -54.52 111.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 43.13 110.829 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.408 ' OD1' ' CG2' ' A' ' 54' ' ' VAL . 24.2 m-20 -38.94 -55.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 75.03 110.888 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.21 -33.98 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.846 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' SER . 6.6 tp60 -68.31 -46.48 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.34 110.868 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' CD2' ' O ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -70.01 -54.06 14.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.955 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 27' ' ' GLY . 16.8 m -41.14 -48.35 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.4 111.169 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' THR . . . -34.91 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 55.43 112.502 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 31' ' ' TYR . 10.3 m-20 -59.5 -64.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 72.43 110.909 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.532 HG23 ' CE1' ' A' ' 57' ' ' HIS . 72.7 mt -36.58 -41.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.33 111.163 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.59 -45.6 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' ASN . 3.4 t80 -73.55 -58.28 3.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.14 110.887 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.525 ' CB ' ' CG ' ' A' ' 38' ' ' ASP . . . -48.1 -50.05 29.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 71.32 111.072 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.79 -22.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 72.31 110.929 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -80.52 13.33 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 74.12 110.861 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.498 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -97.96 -45.79 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 75.11 110.942 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.9 -43.91 1.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 71.4 112.5 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -101.54 2.29 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.346 . . . . 70.35 111.129 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' CG ' ' CB ' ' A' ' 32' ' ' ALA . 1.4 m-20 -74.99 -70.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 74.15 110.823 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -80.4 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 72.41 110.862 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 42' ' ' ILE . . . 123.11 -68.78 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 74.32 112.466 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.61 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.71 6.97 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 74.05 112.36 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 57' ' ' HIS . 8.0 pt -82.14 17.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 74.41 111.136 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.25 121.69 85.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.628 0.728 . . . . 74.42 110.912 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -169.46 0.33 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 72.21 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.99 -28.74 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 73.54 112.5 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.08 -26.23 8.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 61.41 112.461 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.37 -68.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 72.5 111.138 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 13.8 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 73.4 110.843 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 10.9 t80 -47.88 -60.52 2.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.944 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 28.5 mt-10 -92.56 142.39 25.77 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.697 0.761 . . . . 74.41 110.844 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.75 146.86 83.35 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 -1.796 . . . . 73.11 112.332 -0.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -99.91 142.21 31.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 73.33 110.901 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -97.86 160.06 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 64.2 111.184 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.408 ' CG2' ' OD1' ' A' ' 22' ' ' ASP . 40.9 t -65.87 -56.43 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 74.15 111.156 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.48 17.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 72.21 110.937 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -49.64 -55.29 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.33 111.112 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.722 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -35.23 -51.34 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 71.23 110.873 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.722 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -63.97 -42.14 97.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 72.2 111.126 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.46 -49.54 77.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 70.13 111.076 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -54.21 -63.42 1.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 73.21 110.932 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 3.5 p -54.85 -35.63 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.55 111.159 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' A' ' 62' ' ' MET . 0.0 OUTLIER -44.92 -21.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.872 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 61' ' ' VAL . 33.0 t-20 -72.56 -44.25 62.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 75.25 110.942 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.71 -49.06 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 73.21 110.954 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.451 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.3 t80 -47.0 -46.26 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 73.34 110.937 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.9 t80 -57.14 -30.71 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.904 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -97.25 -5.14 37.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 72.31 110.911 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -40.96 62.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.847 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.51 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.38 -59.98 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.41 111.094 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.85 21.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.713 -0.756 . . . . 55.11 112.499 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 51.69 32.01 8.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 75.21 110.903 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.56 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.2 m-80 -105.55 167.1 9.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 72.3 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.8 p -68.73 -22.75 64.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 71.22 110.856 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.84 2.41 26.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.869 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.36 -16.89 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.44 110.894 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 0.8 OUTLIER -82.8 102.04 11.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 75.31 110.846 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -117.98 8.73 12.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.899 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' N ' ' HD1' ' A' ' 78' ' ' PHE . 3.4 m-30 -58.98 -69.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.14 110.858 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -172.01 177.99 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 73.0 110.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -2.56 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 72.25 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 70.4 p -91.62 -51.44 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 74.51 111.139 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -83.75 102.02 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.22 111.064 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 t -147.93 178.0 8.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.14 111.174 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.61 127.26 31.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 73.32 110.923 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -106.07 168.98 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.1 111.158 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 87' ' ' THR . 15.5 m120 -53.68 -168.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 74.33 110.894 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' ASN . 5.0 t -45.06 174.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 75.21 111.165 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.5 t-20 -51.99 107.24 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 75.45 110.882 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.515 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.75 0.89 4.97 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.714 2.276 . . . . 65.25 112.324 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.8 t -52.06 108.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 65.04 110.854 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -72.18 -16.44 61.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.909 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.407 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 174.41 -109.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 64.21 112.511 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.53 79.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 63.54 111.124 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 102.06 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.838 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 149.42 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 74.43 110.896 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.515 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -90.34 154.84 46.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 74.42 110.932 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.66 3.78 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 71.41 112.35 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.466 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 83.7 p -91.31 -9.78 43.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.852 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.84 19.3 55.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 55.31 112.485 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.96 107.16 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 75.23 110.872 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 73.11 110.871 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.863 0.363 . . . . 73.14 111.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.3 m -119.85 134.77 23.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.569 0.699 . . . . 74.52 111.131 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 106.82 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.729 2.286 . . . . 63.51 112.326 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -140.45 148.54 54.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.523 0.678 . . . . 71.22 111.188 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 139.72 40.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.705 2.27 . . . . 75.21 112.33 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -112.83 143.32 28.83 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.708 . . . . 72.31 111.147 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 4.87 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 2.234 . . . . 74.44 112.392 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -51.96 102.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.92 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 164.52 12.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.55 111.101 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 11' ' ' GLY . . . -80.06 138.51 37.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 65.14 111.097 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.577 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 35.71 91.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 71.34 112.458 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 3.0 m -157.99 127.47 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 74.42 110.843 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.577 ' CH2' ' HA2' ' A' ' 11' ' ' GLY . 3.8 m-90 -133.16 123.36 25.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 65.42 110.907 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.96 102.01 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 65.02 110.916 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.11 152.2 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 75.35 111.191 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD3' ' CE ' ' A' ' 62' ' ' MET . 54.1 Cg_endo -69.76 129.92 18.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.637 2.225 . . . . 74.44 112.39 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -52.0 120.94 17.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 74.4 110.879 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 80.7 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.668 2.245 . . . . 75.32 112.281 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.43 -27.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 74.21 112.516 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 21' ' ' SER . 19.7 t -59.15 164.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 65.24 111.158 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.463 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 31.3 m -55.7 114.83 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 63.11 110.885 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.52 -67.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 74.13 110.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -39.59 -42.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 61.1 110.896 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -48.7 80.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.12 110.941 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' CD1' HG22 ' A' ' 81' ' ' THR . 0.5 OUTLIER -71.11 -27.9 63.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.88 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.6 m -60.77 -41.46 95.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 73.32 111.109 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.18 28.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 71.11 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -55.8 -44.94 78.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 64.02 110.823 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.52 HG22 ' CG ' ' A' ' 57' ' ' HIS . 90.4 mt -60.1 -64.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.01 111.093 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -37.6 -41.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 72.23 110.886 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 4.6 t80 -75.03 -68.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.33 110.946 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' N ' ' CD2' ' A' ' 31' ' ' TYR . . . -47.95 -19.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 71.22 111.107 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.402 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 4.4 t -70.52 1.59 4.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.55 110.914 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.36 17.9 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 71.52 110.862 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.451 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.72 -48.81 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.11 110.954 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.8 -61.47 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 73.24 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.459 ' CG1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.13 12.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 75.0 111.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -88.93 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.43 110.883 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -80.02 119.37 22.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 62.3 110.879 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.4 -68.84 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 72.25 112.46 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.628 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.1 Cg_endo -69.75 6.3 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.726 2.284 . . . . 74.14 112.316 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 38' ' ' ASP . 29.1 pt -82.06 17.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 72.12 111.107 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -73.94 124.6 90.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.711 . . . . 65.21 110.905 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.9 Cg_endo -69.75 -179.37 2.86 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.723 2.282 . . . . 75.44 112.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.02 -36.15 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 63.43 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.1 -27.18 5.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 75.32 112.483 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.18 -68.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 63.51 111.146 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.3 t -117.86 -5.78 11.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 64.05 110.918 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 52' ' ' ASN . 2.6 t80 -40.69 -53.07 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 72.55 110.861 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.74 130.32 28.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 70.12 110.94 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.8 151.83 91.88 Favored 'Cis proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 -1.793 . . . . 55.02 112.327 0.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 7.2 p-10 -101.69 144.32 30.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 72.45 110.907 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.9 p -94.97 160.3 14.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 72.04 111.143 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.14 -52.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 62.33 111.128 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.509 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.97 17.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.881 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.34 -56.43 11.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 73.01 111.131 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.746 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -35.55 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.53 110.818 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.746 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -65.01 -38.39 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 72.01 111.125 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.74 -53.96 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 72.02 111.101 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -54.49 -63.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 73.54 110.953 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 57' ' ' HIS . 1.6 p -53.73 -37.09 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.153 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.575 ' HE2' ' CE2' ' A' ' 78' ' ' PHE . 2.5 mtm -45.96 -21.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 71.2 110.888 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 10.3 t-20 -71.89 -54.53 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.54 110.866 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.459 HD13 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -79.0 -45.88 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.32 110.927 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.451 ' CE2' ' HG3' ' A' ' 35' ' ' GLN . 2.3 t80 -48.91 -49.63 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.883 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.6 t80 -55.32 -32.2 62.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 75.24 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.402 ' OE1' ' O ' ' A' ' 99' ' ' GLY . 35.2 mt-30 -96.12 -4.91 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.32 110.883 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -74.79 -40.68 61.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 73.23 110.86 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.76 -61.57 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 63.15 111.135 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.94 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.677 -0.773 . . . . 75.21 112.484 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.94 33.3 11.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 75.31 110.94 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -106.57 167.71 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 63.41 110.878 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.482 ' CB ' HD13 ' A' ' 84' ' ' LEU . 75.4 p -69.09 -23.01 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 74.13 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.28 2.85 26.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 75.32 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.503 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.4 -24.37 60.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 73.05 110.881 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.95 102.0 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.2 110.901 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -118.0 11.36 13.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.3 110.848 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.575 ' CE2' ' HE2' ' A' ' 62' ' ' MET . 3.8 m-30 -57.75 -68.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 75.3 110.876 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.7 OUTLIER -171.9 178.01 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.04 110.872 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -65.61 -2.13 3.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 71.04 110.943 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.481 HG22 ' CD1' ' A' ' 25' ' ' LEU . 72.4 p -91.76 -51.77 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 63.45 111.107 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.72 107.42 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 71.44 111.146 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -152.49 177.99 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.126 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD13 ' CB ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -66.36 153.73 41.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.926 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -133.69 167.27 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 72.53 111.148 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' THR . 6.5 m120 -53.66 -168.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 73.34 110.86 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.24 174.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 73.12 111.168 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.0 t-20 -52.06 107.0 0.73 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.73 . . . . 73.5 110.895 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.51 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -0.6 7.12 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 75.21 112.369 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 5.3 t -52.0 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.827 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -79.71 -17.23 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.497 . . . . 75.41 110.914 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.421 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 177.58 -112.48 0.38 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 74.25 112.487 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.45 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 75.51 111.127 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.35 101.99 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 71.03 110.867 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.89 142.07 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.4 110.873 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.51 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.05 140.88 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.716 0.77 . . . . 74.05 110.896 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 132.05 22.43 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.635 2.224 . . . . 74.32 112.368 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.476 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 3.1 t -117.95 -2.37 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 70.05 110.869 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' OE1' ' A' ' 67' ' ' GLN . . . 118.21 -36.86 3.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 74.02 112.506 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 106.96 4.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 52.52 110.855 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 72.25 110.873 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.874 0.369 . . . . 74.33 111.073 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.5 m -140.88 120.91 8.62 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.621 0.724 . . . . 74.22 111.077 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -177.99 2.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.669 2.246 . . . . 73.11 112.304 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -66.87 146.92 99.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 70.22 111.133 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.651 2.234 . . . . 62.35 112.335 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 8' ' ' LYS . 29.1 p -156.79 154.04 25.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.569 0.7 . . . . 74.03 111.135 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 9.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.634 2.222 . . . . 75.4 112.341 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 6' ' ' THR . 6.6 ttmm -52.01 106.28 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.906 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 178.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 75.25 111.115 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.12 174.74 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 64.33 111.117 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.584 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 153.38 -29.23 0.78 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 63.23 112.496 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.481 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 7.0 m -143.97 139.95 29.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 73.34 110.839 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.584 ' CZ3' ' C ' ' A' ' 11' ' ' GLY . 4.1 m-90 -134.82 124.97 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 71.21 110.912 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.48 102.05 13.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 75.03 110.883 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -150.65 153.87 34.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 75.43 111.074 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.9 Cg_endo -69.74 126.3 13.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 72.35 112.376 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.08 113.42 4.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 65.34 110.868 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 79.59 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 74.01 112.351 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.14 61.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.792 -0.718 . . . . 63.1 112.487 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.466 HG23 ' CD1' ' A' ' 25' ' ' LEU . 1.7 m -157.56 178.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 72.32 111.122 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.9 m -52.04 114.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 75.05 110.827 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.56 -53.67 5.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 75.14 110.841 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -50.73 -30.09 13.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.12 110.899 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -51.35 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 71.23 110.939 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 0.1 OUTLIER -71.42 -32.06 67.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 75.14 110.905 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 m -66.72 -1.0 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 62.34 111.121 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.29 -38.13 6.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.51 112.474 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 3.3 p30 -57.68 -56.39 22.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 72.33 110.894 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 40.6 mt -43.52 -45.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 74.23 111.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.96 -50.88 33.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.13 110.877 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -74.77 -52.43 11.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 72.5 110.906 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 35' ' ' GLN . . . -46.55 -57.15 5.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 64.02 111.108 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.41 -20.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.864 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -81.41 12.55 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 70.53 110.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -98.0 -47.16 5.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 71.31 110.901 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.38 -53.1 0.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 63.14 112.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.492 HD11 ' CD2' ' A' ' 68' ' ' HIS . 1.2 pt -82.06 5.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 73.43 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.579 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 6.9 m-20 -87.64 -56.71 3.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 72.53 110.878 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.427 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.2 OUTLIER -78.29 120.03 22.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.33 110.88 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.19 -67.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.75 -0.738 . . . . 73.41 112.492 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.62 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.72 4.81 1.96 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.722 2.281 . . . . 62.33 112.367 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 57' ' ' HIS . 29.7 pt -82.41 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.44 111.112 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.29 125.73 90.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 74.2 110.913 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.78 7.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 75.11 112.344 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.37 -31.74 1.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 63.22 112.497 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.84 -31.91 5.17 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 61.44 112.499 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.61 -68.25 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 73.43 111.123 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.19 2.81 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 71.21 110.876 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.57 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.1 t80 -39.99 -58.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 74.45 110.914 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.57 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mm-40 -98.24 131.45 26.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 64.23 110.866 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.67 148.98 87.63 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 -1.795 . . . . 72.24 112.368 -0.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.98 134.27 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.4 110.9 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.426 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 43.3 p -79.92 155.57 27.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 74.3 111.152 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.07 -53.58 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 75.42 111.136 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.61 18.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.849 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.4 -55.25 11.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.45 111.105 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.766 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -33.75 -53.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 73.04 110.869 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.766 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -66.23 -38.88 88.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.3 111.118 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.11 -42.45 94.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 73.33 111.086 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.1 t80 -66.32 -60.48 2.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 75.34 110.886 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.507 ' CG1' ' OD1' ' A' ' 38' ' ' ASP . 2.1 p -54.11 -34.77 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 75.55 111.086 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.561 ' HE1' ' CZ ' ' A' ' 78' ' ' PHE . 1.2 mmt -45.77 -25.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 65.25 110.885 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 19.0 t-20 -65.6 -63.56 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.848 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -72.5 -53.18 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 74.4 110.961 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.448 ' HB2' ' CG2' ' A' ' 61' ' ' VAL . 2.2 t80 -39.22 -57.5 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 62.4 110.914 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.583 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 16.7 t80 -50.45 -38.1 41.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.481 . . . . 64.12 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.44 ' OE1' ' C ' ' A' ' 99' ' ' GLY . 9.0 mt-30 -92.27 -4.22 54.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 75.1 110.929 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' CD2' HD11 ' A' ' 37' ' ' ILE . 2.3 t60 -74.88 -41.94 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 73.44 110.844 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.506 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.67 -63.17 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.34 111.099 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.03 18.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 72.25 112.538 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' CG ' ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.94 35.7 16.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 75.32 110.891 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.2 m-80 -107.31 167.84 9.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.953 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.476 ' CB ' HD11 ' A' ' 84' ' ' LEU . 72.1 p -68.98 -24.25 64.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 73.04 110.846 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -81.1 2.17 28.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 75.41 110.907 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.506 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -23.52 59.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.14 110.892 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.14 102.03 10.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 75.31 110.864 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.03 11.31 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.55 110.845 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.561 ' CZ ' ' HE1' ' A' ' 62' ' ' MET . 3.9 m-30 -57.96 -68.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 74.34 110.835 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -172.13 177.99 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 75.11 110.833 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -65.53 -1.61 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 72.02 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.416 ' H ' ' C ' ' A' ' 79' ' ' SER . 69.8 p -92.79 -53.16 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 75.04 111.112 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.95 103.43 11.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.35 111.05 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 t -148.45 178.02 8.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 70.02 111.096 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.481 ' CD2' ' HB3' ' A' ' 12' ' ' SER . 1.3 mt -66.69 152.4 45.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 70.01 110.872 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -133.75 167.32 20.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.12 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 87' ' ' THR . 61.8 m-80 -53.53 -168.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.41 110.867 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 86' ' ' ASN . 7.2 t -45.23 175.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.2 111.155 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.8 t-20 -51.98 108.26 1.03 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 74.31 110.911 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.74 -2.89 10.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.709 2.273 . . . . 65.53 112.368 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 t -52.0 106.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.854 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -73.15 -15.85 61.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.915 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.2 -111.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 72.4 112.499 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.44 -31.56 67.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 53.54 111.101 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 102.04 7.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 71.01 110.859 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.3 139.84 34.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.911 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.576 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.4 m-85 -85.84 157.63 57.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 71.41 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.469 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.81 106.26 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.647 2.231 . . . . 64.41 112.32 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.498 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 74.3 p -81.15 -11.48 59.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 63.14 110.866 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 67' ' ' GLN . . . 35.14 36.34 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 62.13 112.456 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.89 149.8 24.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.852 0.358 . . . . 74.24 110.879 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 75.24 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.898 0.38 . . . . 75.01 111.129 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.52 163.15 7.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 71.12 111.174 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 3.09 2.97 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.744 2.296 . . . . 74.03 112.345 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.5 p -52.06 151.95 6.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.537 0.684 . . . . 71.42 111.188 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 136.4 33.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.683 2.255 . . . . 72.34 112.347 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.5 p -114.37 154.25 46.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 73.41 111.1 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -172.05 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 73.1 112.35 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 126.03 42.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.02 110.872 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.25 127.8 33.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 74.31 111.069 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.1 136.9 52.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 73.31 111.069 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.572 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 91.64 63.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.721 . . . . 62.23 112.484 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 m -158.02 126.9 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.372 . . . . 73.32 110.857 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 5.7 m-90 -129.29 122.64 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.915 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.424 ' C ' HG11 ' A' ' 15' ' ' VAL . 1.1 t -95.47 107.56 19.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 73.43 110.897 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 3.9 m -152.64 154.81 32.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 74.55 111.136 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.74 131.37 21.13 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.701 2.267 . . . . 75.4 112.339 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 110.77 2.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.575 0.702 . . . . 74.23 110.929 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 96.79 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.252 . . . . 75.2 112.352 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.15 -32.31 2.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 53.52 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.495 ' CG1' HD23 ' A' ' 25' ' ' LEU . 3.6 p -58.67 -178.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.344 . . . . 74.34 111.127 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.49 ' H ' ' CG2' ' A' ' 20' ' ' VAL . 3.2 m -52.05 113.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 64.24 110.881 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.409 ' HA ' HD22 ' A' ' 25' ' ' LEU . 29.6 m-20 -58.22 -56.71 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.904 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.4 -15.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 72.52 110.906 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.31 -46.21 16.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 74.53 110.892 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -70.41 -50.23 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 65.21 110.906 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.442 HG21 ' N ' ' A' ' 27' ' ' GLY . 12.3 t -36.89 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.32 111.16 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . -66.34 -44.93 89.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.7 -0.762 . . . . 54.3 112.488 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' LEU . 14.5 m-20 -41.87 -48.82 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 75.42 110.883 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 57' ' ' HIS . 82.1 mt -55.63 -42.46 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 75.34 111.133 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.32 -46.05 80.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 70.32 110.886 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.15 -61.5 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.93 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.06 -46.87 53.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 74.42 111.083 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 40.4 t -50.33 -17.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 74.33 110.866 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -93.03 17.96 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.817 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -96.98 -48.95 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.03 110.935 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.7 -63.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 63.22 112.445 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.472 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.36 4.66 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 72.24 111.164 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 2.3 m-20 -78.08 -68.2 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 75.15 110.869 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.15 129.02 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.34 110.876 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 42' ' ' ILE . . . 122.57 -72.69 0.39 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 73.33 112.496 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.75 8.29 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.675 2.25 . . . . 71.22 112.364 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.474 HD13 ' HB2' ' A' ' 57' ' ' HIS . 29.8 pt -82.12 17.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 63.11 111.106 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -76.06 125.27 88.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.559 0.695 . . . . 75.12 110.91 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 161.62 45.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.24 . . . . 72.54 112.327 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.4 -40.62 1.47 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 70.42 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.71 17.34 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 74.32 112.535 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.79 -68.42 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.356 . . . . 71.11 111.099 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -117.89 11.67 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.898 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.551 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 13.0 t80 -55.32 -52.42 63.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.41 110.881 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.551 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 83.1 mt-10 -98.31 129.17 31.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.696 0.76 . . . . 61.34 110.869 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.79 153.48 93.04 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 -1.81 . . . . 64.4 112.361 -0.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -99.41 141.55 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 55.31 110.85 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.482 ' CG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -98.19 158.38 15.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 70.45 111.138 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.76 -55.17 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 74.4 111.146 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.07 18.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.903 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.9 -58.08 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 71.33 111.114 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.623 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -33.8 -48.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 62.22 110.842 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.623 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -64.53 -46.19 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 73.21 111.106 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -56.28 -46.96 79.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 74.42 111.093 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.6 t80 -59.77 -64.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 71.52 110.92 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 5.7 p -54.52 -36.21 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 75.31 111.116 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.476 ' CE ' ' SG ' ' A' ' 76' ' ' CYS . 8.6 mtp -45.49 -21.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.859 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -71.85 -52.36 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 75.3 110.84 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.472 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -81.14 -45.13 16.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 73.43 110.943 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.3 t80 -50.79 -45.93 59.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.882 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 19.3 t80 -58.9 -32.2 69.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 72.12 110.929 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' CD ' ' O ' ' A' ' 99' ' ' GLY . 27.2 mt-30 -95.95 -4.92 42.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 75.43 110.902 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -73.42 -41.81 62.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.13 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.19 -60.73 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.117 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.15 22.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.694 -0.765 . . . . 75.34 112.457 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.03 36.42 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 73.24 110.857 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.564 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.5 m-80 -108.81 165.55 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 74.22 110.842 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -68.34 -22.67 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 74.53 110.841 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.471 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -80.78 2.16 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 73.25 110.902 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.512 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -23.69 59.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 71.05 110.867 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' CE ' ' A' ' 62' ' ' MET . 4.1 m -82.48 102.01 11.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.887 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.03 12.89 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.868 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 62' ' ' MET . 4.2 m-30 -58.8 -68.26 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -171.73 177.99 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 61.4 110.86 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -1.94 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 75.14 110.921 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.464 ' CB ' HD11 ' A' ' 25' ' ' LEU . 68.2 p -92.01 -52.03 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 73.23 111.145 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB1' ' CE ' ' A' ' 62' ' ' MET . . . -82.51 101.98 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 72.14 111.087 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -148.86 178.08 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 75.14 111.156 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mp -66.89 154.15 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.45 110.871 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -133.92 169.22 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 72.12 111.169 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.06 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 65.34 110.892 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.47 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.02 111.16 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.58 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.5 t-20 -52.04 106.55 0.67 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 74.53 110.855 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.0 Cg_endo -69.76 0.59 5.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.641 2.228 . . . . 73.51 112.357 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.428 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.01 108.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 74.44 110.86 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 1.3 p90 -80.99 -16.29 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 74.31 110.963 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.26 -119.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.54 112.444 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.63 71.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 70.23 111.118 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.2 m -78.77 101.95 7.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 75.52 110.892 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -98.79 136.56 38.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.51 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.532 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.8 m-85 -85.27 147.22 46.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.72 . . . . 74.42 110.888 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 135.77 31.42 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 73.12 112.335 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.466 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 10.6 t -115.83 -8.32 11.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.878 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' O ' ' CD ' ' A' ' 67' ' ' GLN . . . 78.31 39.39 22.81 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 71.41 112.482 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.8 t -93.06 135.71 33.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 72.34 110.844 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 70.14 110.892 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.86 0.362 . . . . 42.12 111.069 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.1 p -141.48 146.26 41.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.549 0.69 . . . . 71.35 111.164 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.701 2.267 . . . . 75.55 112.339 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.9 p -143.92 123.39 7.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.722 . . . . 74.32 111.113 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.34 9.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 72.41 112.33 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 p -147.91 148.82 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.558 0.694 . . . . 72.14 111.17 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -171.89 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 71.12 112.345 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.42 116.95 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 74.4 110.89 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.03 160.11 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 74.42 111.067 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 175.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 54.11 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.503 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 155.92 41.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 64.14 112.474 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.0 124.0 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 75.45 110.854 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.8 m-90 -125.41 118.37 25.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 73.25 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -94.06 102.05 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 63.31 110.879 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.9 153.34 31.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 73.33 111.095 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HA ' ' C ' ' A' ' 81' ' ' THR . 53.5 Cg_endo -69.82 127.94 15.26 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.655 2.236 . . . . 71.43 112.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -51.96 114.71 5.65 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.583 0.706 . . . . 75.44 110.952 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.76 15.3 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 73.11 112.371 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -131.65 62.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.709 -0.758 . . . . 61.04 112.499 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' A' ' 25' ' ' LEU . 2.2 m -158.49 178.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 75.51 111.077 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 m -55.84 127.45 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 74.42 110.826 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.55 -49.4 67.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 73.32 110.833 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -28.03 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.4 110.839 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.03 -49.57 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 74.22 110.905 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HB3' ' CG ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -71.05 -41.33 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 72.33 110.917 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 m -46.29 -43.39 15.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 72.35 111.131 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.62 -29.57 25.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 71.44 112.513 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -59.97 -68.15 0.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 52.05 110.946 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.52 HG23 ' CG ' ' A' ' 57' ' ' HIS . 97.2 mt -40.9 -68.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 74.41 111.123 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 29' ' ' ILE . 5.6 t30 -34.1 -44.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.43 110.838 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -75.72 -68.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.03 110.932 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -45.18 -21.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 73.41 111.082 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.96 5.16 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.01 110.876 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -110.04 15.2 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.3 110.857 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.2 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 73.04 110.866 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.19 -55.78 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 72.14 112.46 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -82.21 9.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 74.14 111.141 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.574 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 1.6 m-20 -88.1 -63.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 74.52 110.868 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 114.93 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 63.13 110.88 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 42' ' ' ILE . . . 130.77 -69.67 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 61.0 112.485 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.8 7.5 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 74.44 112.313 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 57' ' ' HIS . 29.3 pt -82.22 16.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 71.4 111.145 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -73.62 123.74 89.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 61.13 110.932 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 171.25 14.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.719 2.28 . . . . 73.42 112.316 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.83 -33.89 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 72.41 112.485 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.09 5.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 63.32 112.498 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -68.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 73.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.87 2.18 18.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 72.22 110.9 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.487 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 6.1 t80 -40.99 -60.07 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.41 110.877 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.14 134.12 22.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.731 . . . . 73.35 110.905 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.71 150.67 90.38 Favored 'Cis proline' 0 C--N 1.341 0.145 0 C-N-CA 122.7 -1.792 . . . . 62.32 112.313 -0.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -100.47 122.22 42.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.68 157.48 20.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 74.43 111.146 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.92 -49.33 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.23 111.105 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.28 18.07 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.882 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.43 -54.18 23.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 75.33 111.076 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.716 ' HD1' ' N ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -37.25 -50.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.21 110.861 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' N ' ' HD1' ' A' ' 57' ' ' HIS . . . -65.3 -39.48 92.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 65.23 111.098 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.09 -55.85 29.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 75.32 111.105 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.3 t80 -52.6 -62.35 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.22 110.919 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 65' ' ' TYR . 1.5 p -54.38 -37.44 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 75.34 111.137 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.574 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -45.71 -21.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.05 110.875 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -71.37 -52.08 20.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 72.33 110.923 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 HD13 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -83.53 -46.39 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.34 110.899 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 2.2 t80 -46.33 -45.29 17.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.947 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CE1' ' O ' ' A' ' 72' ' ' ASN . 58.7 t80 -60.45 -34.91 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 73.13 110.939 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.412 HE21 ' CA ' ' A' ' 99' ' ' GLY . 39.9 mt-30 -93.07 -4.22 52.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 64.35 110.96 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.449 ' CE1' HG21 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -70.83 -44.58 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 60.42 110.833 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.453 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -76.6 -59.53 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 74.21 111.064 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.79 24.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 74.42 112.466 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.01 32.43 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 74.45 110.846 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.627 ' O ' ' CE1' ' A' ' 66' ' ' TYR . 5.9 m-80 -100.71 163.63 12.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.4 110.891 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.474 ' CB ' HD13 ' A' ' 84' ' ' LEU . 83.8 p -67.55 -21.87 65.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.42 110.885 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.489 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.71 3.5 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 74.12 110.875 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.453 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -76.53 -26.71 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 73.04 110.873 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.417 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 93.1 m -82.4 102.01 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 74.52 110.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -118.01 11.05 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 72.41 110.904 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.574 ' CZ ' ' HE3' ' A' ' 62' ' ' MET . 3.9 m-30 -57.72 -68.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 75.05 110.917 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -171.75 178.0 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.53 110.851 -179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -2.06 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 73.25 110.907 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.472 HG22 ' CD1' ' A' ' 25' ' ' LEU . 67.2 p -91.88 -53.58 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 64.31 111.104 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.49 102.01 11.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.34 111.107 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.3 t -152.88 178.03 10.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.21 111.141 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.474 HD13 ' CB ' ' A' ' 73' ' ' SER . 18.8 mt -65.8 123.69 20.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 73.01 110.949 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -106.17 168.63 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.05 111.132 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.8 m120 -53.88 -167.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 75.02 110.895 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.7 t -45.06 175.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 71.44 111.125 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.589 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.2 t-20 -51.95 107.09 0.75 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.701 . . . . 71.2 110.9 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.512 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.78 3.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 73.14 112.35 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.42 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 19.8 t -52.04 109.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.13 110.824 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -70.36 -16.86 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 74.21 110.967 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 175.16 -110.54 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 63.23 112.474 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.81 73.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 73.11 111.085 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.32 104.66 14.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 72.11 110.886 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -98.64 149.86 22.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 73.44 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.512 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.4 m-85 -90.71 159.87 39.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.652 0.739 . . . . 74.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 104.35 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.261 . . . . 61.52 112.334 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.578 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 40.6 p -73.83 -15.96 61.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 72.23 110.89 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.412 ' CA ' HE21 ' A' ' 67' ' ' GLN . . . 45.0 52.78 7.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.666 -0.778 . . . . 53.02 112.516 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.59 167.0 19.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 75.31 110.866 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 75.34 110.87 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.864 0.364 . . . . 73.41 111.081 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -52.43 141.56 32.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.541 0.686 . . . . 74.41 111.172 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 118.34 5.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.673 2.248 . . . . 73.44 112.34 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.468 ' CG2' ' HD2' ' A' ' 5' ' ' PRO . 21.6 m -79.26 136.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.578 0.704 . . . . 74.24 111.129 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' HD2' ' CG2' ' A' ' 4' ' ' THR . 53.7 Cg_endo -69.81 84.33 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.22 . . . . 74.53 112.347 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.13 159.97 66.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.608 0.718 . . . . 72.12 111.112 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -173.86 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.274 . . . . 74.42 112.335 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' NZ ' ' HA ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -130.59 122.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.892 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.82 155.03 33.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.42 111.093 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 132.91 54.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 54.21 111.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.578 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 108.09 83.77 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 74.52 112.439 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 58.1 m -157.77 138.4 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 72.51 110.84 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.578 ' CH2' ' HA2' ' A' ' 11' ' ' GLY . 10.9 m-90 -145.56 113.24 6.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 75.12 110.932 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.439 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -83.64 108.45 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.21 110.896 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.517 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.4 m -158.63 153.99 22.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 73.22 111.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.51 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.77 122.85 9.52 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.707 2.272 . . . . 63.41 112.36 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 116.97 8.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 74.53 110.927 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 86.85 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 65.25 112.324 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 -27.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 70.41 112.487 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.03 170.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 74.33 111.12 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.97 118.37 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 53.24 110.826 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -42.98 -66.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 71.21 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -41.23 -40.62 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 75.22 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.01 -50.4 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 70.14 110.904 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' CD2' ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -71.31 -31.17 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.947 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.2 m -64.66 -30.03 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 75.23 111.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.72 -23.3 70.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 71.13 112.466 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 57.5 m-20 -63.83 -58.64 6.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 72.24 110.912 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 95.9 mt -47.14 -47.86 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.11 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -51.65 -44.24 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.865 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.12 -56.56 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.881 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -47.85 -43.84 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 74.52 111.089 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -28.31 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.41 110.891 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -81.46 15.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.597 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.95 -46.8 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 75.23 110.932 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -62.43 0.64 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 61.3 112.512 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.46 ' CG1' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -83.07 11.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.43 111.094 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 1.6 t70 -86.98 -56.6 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.897 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.3 m -74.85 120.59 20.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 74.33 110.873 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.33 -69.44 0.43 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 75.53 112.477 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.81 1.28 4.61 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 74.53 112.337 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.576 HD12 ' CD2' ' A' ' 57' ' ' HIS . 33.3 pt -83.2 18.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.14 111.109 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -86.75 135.69 35.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.638 0.733 . . . . 73.42 110.907 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 174.12 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.281 . . . . 73.34 112.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.09 -33.73 0.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 73.24 112.463 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.18 -21.4 6.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 72.52 112.478 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.44 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 75.14 111.078 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.2 m -117.91 -2.27 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.4 110.914 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.3 t80 -36.42 -51.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 72.25 110.867 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 19.1 mm-40 -99.72 129.56 28.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.59 0.71 . . . . 64.53 110.901 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.77 147.85 85.51 Favored 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.69 -1.796 . . . . 71.33 112.366 0.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 6.4 p30 -104.17 133.4 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 72.44 110.934 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.51 166.4 12.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.131 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.35 -56.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 74.45 111.095 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.51 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -80.08 14.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 75.14 110.877 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.38 53.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 73.42 111.109 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.576 ' CD2' HD12 ' A' ' 42' ' ' ILE . 64.8 m80 -51.95 -52.3 51.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.54 110.864 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.02 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.35 111.108 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.73 68.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.12 111.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -68.38 -64.71 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 70.43 110.927 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 7.1 p -55.5 -33.7 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 73.25 111.136 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.57 ' HE1' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -45.85 -27.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 65.32 110.843 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -66.16 -60.51 2.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 63.4 110.835 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -71.4 -47.85 53.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.932 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.597 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 3.0 t80 -45.55 -48.24 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.955 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.4 t80 -62.37 -31.89 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 71.23 110.943 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.64 -4.64 44.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.29 -42.89 68.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 70.53 110.869 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.45 -60.61 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 71.42 111.098 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.19 23.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 72.24 112.494 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.541 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 7.7 mtp180 52.07 43.18 30.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 74.44 110.856 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.3 m-80 -109.19 166.95 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 74.11 110.941 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 p -71.15 -24.93 62.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 51.43 110.819 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -78.52 -1.1 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 74.3 110.907 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.82 -22.07 59.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 72.55 110.879 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -82.78 102.05 11.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.51 110.855 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -117.98 6.88 12.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 73.34 110.868 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE1' ' HE1' ' A' ' 62' ' ' MET . 3.3 m-30 -58.96 -71.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 64.21 110.89 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.16 178.01 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.807 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -2.78 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 71.41 110.904 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.494 ' HG1' ' N ' ' A' ' 82' ' ' ALA . 29.1 p -97.99 -46.68 5.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 75.35 111.148 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.517 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -80.97 24.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 72.31 111.062 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -84.47 -178.18 6.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 62.15 111.141 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.445 ' CD2' ' HB3' ' A' ' 12' ' ' SER . 1.6 mt -66.89 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.906 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -106.2 169.06 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 75.02 111.164 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 87' ' ' THR . 13.1 m-80 -53.25 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 71.35 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.08 173.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 75.14 111.159 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 6.6 t-20 -52.07 106.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 74.11 110.889 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.72 -13.21 34.44 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 65.44 112.378 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -52.06 105.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 65.53 110.847 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -16.7 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.31 110.908 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.56 -115.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 71.21 112.504 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.27 86.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 71.11 111.082 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 101.99 5.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.918 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.57 139.18 36.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.01 110.892 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.574 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 20.0 m-85 -93.01 141.18 23.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 74.12 110.879 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 129.02 16.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 74.31 112.331 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.556 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 36.8 p -110.03 -6.4 15.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.52 110.898 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 46.43 30.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 64.1 112.478 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 p -155.69 125.24 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.39 . . . . 73.03 110.83 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 73.5 110.864 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.872 0.368 . . . . 73.11 111.119 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.4 p -88.01 137.97 31.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.587 0.708 . . . . 64.52 111.128 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 165.35 31.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.68 2.253 . . . . 71.13 112.369 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.2 p -142.15 127.36 10.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.608 0.718 . . . . 74.14 111.153 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 157.73 59.33 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 75.42 112.353 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 m -142.74 101.95 5.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.599 0.714 . . . . 64.42 111.161 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 3.47 2.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.237 . . . . 73.2 112.397 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.12 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 75.13 110.894 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.75 168.56 17.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 63.23 111.151 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.63 177.98 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 73.11 111.135 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -125.77 -8.69 5.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 63.02 112.469 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.49 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 3.7 m -141.9 148.23 38.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 73.32 110.867 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.561 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 9.2 m-90 -142.85 115.16 8.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 72.23 110.893 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.441 ' C ' HG11 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.79 108.62 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 62.11 110.885 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.519 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.2 m -158.56 154.16 22.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 72.52 111.124 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.52 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.78 120.75 7.48 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 75.05 112.334 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.01 117.7 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.617 0.722 . . . . 74.34 110.877 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.723 2.282 . . . . 73.11 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.06 -21.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 65.55 112.409 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 17' ' ' LYS . 2.3 t -59.07 164.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 70.04 111.155 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 24' ' ' GLN . 2.0 m -53.63 111.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 75.35 110.854 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.7 m-20 -33.78 -64.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 61.13 110.884 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.24 -40.73 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.871 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.4 tp-100 -58.33 -50.44 73.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 70.02 110.896 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.559 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.9 -29.28 65.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 74.04 110.901 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -66.53 -0.24 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.11 111.168 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.92 -38.5 5.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 62.3 112.498 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.4 p30 -53.6 -43.1 68.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 62.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 64.1 mt -59.11 -46.94 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -44.31 38.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 63.53 110.884 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.7 -49.03 27.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 64.22 110.92 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -51.7 -45.13 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 73.3 111.093 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' CA ' ' OD2' ' A' ' 38' ' ' ASP . 9.0 t -57.44 -12.16 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 71.43 110.863 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.13 6.69 47.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 64.02 110.831 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.468 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.96 -43.09 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.43 110.957 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.96 -47.09 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 64.23 112.428 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 pt -89.74 8.21 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 73.31 111.132 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.483 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 9.3 t70 -86.87 -61.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 70.43 110.871 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 m -75.95 124.62 27.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.812 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.28 -74.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 64.1 112.433 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 4.14 2.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 74.11 112.325 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.537 HD12 ' CG ' ' A' ' 57' ' ' HIS . 5.9 pt -82.93 17.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 74.34 111.111 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -79.16 144.33 62.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.608 0.718 . . . . 64.15 110.891 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.2 Cg_endo -69.74 148.13 64.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 74.33 112.388 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.64 -39.28 3.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 72.43 112.5 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.69 15.18 2.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.74 . . . . 72.24 112.52 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.89 -68.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 75.32 111.149 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' PHE . 21.1 t -117.93 -6.73 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 72.13 110.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 3.0 t80 -34.34 -56.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 71.11 110.878 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 9.7 mm-40 -99.6 125.84 39.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 61.25 110.913 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.82 150.71 90.73 Favored 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 -1.813 . . . . 72.32 112.337 0.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.47 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -111.29 133.52 53.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 72.23 110.852 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.81 176.63 6.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 64.42 111.098 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.32 -54.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.12 111.114 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.71 17.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 75.11 110.862 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.28 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 73.15 111.101 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.537 ' CG ' HD12 ' A' ' 42' ' ' ILE . 26.8 m170 -57.25 -57.77 11.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 73.2 110.893 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -50.02 -36.52 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 74.04 111.086 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.31 92.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.1 111.059 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 5.7 t80 -68.01 -59.09 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 75.14 110.904 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 58' ' ' ALA . 7.5 p -55.1 -35.97 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 74.02 111.152 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.564 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 0.3 OUTLIER -46.46 -29.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 74.41 110.892 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.38 -65.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.935 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -47.87 74.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 73.25 110.902 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.468 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 2.2 t80 -49.71 -47.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.13 110.929 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.1 t80 -60.6 -30.62 69.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.41 110.882 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -98.87 3.34 47.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.881 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.535 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -75.41 -48.8 21.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.878 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.535 ' N ' ' CG ' ' A' ' 68' ' ' HIS . . . -70.16 -54.55 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.24 111.065 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.67 26.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 71.11 112.489 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.97 47.96 23.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 72.41 110.847 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.563 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 4.1 m-80 -114.19 162.07 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.928 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.5 p -67.96 -24.43 65.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 74.4 110.818 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -80.04 1.19 28.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 75.4 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.46 -19.79 55.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.35 110.919 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -83.54 102.08 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 72.11 110.833 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.04 7.56 12.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.898 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.564 ' CE2' ' HG2' ' A' ' 62' ' ' MET . 3.3 m-30 -59.27 -71.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 75.23 110.913 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -173.71 177.97 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.883 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -65.5 -1.99 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 72.45 110.931 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.559 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 26.9 p -97.92 -47.48 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 62.54 111.157 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.519 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -81.03 26.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 63.24 111.088 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.6 t -86.75 -177.83 6.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 63.33 111.158 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 mt -67.04 130.51 43.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.442 . . . . 70.51 110.899 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.5 t -106.02 169.51 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 75.02 111.139 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.0 m120 -53.15 -169.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 71.32 110.883 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.5 t -44.66 172.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 61.13 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.561 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 15.7 t-20 -52.09 106.79 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.662 0.744 . . . . 75.21 110.869 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.74 -3.7 12.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 73.44 112.353 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 1.9 t -52.02 104.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 75.11 110.889 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -17.83 25.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 74.24 110.899 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.08 -117.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 63.55 112.519 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.8 -26.79 65.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 72.33 111.07 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 t -76.13 102.02 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 63.02 110.87 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.77 127.94 45.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.525 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 25.6 m-85 -92.45 141.15 24.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 72.31 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.24 25.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.688 2.259 . . . . 75.53 112.361 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 99' ' ' GLY . 18.4 p -106.1 -14.34 15.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.3 110.859 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 98' ' ' SER . . . 35.49 38.77 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 72.24 112.472 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.1 p -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 74.04 110.826 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 73.53 110.877 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.857 0.361 . . . . 60.22 111.087 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.0 p -94.48 132.99 27.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.638 0.733 . . . . 75.21 111.141 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -176.28 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 71.44 112.346 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.7 p -156.44 147.45 16.51 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.604 0.716 . . . . 74.04 111.105 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.42 6.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.707 2.271 . . . . 75.31 112.356 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.0 p -100.34 143.55 26.74 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.589 0.709 . . . . 72.44 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -172.85 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.687 2.258 . . . . 74.3 112.372 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -114.52 126.67 55.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 74.33 110.904 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.441 ' N ' ' HD3' ' A' ' 8' ' ' LYS . . . -56.01 113.32 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 64.34 111.093 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.53 177.96 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.088 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.569 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -59.78 -177.15 1.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 74.41 112.44 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.656 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -146.3 153.92 41.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 71.43 110.856 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.656 ' CE3' ' C ' ' A' ' 12' ' ' SER . 8.6 m-90 -153.4 112.2 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.908 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -79.41 110.76 15.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.44 110.927 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.491 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 5.6 m -159.96 155.88 22.92 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.668 0.747 . . . . 75.55 111.078 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.77 122.9 9.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 74.44 112.331 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -52.02 114.53 5.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.525 0.678 . . . . 73.32 110.918 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 99.89 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 74.01 112.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.63 -28.28 2.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 72.53 112.474 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' CG2' ' H ' ' A' ' 21' ' ' SER . 5.8 p -58.89 173.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 52.44 111.155 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.491 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -52.0 109.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.45 110.853 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.77 -68.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.12 110.861 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -41.22 -27.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 73.24 110.894 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 21' ' ' SER . 6.1 tm0? -63.99 -51.49 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 73.3 110.915 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' CD1' HG23 ' A' ' 81' ' ' THR . 0.2 OUTLIER -70.24 -33.41 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 73.31 110.915 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 m -51.01 -18.84 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 74.2 111.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.97 -27.65 49.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 75.41 112.493 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 78.7 m-20 -59.81 -46.51 88.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 75.41 110.917 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 54' ' ' VAL . 65.2 mt -62.96 -53.24 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 75.11 111.117 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -52.43 -47.21 66.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.24 110.873 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -69.37 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.69 -33.36 33.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.081 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.8 t -57.27 -11.3 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 64.02 110.859 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 17.99 14.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 71.04 110.863 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.433 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -90.84 -51.83 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 73.14 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 168.02 -97.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 75.43 112.471 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.99 18.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 75.41 111.121 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -75.09 -62.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.53 110.89 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.37 126.14 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.83 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.13 -70.06 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 74.23 112.467 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' CG ' ' O ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.81 6.0 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.683 2.255 . . . . 65.02 112.325 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 57' ' ' HIS . 22.6 pt -82.63 18.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.01 111.135 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -79.89 129.51 70.31 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 74.33 110.922 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 170.1 17.46 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.678 2.252 . . . . 75.0 112.299 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.6 -41.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 61.44 112.48 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.35 -17.49 5.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 61.15 112.505 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.14 -68.64 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 72.21 111.132 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.05 6.29 12.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 72.3 110.859 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.551 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 3.7 t80 -40.87 -68.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.04 110.885 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.551 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -93.24 137.74 23.45 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.617 0.722 . . . . 73.11 110.913 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.2 Cg_endo -69.75 139.87 57.18 Favored 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.712 -1.786 . . . . 74.25 112.317 -0.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.73 133.66 52.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.437 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -86.93 174.24 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.479 . . . . 74.13 111.129 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 29' ' ' ILE . 56.4 t -65.76 -55.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 64.45 111.162 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.619 ' HZ2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -78.42 13.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 75.04 110.904 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' N ' ' HZ2' ' A' ' 55' ' ' LYS . . . -51.15 -48.89 61.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 73.11 111.112 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.585 ' CD2' HD12 ' A' ' 42' ' ' ILE . 65.5 m80 -49.04 -48.13 44.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 74.34 110.847 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.488 ' HB3' ' CE ' ' A' ' 62' ' ' MET . . . -57.66 -38.06 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.3 111.116 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' N ' ' HE1' ' A' ' 62' ' ' MET . . . -55.97 -37.54 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 41.13 111.119 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 3.4 t80 -68.53 -59.14 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.905 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 2.0 p -54.71 -39.19 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 73.22 111.125 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.563 ' HE3' ' CE2' ' A' ' 78' ' ' PHE . 5.0 mtm -45.96 -32.62 2.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 74.54 110.858 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 62.34 110.862 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -63.69 -59.5 4.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.911 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.436 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 4.4 t80 -39.65 -43.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.901 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.0 t80 -61.15 -41.34 96.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 63.44 110.927 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 99' ' ' GLY . 29.2 mt-30 -91.62 -3.82 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 64.21 110.931 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.3 t60 -75.26 -40.68 58.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 74.24 110.89 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . . . -75.76 -60.6 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.52 111.081 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.62 20.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 72.51 112.51 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 51.96 33.91 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 73.44 110.887 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.9 m-80 -102.98 167.24 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.897 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -71.26 -24.3 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 74.2 110.858 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.436 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -78.19 0.52 24.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 75.13 110.927 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.499 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -6.17 45.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 75.24 110.925 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -94.28 102.21 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.32 110.85 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.03 5.29 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 71.31 110.819 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.563 ' CE2' ' HE3' ' A' ' 62' ' ' MET . 3.0 m-30 -59.31 -71.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 70.1 110.879 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.37 177.99 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 75.11 110.86 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.37 -2.84 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.51 110.936 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.506 ' HG1' ' N ' ' A' ' 82' ' ' ALA . 27.5 p -98.04 -47.25 5.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.14 111.103 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' N ' ' HG1' ' A' ' 81' ' ' THR . . . -81.44 24.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 64.03 111.06 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 t -85.05 -177.29 6.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 70.44 111.173 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.4 mt -66.86 125.28 25.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 75.2 110.875 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.7 t -98.01 169.39 9.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 73.14 111.161 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 85' ' ' THR . 51.8 m-80 -52.95 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.32 110.901 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 1.6 t -44.39 170.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 63.04 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.566 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.3 t-20 -52.01 106.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.643 0.735 . . . . 73.45 110.902 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -3.09 11.28 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 73.53 112.323 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.632 ' HG ' ' ND2' ' A' ' 95' ' ' ASN . 3.5 t -51.97 107.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.45 110.857 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -17.88 45.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 75.42 110.913 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.56 -113.59 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 72.51 112.471 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.18 -38.16 90.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 65.24 111.103 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 101.99 5.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 74.35 110.905 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.632 ' ND2' ' HG ' ' A' ' 90' ' ' SER . 0.4 OUTLIER -99.51 144.97 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 60.31 110.906 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 8.6 m-85 -92.45 150.35 39.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.657 0.741 . . . . 74.01 110.924 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 115.97 4.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 72.21 112.333 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.562 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 8.5 p -109.42 16.58 22.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 53.03 110.876 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.465 ' O ' ' NE2' ' A' ' 67' ' ' GLN . . . 68.04 -80.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 75.22 112.509 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 106.69 15.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 71.35 110.852 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 64.23 110.86 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.874 0.369 . . . . 71.04 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.7 m -98.03 119.66 61.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.558 0.694 . . . . 73.15 111.154 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 161.9 44.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 65.24 112.359 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.8 p -80.32 115.91 58.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 70.41 111.157 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 177.91 5.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 74.33 112.356 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 p -97.81 102.69 14.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.597 0.713 . . . . 64.21 111.11 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -173.85 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.643 2.229 . . . . 72.04 112.327 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -88.07 123.97 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 62.02 110.871 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.55 163.56 2.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 75.24 111.063 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -160.47 177.43 10.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.34 111.09 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.99 -134.66 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 73.14 112.51 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.571 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -154.71 154.57 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 73.32 110.836 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.571 ' CE3' ' C ' ' A' ' 12' ' ' SER . 7.6 m-90 -146.7 105.24 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 74.52 110.929 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.435 ' C ' HG12 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -72.28 105.34 4.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 53.43 110.867 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.505 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.2 m -158.77 153.62 21.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 75.11 111.098 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.76 120.27 7.08 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 50.25 112.371 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.0 119.37 14.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 75.24 110.904 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 85.3 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.725 2.283 . . . . 71.44 112.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.42 -22.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 70.44 112.457 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.4 t -65.81 164.13 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 73.15 111.123 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 22' ' ' ASP . 5.4 m -54.0 103.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 63.2 110.88 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 21' ' ' SER . 34.8 m-20 -34.06 -65.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 74.03 110.876 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . 35.2 m-20 -36.21 -41.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 73.31 110.895 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -62.62 -46.91 86.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.911 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 HD12 ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER -70.27 -33.54 71.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.3 110.93 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 m -56.6 -35.0 67.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 72.54 111.145 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.9 -26.63 67.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 73.1 112.509 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -63.46 -43.2 98.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 73.43 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 24.9 mt -62.38 -51.63 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.01 111.102 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -54.07 -45.41 71.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.42 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -68.95 -58.07 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 75.44 110.895 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -49.94 -47.03 52.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 75.31 111.127 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.456 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -50.77 -17.43 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.863 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -88.0 13.58 10.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.897 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.45 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.03 -46.06 6.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 72.0 110.918 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 136.53 -55.57 0.7 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.714 -0.755 . . . . 71.53 112.457 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -88.13 4.1 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 64.1 111.135 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 1.9 m-20 -80.6 -58.98 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 75.51 110.857 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -75.37 127.31 32.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 75.25 110.874 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.17 -73.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 43.15 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.602 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.8 3.61 2.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.686 2.257 . . . . 73.14 112.336 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.581 HD11 ' CD2' ' A' ' 57' ' ' HIS . 12.7 pt -83.1 17.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 72.53 111.08 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.52 135.54 53.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 64.42 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 176.56 6.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.695 2.263 . . . . 72.33 112.381 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.95 -35.43 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 71.44 112.466 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.1 -25.86 9.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 61.21 112.471 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.78 -68.14 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 65.34 111.108 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.09 -8.96 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.22 110.866 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -37.49 -48.44 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.52 110.842 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.32 126.97 37.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 74.52 110.858 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.72 148.26 86.26 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 -1.789 . . . . 63.13 112.335 -0.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 8.7 t-20 -103.14 150.63 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 53.03 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.9 p -106.46 163.82 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 72.13 111.119 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.8 -56.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 73.3 111.122 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -80.49 16.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 73.41 110.864 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.24 -47.89 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.0 111.127 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.581 ' CD2' HD11 ' A' ' 42' ' ' ILE . 68.2 m80 -45.34 -58.97 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 65.22 110.84 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.431 ' O ' ' CG ' ' A' ' 62' ' ' MET . . . -51.46 -38.81 55.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.44 111.096 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.42 72.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.2 111.111 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.602 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 9.4 t80 -68.13 -63.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.04 110.923 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.495 ' CG1' ' OD1' ' A' ' 38' ' ' ASP . 7.4 p -55.12 -33.56 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 73.13 111.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.57 ' HE3' ' CD1' ' A' ' 78' ' ' PHE . 1.3 mmt -46.13 -29.66 1.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.885 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.37 -65.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.1 110.858 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -51.03 62.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 64.53 110.901 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 35' ' ' GLN . 2.8 t80 -44.64 -43.71 8.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 74.03 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 3.7 t80 -64.08 -30.71 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.33 110.936 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -98.21 -2.33 39.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.928 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -72.99 -48.18 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 75.11 110.85 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' N ' ' CG ' ' A' ' 68' ' ' HIS . . . -68.82 -57.06 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 73.43 111.136 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.7 24.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 75.13 112.482 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 52.0 35.61 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 74.24 110.839 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -103.14 166.3 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 54.04 110.846 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -71.3 -23.24 61.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 65.53 110.81 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.44 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -79.29 0.26 29.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.468 . . . . 74.34 110.936 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.463 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -23.19 59.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.3 110.891 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -84.11 102.11 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.13 110.846 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -118.08 8.44 12.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.828 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CD1' ' HE3' ' A' ' 62' ' ' MET . 3.5 m-30 -59.46 -70.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.876 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.75 177.98 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.13 110.803 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -65.33 -2.35 3.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 71.4 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.492 ' CG2' HD12 ' A' ' 25' ' ' LEU . 29.0 p -97.96 -46.46 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.13 111.17 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -81.66 25.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 75.21 111.077 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 t -86.56 -177.6 6.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 75.04 111.18 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.89 106.9 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.915 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -77.98 167.55 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 70.53 111.152 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 17.2 m-20 -53.27 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 75.21 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.65 173.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 74.4 111.099 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.558 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 21.5 t-20 -52.0 106.0 0.6 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.647 0.737 . . . . 62.14 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.2 Cg_endo -69.74 -23.03 31.33 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.272 . . . . 70.3 112.298 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.1 t -52.0 106.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 72.32 110.832 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -80.03 -15.3 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.917 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.01 -124.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 74.33 112.474 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -37.86 -43.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 73.45 111.088 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 62.22 110.852 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.84 133.83 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.12 110.907 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.521 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 23.8 m-85 -92.71 146.48 32.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.678 0.751 . . . . 74.5 110.869 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 117.13 4.89 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.674 2.249 . . . . 71.45 112.345 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.557 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 91.9 p -102.6 -1.36 30.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 71.32 110.87 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.87 -88.04 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 65.04 112.509 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -77.47 124.11 27.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 74.04 110.895 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 52.4 110.894 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.897 0.38 . . . . 70.04 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.9 p -118.0 143.5 32.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 75.21 111.175 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.249 . . . . 73.41 112.343 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p -103.26 145.11 29.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.699 . . . . 72.42 111.148 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -175.5 1.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.234 . . . . 73.5 112.353 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 p -90.64 119.75 68.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.693 . . . . 74.22 111.176 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -173.05 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 71.5 112.333 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.31 124.93 19.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 74.35 110.884 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.67 160.25 31.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.53 111.123 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.85 168.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 73.1 111.153 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.45 36.65 1.29 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 64.13 112.544 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.665 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 58.8 m -159.79 152.05 20.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 71.5 110.836 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.665 ' CE3' ' C ' ' A' ' 12' ' ' SER . 9.2 m-90 -152.8 123.19 7.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.3 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.48 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -90.7 111.72 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.12 110.886 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 14' ' ' CYS . 4.2 m -160.09 154.89 20.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 72.24 111.133 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -69.75 125.59 12.33 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.717 2.278 . . . . 71.55 112.35 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 110.13 1.73 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.512 0.672 . . . . 71.3 110.882 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 97.58 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 74.31 112.29 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.83 -33.73 2.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 54.23 112.483 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.429 ' CG2' ' H ' ' A' ' 21' ' ' SER . 2.8 p -58.98 178.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 73.1 111.136 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.429 ' H ' ' CG2' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -52.0 128.46 24.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 73.21 110.838 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 24' ' ' GLN . 72.9 m-20 -58.26 -67.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 74.14 110.854 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.454 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 1.1 m-20 -41.81 -23.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.42 110.834 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 22' ' ' ASP . 1.0 OUTLIER -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 73.04 110.904 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' CG ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -70.89 -56.67 5.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.898 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.454 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 12.0 t -44.9 -20.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 72.32 111.108 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 25' ' ' LEU . . . -69.15 -37.93 82.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 73.2 112.48 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.88 -56.24 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.782 0.325 . . . . 74.51 110.916 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 23.4 mt -46.44 -41.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 63.44 111.128 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -56.66 -48.08 78.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.12 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.13 -56.18 5.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.1 110.967 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -51.05 -43.47 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 75.22 111.099 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 37.4 t -52.75 -15.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.51 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.32 15.87 16.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 60.02 110.886 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -97.98 -48.04 5.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 74.22 110.922 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.73 -64.14 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.748 . . . . 54.44 112.486 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 ' CD1' HD13 ' A' ' 64' ' ' LEU . 3.4 pt -82.3 14.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 71.35 111.121 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.463 ' OD1' ' CB ' ' A' ' 32' ' ' ALA . 3.2 m-20 -89.5 -65.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.846 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 m -76.08 124.49 27.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.858 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.45 -74.58 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 73.32 112.499 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.5 Cg_endo -69.78 5.73 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 71.01 112.322 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.583 HD11 ' CD2' ' A' ' 57' ' ' HIS . 5.1 pt -85.23 17.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 70.02 111.105 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -76.69 135.49 68.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.722 . . . . 75.41 110.93 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 170.66 16.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.625 2.216 . . . . 74.1 112.318 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.78 -38.83 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 71.33 112.444 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.57 -26.16 4.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 74.23 112.434 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.83 -68.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 63.42 111.093 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.96 14.43 14.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.897 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 3.1 t80 -56.48 -50.9 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.24 110.899 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -97.52 128.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.699 0.762 . . . . 74.44 110.853 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 150.84 90.87 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.68 -1.8 . . . . 74.54 112.37 -0.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 4.1 t30 -99.74 131.62 45.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.33 110.86 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.424 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 65.7 p -90.9 167.31 12.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 75.02 111.193 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.2 -59.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 71.4 111.141 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' CG ' ' HG3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.49 17.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 63.44 110.929 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -48.55 -41.12 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.4 111.043 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.583 ' CD2' HD11 ' A' ' 42' ' ' ILE . 47.2 m80 -54.76 -55.26 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 74.14 110.874 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -50.57 -41.93 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.15 111.106 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.43 -40.23 77.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 74.43 111.101 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 6.3 t80 -68.92 -57.0 6.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 73.33 110.972 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.479 ' CG1' ' HA ' ' A' ' 58' ' ' ALA . 3.3 p -54.39 -43.79 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 72.32 111.134 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.462 ' CE ' ' HD3' ' A' ' 16' ' ' PRO . 2.8 ttm -45.76 -29.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 75.4 110.863 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.502 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 32.8 t30 -59.3 -62.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.54 110.855 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.58 -46.22 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.93 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 3.4 t80 -47.43 -54.59 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.599 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.0 t80 -55.59 -30.55 61.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 74.12 110.905 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 49.4 mt-30 -95.41 -4.51 45.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 73.41 110.895 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -68.4 -44.14 75.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 70.41 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.494 ' N ' ' CG ' ' A' ' 68' ' ' HIS . . . -76.42 -60.23 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.52 111.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.82 23.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 33.12 112.475 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.563 ' C ' ' CE1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.02 37.24 20.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 75.23 110.858 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.599 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 2.4 m-80 -100.97 164.76 11.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.23 110.913 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 p -68.38 -25.57 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.15 110.825 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -79.55 1.78 24.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 74.42 110.951 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.46 ' OD1' ' CB ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -79.92 -3.93 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 72.52 110.868 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -101.57 102.01 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 63.33 110.888 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -117.96 9.54 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.32 110.904 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -58.33 -70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.929 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -173.78 178.01 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 62.23 110.868 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -3.07 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 74.42 110.937 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.503 ' HG1' ' N ' ' A' ' 82' ' ' ALA . 26.5 p -97.95 -49.01 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 55.14 111.146 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.503 ' N ' ' HG1' ' A' ' 81' ' ' THR . . . -81.73 25.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.02 111.139 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -86.3 -178.5 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 72.33 111.16 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.9 mm? -66.91 130.89 44.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 73.42 110.899 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.05 167.85 9.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 73.02 111.149 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.9 m-20 -53.71 -168.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 71.31 110.878 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -44.53 171.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 75.43 111.163 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 13.6 t-20 -51.95 105.94 0.59 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.33 110.878 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.79 -1.27 8.21 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 72.44 112.347 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.456 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 4.9 t -51.98 110.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 72.44 110.874 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -86.98 -18.06 31.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 65.02 110.918 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.44 -120.72 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 64.43 112.452 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 74.14 111.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.98 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.35 110.854 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.03 140.32 33.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.891 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.5 m-85 -92.11 146.03 31.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 74.43 110.865 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 122.83 9.49 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 74.2 112.37 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.419 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 25.7 p -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 74.42 110.866 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 -57.0 2.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 61.23 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 t -88.99 176.17 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 54.25 110.86 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 65.03 110.885 -179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.9 0.381 . . . . 63.22 111.048 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.477 ' CG2' ' HD2' ' A' ' 3' ' ' PRO . 95.6 m -68.39 139.03 91.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.565 0.698 . . . . 74.31 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.477 ' HD2' ' CG2' ' A' ' 2' ' ' THR . 54.0 Cg_endo -69.73 -177.28 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 60.23 112.376 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.6 p -53.93 129.54 57.05 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.624 0.726 . . . . 75.21 111.112 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -179.45 2.94 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.647 2.231 . . . . 73.42 112.326 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 p -53.92 156.07 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 74.23 111.149 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -174.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.687 2.258 . . . . 73.42 112.324 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 121.0 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 72.44 110.902 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.23 171.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.43 111.109 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 125.46 23.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 71.21 111.129 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -41.12 121.37 2.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 73.21 112.539 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.651 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 2.7 m -157.92 129.68 6.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 73.4 110.874 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.651 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 6.4 m-90 -141.07 114.14 8.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.916 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.0 110.67 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 74.2 110.861 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.499 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 m -159.59 154.34 21.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.626 0.727 . . . . 75.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.507 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 54.1 Cg_endo -69.8 123.28 9.94 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 73.43 112.326 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.98 114.3 5.18 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 74.42 110.871 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 92.37 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.715 2.277 . . . . 72.14 112.37 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.74 -24.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 53.32 112.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 21' ' ' SER . 44.3 t -59.05 165.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 74.14 111.142 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 24' ' ' GLN . 3.2 m -52.08 108.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.45 110.877 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 21' ' ' SER . 5.5 m-20 -32.99 -65.27 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 70.43 110.853 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.02 -40.68 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.905 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -60.26 -49.17 78.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 73.25 110.907 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.22 -29.04 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 61.52 110.945 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.413 ' OG1' ' CG1' ' A' ' 54' ' ' VAL . 17.3 m -67.11 0.07 2.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 73.52 111.166 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -90.92 -40.34 5.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 75.41 112.506 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.3 p30 -50.47 -44.3 55.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.367 . . . . 75.21 110.883 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.506 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 61.6 mt -58.21 -49.05 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 74.05 111.142 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.19 -41.07 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.31 110.9 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.15 -52.68 11.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.35 110.967 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . . . -52.82 -41.6 64.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 70.3 111.099 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.42 -9.69 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 70.22 110.9 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.19 3.89 40.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.848 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.18 -36.48 6.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.923 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 -31.18 7.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 74.03 112.506 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.503 ' O ' ' CG1' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -83.22 -11.41 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 74.43 111.168 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -77.65 -63.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 75.23 110.876 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 62.9 m -75.83 129.57 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 64.11 110.834 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.7 -85.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 54.31 112.51 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 7.02 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.242 . . . . 74.34 112.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.536 HD13 ' CG ' ' A' ' 57' ' ' HIS . 5.1 pt -82.62 17.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.54 111.16 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -79.53 132.85 60.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.601 0.715 . . . . 70.15 110.916 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 171.52 14.33 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.686 2.258 . . . . 64.42 112.323 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 72.24 112.492 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.36 -25.72 3.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.35 112.449 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.41 -68.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 75.21 111.12 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.95 14.88 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 65.44 110.907 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.567 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 2.9 t80 -51.66 -56.55 13.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 73.14 110.847 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 1.3 mm-40 -96.41 133.18 25.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 65.45 110.879 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 157.04 92.57 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.705 -1.79 . . . . 75.4 112.33 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -117.24 142.22 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 73.12 110.912 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.0 p -106.84 172.82 6.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.118 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' CG1' ' OG1' ' A' ' 26' ' ' THR . 43.9 t -65.73 -54.73 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.153 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -79.7 17.23 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.893 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.3 -45.44 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.34 111.115 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.536 ' CG ' HD13 ' A' ' 42' ' ' ILE . 32.9 m170 -53.79 -60.18 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 71.55 110.843 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' HB3' ' CE ' ' A' ' 62' ' ' MET . . . -43.97 -47.21 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 70.3 111.1 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' N ' ' HE3' ' A' ' 62' ' ' MET . . . -50.89 -38.35 49.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 75.14 111.134 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 8.9 t80 -69.33 -65.01 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.947 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.469 ' CG2' HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -54.42 -26.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 75.02 111.127 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.473 ' CE ' ' HB3' ' A' ' 58' ' ' ALA . 1.5 mtm -52.26 -20.38 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.889 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.07 -65.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 74.4 110.877 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.46 HD11 ' CD1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -63.74 -41.77 97.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.4 110.908 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 3.4 t80 -58.51 -45.11 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.916 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 4.6 t80 -65.21 -30.43 71.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.41 110.926 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -96.21 -3.71 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 73.34 110.949 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -45.74 74.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.23 110.83 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.82 -57.75 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.23 111.071 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.11 25.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 71.4 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.545 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.04 47.09 25.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 72.01 110.897 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.6 m-80 -110.27 165.6 11.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.886 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.4 p -70.74 -25.84 63.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 65.21 110.841 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -77.74 0.3 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.946 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.54 -14.42 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 75.53 110.886 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -91.39 102.03 14.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.24 110.864 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.06 7.75 12.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.43 110.877 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.468 ' HB3' ' CB ' ' A' ' 28' ' ' ASN . 3.3 m-30 -59.03 -70.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.853 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.85 178.03 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 75.54 110.884 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -1.84 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.33 110.908 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.58 ' CG2' ' CD1' ' A' ' 25' ' ' LEU . 37.3 p -95.0 -50.33 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.22 111.147 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -80.66 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 71.4 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 81' ' ' THR . 12.3 t -87.01 -179.52 6.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 75.22 111.148 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' A' ' 12' ' ' SER . 2.5 mt -67.36 131.51 45.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.938 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.08 168.43 9.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.129 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.25 -169.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 65.13 110.867 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -44.22 172.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 74.33 111.127 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.4 t-20 -52.01 106.78 0.7 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 74.11 110.89 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.52 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.7 -4.03 13.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.678 2.252 . . . . 74.15 112.34 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 2.5 t -51.98 110.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 65.25 110.838 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -15.69 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 72.41 110.921 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.89 -128.92 1.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 62.1 112.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.59 65.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 74.52 111.142 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.49 101.98 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.902 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -99.75 141.29 32.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 75.45 110.939 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.52 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 15.9 m-85 -93.14 147.76 34.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 75.3 110.896 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.4 4.08 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 72.24 112.289 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.448 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 27.9 p -95.08 -6.8 41.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 75.31 110.878 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.39 -83.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.757 . . . . 71.43 112.488 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.59 120.76 34.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 73.13 110.853 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 74.22 110.827 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 62.41 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.2 p -116.12 145.88 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.641 0.734 . . . . 75.24 111.099 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.09 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 75.13 112.318 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 p -95.96 144.22 27.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.711 . . . . 54.25 111.138 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -166.38 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.728 2.285 . . . . 74.21 112.357 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -74.46 141.97 77.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.611 0.72 . . . . 72.33 111.118 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.81 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.726 2.284 . . . . 60.14 112.343 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 124.19 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 75.12 110.85 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.58 42.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 74.42 111.079 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.32 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 65.32 111.139 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.36 8.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 65.5 112.515 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.662 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 70.8 m -150.32 161.52 42.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 75.22 110.825 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.662 ' CE3' ' C ' ' A' ' 12' ' ' SER . 7.2 m-90 -152.94 107.06 3.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.956 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -72.87 105.59 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 65.23 110.853 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.539 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.8 m -158.88 154.82 23.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.647 0.736 . . . . 74.51 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.508 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.78 118.43 5.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 72.14 112.329 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.98 110.16 1.74 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.714 . . . . 75.52 110.89 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 79.65 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.705 2.27 . . . . 71.43 112.356 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.41 58.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 41.01 112.484 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -158.26 177.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 65.34 111.105 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 2.4 m -51.97 116.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 71.55 110.878 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -40.94 -66.22 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.887 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.33 -27.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.824 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' SER . 21.8 tt0 -63.54 -52.45 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.908 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB3' ' CG ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -71.65 -51.14 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 64.42 110.903 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.41 ' OG1' ' CG1' ' A' ' 54' ' ' VAL . 25.7 m -45.5 -43.86 12.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 72.11 111.144 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.4 -30.49 2.05 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 75.25 112.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -64.37 -66.68 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 73.41 110.876 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 37.1 mt -38.21 -49.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.1 111.178 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.442 ' OD1' ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -52.14 -44.84 64.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.03 110.873 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -74.05 -54.6 7.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 74.54 110.937 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -51.57 -38.89 56.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 64.41 111.088 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -12.66 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.3 110.874 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -115.2 18.04 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.844 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 1.8 mm100 -93.02 -52.02 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.918 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 161.72 -91.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 71.22 112.482 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' C ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.55 17.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 70.42 111.132 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -85.41 -60.68 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.869 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.88 110.06 8.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 75.3 110.924 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 42' ' ' ILE . . . 138.65 -70.99 0.46 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 63.42 112.486 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.558 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.75 8.1 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.691 2.26 . . . . 74.41 112.309 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.572 HD13 ' CD2' ' A' ' 57' ' ' HIS . 20.2 pt -82.32 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 73.31 111.142 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -82.85 122.56 78.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 71.22 110.926 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 168.53 21.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 71.43 112.303 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.56 -35.45 1.08 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 51.33 112.503 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.57 -19.42 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 64.34 112.519 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 -68.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 74.21 111.089 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -117.98 12.75 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 75.21 110.914 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.524 ' CE1' ' CB ' ' A' ' 52' ' ' ASN . 2.1 t80 -56.97 -47.37 80.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.42 110.863 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.475 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.57 129.12 33.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.652 0.739 . . . . 74.24 110.909 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.76 150.54 90.33 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 -1.8 . . . . 61.3 112.367 0.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.524 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -114.5 118.2 33.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.936 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.82 170.18 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 72.41 111.156 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' OG1' ' A' ' 26' ' ' THR . 50.3 t -64.4 -52.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.23 111.134 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.73 13.63 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 65.31 110.873 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 54' ' ' VAL . . . -50.99 -43.06 60.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.35 111.098 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.572 ' CD2' HD13 ' A' ' 42' ' ' ILE . 61.8 m80 -55.2 -46.97 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 72.32 110.834 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.67 -37.53 79.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 73.11 111.098 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.34 80.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 74.22 111.12 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.558 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -68.74 -61.19 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 74.12 110.915 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -54.79 -45.36 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 75.11 111.145 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -46.07 -21.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.876 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -69.41 -59.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.51 110.906 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -47.18 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 72.12 110.938 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t80 -46.52 -40.11 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.929 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 6.3 t80 -60.47 -31.07 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 72.31 110.956 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -96.3 -4.32 42.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 74.35 110.888 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -50.4 45.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.43 110.863 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.01 -57.84 5.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 65.34 111.09 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.14 25.09 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 73.45 112.501 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.01 35.82 17.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 74.15 110.888 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.476 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.2 m-80 -102.84 169.69 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.25 110.9 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.5 p -71.72 -22.49 61.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.35 110.83 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.66 0.82 32.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 74.11 110.892 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -73.71 -10.28 59.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 72.02 110.906 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -90.66 103.33 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.917 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -118.03 2.23 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 72.25 110.879 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 62' ' ' MET . 2.8 m-85 -58.94 -71.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.53 110.924 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.35 177.97 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 63.23 110.895 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -65.41 -2.48 3.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.54 110.922 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.489 ' HG1' ' N ' ' A' ' 82' ' ' ALA . 30.1 p -98.02 -48.43 5.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 64.35 111.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.539 ' HA ' ' C ' ' A' ' 15' ' ' VAL . . . -80.42 23.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.21 111.137 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 81' ' ' THR . 7.4 t -84.98 -176.69 6.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 70.33 111.209 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.21 107.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 74.45 110.901 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -78.14 168.97 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.35 111.147 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' THR . 75.3 m-20 -53.54 -168.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 65.25 110.907 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 10.2 t -44.46 171.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 71.13 111.145 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.01 106.27 0.63 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.636 0.732 . . . . 73.24 110.872 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.54 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.72 -1.6 8.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.701 2.268 . . . . 75.04 112.385 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -52.01 108.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.901 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 4.1 p90 -82.82 -18.14 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 71.44 110.914 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 -114.48 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 65.21 112.5 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -36.92 85.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 73.35 111.049 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -79.41 101.98 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.91 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.08 147.82 25.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 65.24 110.908 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.54 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -93.1 156.41 40.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 75.34 110.904 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 125.95 12.69 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.262 . . . . 74.11 112.291 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.457 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 1.2 p -117.57 5.24 12.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.51 110.843 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.88 -142.68 25.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 71.11 112.53 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 m -81.56 113.71 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 71.11 110.866 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 73.24 110.905 -179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.589 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.847 0.356 . . . . 54.030000000000001 110.876 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CE3' ' C ' ' A' ' 12' ' ' SER . 2.5 m-90 -138.08 120.86 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 72.420000000000002 110.93 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.81 102.09 14.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 63.009999999999998 110.871 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.99 152.43 26.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 71.209999999999994 111.166 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.74 127.78 15.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.664 2.243 . . . . 71.129999999999995 112.329 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -52.02 118.23 11.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 73.129999999999995 110.911 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 73.299999999999997 112.312 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.28 -25.61 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.748 . . . . 74.319999999999993 112.461 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.766 ' HB ' HD11 ' A' ' 25' ' ' LEU . 13.2 t -59.1 166.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 74.109999999999999 111.104 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.836 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.3 m -56.44 113.19 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.811 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 21' ' ' SER . 24.3 m-20 -36.57 -59.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 65.439999999999998 110.898 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -36.43 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.030000000000001 110.891 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -63.72 -48.51 76.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.458 . . . . 65.200000000000003 110.899 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -70.98 -30.46 66.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.430000000000007 110.877 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.52 ' OG1' HG11 ' A' ' 54' ' ' VAL . 9.8 m -55.8 -30.24 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 60.25 111.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.13 58.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 62.109999999999999 112.532 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 4.6 m-20 -64.14 -68.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.328 . . . . 73.319999999999993 110.901 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 84.9 mt -43.82 -43.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.117 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -46.99 83.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.409999999999997 110.886 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 1.2 t80 -73.95 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 61.130000000000003 110.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.92 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -51.15 -43.19 61.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 65.519999999999996 111.097 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 35.5 t -53.37 -14.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 64.209999999999994 110.939 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.87 14.5 19.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 63.420000000000002 110.901 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -46.48 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 71.230000000000004 110.94 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.65 -62.41 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 34.340000000000003 112.493 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -82.32 5.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 73.209999999999994 111.159 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.92 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 6.0 m-20 -82.86 -63.81 1.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 53.140000000000001 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.45 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.11 126.19 30.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.901 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.85 -70.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 62.219999999999999 112.471 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.616 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.82 4.85 1.98 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.694 2.263 . . . . 62.119999999999997 112.319 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.772 HD12 ' CG ' ' A' ' 57' ' ' HIS . 27.3 pt -83.35 18.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 63.439999999999998 111.113 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -74.12 129.28 84.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 73.230000000000004 110.92 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 161.24 46.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 72.099999999999994 112.352 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.87 -35.33 2.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 63.009999999999998 112.435 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.13 -26.1 5.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 75.450000000000003 112.487 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.1 -68.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 73.129999999999995 111.12 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' A' ' 49' ' ' PHE . 28.8 m -118.07 -4.36 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.450000000000003 110.866 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.7 t80 -34.28 -54.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.33 124.76 41.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 71.150000000000006 110.909 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.15 88.13 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 -1.811 . . . . 70.140000000000001 112.345 0.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.43 ' CA ' ' O ' ' A' ' 49' ' ' PHE . 13.7 p-10 -106.03 127.08 52.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.319999999999993 110.882 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 59.1 p -83.5 166.8 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 54.399999999999999 111.16 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.52 HG11 ' OG1' ' A' ' 26' ' ' THR . 41.0 t -65.8 -57.84 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 111.123 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -78.97 13.94 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 45.119999999999997 110.923 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -51.3 -48.42 62.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.230000000000004 111.084 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.772 ' CG ' HD12 ' A' ' 42' ' ' ILE . 34.7 m170 -50.33 -50.41 51.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 73.310000000000002 110.828 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.711 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -56.66 -37.55 70.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.219999999999999 111.106 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.34 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 71.150000000000006 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 6.8 t80 -68.27 -63.11 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 70.129999999999995 110.951 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 65' ' ' TYR . 2.6 p -54.82 -33.39 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 111.147 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.46 ' HE3' ' CD1' ' A' ' 78' ' ' PHE . 1.5 mmt -45.54 -24.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 65.299999999999997 110.862 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -68.87 -58.15 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 63.109999999999999 110.905 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.673 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -74.86 -50.73 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 61.409999999999997 110.933 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.658 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.4 t80 -46.3 -50.02 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.030000000000001 110.936 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.553 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 31.4 t80 -53.53 -36.78 62.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 73.219999999999999 110.939 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -94.09 -2.68 52.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.5 110.91 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.55 -42.62 58.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.150000000000006 110.879 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.988 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.48 -60.9 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 51.399999999999999 111.098 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.02 19.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 41.240000000000002 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.98 32.08 9.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 70.040000000000006 110.866 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.553 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 1.9 m-80 -104.75 166.38 10.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 45.130000000000003 110.857 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.575 ' HB3' HD21 ' A' ' 84' ' ' LEU . 57.8 p -68.06 -23.15 64.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 60.329999999999998 110.852 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.13 2.23 28.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.439999999999998 110.914 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.988 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -13.45 61.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 55.299999999999997 110.911 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.73 101.98 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 8.6 m-20 -118.0 7.63 12.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.868 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.3 m-30 -59.08 -68.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.040000000000006 110.907 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.91 178.04 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 63.350000000000001 110.87 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -1.94 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.833 HG21 ' CD1' ' A' ' 25' ' ' LEU . 72.2 p -93.17 -52.52 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 111.132 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -82.43 102.01 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 70.230000000000004 111.132 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -148.94 178.06 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 111.117 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 73' ' ' SER . 6.2 mp -66.32 126.75 29.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 65.230000000000004 110.947 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -106.38 169.36 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 62.140000000000001 111.121 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' THR . 33.4 m-80 -54.06 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 61.130000000000003 110.921 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -45.13 175.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 65.319999999999993 111.185 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 5.8 t-20 -51.97 105.96 0.59 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.626 0.727 . . . . 71.010000000000005 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.4 Cg_endo -69.79 -16.44 37.42 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.254 . . . . 65.310000000000002 112.31 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 29.8 t -51.97 110.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 64.349999999999994 110.848 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -77.2 -15.71 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.932 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 168.65 -122.43 1.02 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.748 -0.739 . . . . 41.109999999999999 112.501 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -40.09 -42.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 52.420000000000002 111.045 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.64 102.26 7.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 62.520000000000003 110.859 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -99.0 130.85 45.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 75.120000000000005 110.921 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 20.8 m-85 -83.93 144.38 44.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.659 0.742 . . . . 70.010000000000005 110.886 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 120.34 7.14 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.236 . . . . 61.200000000000003 112.369 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 52.6 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 62.009999999999998 110.828 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.63 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.854 0.359 . . . . 41.219999999999999 110.852 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.63 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 1.6 m-90 -134.29 111.69 10.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.118 -0.492 . . . . 64.349999999999994 110.93 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -82.42 101.99 11.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.86 152.42 26.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 72.329999999999998 111.124 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.74 129.17 17.15 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 75.540000000000006 112.355 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 115.93 7.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 74.340000000000003 110.883 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 84.49 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 41.130000000000003 112.371 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.74 -25.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.745 -0.741 . . . . 61.329999999999998 112.457 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.8 t -59.1 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.073 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.696 ' O ' HD22 ' A' ' 25' ' ' LEU . 14.8 m -52.06 109.2 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.099999999999994 110.836 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 21' ' ' SER . 42.8 m-20 -33.87 -64.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 63.25 110.878 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.34 -40.53 2.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.883 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.9 tp60 -58.13 -51.38 69.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 43.329999999999998 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.794 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -71.68 -27.04 62.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.877 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.809 ' OG1' HG11 ' A' ' 54' ' ' VAL . 11.0 m -62.89 -6.88 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 60.119999999999997 111.14 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -25.8 45.21 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 61.399999999999999 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.39 -67.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 63.43 110.879 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 80.7 mt -39.21 -44.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 72.150000000000006 111.112 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.52 -47.6 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.53 -58.12 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 110.889 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.89 -41.16 61.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 13.3 t -56.84 -9.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 65.409999999999997 110.851 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.05 18.0 19.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.453 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 13.6 mm-40 -94.46 -50.57 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 71.230000000000004 110.916 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.83 -81.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 72.310000000000002 112.446 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.76 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.3 pt -81.6 17.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 74.340000000000003 111.128 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -89.44 -61.13 1.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 74.0 110.872 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -74.47 124.58 26.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.409999999999997 110.892 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.19 -69.77 0.42 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 65.540000000000006 112.512 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.589 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.666 2.244 . . . . 74.109999999999999 112.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 38' ' ' ASP . 21.6 pt -82.53 17.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.099999999999994 111.117 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.75 138.65 62.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 75.230000000000004 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.74 145.9 58.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 61.140000000000001 112.336 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.3 -29.94 4.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 74.310000000000002 112.463 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.15 -13.1 7.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 54.450000000000003 112.536 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 -68.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 74.420000000000002 111.114 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 m -118.05 11.11 13.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.549999999999997 110.914 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 1.5 t80 -54.92 -57.39 11.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 75.310000000000002 110.909 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.588 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -100.53 127.09 33.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 73.430000000000007 110.887 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.73 153.92 93.04 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 -1.797 . . . . 64.340000000000003 112.367 -0.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -101.58 119.31 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.877 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 56.5 p -83.19 171.43 13.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 74.450000000000003 111.163 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.809 HG11 ' OG1' ' A' ' 26' ' ' THR . 69.1 t -65.84 -61.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 34.299999999999997 111.125 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.55 16.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 72.129999999999995 110.911 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -51.47 -47.5 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.106 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.642 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.8 m80 -50.15 -50.25 49.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.831 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.681 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.93 -33.14 68.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 51.030000000000001 111.109 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.14 86.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 111.083 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.589 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -68.32 -60.65 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.349999999999994 110.961 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -55.26 -34.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 71.120000000000005 111.152 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.574 ' HE2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -50.67 -29.99 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.846 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -65.38 -67.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.893 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.82 -53.35 41.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.908 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.76 ' HA ' HD11 ' A' ' 37' ' ' ILE . 3.3 t80 -46.94 -45.79 20.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.299999999999997 110.907 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 35.6 t80 -58.76 -26.41 63.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 72.400000000000006 110.9 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.29 -1.89 28.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 74.019999999999996 110.921 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -70.17 -42.19 72.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 73.010000000000005 110.852 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.638 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.63 -56.09 4.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 111.121 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.42 24.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 62.109999999999999 112.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 52.04 46.57 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 74.319999999999993 110.85 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -112.71 168.23 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 71.430000000000007 110.902 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.514 ' HA ' HD11 ' A' ' 84' ' ' LEU . 73.2 p -71.2 -24.59 62.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 50.43 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -78.87 1.35 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 74.430000000000007 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -22.47 59.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 110.888 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.407 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.3 m -82.31 102.0 10.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 110.906 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.0 8.81 12.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 70.209999999999994 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.681 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -58.54 -68.67 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.867 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -172.07 178.01 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 65.140000000000001 110.819 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -65.7 -1.52 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 72.540000000000006 110.939 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.583 HG21 ' CD1' ' A' ' 25' ' ' LEU . 64.9 p -92.91 -52.62 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 53.420000000000002 111.157 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.34 102.33 11.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.409999999999997 111.092 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 t -148.78 178.01 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 70.200000000000003 111.162 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -66.65 112.06 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 65.230000000000004 110.958 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -89.23 168.18 12.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 64.140000000000001 111.107 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' THR . 72.1 m-20 -54.39 -167.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.6 t -44.46 173.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 65.349999999999994 111.138 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.8 t-20 -52.11 106.92 0.72 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 65.329999999999998 110.86 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.73 -2.77 10.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 72.150000000000006 112.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.402 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 11.7 t -51.99 105.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.887 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -74.6 -16.39 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 73.049999999999997 110.931 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.08 -113.25 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 51.210000000000001 112.52 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.31 79.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 72.209999999999994 111.08 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 63.32 110.876 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -99.36 140.16 33.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.530000000000001 110.894 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.543 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.07 151.14 40.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 74.519999999999996 110.841 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.623 2.215 . . . . 62.32 112.371 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 6.0 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 73.340000000000003 110.842 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.819 0.342 . . . . 72.219999999999999 110.891 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.4 m-90 -125.98 116.52 21.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 74.040000000000006 110.926 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.92 106.24 18.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 70.420000000000002 110.859 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -155.4 152.43 24.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.585 0.707 . . . . 74.420000000000002 111.133 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 Cg_endo -69.75 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 73.340000000000003 112.336 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -51.97 113.55 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.601 0.715 . . . . 61.350000000000001 110.903 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' HZ3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.77 79.93 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.732 2.288 . . . . 73.420000000000002 112.325 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -26.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 71.430000000000007 112.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.811 ' HB ' HD11 ' A' ' 25' ' ' LEU . 3.3 t -58.96 167.73 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.239999999999995 111.131 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.763 ' O ' HD22 ' A' ' 25' ' ' LEU . 3.6 m -53.89 111.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 41.399999999999999 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 21' ' ' SER . 23.1 m-20 -34.96 -61.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.888 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.28 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.319999999999993 110.889 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.1 tp60 -60.34 -50.25 74.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.400000000000006 110.919 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.891 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.93 -23.78 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.530000000000001 110.88 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.418 HG23 ' CG1' ' A' ' 54' ' ' VAL . 3.1 m -66.35 0.08 2.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.109999999999999 111.134 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.43 -35.64 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 65.120000000000005 112.517 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 7.9 p30 -55.15 -45.37 75.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 74.010000000000005 110.916 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 55' ' ' LYS . 63.6 mt -59.24 -59.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 72.439999999999998 111.162 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -44.63 -40.0 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 71.319999999999993 110.93 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -73.94 -60.7 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.299999999999997 110.905 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -52.17 -26.46 11.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 60.229999999999997 111.083 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -70.59 1.65 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.887 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.15 9.39 32.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.851 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.03 -44.63 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 62.020000000000003 110.857 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.6 -51.95 0.84 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 74.349999999999994 112.482 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.654 HD12 HD12 ' A' ' 64' ' ' LEU . 2.5 pt -82.18 8.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 72.540000000000006 111.12 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.1 t70 -89.1 -60.71 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.230000000000004 110.886 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.62 119.01 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 63.350000000000001 110.857 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.22 -67.86 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 50.420000000000002 112.474 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -69.72 -1.05 7.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 55.25 112.377 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.699 HD12 ' CG ' ' A' ' 57' ' ' HIS . 17.4 pt -82.87 14.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 71.030000000000001 111.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -76.75 126.54 85.72 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.637 0.732 . . . . 73.019999999999996 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.67 10.61 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 72.540000000000006 112.337 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.29 -38.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.773 -0.727 . . . . 23.52 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.92 -34.36 2.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 75.319999999999993 112.465 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.06 -68.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 73.409999999999997 111.078 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.98 15.76 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 75.150000000000006 110.876 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 50' ' ' GLU . 2.5 t80 -51.85 -66.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.837 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.1 136.66 35.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.749 . . . . 65.310000000000002 110.853 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.73 146.13 81.25 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 -1.799 . . . . 73.099999999999994 112.385 -0.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 9.0 p-10 -104.8 134.04 48.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 p -95.12 169.11 10.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 61.210000000000001 111.128 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' CG1' HG23 ' A' ' 26' ' ' THR . 59.4 t -65.18 -56.98 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 111.093 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -78.67 13.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 73.530000000000001 110.931 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -51.64 -46.96 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.209999999999994 111.104 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.699 ' CG ' HD12 ' A' ' 42' ' ' ILE . 38.9 m80 -50.46 -59.67 3.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 75.540000000000006 110.83 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.746 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -47.75 -38.01 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.106 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 56' ' ' ALA . . . -57.84 -42.06 83.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 65.230000000000004 111.062 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.604 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 2.7 t80 -67.31 -57.78 6.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 72.329999999999998 110.934 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 65' ' ' TYR . 3.6 p -55.22 -38.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 64.200000000000003 111.153 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.585 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 36.3 mtp -46.22 -25.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 54.520000000000003 110.91 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -66.41 -60.36 2.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 70.219999999999999 110.873 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.654 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -73.46 -45.69 52.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 55.100000000000001 110.936 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.65 ' HA ' HD11 ' A' ' 37' ' ' ILE . 2.4 t80 -51.4 -54.2 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 61.240000000000002 110.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 26.4 t80 -50.95 -36.15 37.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 110.924 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.49 -3.64 49.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 44.310000000000002 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.93 -42.56 60.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.83 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.003 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.2 -62.05 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.349999999999994 111.052 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.42 20.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 45.350000000000001 112.546 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.99 37.44 21.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 74.129999999999995 110.891 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -108.84 168.26 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 75.230000000000004 110.899 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.594 ' CB ' HD11 ' A' ' 84' ' ' LEU . 89.2 p -69.03 -24.93 64.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -80.22 1.17 29.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 71.030000000000001 110.922 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 1.003 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -26.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 70.239999999999995 110.9 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.5 m -82.47 102.04 11.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 63.409999999999997 110.9 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.03 14.24 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.149 -0.478 . . . . 55.329999999999998 110.873 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.746 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.3 m-30 -58.92 -67.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 110.908 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.64 178.02 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 110.834 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -64.88 -2.33 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.891 HG21 ' CD1' ' A' ' 25' ' ' LEU . 50.9 p -93.36 -51.77 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 65.310000000000002 111.135 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.11 104.82 12.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.099 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 t -154.82 178.01 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.164 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD11 ' CB ' ' A' ' 73' ' ' SER . 37.6 mt -67.29 127.7 33.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.9 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.6 t -106.3 167.58 9.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 72.530000000000001 111.12 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 87' ' ' THR . 50.2 m-80 -53.85 -168.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.913 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.85 172.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 74.340000000000003 111.153 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.08 106.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 71.219999999999999 110.862 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -1.09 7.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.010000000000005 112.34 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 14.9 t -51.97 108.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.430000000000007 110.861 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -75.12 -17.11 60.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 70.310000000000002 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.71 -111.38 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 75.200000000000003 112.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.93 85.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 72.219999999999999 111.114 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 102.09 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 63.100000000000001 110.899 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.82 151.65 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 110.864 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.1 m-85 -92.41 148.93 37.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.628 0.728 . . . . 71.120000000000005 110.854 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 124.43 11.06 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.665 2.243 . . . . 74.25 112.34 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.556 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 13.1 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 75.230000000000004 110.909 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.607 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 36.0 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.807 0.337 . . . . 73.5 110.844 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 4.6 m-90 -133.33 116.14 15.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 74.439999999999998 110.883 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -87.36 101.99 14.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 71.319999999999993 110.904 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.436 HG21 ' CE2' ' A' ' 96' ' ' PHE . 2.9 m -148.9 153.54 38.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 64.439999999999998 111.135 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.75 126.17 13.01 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.672 2.248 . . . . 73.299999999999997 112.336 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -51.98 107.07 0.74 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.576 0.703 . . . . 73.310000000000002 110.909 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 53.7 Cg_endo -69.74 79.81 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.717 2.278 . . . . 74.040000000000006 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 163.43 55.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 52.009999999999998 112.476 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 25' ' ' LEU . 1.2 m -158.59 177.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 72.329999999999998 111.108 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -52.01 119.05 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 63.450000000000003 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 52.0 m-20 -52.2 -37.02 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 44.109999999999999 110.877 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -20.53 55.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 70.420000000000002 110.845 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -77.79 -48.43 16.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 65.019999999999996 110.919 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.836 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.67 -53.03 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 70.420000000000002 110.924 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.569 HG23 ' N ' ' A' ' 27' ' ' GLY . 14.2 t -37.49 -47.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.310000000000002 111.135 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.569 ' N ' HG23 ' A' ' 26' ' ' THR . . . -46.4 -41.73 12.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 55.340000000000003 112.479 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -47.18 -69.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 72.439999999999998 110.866 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 70.1 mt -40.08 -57.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 75.329999999999998 111.139 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -46.12 -42.68 14.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.150000000000006 110.869 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 78' ' ' PHE . 4.6 t80 -73.86 -58.37 3.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 110.909 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -51.09 -24.78 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 70.430000000000007 111.101 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.08 2.27 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.140000000000001 110.859 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 5.73 37.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.409999999999997 110.818 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.04 -42.75 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.89 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.48 -46.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 44.210000000000001 112.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.1 pt -82.34 5.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 72.030000000000001 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.74 ' O ' HG23 ' A' ' 42' ' ' ILE . 16.4 t70 -89.36 -58.06 2.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 110.855 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.73 119.34 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.881 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.36 -70.84 0.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 74.129999999999995 112.465 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.5 Cg_endo -69.8 -0.84 7.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.655 2.236 . . . . 75.030000000000001 112.313 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.771 HD12 ' CG ' ' A' ' 57' ' ' HIS . 14.2 pt -83.08 17.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 54.530000000000001 111.13 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.93 137.97 69.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 64.109999999999999 110.876 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 173.92 10.3 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.221 . . . . 64.0 112.375 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.76 -35.35 1.07 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 41.409999999999997 112.462 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.13 -27.75 5.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 74.25 112.498 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 -68.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.824 0.345 . . . . 61.009999999999998 111.061 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.98 18.06 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.89 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.9 t80 -56.84 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.885 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -94.8 129.02 37.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 75.109999999999999 110.89 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.72 148.01 85.75 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.655 -1.81 . . . . 63.229999999999997 112.376 -0.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.39 142.27 34.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.897 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 19.8 p -92.39 167.32 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.109999999999999 111.163 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG11 ' HB ' ' A' ' 26' ' ' THR . 84.5 t -65.61 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 73.140000000000001 111.081 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.19 17.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.888 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.76 -42.84 58.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 111.076 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.771 ' CG ' HD12 ' A' ' 42' ' ' ILE . 41.3 m170 -54.49 -56.59 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.020000000000003 110.832 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -49.99 -36.57 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.109999999999999 111.099 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 35.43 111.068 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -67.86 -58.53 4.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 71.349999999999994 110.91 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 65' ' ' TYR . 3.5 p -55.06 -36.56 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 64.019999999999996 111.095 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.622 ' HE2' ' CZ ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER -46.7 -23.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.130000000000003 110.858 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -69.41 -62.35 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.120000000000005 110.896 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -70.8 -45.28 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 110.928 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.634 ' HA ' HD11 ' A' ' 37' ' ' ILE . 2.4 t80 -53.45 -50.82 64.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 110.953 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 58.2 t80 -53.02 -29.13 27.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 63.409999999999997 110.892 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -99.28 -4.02 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 73.420000000000002 110.933 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -71.51 -42.2 68.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.874 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.04 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.019999999999996 111.085 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 23.19 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 55.340000000000003 112.477 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.0 39.36 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 54.5 110.903 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.609 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 4.7 m-80 -110.94 171.94 7.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.883 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.53 ' HA ' HD11 ' A' ' 84' ' ' LEU . 79.4 p -71.86 -23.56 61.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 70.420000000000002 110.85 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.78 2.48 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 73.150000000000006 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.866 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -24.69 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 110.844 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.4 m -82.32 101.95 10.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 64.340000000000003 110.845 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -117.96 11.31 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.892 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.716 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.0 m-30 -58.47 -68.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 72.019999999999996 110.867 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.69 177.98 3.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 53.299999999999997 110.849 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.33 -1.96 2.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.493 . . . . 72.439999999999998 110.968 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 25' ' ' LEU . 61.1 p -92.53 -52.91 4.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.15 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.47 106.06 14.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 70.310000000000002 111.102 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.5 t -154.7 178.02 10.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 74.409999999999997 111.113 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 73' ' ' SER . 1.4 mt -67.37 123.32 20.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 73.310000000000002 110.913 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -103.82 168.62 9.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' THR . 66.6 m-20 -54.16 -167.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 63.240000000000002 110.873 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.24 170.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 64.450000000000003 111.133 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.4 t-20 -51.97 107.03 0.73 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.624 0.726 . . . . 51.32 110.894 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.3 Cg_endo -69.82 2.55 3.46 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.653 2.235 . . . . 75.439999999999998 112.32 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 44.5 t -52.02 106.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 64.200000000000003 110.883 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 94' ' ' CYS . 11.2 p90 -78.62 -16.21 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 64.549999999999997 110.903 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -113.49 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 62.210000000000001 112.518 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.74 83.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 64.209999999999994 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -76.34 102.66 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 70.439999999999998 110.862 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -98.14 140.48 32.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.928 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 15' ' ' VAL . 6.6 m-85 -92.48 158.02 39.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 61.520000000000003 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 113.82 3.51 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 74.409999999999997 112.337 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.54 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 26.1 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 61.5 110.88 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.473 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.876 0.369 . . . . 74.140000000000001 110.82 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.7 m-90 -137.52 115.75 11.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.01 102.05 12.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 65.150000000000006 110.867 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -152.65 152.02 27.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.731 . . . . 74.120000000000005 111.099 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.83 124.66 11.26 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.659 2.239 . . . . 70.420000000000002 112.304 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.8 mmtm -52.0 119.57 14.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 74.329999999999998 110.863 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 80.72 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 54.310000000000002 112.308 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -25.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 72.219999999999999 112.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 21' ' ' SER . 2.5 t -59.0 173.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 64.209999999999994 111.144 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.882 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.69 115.28 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 74.329999999999998 110.857 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' HA ' HD23 ' A' ' 25' ' ' LEU . 53.2 m-20 -40.73 -47.81 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 75.340000000000003 110.85 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -57.76 -34.38 69.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.140000000000001 110.872 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 14.1 mm100 -69.04 -46.12 68.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.959 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.882 HD22 ' O ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -70.29 -56.54 6.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 110.947 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 27' ' ' GLY . 11.3 t -41.05 -45.25 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.144 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 26' ' ' THR . . . -39.39 -37.8 0.84 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 72.109999999999999 112.43 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 29' ' ' ILE . 3.7 m-20 -56.14 -68.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 62.210000000000001 110.86 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 55' ' ' LYS . 76.9 mt -35.31 -44.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.200000000000003 111.076 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -56.12 -49.18 74.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 62.450000000000003 110.89 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' ASN . 1.1 t80 -74.46 -54.43 7.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.912 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.92 -40.3 60.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 74.299999999999997 111.154 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.5 t -56.75 -10.04 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 55.219999999999999 110.839 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 m -112.55 18.1 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 71.430000000000007 110.845 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.471 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 10.5 mm-40 -93.9 -50.93 5.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 63.020000000000003 110.911 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.82 -85.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 70.519999999999996 112.473 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 64' ' ' LEU . 2.6 pt -81.38 17.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 74.109999999999999 111.115 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.623 ' HA ' HG21 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -85.38 -61.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 63.119999999999997 110.851 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.02 122.43 23.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 50.340000000000003 110.819 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.49 -67.42 0.51 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 63.210000000000001 112.477 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.71 1.98 3.92 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 64.040000000000006 112.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.683 HD12 ' CD2' ' A' ' 57' ' ' HIS . 24.7 pt -84.54 17.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.122 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -85.85 127.29 63.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.72 . . . . 64.430000000000007 110.912 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.75 156.45 63.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.717 2.278 . . . . 63.25 112.337 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.43 -47.13 1.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 74.420000000000002 112.457 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.04 -0.94 2.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.784 -0.722 . . . . 52.119999999999997 112.508 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.27 -68.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 73.430000000000007 111.11 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -117.94 9.86 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.925 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.5 t80 -56.21 -60.3 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 71.010000000000005 110.891 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 mt-10 -96.72 128.93 34.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.643 0.735 . . . . 61.210000000000001 110.89 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.81 145.09 78.59 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 -1.804 . . . . 72.319999999999993 112.372 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 1.2 p30 -107.23 151.74 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.129999999999995 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 39.7 p -99.92 170.87 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 71.129999999999995 111.172 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 26' ' ' THR . 72.0 t -65.43 -62.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 71.340000000000003 111.081 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.78 18.04 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.209999999999994 110.914 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.23 -40.91 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 65.109999999999999 111.064 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.3 m80 -53.19 -52.65 58.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 71.230000000000004 110.875 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.47 -38.14 74.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 62.130000000000003 111.086 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.04 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 52.310000000000002 111.124 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 10.5 t80 -61.58 -65.08 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 110.945 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 38' ' ' ASP . 2.7 p -55.2 -34.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 74.030000000000001 111.088 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.485 ' HE3' ' HD3' ' A' ' 16' ' ' PRO . 2.7 mtm -44.89 -26.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.040000000000006 110.908 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -67.25 -60.74 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.54 -52.3 18.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 110.91 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.604 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.7 t80 -46.46 -44.59 17.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 73.0 110.928 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 12.6 t80 -58.96 -28.43 66.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 70.230000000000004 110.903 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -99.56 -4.79 30.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 70.319999999999993 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -41.67 69.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 110.881 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.846 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.17 -58.12 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 51.310000000000002 111.094 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 23.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 13.199999999999999 112.487 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.02 43.79 30.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 73.439999999999998 110.852 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.504 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.5 m-80 -114.4 169.92 8.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 75.230000000000004 110.932 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.414 ' CB ' HD11 ' A' ' 84' ' ' LEU . 78.4 p -71.7 -23.19 61.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 52.520000000000003 110.873 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.06 1.89 26.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 74.530000000000001 110.907 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.846 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -24.32 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 52.020000000000003 110.916 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -82.55 102.02 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.857 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -118.03 11.83 13.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 54.439999999999998 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.73 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.7 m-30 -59.04 -68.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.895 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.46 178.02 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 43.530000000000001 110.824 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -65.9 -1.78 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 75.510000000000005 110.963 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 25' ' ' LEU . 73.3 p -91.81 -50.01 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 111.118 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.14 102.01 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.076 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 t -147.37 178.47 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 63.149999999999999 111.124 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD11 ' CB ' ' A' ' 73' ' ' SER . 35.7 mt -66.16 122.9 18.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.914 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -99.57 168.03 10.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.159 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.96 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 52.450000000000003 110.867 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.0 t -44.46 172.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 111.067 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.3 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 63.329999999999998 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.8 -2.37 10.09 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 63.020000000000003 112.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.4 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 8.0 t -52.04 108.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 62.329999999999998 110.845 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 5.9 p90 -81.57 -15.28 55.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 74.310000000000002 110.947 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.97 -115.12 0.5 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 74.219999999999999 112.566 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.96 89.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 73.120000000000005 111.142 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -76.45 102.03 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 62.32 110.867 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -99.5 142.84 30.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 61.229999999999997 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 10.0 m-85 -92.08 150.87 41.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.671 0.748 . . . . 70.209999999999994 110.839 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.23 11.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 51.409999999999997 112.37 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 9.1 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 61.32 110.877 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.529 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 25.2 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.915 0.388 . . . . 71.340000000000003 110.806 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.0 m-90 -137.75 119.52 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 74.540000000000006 110.927 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 101.98 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 65.299999999999997 110.884 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -151.84 152.6 30.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 75.310000000000002 111.091 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.77 127.76 15.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.682 2.255 . . . . 60.530000000000001 112.327 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -52.02 113.44 4.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 65.450000000000003 110.912 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 91.4 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.678 2.252 . . . . 63.020000000000003 112.393 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.13 -27.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 40.140000000000001 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 25' ' ' LEU . 3.1 t -59.01 165.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 71.219999999999999 111.17 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.6 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -52.12 114.51 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.855 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 21' ' ' SER . 6.0 m-20 -33.65 -65.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 72.400000000000006 110.822 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.2 -39.17 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 63.439999999999998 110.872 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.7 tp-100 -58.36 -50.87 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 110.91 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.723 HD11 ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 65.519999999999996 110.926 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.603 ' OG1' HG11 ' A' ' 54' ' ' VAL . 1.7 m -59.54 -31.48 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 71.5 111.154 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.77 -30.66 56.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 45.32 112.47 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' ILE . 1.1 m-20 -61.86 -68.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 74.310000000000002 110.867 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 67.6 mt -37.09 -48.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 111.073 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.06 -47.37 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 110.91 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.1 -53.65 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.479 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.12 -43.13 61.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 54.149999999999999 111.116 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -11.58 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.120000000000005 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -109.06 18.03 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.821 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.49 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 15.5 mm-40 -97.86 -49.96 4.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.420000000000002 110.887 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.65 -82.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 72.310000000000002 112.47 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.771 HD12 HD12 ' A' ' 64' ' ' LEU . 3.6 pt -80.97 17.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 64.140000000000001 111.123 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.56 -59.86 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 52.439999999999998 110.843 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.475 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.71 122.35 23.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.129999999999995 110.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.47 -71.34 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 71.400000000000006 112.463 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.601 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.77 4.24 2.31 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.684 2.256 . . . . 74.219999999999999 112.316 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 38' ' ' ASP . 9.6 pt -82.87 18.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.239999999999995 111.136 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -80.31 148.36 66.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 70.140000000000001 110.886 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.1 Cg_endo -69.79 152.61 69.18 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.709 2.273 . . . . 71.439999999999998 112.351 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.83 -47.9 2.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 55.109999999999999 112.483 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.83 3.08 2.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 72.019999999999996 112.484 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 64.120000000000005 111.106 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.0 7.85 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.898 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -43.27 -59.0 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.875 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.562 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 2.4 mm-40 -96.72 131.02 28.89 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.671 0.748 . . . . 70.329999999999998 110.826 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.75 153.61 92.98 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 -1.801 . . . . 65.219999999999999 112.32 -0.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 10.4 p30 -101.73 130.55 48.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.876 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.78 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 41.2 p -82.97 169.99 15.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 72.310000000000002 111.163 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.603 HG11 ' OG1' ' A' ' 26' ' ' THR . 51.8 t -67.1 -58.9 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 63.229999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -87.91 18.04 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 73.530000000000001 110.901 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.78 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -49.7 -51.88 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 111.092 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.618 ' ND1' HD12 ' A' ' 42' ' ' ILE . 63.1 m170 -43.65 -58.16 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 65.120000000000005 110.841 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -52.22 -39.8 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 62.439999999999998 111.145 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.15 74.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 75.319999999999993 111.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 11.2 t80 -68.57 -63.45 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.931 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 65' ' ' TYR . 2.3 p -54.9 -33.47 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 61.539999999999999 111.132 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.63 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 3.8 mtt -45.61 -27.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.882 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.63 -61.68 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 63.130000000000003 110.842 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.771 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -70.29 -49.33 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 64.420000000000002 110.918 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.596 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.5 t80 -50.29 -47.0 55.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 110.926 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 30.4 t80 -55.88 -28.57 57.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 62.049999999999997 110.915 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -99.93 -4.59 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 70.049999999999997 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.11 -40.33 65.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.861 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.949 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -59.39 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 111.101 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.29 22.03 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 62.130000000000003 112.508 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.01 41.07 29.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 71.209999999999994 110.841 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.8 m-80 -114.11 169.12 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.863 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.408 ' HB2' ' CD1' ' A' ' 84' ' ' LEU . 96.5 p -70.28 -23.14 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 70.209999999999994 110.849 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -81.02 2.2 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 75.219999999999999 110.943 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.949 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -20.62 60.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 70.120000000000005 110.887 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.46 102.01 11.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 72.430000000000007 110.859 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.02 10.68 13.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 110.847 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.63 ' CD2' ' HE2' ' A' ' 62' ' ' MET . 2.7 m-30 -58.32 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.917 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.62 178.01 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 61.009999999999998 110.897 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -2.2 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.119999999999997 110.9 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.544 ' HB ' HD12 ' A' ' 25' ' ' LEU . 65.4 p -92.15 -52.37 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.310000000000002 111.175 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.52 102.15 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.114 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -148.64 178.02 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 111.154 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 12' ' ' SER . 6.2 mp -65.57 127.2 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.874 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.04 167.76 9.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 71.219999999999999 111.179 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 87' ' ' THR . 10.4 m120 -54.03 -168.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 74.329999999999998 110.884 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.99 173.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 111.17 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.7 t-20 -51.97 106.33 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.653 0.739 . . . . 73.329999999999998 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.78 -4.39 13.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 61.329999999999998 112.353 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -52.02 112.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 54.32 110.81 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 94' ' ' CYS . 1.8 p90 -79.8 -16.62 55.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 110.926 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.85 -123.83 0.94 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.439999999999998 112.454 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.35 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 43.039999999999999 111.08 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -76.35 104.16 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 62.140000000000001 110.882 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.0 129.24 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.329999999999998 110.919 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.545 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.1 m-85 -78.42 154.97 79.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.655 0.74 . . . . 72.409999999999997 110.876 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.75 108.08 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.647 2.231 . . . . 54.219999999999999 112.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 54.6 p . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.842 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.52 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.915 0.388 . . . . 73.510000000000005 110.836 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.594 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.0 m-90 -136.03 123.06 21.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 110.913 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 102.01 13.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 74.209999999999994 110.836 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -154.58 153.06 27.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 54.219999999999999 111.09 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.4 Cg_endo -69.82 129.34 17.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 71.019999999999996 112.383 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 118.12 11.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.522 0.677 . . . . 75.219999999999999 110.947 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 79.87 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.686 2.257 . . . . 73.140000000000001 112.324 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.58 -24.3 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 72.099999999999994 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 25' ' ' LEU . 4.8 t -59.0 166.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.328 . . . . 71.450000000000003 111.164 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.779 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.01 107.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 52.119999999999997 110.849 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 54' ' ' VAL . 72.9 m-20 -33.36 -63.41 0.24 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 73.129999999999995 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.99 -39.74 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 75.150000000000006 110.862 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -58.34 -50.93 71.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 53.340000000000003 110.875 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.782 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -71.49 -29.65 65.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 71.510000000000005 110.883 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.434 ' OG1' HG11 ' A' ' 54' ' ' VAL . 97.1 m -52.13 -26.53 11.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 54.25 111.129 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.36 -24.77 72.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 21.120000000000001 112.49 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.27 -51.4 63.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 65.439999999999998 110.864 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 55' ' ' LYS . 73.1 mt -62.53 -52.46 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 62.340000000000003 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -50.25 -43.63 53.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.16 -58.11 3.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 110.934 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.786 ' HB1' ' CG ' ' A' ' 38' ' ' ASP . . . -51.46 -31.65 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 63.210000000000001 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.91 -11.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.883 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 18.0 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 41.299999999999997 110.855 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -92.17 -52.1 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.219999999999999 110.887 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.38 -92.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.786 -0.721 . . . . 75.310000000000002 112.512 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.41 4.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 75.439999999999998 111.138 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.88 ' HA ' HG21 ' A' ' 61' ' ' VAL . 2.5 m-20 -66.66 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.84 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -76.07 134.92 39.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 52.130000000000003 110.88 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.94 -72.3 0.33 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 61.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.597 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.78 6.47 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.674 2.25 . . . . 72.510000000000005 112.358 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.626 HD12 ' CG ' ' A' ' 57' ' ' HIS . 22.9 pt -82.44 18.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.450000000000003 111.141 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -80.16 123.75 83.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 75.030000000000001 110.895 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.32 38.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 71.510000000000005 112.315 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.34 -32.99 1.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 62.109999999999999 112.514 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.49 -31.22 3.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 72.420000000000002 112.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.05 -68.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 111.126 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' PHE . 13.7 t -113.05 -13.77 13.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.430000000000007 110.926 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -34.46 -44.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 64.209999999999994 110.849 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.41 125.75 38.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 64.299999999999997 110.88 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.5 Cg_endo -69.75 151.89 91.82 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.726 -1.781 . . . . 44.140000000000001 112.317 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.38 120.02 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 63.100000000000001 110.875 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.76 168.59 16.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 71.030000000000001 111.115 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.631 HG21 ' HB3' ' A' ' 22' ' ' ASP . 91.8 t -65.79 -56.79 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 61.32 111.147 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HG3' ' CG ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.24 17.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 64.450000000000003 110.85 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.63 -42.29 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 64.5 111.061 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.626 ' CG ' HD12 ' A' ' 42' ' ' ILE . 67.5 m80 -52.28 -54.78 27.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.839 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.779 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -56.72 -37.74 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 62.310000000000002 111.105 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.14 -30.6 71.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 72.099999999999994 111.094 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 12.2 t80 -67.86 -66.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 110.902 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.88 HG21 ' HA ' ' A' ' 38' ' ' ASP . 7.5 p -55.24 -29.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 74.420000000000002 111.165 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 1.6 mmt -45.53 -22.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.845 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -71.95 -56.61 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -76.14 -53.13 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 110.948 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.4 t80 -45.72 -48.2 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 63.100000000000001 110.953 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.606 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 33.8 t80 -58.51 -26.86 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 72.219999999999999 110.93 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -100.04 -2.78 33.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 74.319999999999993 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -40.09 52.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 71.099999999999994 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.898 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -55.41 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 111.082 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.35 24.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 54.530000000000001 112.496 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 49.2 31.98 3.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 72.430000000000007 110.912 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.606 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 5.2 m-80 -102.81 168.59 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 65.040000000000006 110.864 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.8 p -70.93 -21.97 62.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.827 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.437 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.08 2.03 29.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.902 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.898 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.57 -18.94 61.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 72.140000000000001 110.898 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 102.05 11.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 71.450000000000003 110.87 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 8.93 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 64.120000000000005 110.886 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.779 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -58.51 -68.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 73.140000000000001 110.844 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -171.93 178.06 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.450000000000003 110.875 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -65.8 -0.99 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 65.540000000000006 110.895 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.735 HG21 ' CD1' ' A' ' 25' ' ' LEU . 62.3 p -92.84 -52.1 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 111.143 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.86 106.37 13.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 71.400000000000006 111.09 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.9 t -150.64 177.98 9.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 63.439999999999998 111.162 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.03 149.85 49.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 110.947 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -133.77 168.55 18.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.319999999999993 111.156 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 87' ' ' THR . 14.4 m-20 -53.63 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.889 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.9 t -44.36 174.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 111.104 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.594 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 72.239999999999995 110.877 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 88' ' ' ASN . 53.3 Cg_endo -69.85 -0.15 6.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.303 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.404 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 12.9 t -52.04 106.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 110.834 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.65 -16.33 59.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.918 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.74 -115.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 55.520000000000003 112.472 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.34 69.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 62.039999999999999 111.108 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.37 102.03 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 52.219999999999999 110.886 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -99.97 137.95 37.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.150000000000006 110.903 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.26 146.52 32.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.637 0.732 . . . . 75.430000000000007 110.9 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.02 12.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 73.400000000000006 112.334 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.454 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 2.0 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.099999999999994 110.806 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.44 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 9.3 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.881 0.372 . . . . 73.129999999999995 110.898 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.2 m-90 -135.67 109.65 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 72.25 110.905 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 102.17 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 72.230000000000004 110.832 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.66 152.43 24.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 73.120000000000005 111.131 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.71 123.55 10.23 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.686 2.257 . . . . 72.040000000000006 112.336 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -51.98 122.42 22.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.551 0.691 . . . . 74.030000000000001 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 88.06 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 74.319999999999993 112.353 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.37 -20.79 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 31.219999999999999 112.497 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 25' ' ' LEU . 11.0 t -63.62 158.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 74.430000000000007 111.133 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 24' ' ' GLN . 1.8 m -52.09 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 71.040000000000006 110.817 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 21' ' ' SER . 85.9 m-20 -33.5 -68.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 75.230000000000004 110.873 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.4 -39.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 73.150000000000006 110.86 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 25.4 tt0 -58.11 -51.3 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 110.938 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.841 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -70.96 -36.18 72.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.914 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.417 ' OG1' HG11 ' A' ' 54' ' ' VAL . 25.7 m -52.2 -15.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.98 -35.48 57.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 65.129999999999995 112.493 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -57.19 -68.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 75.319999999999993 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 55' ' ' LYS . 73.6 mt -37.49 -47.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 70.400000000000006 111.121 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.42 -47.76 72.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 71.349999999999994 110.849 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -73.55 -56.1 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 44.450000000000003 110.942 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . . . -51.95 -35.7 46.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 54.109999999999999 111.102 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.5 t -56.39 -12.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.109999999999999 110.875 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.75 18.02 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 110.828 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -89.8 -52.82 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 72.349999999999994 110.899 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 165.19 -94.81 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 64.310000000000002 112.503 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.517 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -81.96 17.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 72.109999999999999 111.118 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.563 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -83.08 -59.95 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 64.519999999999996 110.902 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 122.31 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 71.5 110.902 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.14 -67.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 63.119999999999997 112.474 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 4.51 2.14 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.246 . . . . 73.109999999999999 112.339 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.604 HD12 ' CD2' ' A' ' 57' ' ' HIS . 19.4 pt -82.77 17.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 70.420000000000002 111.112 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -84.48 125.15 72.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.623 0.725 . . . . 75.439999999999998 110.899 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.525 ' CB ' ' CD1' ' A' ' 49' ' ' PHE . 53.7 Cg_endo -69.74 154.58 67.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.668 2.245 . . . . 64.129999999999995 112.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.88 -40.08 1.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 32.43 112.495 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.47 -23.51 3.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.74 . . . . 61.210000000000001 112.494 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.06 -68.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 111.089 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -118.04 -11.28 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 54.509999999999998 110.873 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CD1' ' CB ' ' A' ' 44' ' ' PRO . 2.6 t80 -33.92 -52.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 71.120000000000005 110.897 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -99.57 127.97 32.73 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.623 0.725 . . . . 73.200000000000003 110.87 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.51 88.72 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 -1.806 . . . . 54.130000000000003 112.329 -0.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -107.98 152.75 24.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 63.149999999999999 110.891 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 43.5 p -106.69 172.38 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 111.153 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.417 HG11 ' OG1' ' A' ' 26' ' ' THR . 98.0 t -66.21 -64.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.420000000000002 111.143 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.25 18.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.897 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.91 -38.9 52.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 44.420000000000002 111.054 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.604 ' CD2' HD12 ' A' ' 42' ' ' ILE . 60.2 m80 -54.08 -52.72 60.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 110.855 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.709 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.27 -37.53 72.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 72.329999999999998 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.34 74.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 44.100000000000001 111.131 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 3.0 t80 -68.45 -57.96 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.891 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.484 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 1.8 p -54.57 -37.44 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 71.439999999999998 111.164 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.661 ' HE2' ' CE2' ' A' ' 78' ' ' PHE . 9.7 mtt -49.09 -20.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.030000000000001 110.912 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.533 ' HB3' HD23 ' A' ' 64' ' ' LEU . 44.9 t30 -69.16 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 110.896 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -74.93 -52.25 11.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 44.140000000000001 110.927 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.6 t80 -45.7 -49.55 14.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 71.519999999999996 110.87 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 2.8 t80 -58.42 -27.38 64.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.923 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 42.5 mt-30 -101.11 -2.26 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.120000000000005 110.918 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -74.04 -41.43 61.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.864 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.15 -55.51 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 44.520000000000003 111.095 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.85 24.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.040000000000006 112.508 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 51.1 44.17 28.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 70.120000000000005 110.872 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.546 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.9 m-80 -109.89 172.44 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.913 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -74.22 -24.78 59.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 52.450000000000003 110.908 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -79.67 2.0 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 75.319999999999993 110.91 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.733 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.78 -23.26 59.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.329999999999998 110.912 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.37 101.96 10.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 54.329999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.0 10.1 12.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 110.847 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.0 m-30 -58.84 -68.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.84 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 t -172.0 178.01 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.399999999999999 110.836 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.51 -2.48 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 64.310000000000002 110.926 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 25' ' ' LEU . 66.4 p -91.54 -50.57 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 63.539999999999999 111.149 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.479 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.71 102.09 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.108 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 t -148.81 178.01 9.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.43 111.11 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.67 114.0 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -89.71 167.47 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 63.210000000000001 111.168 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.84 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 62.409999999999997 110.905 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.24 172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.549999999999997 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 9.5 t-20 -51.98 106.66 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 63.520000000000003 110.907 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.19 3.74 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.743 2.295 . . . . 54.149999999999999 112.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.411 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 23.0 t -52.03 106.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.783 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -17.04 61.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 54.299999999999997 110.941 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.44 -111.24 0.42 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.94 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 111.06 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.85 102.0 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 73.019999999999996 110.879 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -99.0 151.73 20.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 61.210000000000001 110.883 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.7 m-85 -92.35 154.07 42.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.669 0.747 . . . . 74.129999999999995 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 114.21 3.62 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 72.099999999999994 112.356 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.528 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 12.1 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 65.219999999999999 110.836 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.571 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.835 0.35 . . . . 71.209999999999994 110.846 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.5 m-90 -129.74 116.55 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 62.340000000000003 110.922 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.21 102.05 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 71.439999999999998 110.946 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -152.83 152.55 28.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 70.219999999999999 111.108 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 127.62 14.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.645 2.23 . . . . 72.140000000000001 112.327 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.06 118.15 11.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 74.040000000000006 110.939 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 92.12 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.673 2.248 . . . . 63.32 112.334 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.78 -26.78 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 42.240000000000002 112.488 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.72 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.3 t -59.0 168.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 72.140000000000001 111.174 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.878 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -54.52 111.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 43.130000000000003 110.829 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' HG21 ' A' ' 54' ' ' VAL . 24.2 m-20 -38.94 -55.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 63.100000000000001 110.888 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.21 -33.98 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 110.846 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' SER . 6.6 tp60 -68.31 -46.48 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.868 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.878 HD22 ' O ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -70.01 -54.06 14.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 72.299999999999997 110.955 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 27' ' ' GLY . 16.8 m -41.14 -48.35 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.400000000000006 111.169 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' THR . . . -34.91 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 23.219999999999999 112.502 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 31' ' ' TYR . 10.3 m-20 -59.5 -64.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 72.030000000000001 110.909 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.91 HG23 ' CG ' ' A' ' 57' ' ' HIS . 72.7 mt -36.58 -41.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 111.163 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.59 -45.6 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' ASN . 3.4 t80 -73.55 -58.28 3.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.140000000000001 110.887 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.947 ' HB1' ' CG ' ' A' ' 38' ' ' ASP . . . -48.1 -50.05 29.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 64.129999999999995 111.072 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.79 -22.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.929 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -80.52 13.33 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 70.430000000000007 110.861 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -45.79 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.942 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.9 -43.91 1.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 71.400000000000006 112.5 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.658 HD13 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -101.54 2.29 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.346 . . . . 54.310000000000002 111.129 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.947 ' CG ' ' HB1' ' A' ' 32' ' ' ALA . 1.4 m-20 -74.99 -70.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 74.150000000000006 110.823 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -80.4 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 110.862 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.11 -68.78 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 74.319999999999993 112.466 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.61 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.71 6.97 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 70.140000000000001 112.36 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.791 HD13 ' HB2' ' A' ' 57' ' ' HIS . 8.0 pt -82.14 17.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 74.409999999999997 111.136 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.25 121.69 85.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.628 0.728 . . . . 44.329999999999998 110.912 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -169.46 0.33 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 71.299999999999997 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.99 -28.74 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 73.540000000000006 112.5 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.08 -26.23 8.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 61.409999999999997 112.461 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.37 -68.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 72.5 111.138 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 13.8 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 60.049999999999997 110.843 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.578 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 10.9 t80 -47.88 -60.52 2.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.944 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 28.5 mt-10 -92.56 142.39 25.77 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.697 0.761 . . . . 74.409999999999997 110.844 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.75 146.86 83.35 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 -1.796 . . . . 73.109999999999999 112.332 -0.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -99.91 142.21 31.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 54.140000000000001 110.901 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -97.86 160.06 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 64.200000000000003 111.184 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 ' OD1' ' A' ' 22' ' ' ASP . 40.9 t -65.87 -56.43 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 71.340000000000003 111.156 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.48 17.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 65.019999999999996 110.937 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -49.64 -55.29 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.239999999999995 111.112 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.91 ' CG ' HG23 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -35.23 -51.34 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 71.230000000000004 110.873 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.786 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -63.97 -42.14 97.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 111.126 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.46 -49.54 77.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 70.129999999999995 111.076 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -54.21 -63.42 1.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 110.932 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.796 HG11 ' OD1' ' A' ' 38' ' ' ASP . 3.5 p -54.85 -35.63 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.549999999999997 111.159 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.475 ' HE2' ' HA ' ' A' ' 62' ' ' MET . 0.0 OUTLIER -44.92 -21.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 64.420000000000002 110.872 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.546 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 33.0 t-20 -72.56 -44.25 62.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.942 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -90.71 -49.06 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.954 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.732 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -47.0 -46.26 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 73.340000000000003 110.937 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.9 t80 -57.14 -30.71 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 110.904 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 46.3 mt-30 -97.25 -5.14 37.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 72.310000000000002 110.911 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -40.96 62.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.847 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.991 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.38 -59.98 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.094 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.85 21.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.713 -0.756 . . . . 55.109999999999999 112.499 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 51.69 32.01 8.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 75.209999999999994 110.903 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.56 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.2 m-80 -105.55 167.1 9.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 72.299999999999997 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.8 p -68.73 -22.75 64.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 71.219999999999999 110.856 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.84 2.41 26.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.869 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.991 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.36 -16.89 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.439999999999998 110.894 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 0.8 OUTLIER -82.8 102.04 11.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 75.310000000000002 110.846 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -117.98 8.73 12.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 75.420000000000002 110.899 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.786 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.4 m-30 -58.98 -69.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 110.858 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -172.01 177.99 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 45.350000000000001 110.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -2.56 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 63.409999999999997 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.598 HG21 HD13 ' A' ' 25' ' ' LEU . 70.4 p -91.62 -51.44 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 111.139 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -83.75 102.02 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.219999999999999 111.064 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 t -147.93 178.0 8.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 62.219999999999999 111.174 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.61 127.26 31.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 62.340000000000003 110.923 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -106.07 168.98 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 41.539999999999999 111.158 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 87' ' ' THR . 15.5 m120 -53.68 -168.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 110.894 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' ASN . 5.0 t -45.06 174.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.165 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.5 t-20 -51.99 107.24 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 75.450000000000003 110.882 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.75 0.89 4.97 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.714 2.276 . . . . 61.109999999999999 112.324 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.412 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 21.8 t -52.06 108.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 54.310000000000002 110.854 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -72.18 -16.44 61.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.040000000000006 110.909 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.407 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 174.41 -109.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 64.209999999999994 112.511 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.53 79.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 63.539999999999999 111.124 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 102.06 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 72.109999999999999 110.838 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 149.42 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 64.239999999999995 110.896 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.543 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -90.34 154.84 46.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 65.219999999999999 110.932 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.66 3.78 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 71.409999999999997 112.35 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.482 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 83.7 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.852 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 3.0 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.843 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.573 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 3.8 m-90 -133.16 123.36 25.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.907 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.96 102.01 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.130000000000003 110.916 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.11 152.2 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 75.349999999999994 111.191 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' CE ' ' A' ' 62' ' ' MET . 54.1 Cg_endo -69.76 129.92 18.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.637 2.225 . . . . 72.329999999999998 112.39 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -52.0 120.94 17.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 74.400000000000006 110.879 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 80.7 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.668 2.245 . . . . 75.319999999999993 112.281 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.43 -27.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 74.209999999999994 112.516 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.656 ' HB ' HD11 ' A' ' 25' ' ' LEU . 19.7 t -59.15 164.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 65.239999999999995 111.158 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.89 ' O ' HD22 ' A' ' 25' ' ' LEU . 31.3 m -55.7 114.83 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 63.109999999999999 110.885 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.52 -67.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 74.129999999999995 110.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -39.59 -42.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 54.240000000000002 110.896 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -48.7 80.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.941 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.89 HD22 ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -71.11 -27.9 63.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.88 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 54' ' ' VAL . 12.6 m -60.77 -41.46 95.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 73.319999999999993 111.109 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.18 28.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 53.140000000000001 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -55.8 -44.94 78.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 51.43 110.823 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.852 HG23 ' CG ' ' A' ' 57' ' ' HIS . 90.4 mt -60.1 -64.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.010000000000005 111.093 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -37.6 -41.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 63.109999999999999 110.886 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 4.6 t80 -75.03 -68.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.329999999999998 110.946 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -47.95 -19.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 71.219999999999999 111.107 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 4.4 t -70.52 1.59 4.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.549999999999997 110.914 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.36 17.9 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 71.519999999999996 110.862 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.72 -48.81 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.109999999999999 110.954 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.8 -61.47 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 33.119999999999997 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -82.13 12.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 74.439999999999998 111.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.838 ' OD1' HG11 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -88.93 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.450000000000003 110.883 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -80.02 119.37 22.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 62.299999999999997 110.879 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.4 -68.84 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 72.25 112.46 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.628 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.1 Cg_endo -69.75 6.3 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.726 2.284 . . . . 54.310000000000002 112.316 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.1 pt -82.06 17.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 65.230000000000004 111.107 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -73.94 124.6 90.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.711 . . . . 65.209999999999994 110.905 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.9 Cg_endo -69.75 -179.37 2.86 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.723 2.282 . . . . 75.439999999999998 112.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.02 -36.15 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 63.43 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.1 -27.18 5.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 73.329999999999998 112.483 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.18 -68.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 63.509999999999998 111.146 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.3 t -117.86 -5.78 11.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 64.049999999999997 110.918 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 52' ' ' ASN . 2.6 t80 -40.69 -53.07 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.299999999999997 110.861 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.74 130.32 28.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 70.120000000000005 110.94 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.8 151.83 91.88 Favored 'Cis proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 -1.793 . . . . 55.020000000000003 112.327 0.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 7.2 p-10 -101.69 144.32 30.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 70.200000000000003 110.907 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.9 p -94.97 160.3 14.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 72.040000000000006 111.143 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 26' ' ' THR . 88.8 t -66.14 -52.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 62.020000000000003 111.128 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.617 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.97 17.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 74.510000000000005 110.881 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.34 -56.43 11.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 111.131 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.955 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -35.55 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.818 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.688 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -65.01 -38.39 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 64.209999999999994 111.125 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.74 -53.96 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 63.0 111.101 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -54.49 -63.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 73.540000000000006 110.953 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 57' ' ' HIS . 1.6 p -53.73 -37.09 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 71.120000000000005 111.153 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.495 ' CE ' ' HD3' ' A' ' 16' ' ' PRO . 2.5 mtm -45.96 -21.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 61.43 110.888 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.504 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 10.3 t-20 -71.89 -54.53 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.540000000000006 110.866 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -79.0 -45.88 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 110.927 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.545 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -48.91 -49.63 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.883 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.6 t80 -55.32 -32.2 62.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 26.9 mt-30 -96.12 -4.91 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.883 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.401 ' HB3' ' O ' ' A' ' 65' ' ' TYR . 7.3 t60 -74.79 -40.68 61.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 73.230000000000004 110.86 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.983 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.76 -61.57 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 54.340000000000003 111.135 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.94 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.677 -0.773 . . . . 75.209999999999994 112.484 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.94 33.3 11.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 63.350000000000001 110.94 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -106.57 167.71 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 63.409999999999997 110.878 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.469 ' CB ' HD11 ' A' ' 84' ' ' LEU . 75.4 p -69.09 -23.01 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 74.129999999999995 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.28 2.85 26.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 75.319999999999993 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.983 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.4 -24.37 60.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.540000000000006 110.881 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.95 102.0 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.200000000000003 110.901 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -118.0 11.36 13.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.299999999999997 110.848 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.688 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.8 m-30 -57.75 -68.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 75.299999999999997 110.876 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -171.9 178.01 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.040000000000006 110.872 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -65.61 -2.13 3.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 71.040000000000006 110.943 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 25' ' ' LEU . 72.4 p -91.76 -51.77 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 52.210000000000001 111.107 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.72 107.42 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 71.439999999999998 111.146 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -152.49 177.99 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 64.25 111.126 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -66.36 153.73 41.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.926 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -133.69 167.27 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 63.030000000000001 111.148 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' THR . 6.5 m120 -53.66 -168.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 73.340000000000003 110.86 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.24 174.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 73.120000000000005 111.168 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.572 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.0 t-20 -52.06 107.0 0.73 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.73 . . . . 63.409999999999997 110.895 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -0.6 7.12 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 75.019999999999996 112.369 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 5.3 t -52.0 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 42.530000000000001 110.827 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -79.71 -17.23 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.497 . . . . 75.409999999999997 110.914 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.421 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 177.58 -112.48 0.38 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 71.430000000000007 112.487 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.45 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 75.510000000000005 111.127 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.35 101.99 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 71.030000000000001 110.867 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.89 142.07 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 60.25 110.873 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.05 140.88 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.716 0.77 . . . . 55.229999999999997 110.896 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 132.05 22.43 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.635 2.224 . . . . 64.430000000000007 112.368 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.498 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 3.1 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 70.049999999999997 110.869 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.488 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 7.0 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.872 0.368 . . . . 73.340000000000003 110.839 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.1 m-90 -134.82 124.97 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 71.209999999999994 110.912 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.48 102.05 13.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 75.030000000000001 110.883 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.492 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -150.65 153.87 34.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 75.430000000000007 111.074 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.9 Cg_endo -69.74 126.3 13.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 70.150000000000006 112.376 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.08 113.42 4.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 64.329999999999998 110.868 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 79.59 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 71.450000000000003 112.351 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.492 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 161.14 61.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.792 -0.718 . . . . 63.100000000000001 112.487 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.762 ' CG2' HD11 ' A' ' 25' ' ' LEU . 1.7 m -157.56 178.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 72.319999999999993 111.122 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' HD22 ' A' ' 25' ' ' LEU . 48.9 m -52.04 114.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 63.5 110.827 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.56 -53.67 5.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 75.140000000000001 110.841 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -50.73 -30.09 13.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.899 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -51.35 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 71.230000000000004 110.939 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.42 -32.06 67.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 62.100000000000001 110.905 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' THR . 11.9 m -66.72 -1.0 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 62.340000000000003 111.121 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.29 -38.13 6.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.474 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 3.3 p30 -57.68 -56.39 22.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 65.439999999999998 110.894 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' HB3' ' A' ' 57' ' ' HIS . 40.6 mt -43.52 -45.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 53.439999999999998 111.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.96 -50.88 33.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.129999999999995 110.877 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -74.77 -52.43 11.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.906 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 35' ' ' GLN . . . -46.55 -57.15 5.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 111.108 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.41 -20.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.864 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -81.41 12.55 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 70.530000000000001 110.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.16 5.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 110.901 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.38 -53.1 0.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 63.140000000000001 112.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.698 HD12 HD12 ' A' ' 64' ' ' LEU . 1.2 pt -82.06 5.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 73.430000000000007 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.799 ' OD1' HG21 ' A' ' 61' ' ' VAL . 6.9 m-20 -87.64 -56.71 3.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 72.530000000000001 110.878 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.2 OUTLIER -78.29 120.03 22.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.88 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.19 -67.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.75 -0.738 . . . . 64.129999999999995 112.492 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.62 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.72 4.81 1.96 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.722 2.281 . . . . 62.329999999999998 112.367 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.7 pt -82.41 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.112 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.29 125.73 90.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 74.200000000000003 110.913 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.78 7.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 75.109999999999999 112.344 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.37 -31.74 1.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 33.520000000000003 112.497 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.84 -31.91 5.17 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 53.25 112.499 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.61 -68.25 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 45.539999999999999 111.123 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.19 2.81 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 110.876 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.1 t80 -39.99 -58.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.914 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mm-40 -98.24 131.45 26.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 64.230000000000004 110.866 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.67 148.98 87.63 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 -1.795 . . . . 62.229999999999997 112.368 -0.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -102.98 134.27 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.9 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.428 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 43.3 p -79.92 155.57 27.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.152 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.07 -53.58 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 61.210000000000001 111.136 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.636 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.61 18.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.849 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.4 -55.25 11.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.450000000000003 111.105 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.741 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -33.75 -53.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.869 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.784 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -66.23 -38.88 88.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 61.100000000000001 111.118 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.11 -42.45 94.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 73.329999999999998 111.086 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.1 t80 -66.32 -60.48 2.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.886 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.799 HG21 ' OD1' ' A' ' 38' ' ' ASP . 2.1 p -54.11 -34.77 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.086 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.6 ' HE2' ' CZ ' ' A' ' 78' ' ' PHE . 1.2 mmt -45.77 -25.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 53.109999999999999 110.885 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 19.0 t-20 -65.6 -63.56 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 110.848 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.698 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -72.5 -53.18 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 74.400000000000006 110.961 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.675 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -39.22 -57.5 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 62.399999999999999 110.914 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.583 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 16.7 t80 -50.45 -38.1 41.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.481 . . . . 64.120000000000005 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.434 ' HA ' ' CG ' ' A' ' 71' ' ' ARG . 46.0 mt-30 -92.27 -4.22 54.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 75.099999999999994 110.929 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.539 ' CD2' HD13 ' A' ' 37' ' ' ILE . 2.3 t60 -74.88 -41.94 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 62.310000000000002 110.844 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.022 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.67 -63.17 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 111.099 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.03 18.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 71.219999999999999 112.538 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.94 35.7 16.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 75.319999999999993 110.891 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.2 m-80 -107.31 167.84 9.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.953 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.504 ' CB ' HD11 ' A' ' 84' ' ' LEU . 72.1 p -68.98 -24.25 64.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 73.040000000000006 110.846 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -81.1 2.17 28.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.907 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 1.022 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -23.52 59.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.140000000000001 110.892 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.14 102.03 10.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 75.310000000000002 110.864 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.03 11.31 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 110.845 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.784 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.9 m-30 -57.96 -68.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.835 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.13 177.99 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.310000000000002 110.833 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -65.53 -1.61 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 72.019999999999996 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 69.8 p -92.79 -53.16 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 71.430000000000007 111.112 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.95 103.43 11.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 111.05 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 t -148.45 178.02 8.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 70.019999999999996 111.096 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD11 ' CB ' ' A' ' 73' ' ' SER . 1.3 mt -66.69 152.4 45.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 54.439999999999998 110.872 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -133.75 167.32 20.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 87' ' ' THR . 61.8 m-80 -53.53 -168.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.140000000000001 110.867 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 86' ' ' ASN . 7.2 t -45.23 175.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.200000000000003 111.155 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.8 t-20 -51.98 108.26 1.03 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 72.239999999999995 110.911 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.591 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.74 -2.89 10.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.709 2.273 . . . . 65.530000000000001 112.368 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.405 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.0 106.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.854 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -73.15 -15.85 61.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.915 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.2 -111.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 72.400000000000006 112.499 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.44 -31.56 67.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 53.439999999999998 111.101 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 102.04 7.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 54.240000000000002 110.859 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.3 139.84 34.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 65.120000000000005 110.911 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.591 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.4 m-85 -85.84 157.63 57.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 71.409999999999997 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.492 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.81 106.26 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.647 2.231 . . . . 53.119999999999997 112.32 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.497 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 74.3 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.520000000000003 110.866 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' HD23 ' A' ' 84' ' ' LEU . 41.4 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.882 0.372 . . . . 73.319999999999993 110.857 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.577 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 5.7 m-90 -129.29 122.64 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.915 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 62' ' ' MET . 1.1 t -95.47 107.56 19.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 73.430000000000007 110.897 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 3.9 m -152.64 154.81 32.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 60.109999999999999 111.136 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.74 131.37 21.13 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.701 2.267 . . . . 65.540000000000006 112.339 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 110.77 2.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.575 0.702 . . . . 74.230000000000004 110.929 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 96.79 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.252 . . . . 72.209999999999994 112.352 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.15 -32.31 2.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 43.399999999999999 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 21' ' ' SER . 3.6 p -58.67 -178.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.344 . . . . 54.450000000000003 111.127 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.853 ' H ' HG22 ' A' ' 20' ' ' VAL . 3.2 m -52.05 113.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 64.239999999999995 110.881 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.22 -56.71 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 63.140000000000001 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 26' ' ' THR . 0.4 OUTLIER -52.4 -15.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.906 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.31 -46.21 16.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 74.530000000000001 110.892 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -70.41 -50.23 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.140000000000001 110.906 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' ASP . 12.3 t -36.89 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 63.530000000000001 111.16 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . -66.34 -44.93 89.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.7 -0.762 . . . . 54.299999999999997 112.488 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' LEU . 14.5 m-20 -41.87 -48.82 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 74.450000000000003 110.883 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.805 HG23 ' CG ' ' A' ' 57' ' ' HIS . 82.1 mt -55.63 -42.46 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 75.340000000000003 111.133 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.32 -46.05 80.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 54.439999999999998 110.886 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.15 -61.5 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 54.119999999999997 110.93 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.708 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -50.06 -46.87 53.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 61.5 111.083 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 40.4 t -50.33 -17.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 71.099999999999994 110.866 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -93.03 17.96 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.817 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.415 ' C ' ' CD ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -96.98 -48.95 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.230000000000004 110.935 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.7 -63.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 63.219999999999999 112.445 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.669 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.36 4.66 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 72.239999999999995 111.164 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.838 ' OD1' HG11 ' A' ' 61' ' ' VAL . 2.3 m-20 -78.08 -68.2 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 35.439999999999998 110.869 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.15 129.02 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.340000000000003 110.876 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.57 -72.69 0.39 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 71.349999999999994 112.496 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.75 8.29 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.675 2.25 . . . . 71.219999999999999 112.364 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.71 HD13 ' HD2' ' A' ' 57' ' ' HIS . 29.8 pt -82.12 17.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 53.450000000000003 111.106 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -76.06 125.27 88.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.559 0.695 . . . . 75.120000000000005 110.91 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 161.62 45.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.24 . . . . 53.100000000000001 112.327 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.4 -40.62 1.47 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 70.140000000000001 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.71 17.34 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 64.420000000000002 112.535 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.79 -68.42 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.356 . . . . 71.109999999999999 111.099 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -117.89 11.67 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 110.898 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 13.0 t80 -55.32 -52.42 63.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.109999999999999 110.881 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 83.1 mt-10 -98.31 129.17 31.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.696 0.76 . . . . 61.340000000000003 110.869 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.79 153.48 93.04 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 -1.81 . . . . 64.400000000000006 112.361 -0.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -99.41 141.55 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 55.310000000000002 110.85 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.489 ' CG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -98.19 158.38 15.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 70.450000000000003 111.138 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.76 -55.17 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 111.146 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.07 18.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.519999999999996 110.903 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.9 -58.08 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 71.329999999999998 111.114 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.805 ' CG ' HG23 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -33.8 -48.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 60.32 110.842 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.688 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -64.53 -46.19 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 111.106 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -56.28 -46.96 79.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.150000000000006 111.093 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.6 t80 -59.77 -64.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.92 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.838 HG11 ' OD1' ' A' ' 38' ' ' ASP . 5.7 p -54.52 -36.21 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 64.540000000000006 111.116 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.476 ' CE ' ' SG ' ' A' ' 76' ' ' CYS . 8.6 mtp -45.49 -21.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.859 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.537 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 57.9 t-20 -71.85 -52.36 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 75.299999999999997 110.84 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.669 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -81.14 -45.13 16.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 65.430000000000007 110.943 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.634 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -50.79 -45.93 59.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.882 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 19.3 t80 -58.9 -32.2 69.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 72.120000000000005 110.929 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 38.5 mt-30 -95.95 -4.92 42.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 63.409999999999997 110.902 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -73.42 -41.81 62.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.992 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.19 -60.73 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.130000000000003 111.117 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.15 22.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.694 -0.765 . . . . 75.340000000000003 112.457 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.03 36.42 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 73.239999999999995 110.857 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.564 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.5 m-80 -108.81 165.55 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 74.219999999999999 110.842 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.413 ' HB3' HD21 ' A' ' 84' ' ' LEU . 11.5 p -68.34 -22.67 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 74.530000000000001 110.841 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.471 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -80.78 2.16 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 73.25 110.902 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.992 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -23.69 59.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 42.039999999999999 110.867 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' CE ' ' A' ' 62' ' ' MET . 4.1 m -82.48 102.01 11.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.887 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.03 12.89 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.868 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.688 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.2 m-30 -58.8 -68.26 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.73 177.99 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 53.229999999999997 110.86 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -1.94 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 110.921 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.622 HG21 ' CD1' ' A' ' 25' ' ' LEU . 68.2 p -92.01 -52.03 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.209999999999994 111.145 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.476 ' HB1' ' CE ' ' A' ' 62' ' ' MET . . . -82.51 101.98 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 53.310000000000002 111.087 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -148.86 178.08 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 111.156 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 84' ' ' LEU . 4.2 mp -66.89 154.15 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.450000000000003 110.871 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -133.92 169.22 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 111.169 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.06 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 65.340000000000003 110.892 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.47 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.16 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.577 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.5 t-20 -52.04 106.55 0.67 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 74.530000000000001 110.855 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.0 Cg_endo -69.76 0.59 5.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.641 2.228 . . . . 71.200000000000003 112.357 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.428 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.01 108.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 74.439999999999998 110.86 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 1.3 p90 -80.99 -16.29 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 74.310000000000002 110.963 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.26 -119.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.540000000000006 112.444 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.63 71.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 45.420000000000002 111.118 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.2 m -78.77 101.95 7.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.892 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -98.79 136.56 38.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.510000000000005 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.8 m-85 -85.27 147.22 46.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.72 . . . . 74.420000000000002 110.888 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 135.77 31.42 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 73.120000000000005 112.335 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 10.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 64.239999999999995 110.878 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.855 0.36 . . . . 74.030000000000001 110.854 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.8 m-90 -125.41 118.37 25.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 73.25 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -94.06 102.05 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 63.310000000000002 110.879 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 2.7 m -151.9 153.34 31.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 73.329999999999998 111.095 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.5 Cg_endo -69.82 127.94 15.26 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.655 2.236 . . . . 71.430000000000007 112.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -51.96 114.71 5.65 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.583 0.706 . . . . 75.439999999999998 110.952 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.76 15.3 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 71.129999999999995 112.371 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 20' ' ' VAL . . . -131.65 62.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.709 -0.758 . . . . 54.329999999999998 112.499 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 25' ' ' LEU . 2.2 m -158.49 178.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 75.510000000000005 111.077 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.604 ' O ' HD22 ' A' ' 25' ' ' LEU . 34.3 m -55.84 127.45 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.826 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.55 -49.4 67.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 73.319999999999993 110.833 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -28.03 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.839 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.03 -49.57 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 110.905 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -71.05 -41.33 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 72.329999999999998 110.917 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 m -46.29 -43.39 15.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.219999999999999 111.131 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.62 -29.57 25.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 71.439999999999998 112.513 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -59.97 -68.15 0.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 44.219999999999999 110.946 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.643 HG23 ' CG ' ' A' ' 57' ' ' HIS . 97.2 mt -40.9 -68.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 74.409999999999997 111.123 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 29' ' ' ILE . 5.6 t30 -34.1 -44.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.838 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -75.72 -68.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 110.932 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB1' ' OD2' ' A' ' 38' ' ' ASP . . . -45.18 -21.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 73.409999999999997 111.082 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -71.96 5.16 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.876 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -110.04 15.2 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 110.857 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.2 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 51.43 110.866 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.19 -55.78 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 70.140000000000001 112.46 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.704 HG21 ' NE2' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.21 9.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 51.5 111.141 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.771 ' OD2' ' HB1' ' A' ' 32' ' ' ALA . 1.6 m-20 -88.1 -63.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 110.868 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 114.93 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 63.130000000000003 110.88 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.77 -69.67 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 31.219999999999999 112.485 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.614 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.8 7.5 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.200000000000003 112.313 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.3 pt -82.22 16.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 111.145 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -73.62 123.74 89.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 61.130000000000003 110.932 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 171.25 14.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.719 2.28 . . . . 73.420000000000002 112.316 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.83 -33.89 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 12.01 112.485 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.09 5.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 63.32 112.498 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -68.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 53.219999999999999 111.082 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.87 2.18 18.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 72.219999999999999 110.9 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 6.1 t80 -40.99 -60.07 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.409999999999997 110.877 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.14 134.12 22.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.731 . . . . 73.340000000000003 110.905 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.71 150.67 90.38 Favored 'Cis proline' 0 C--N 1.341 0.145 0 C-N-CA 122.7 -1.792 . . . . 53.5 112.313 -0.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -100.47 122.22 42.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' NZ ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -85.68 157.48 20.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 54.149999999999999 111.146 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.92 -49.33 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 111.105 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' NZ ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -81.28 18.07 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 65.340000000000003 110.882 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.43 -54.18 23.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 62.450000000000003 111.076 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.946 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -37.25 -50.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.861 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.812 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -65.3 -39.48 92.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 65.230000000000004 111.098 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.09 -55.85 29.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 62.200000000000003 111.105 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.3 t80 -52.6 -62.35 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 110.919 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.946 HG12 ' O ' ' A' ' 57' ' ' HIS . 1.5 p -54.38 -37.44 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 73.120000000000005 111.137 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.417 ' SD ' ' SG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -45.71 -21.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 110.875 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -71.37 -52.08 20.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 72.329999999999998 110.923 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.665 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -83.53 -46.39 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 110.899 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.626 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -46.33 -45.29 17.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 53.520000000000003 110.947 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CE1' ' O ' ' A' ' 72' ' ' ASN . 58.7 t80 -60.45 -34.91 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 63.240000000000002 110.939 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -93.07 -4.22 52.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 64.349999999999994 110.96 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.704 ' NE2' HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.83 -44.58 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 54.420000000000002 110.833 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.907 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.6 -59.53 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 65.099999999999994 111.064 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.79 24.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 74.420000000000002 112.466 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.01 32.43 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 110.846 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.627 ' O ' ' CE1' ' A' ' 66' ' ' TYR . 5.9 m-80 -100.71 163.63 12.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.400000000000006 110.891 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.523 ' CB ' HD11 ' A' ' 84' ' ' LEU . 83.8 p -67.55 -21.87 65.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.420000000000002 110.885 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.489 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.71 3.5 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.875 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.907 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -76.53 -26.71 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 110.873 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.417 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 93.1 m -82.4 102.01 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -118.01 11.05 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 64.409999999999997 110.904 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.812 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.9 m-30 -57.72 -68.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 75.049999999999997 110.917 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.75 178.0 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 110.851 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -2.06 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 110.907 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.523 HG21 ' CD1' ' A' ' 25' ' ' LEU . 67.2 p -91.88 -53.58 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 60.210000000000001 111.104 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.49 102.01 11.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.030000000000001 111.107 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.3 t -152.88 178.03 10.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.209999999999994 111.141 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.559 HD23 ' SG ' ' A' ' 14' ' ' CYS . 18.8 mt -65.8 123.69 20.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 73.010000000000005 110.949 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.472 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -106.17 168.63 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.049999999999997 111.132 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.8 m120 -53.88 -167.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 110.895 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.7 t -45.06 175.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 43.149999999999999 111.125 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.2 t-20 -51.95 107.09 0.75 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.701 . . . . 61.43 110.9 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.78 3.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 73.140000000000001 112.35 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.42 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 19.8 t -52.04 109.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 110.824 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -70.36 -16.86 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 74.209999999999994 110.967 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 175.16 -110.54 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 63.229999999999997 112.474 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.81 73.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 62.409999999999997 111.085 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.32 104.66 14.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 110.886 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -98.64 149.86 22.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 65.129999999999995 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.534 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.4 m-85 -90.71 159.87 39.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.652 0.739 . . . . 74.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 104.35 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.261 . . . . 55.229999999999997 112.334 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.578 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 40.6 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 64.230000000000004 110.89 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.71 ' HB3' HD22 ' A' ' 84' ' ' LEU . 58.1 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.837 0.351 . . . . 53.299999999999997 110.84 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.684 ' HB2' HG22 ' A' ' 85' ' ' THR . 10.9 m-90 -145.56 113.24 6.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 75.120000000000005 110.932 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.435 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -83.64 108.45 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 110.896 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.53 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.4 m -158.63 153.99 22.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.109999999999999 111.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.522 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.77 122.85 9.52 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.707 2.272 . . . . 60.43 112.36 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -51.92 116.97 8.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 74.530000000000001 110.927 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 86.85 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 65.25 112.324 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 -27.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 70.409999999999997 112.487 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 21' ' ' SER . 2.6 t -59.03 170.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 52.340000000000003 111.12 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.885 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.97 118.37 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 53.240000000000002 110.826 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -42.98 -66.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 71.209999999999994 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -41.23 -40.62 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.01 -50.4 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 52.100000000000001 110.904 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -71.31 -31.17 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 54.149999999999999 110.947 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.2 m -64.66 -30.03 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 111.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.72 -23.3 70.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 71.129999999999995 112.466 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 57.5 m-20 -63.83 -58.64 6.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 72.239999999999995 110.912 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 55' ' ' LYS . 95.9 mt -47.14 -47.86 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 72.329999999999998 111.11 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -51.65 -44.24 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.439999999999998 110.865 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.12 -56.56 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.881 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -47.85 -43.84 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 74.519999999999996 111.089 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -28.31 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 110.891 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -81.46 15.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 70.200000000000003 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.597 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.95 -46.8 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 61.210000000000001 110.932 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -62.43 0.64 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 54.399999999999999 112.512 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.79 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -83.07 11.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.094 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.863 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.6 t70 -86.98 -56.6 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.897 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.452 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.3 m -74.85 120.59 20.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.873 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.33 -69.44 0.43 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 75.530000000000001 112.477 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.81 1.28 4.61 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 63.329999999999998 112.337 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 38' ' ' ASP . 33.3 pt -83.2 18.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 111.109 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -86.75 135.69 35.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.638 0.733 . . . . 72.200000000000003 110.907 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 174.12 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.281 . . . . 63.439999999999998 112.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.09 -33.73 0.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 73.239999999999995 112.463 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.18 -21.4 6.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 72.519999999999996 112.478 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.44 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 60.200000000000003 111.078 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.2 m -117.91 -2.27 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.400000000000006 110.914 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.3 t80 -36.42 -51.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.867 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.582 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 19.1 mm-40 -99.72 129.56 28.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.59 0.71 . . . . 64.530000000000001 110.901 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.77 147.85 85.51 Favored 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.69 -1.796 . . . . 60.299999999999997 112.366 0.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.531 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 5.5 p-10 -104.17 133.4 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 70.530000000000001 110.934 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.51 166.4 12.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 70.329999999999998 111.131 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.35 -56.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 111.095 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.08 14.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 75.140000000000001 110.877 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.38 53.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 41.020000000000003 111.109 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.733 ' CD2' HD12 ' A' ' 42' ' ' ILE . 64.8 m80 -51.95 -52.3 51.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 71.409999999999997 110.864 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -55.35 -43.02 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 111.108 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.73 68.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -68.38 -64.71 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 70.430000000000007 110.927 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 65' ' ' TYR . 7.1 p -55.5 -33.7 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 73.25 111.136 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.514 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -45.85 -27.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 65.319999999999993 110.843 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -66.16 -60.51 2.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 63.399999999999999 110.835 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.79 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -71.4 -47.85 53.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.932 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.597 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 3.0 t80 -45.55 -48.24 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.955 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.4 t80 -62.37 -31.89 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 71.230000000000004 110.943 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.64 -4.64 44.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 71.439999999999998 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.29 -42.89 68.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 70.530000000000001 110.869 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.904 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.45 -60.61 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 71.420000000000002 111.098 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.19 23.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 72.239999999999995 112.494 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 7.7 mtp180 52.07 43.18 30.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 74.439999999999998 110.856 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.3 m-80 -109.19 166.95 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 40.520000000000003 110.941 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.475 ' HB2' HD11 ' A' ' 84' ' ' LEU . 32.6 p -71.15 -24.93 62.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 41.43 110.819 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -78.52 -1.1 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 64.409999999999997 110.907 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.904 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.82 -22.07 59.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 72.549999999999997 110.879 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -82.78 102.05 11.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.510000000000005 110.855 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -117.98 6.88 12.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.868 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.3 m-30 -58.96 -71.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 64.209999999999994 110.89 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.16 178.01 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.807 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -2.78 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 63.200000000000003 110.904 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.643 HG21 ' CD1' ' A' ' 25' ' ' LEU . 29.1 p -97.99 -46.68 5.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 75.349999999999994 111.148 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -80.97 24.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.130000000000003 111.062 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -84.47 -178.18 6.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 62.149999999999999 111.141 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 12' ' ' SER . 1.6 mt -66.89 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.229999999999997 110.906 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.684 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.2 t -106.2 169.06 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.164 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 87' ' ' THR . 13.1 m-80 -53.25 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 70.019999999999996 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.08 173.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 75.140000000000001 111.159 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 6.6 t-20 -52.07 106.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 74.109999999999999 110.889 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.72 -13.21 34.44 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 60.219999999999999 112.378 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -52.06 105.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 62.420000000000002 110.847 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -16.7 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.310000000000002 110.908 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.56 -115.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 63.229999999999997 112.504 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.27 86.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 111.082 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 101.99 5.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 110.918 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.57 139.18 36.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 61.049999999999997 110.892 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 20.0 m-85 -93.01 141.18 23.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 74.120000000000005 110.879 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 129.02 16.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 74.310000000000002 112.331 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 36.8 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.519999999999996 110.898 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB3' HD22 ' A' ' 84' ' ' LEU . 3.7 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.854 0.359 . . . . 64.230000000000004 110.867 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.558 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 9.2 m-90 -142.85 115.16 8.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 71.310000000000002 110.893 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.79 108.62 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 62.109999999999999 110.885 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG21 ' CD2' ' A' ' 96' ' ' PHE . 3.2 m -158.56 154.16 22.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 72.519999999999996 111.124 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.542 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.78 120.75 7.48 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 75.049999999999997 112.334 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.01 117.7 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.617 0.722 . . . . 74.340000000000003 110.877 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.723 2.282 . . . . 50.219999999999999 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.06 -21.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 65.549999999999997 112.409 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.826 ' HB ' HD11 ' A' ' 25' ' ' LEU . 2.3 t -59.07 164.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 65.030000000000001 111.155 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.769 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.0 m -53.63 111.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 53.310000000000002 110.854 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.7 m-20 -33.78 -64.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 61.130000000000003 110.884 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.24 -40.73 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.871 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.4 tp-100 -58.33 -50.44 73.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 70.019999999999996 110.896 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.926 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.9 -29.28 65.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.901 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -66.53 -0.24 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 111.168 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.92 -38.5 5.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 45.340000000000003 112.498 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.4 p30 -53.6 -43.1 68.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 62.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 55' ' ' LYS . 64.1 mt -59.11 -46.94 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 70.040000000000006 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -44.31 38.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 63.43 110.884 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.7 -49.03 27.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.92 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -51.7 -45.13 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 73.299999999999997 111.093 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.443 ' CA ' ' OD2' ' A' ' 38' ' ' ASP . 9.0 t -57.44 -12.16 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 51.109999999999999 110.863 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.13 6.69 47.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 64.019999999999996 110.831 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.468 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.96 -43.09 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.957 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.96 -47.09 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 64.230000000000004 112.428 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 HD12 ' A' ' 64' ' ' LEU . 1.5 pt -89.74 8.21 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 73.049999999999997 111.132 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 42' ' ' ILE . 9.3 t70 -86.87 -61.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 70.430000000000007 110.871 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 3.8 m -75.95 124.62 27.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.812 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.28 -74.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 64.099999999999994 112.433 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' C ' ' A' ' 39' ' ' CYS . 53.3 Cg_endo -69.81 4.14 2.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 74.109999999999999 112.325 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 38' ' ' ASP . 5.9 pt -82.93 17.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 111.111 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -79.16 144.33 62.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.608 0.718 . . . . 64.150000000000006 110.891 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.595 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.2 Cg_endo -69.74 148.13 64.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 64.519999999999996 112.388 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.64 -39.28 3.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.5 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.69 15.18 2.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.74 . . . . 72.239999999999995 112.52 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.89 -68.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 60.219999999999999 111.149 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' PHE . 21.1 t -117.93 -6.73 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.310000000000002 110.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 3.0 t80 -34.34 -56.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 71.109999999999999 110.878 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 9.7 mm-40 -99.6 125.84 39.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 61.25 110.913 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.82 150.71 90.73 Favored 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 -1.813 . . . . 72.319999999999993 112.337 0.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -111.29 133.52 53.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 72.230000000000004 110.852 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.81 176.63 6.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 64.420000000000002 111.098 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.32 -54.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.120000000000005 111.114 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.71 17.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.862 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.28 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 73.150000000000006 111.101 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.719 ' CG ' HD12 ' A' ' 42' ' ' ILE . 26.8 m170 -57.25 -57.77 11.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 72.140000000000001 110.893 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.667 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -50.02 -36.52 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 74.040000000000006 111.086 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.31 92.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 111.059 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 5.7 t80 -68.01 -59.09 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 74.219999999999999 110.904 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 65' ' ' TYR . 7.5 p -55.1 -35.97 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 73.150000000000006 111.152 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.633 ' HE3' ' HA ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -46.46 -29.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.892 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.38 -65.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.935 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.53 -47.87 74.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.902 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.527 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -49.71 -47.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.929 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.1 t80 -60.6 -30.62 69.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.129999999999995 110.882 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -98.87 3.34 47.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 73.310000000000002 110.881 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.535 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -75.41 -48.8 21.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.878 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -70.16 -54.55 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.240000000000002 111.065 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.67 26.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 62.240000000000002 112.489 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.97 47.96 23.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 72.409999999999997 110.847 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.563 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 4.1 m-80 -114.19 162.07 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 62.119999999999997 110.928 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.577 ' HB2' HD11 ' A' ' 84' ' ' LEU . 59.5 p -67.96 -24.43 65.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 62.109999999999999 110.818 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -80.04 1.19 28.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 75.400000000000006 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.667 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -77.46 -19.79 55.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.919 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -83.54 102.08 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 41.229999999999997 110.833 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.04 7.56 12.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 72.239999999999995 110.898 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.667 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.3 m-30 -59.27 -71.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 110.913 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.71 177.97 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.883 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -65.5 -1.99 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 72.409999999999997 110.931 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.926 HG21 ' CD1' ' A' ' 25' ' ' LEU . 26.9 p -97.92 -47.48 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 53.310000000000002 111.157 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.03 26.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 44.130000000000003 111.088 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.6 t -86.75 -177.83 6.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 63.329999999999998 111.158 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 73' ' ' SER . 14.5 mt -67.04 130.51 43.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.442 . . . . 64.519999999999996 110.899 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.5 t -106.02 169.51 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 64.519999999999996 111.139 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.0 m120 -53.15 -169.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 61.310000000000002 110.883 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.5 t -44.66 172.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 61.130000000000003 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.558 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 15.7 t-20 -52.09 106.79 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.662 0.744 . . . . 75.209999999999994 110.869 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.555 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.74 -3.7 12.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 73.439999999999998 112.353 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 1.9 t -52.02 104.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 61.100000000000001 110.889 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -17.83 25.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.899 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.08 -117.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 51.130000000000003 112.519 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.8 -26.79 65.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 72.329999999999998 111.07 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 t -76.13 102.02 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 53.549999999999997 110.87 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.77 127.94 45.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 25.6 m-85 -92.45 141.15 24.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 63.229999999999997 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.24 25.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.688 2.259 . . . . 75.530000000000001 112.361 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.417 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 18.4 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.859 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.656 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.892 0.377 . . . . 71.430000000000007 110.856 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.656 ' CE3' ' C ' ' A' ' 12' ' ' SER . 8.6 m-90 -153.4 112.2 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 75.310000000000002 110.908 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -79.41 110.76 15.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 110.927 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.505 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 5.6 m -159.96 155.88 22.92 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.668 0.747 . . . . 74.439999999999998 111.078 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.77 122.9 9.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 74.439999999999998 112.331 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -52.02 114.53 5.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.525 0.678 . . . . 71.400000000000006 110.918 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 99.89 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 74.010000000000005 112.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.63 -28.28 2.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 72.530000000000001 112.474 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.882 HG11 HD11 ' A' ' 25' ' ' LEU . 5.8 p -58.89 173.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 42.450000000000003 111.155 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.701 ' H ' HG22 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.0 109.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.853 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.77 -68.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 50.340000000000003 110.861 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -41.22 -27.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 65.340000000000003 110.894 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 21' ' ' SER . 6.1 tm0? -63.99 -51.49 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 73.299999999999997 110.915 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.882 HD11 HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -70.24 -33.41 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 43.100000000000001 110.915 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 m -51.01 -18.84 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 62.009999999999998 111.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.97 -27.65 49.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 71.420000000000002 112.493 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 78.7 m-20 -59.81 -46.51 88.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 51.43 110.917 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 54' ' ' VAL . 65.2 mt -62.96 -53.24 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 62.030000000000001 111.117 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -52.43 -47.21 66.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.239999999999995 110.873 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -69.37 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 63.140000000000001 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.69 -33.36 33.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.081 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 43.8 t -57.27 -11.3 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 63.539999999999999 110.859 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 17.99 14.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 70.030000000000001 110.863 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -90.84 -51.83 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 62.43 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 168.02 -97.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 73.109999999999999 112.471 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.796 HG12 HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -81.99 18.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 64.530000000000001 111.121 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -75.09 -62.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 65.439999999999998 110.89 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.37 126.14 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 51.240000000000002 110.83 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.13 -70.06 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 63.25 112.467 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' CG ' ' O ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.81 6.0 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.683 2.255 . . . . 64.129999999999995 112.325 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.653 HD12 ' CG ' ' A' ' 57' ' ' HIS . 22.6 pt -82.63 18.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 111.135 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -79.89 129.51 70.31 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.922 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 170.1 17.46 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.678 2.252 . . . . 75.0 112.299 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.6 -41.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 61.439999999999998 112.48 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.35 -17.49 5.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 61.149999999999999 112.505 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.14 -68.64 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 72.209999999999994 111.132 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.05 6.29 12.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 64.329999999999998 110.859 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.573 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 3.7 t80 -40.87 -68.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 45.32 110.885 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -93.24 137.74 23.45 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.617 0.722 . . . . 73.109999999999999 110.913 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.555 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.2 Cg_endo -69.75 139.87 57.18 Favored 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.712 -1.786 . . . . 74.25 112.317 -0.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.73 133.66 52.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.438 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -86.93 174.24 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.479 . . . . 74.129999999999995 111.129 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 29' ' ' ILE . 56.4 t -65.76 -55.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.162 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HZ2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -78.42 13.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 110.904 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.579 ' N ' ' HZ2' ' A' ' 55' ' ' LYS . . . -51.15 -48.89 61.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 41.530000000000001 111.112 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.653 ' CG ' HD12 ' A' ' 42' ' ' ILE . 65.5 m80 -49.04 -48.13 44.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 74.340000000000003 110.847 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB1' ' HE2' ' A' ' 78' ' ' PHE . . . -57.66 -38.06 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 61.439999999999998 111.116 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.54 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 34.43 111.119 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.607 ' CE1' HD21 ' A' ' 64' ' ' LEU . 3.4 t80 -68.53 -59.14 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 63.439999999999998 110.905 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 2.0 p -54.71 -39.19 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 73.219999999999999 111.125 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.706 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 5.0 mtm -45.96 -32.62 2.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 71.129999999999995 110.858 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -64.63 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 62.340000000000003 110.862 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.796 HD12 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.69 -59.5 4.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 71.329999999999998 110.911 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.436 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 4.4 t80 -39.65 -43.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.901 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.0 t80 -61.15 -41.34 96.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 63.439999999999998 110.927 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' LEU . 32.2 mt-30 -91.62 -3.82 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 64.209999999999994 110.931 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.3 t60 -75.26 -40.68 58.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 74.140000000000001 110.89 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.998 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -75.76 -60.6 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 111.081 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.62 20.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 72.510000000000005 112.51 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 51.96 33.91 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 72.530000000000001 110.887 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.9 m-80 -102.98 167.24 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.109999999999999 110.897 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.655 ' HB2' HD11 ' A' ' 84' ' ' LEU . 93.7 p -71.26 -24.3 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.319999999999993 110.858 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.436 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -78.19 0.52 24.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 75.129999999999995 110.927 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.998 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -6.17 45.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.925 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -94.28 102.21 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.319999999999993 110.85 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.03 5.29 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 44.119999999999997 110.819 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.0 m-30 -59.31 -71.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 62.329999999999998 110.879 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.37 177.99 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.86 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.37 -2.84 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.936 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.49 HG21 ' CD1' ' A' ' 25' ' ' LEU . 27.5 p -98.04 -47.25 5.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 111.103 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.706 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -81.44 24.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 64.030000000000001 111.06 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 t -85.05 -177.29 6.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 70.439999999999998 111.173 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 73' ' ' SER . 15.4 mt -66.86 125.28 25.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.140000000000001 110.875 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.7 t -98.01 169.39 9.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 73.140000000000001 111.161 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 85' ' ' THR . 51.8 m-80 -52.95 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 110.901 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 1.6 t -44.39 170.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 63.039999999999999 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.563 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.3 t-20 -52.01 106.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.643 0.735 . . . . 62.240000000000002 110.902 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -3.09 11.28 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 71.450000000000003 112.323 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 3.5 t -51.97 107.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.450000000000003 110.857 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -17.88 45.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 110.913 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.56 -113.59 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 72.510000000000005 112.471 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.18 -38.16 90.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 61.439999999999998 111.103 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 101.99 5.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 110.905 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.51 144.97 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 55.299999999999997 110.906 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 8.6 m-85 -92.45 150.35 39.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.657 0.741 . . . . 74.010000000000005 110.924 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 115.97 4.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 72.209999999999994 112.333 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 8.5 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 53.030000000000001 110.876 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.571 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.885 0.374 . . . . 73.319999999999993 110.836 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.574 ' CD1' ' HB3' ' A' ' 98' ' ' SER . 7.6 m-90 -146.7 105.24 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 63.119999999999997 110.929 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.428 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -72.28 105.34 4.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 53.43 110.867 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.519 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.2 m -158.77 153.62 21.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 63.130000000000003 111.098 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.76 120.27 7.08 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 50.25 112.371 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.0 119.37 14.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 75.239999999999995 110.904 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 85.3 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.725 2.283 . . . . 62.100000000000001 112.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.42 -22.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 70.439999999999998 112.457 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 21' ' ' SER . 24.4 t -65.81 164.13 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 62.039999999999999 111.123 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.582 ' N ' HG12 ' A' ' 20' ' ' VAL . 5.4 m -54.0 103.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 62.020000000000003 110.88 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 21' ' ' SER . 34.8 m-20 -34.06 -65.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 110.876 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . 35.2 m-20 -36.21 -41.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.895 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -62.62 -46.91 86.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 64.209999999999994 110.911 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.794 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.1 OUTLIER -70.27 -33.54 71.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.299999999999997 110.93 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 m -56.6 -35.0 67.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 32.420000000000002 111.145 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.9 -26.63 67.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 73.099999999999994 112.509 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -63.46 -43.2 98.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 73.109999999999999 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 57' ' ' HIS . 24.9 mt -62.38 -51.63 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.010000000000005 111.102 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -54.07 -45.41 71.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -68.95 -58.07 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 110.895 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.894 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -49.94 -47.03 52.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 75.310000000000002 111.127 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -50.77 -17.43 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 54.25 110.863 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -88.0 13.58 10.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 52.340000000000003 110.897 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.03 -46.06 6.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 72.0 110.918 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 136.53 -55.57 0.7 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.714 -0.755 . . . . 55.32 112.457 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.3 pt -88.13 4.1 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 60.100000000000001 111.135 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.894 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 1.9 m-20 -80.6 -58.98 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 75.510000000000005 110.857 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -75.37 127.31 32.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 75.25 110.874 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.17 -73.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 40.409999999999997 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.602 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.8 3.61 2.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.686 2.257 . . . . 62.450000000000003 112.336 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 38' ' ' ASP . 12.7 pt -83.1 17.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 54.240000000000002 111.08 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.52 135.54 53.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 64.420000000000002 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 176.56 6.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.695 2.263 . . . . 71.0 112.381 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.95 -35.43 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 71.439999999999998 112.466 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.1 -25.86 9.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 53.340000000000003 112.471 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.78 -68.14 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 63.240000000000002 111.108 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.09 -8.96 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.219999999999999 110.866 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -37.49 -48.44 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.519999999999996 110.842 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.32 126.97 37.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 74.519999999999996 110.858 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.72 148.26 86.26 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 -1.789 . . . . 61.439999999999998 112.335 -0.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 41.2 t30 -103.14 150.63 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 53.030000000000001 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.4 ' CB ' ' HE2' ' A' ' 55' ' ' LYS . 27.9 p -106.46 163.82 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 71.319999999999993 111.119 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.8 -56.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 53.509999999999998 111.122 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.609 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.49 16.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.864 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -51.24 -47.89 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.0 111.127 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.724 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.2 m80 -45.34 -58.97 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 110.84 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.696 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -51.46 -38.81 55.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.096 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 56' ' ' ALA . . . -55.89 -40.42 72.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.200000000000003 111.111 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.602 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 9.4 t80 -68.13 -63.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.040000000000006 110.923 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.881 HG11 ' OD1' ' A' ' 38' ' ' ASP . 7.4 p -55.12 -33.56 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 73.129999999999995 111.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.686 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 mmt -46.13 -29.66 1.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 110.885 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.37 -65.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 64.310000000000002 110.858 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.569 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.87 -51.03 62.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 62.530000000000001 110.901 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.561 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.8 t80 -44.64 -43.71 8.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 74.030000000000001 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 3.7 t80 -64.08 -30.71 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.936 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -98.21 -2.33 39.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 74.329999999999998 110.928 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -72.99 -48.18 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 75.109999999999999 110.85 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.937 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -68.82 -57.06 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 111.136 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.7 24.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 74.109999999999999 112.482 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 52.0 35.61 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 70.230000000000004 110.839 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -103.14 166.3 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 35.399999999999999 110.846 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -71.3 -23.24 61.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 65.530000000000001 110.81 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.44 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -79.29 0.26 29.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.468 . . . . 74.340000000000003 110.936 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.937 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -23.19 59.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.299999999999997 110.891 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -84.11 102.11 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 61.009999999999998 110.846 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -118.08 8.44 12.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.828 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.696 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -59.46 -70.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.876 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.75 177.98 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.129999999999995 110.803 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -65.33 -2.35 3.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 71.400000000000006 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.794 HG21 ' CD1' ' A' ' 25' ' ' LEU . 29.0 p -97.96 -46.46 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 111.17 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.67 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.66 25.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 111.077 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 t -86.56 -177.6 6.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 74.519999999999996 111.18 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 12' ' ' SER . 16.7 mt -66.89 106.9 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 53.130000000000003 110.915 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.2 t -77.98 167.55 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 64.099999999999994 111.152 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 17.2 m-20 -53.27 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.65 173.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 73.400000000000006 111.099 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 21.5 t-20 -52.0 106.0 0.6 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.647 0.737 . . . . 54.520000000000003 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.2 Cg_endo -69.74 -23.03 31.33 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.272 . . . . 70.299999999999997 112.298 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.1 t -52.0 106.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 71.219999999999999 110.832 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -80.03 -15.3 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 73.129999999999995 110.917 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.01 -124.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 74.329999999999998 112.474 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -37.86 -43.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 73.450000000000003 111.088 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 62.219999999999999 110.852 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.84 133.83 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 110.907 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.546 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 23.8 m-85 -92.71 146.48 32.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.678 0.751 . . . . 74.5 110.869 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 117.13 4.89 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.674 2.249 . . . . 70.129999999999995 112.345 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 91.9 p . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 63.299999999999997 110.87 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.665 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 58.8 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.856 0.36 . . . . 71.5 110.836 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.665 ' CE3' ' C ' ' A' ' 12' ' ' SER . 9.2 m-90 -152.8 123.19 7.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.299999999999997 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.48 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -90.7 111.72 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.120000000000005 110.886 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.488 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.2 m -160.09 154.89 20.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.450000000000003 111.133 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HD3' ' HE1' ' A' ' 62' ' ' MET . 53.5 Cg_endo -69.75 125.59 12.33 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.717 2.278 . . . . 63.32 112.35 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 110.13 1.73 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.512 0.672 . . . . 71.299999999999997 110.882 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 97.58 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 74.310000000000002 112.29 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.83 -33.73 2.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 54.229999999999997 112.483 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 21' ' ' SER . 2.8 p -58.98 178.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 64.040000000000006 111.136 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.775 ' H ' HG22 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -52.0 128.46 24.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.838 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 24' ' ' GLN . 72.9 m-20 -58.26 -67.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.854 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' HA ' HG22 ' A' ' 26' ' ' THR . 1.1 m-20 -41.81 -23.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 70.510000000000005 110.834 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 22' ' ' ASP . 1.0 OUTLIER -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 53.450000000000003 110.904 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.654 HD11 ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -70.89 -56.67 5.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.898 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 23' ' ' ASP . 12.0 t -44.9 -20.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 70.310000000000002 111.108 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 25' ' ' LEU . . . -69.15 -37.93 82.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 73.200000000000003 112.48 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.88 -56.24 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.782 0.325 . . . . 74.510000000000005 110.916 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 57' ' ' HIS . 23.4 mt -46.44 -41.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 62.109999999999999 111.128 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -56.66 -48.08 78.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.13 -56.18 5.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 62.539999999999999 110.967 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.878 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -51.05 -43.47 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 75.219999999999999 111.099 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 37.4 t -52.75 -15.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.510000000000005 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.32 15.87 16.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 60.020000000000003 110.886 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.98 -48.04 5.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 73.230000000000004 110.922 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.73 -64.14 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.748 . . . . 34.200000000000003 112.486 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.115 HD12 HD12 ' A' ' 64' ' ' LEU . 3.4 pt -82.3 14.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 71.349999999999994 111.121 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.878 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 3.2 m-20 -89.5 -65.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 73.519999999999996 110.846 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.4 m -76.08 124.49 27.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.858 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.45 -74.58 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 71.239999999999995 112.499 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD2' ' C ' ' A' ' 39' ' ' CYS . 53.5 Cg_endo -69.78 5.73 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 62.25 112.322 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 38' ' ' ASP . 5.1 pt -85.23 17.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 70.019999999999996 111.105 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -76.69 135.49 68.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.722 . . . . 75.409999999999997 110.93 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 170.66 16.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.625 2.216 . . . . 74.099999999999994 112.318 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.78 -38.83 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 71.329999999999998 112.444 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.57 -26.16 4.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 45.299999999999997 112.434 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.83 -68.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 63.420000000000002 111.093 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.96 14.43 14.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 44.100000000000001 110.897 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 3.1 t80 -56.48 -50.9 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.899 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -97.52 128.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.699 0.762 . . . . 72.430000000000007 110.853 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 150.84 90.87 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.68 -1.8 . . . . 74.540000000000006 112.37 -0.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.553 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 16.2 t-20 -99.74 131.62 45.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.329999999999998 110.86 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.545 ' HB ' ' HZ3' ' A' ' 55' ' ' LYS . 65.7 p -90.9 167.31 12.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 52.119999999999997 111.193 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.2 -59.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 71.400000000000006 111.141 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.49 17.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 110.929 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -48.55 -41.12 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.400000000000006 111.043 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.596 ' CD2' HD12 ' A' ' 42' ' ' ILE . 47.2 m80 -54.76 -55.26 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 74.140000000000001 110.874 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.497 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -50.57 -41.93 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 34.399999999999999 111.106 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' HE3' ' A' ' 62' ' ' MET . . . -57.43 -40.23 77.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 111.101 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 6.3 t80 -68.92 -57.0 6.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 73.329999999999998 110.972 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.513 HG21 ' OD1' ' A' ' 38' ' ' ASP . 3.3 p -54.39 -43.79 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 72.319999999999993 111.134 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.563 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 2.8 ttm -45.76 -29.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 75.400000000000006 110.863 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.502 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 32.8 t30 -59.3 -62.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.540000000000006 110.855 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.115 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.58 -46.22 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 73.319999999999993 110.93 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.469 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.4 t80 -47.43 -54.59 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 72.329999999999998 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.599 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.0 t80 -55.59 -30.55 61.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 74.120000000000005 110.905 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 49.4 mt-30 -95.41 -4.51 45.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 73.409999999999997 110.895 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.706 ' CD2' ' C ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -68.4 -44.14 75.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 54.399999999999999 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.978 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.42 -60.23 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 111.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.82 23.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 32.509999999999998 112.475 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.563 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.02 37.24 20.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.0 110.858 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.599 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 2.4 m-80 -100.97 164.76 11.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.230000000000004 110.913 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 p -68.38 -25.57 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 110.825 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -79.55 1.78 24.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 71.319999999999993 110.951 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.978 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -79.92 -3.93 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 43.420000000000002 110.868 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -101.57 102.01 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 44.039999999999999 110.888 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -117.96 9.54 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.904 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.638 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.6 m-30 -58.33 -70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.929 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.78 178.01 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 61.100000000000001 110.868 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -3.07 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 74.420000000000002 110.937 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 25' ' ' LEU . 26.5 p -97.95 -49.01 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 44.340000000000003 111.146 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.73 25.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.139 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -86.3 -178.5 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 71.430000000000007 111.16 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 12' ' ' SER . 2.9 mm? -66.91 130.89 44.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 63.539999999999999 110.899 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.05 167.85 9.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 73.019999999999996 111.149 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.9 m-20 -53.71 -168.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 71.310000000000002 110.878 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -44.53 171.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 111.163 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.557 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 13.6 t-20 -51.95 105.94 0.59 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.329999999999998 110.878 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.79 -1.27 8.21 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 72.439999999999998 112.347 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.456 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 4.9 t -51.98 110.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.450000000000003 110.874 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -86.98 -18.06 31.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 64.230000000000004 110.918 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.44 -120.72 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 64.430000000000007 112.452 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.98 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.349999999999994 110.854 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.03 140.32 33.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 110.891 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.5 m-85 -92.11 146.03 31.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 74.430000000000007 110.865 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 122.83 9.49 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 74.200000000000003 112.37 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 25.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 74.420000000000002 110.866 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.651 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 2.7 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.833 0.349 . . . . 73.400000000000006 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.651 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 6.4 m-90 -141.07 114.14 8.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 63.409999999999997 110.916 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.0 110.67 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 74.200000000000003 110.861 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.51 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 m -159.59 154.34 21.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.626 0.727 . . . . 75.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.527 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 54.1 Cg_endo -69.8 123.28 9.94 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 63.119999999999997 112.326 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.98 114.3 5.18 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 74.420000000000002 110.871 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 92.37 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.715 2.277 . . . . 72.140000000000001 112.37 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.74 -24.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 52.200000000000003 112.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.636 ' HB ' HD21 ' A' ' 25' ' ' LEU . 44.3 t -59.05 165.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 64.340000000000003 111.142 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.632 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.2 m -52.08 108.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.450000000000003 110.877 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 21' ' ' SER . 5.5 m-20 -32.99 -65.27 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.140000000000001 110.853 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.02 -40.68 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.905 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -60.26 -49.17 78.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 73.25 110.907 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.22 -29.04 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 61.520000000000003 110.945 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.778 ' OG1' HG11 ' A' ' 54' ' ' VAL . 17.3 m -67.11 0.07 2.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 73.519999999999996 111.166 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.92 -40.34 5.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 65.129999999999995 112.506 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.3 p30 -50.47 -44.3 55.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.367 . . . . 74.25 110.883 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 55' ' ' LYS . 61.6 mt -58.21 -49.05 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 74.049999999999997 111.142 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.19 -41.07 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.9 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.15 -52.68 11.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 110.967 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 38' ' ' ASP . . . -52.82 -41.6 64.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 70.299999999999997 111.099 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.42 -9.69 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 60.509999999999998 110.9 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.19 3.89 40.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.019999999999996 110.848 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.18 -36.48 6.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 110.923 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 -31.18 7.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 34.130000000000003 112.506 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.728 ' CD1' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -83.22 -11.41 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 74.430000000000007 111.168 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.726 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.65 -63.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.876 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 62.9 m -75.83 129.57 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 41.210000000000001 110.834 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.7 -85.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 54.310000000000002 112.51 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 7.02 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.242 . . . . 74.340000000000003 112.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.697 HD12 ' CG ' ' A' ' 57' ' ' HIS . 5.1 pt -82.62 17.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.540000000000006 111.16 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -79.53 132.85 60.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.601 0.715 . . . . 64.430000000000007 110.916 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 171.52 14.33 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.686 2.258 . . . . 61.530000000000001 112.323 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 63.130000000000003 112.492 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.36 -25.72 3.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.349999999999994 112.449 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.41 -68.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 61.039999999999999 111.12 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.95 14.88 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 51.420000000000002 110.907 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.591 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 2.9 t80 -51.66 -56.55 13.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 71.109999999999999 110.847 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.591 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 1.3 mm-40 -96.41 133.18 25.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 65.450000000000003 110.879 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 157.04 92.57 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.705 -1.79 . . . . 65.299999999999997 112.33 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -117.24 142.22 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 60.149999999999999 110.912 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.0 p -106.84 172.82 6.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 111.118 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.778 HG11 ' OG1' ' A' ' 26' ' ' THR . 43.9 t -65.73 -54.73 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 71.430000000000007 111.153 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -79.7 17.23 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.893 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.3 -45.44 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.340000000000003 111.115 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.697 ' CG ' HD12 ' A' ' 42' ' ' ILE . 32.9 m170 -53.79 -60.18 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 71.549999999999997 110.843 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.497 ' C ' ' HE2' ' A' ' 62' ' ' MET . . . -43.97 -47.21 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 44.310000000000002 111.1 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.35 49.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 75.140000000000001 111.134 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 8.9 t80 -69.33 -65.01 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.947 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.664 HG23 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -54.42 -26.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 75.019999999999996 111.127 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.723 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 1.5 mtm -52.26 -20.38 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.889 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.07 -65.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 61.340000000000003 110.877 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.728 HD12 ' CD1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -63.74 -41.77 97.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.908 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 3.4 t80 -58.51 -45.11 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.916 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 4.6 t80 -65.21 -30.43 71.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.409999999999997 110.926 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -96.21 -3.71 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 71.010000000000005 110.949 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -45.74 74.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 71.530000000000001 110.83 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.686 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -75.82 -57.75 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.071 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.11 25.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 71.299999999999997 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.04 47.09 25.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 72.010000000000005 110.897 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.6 m-80 -110.27 165.6 11.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.230000000000004 110.886 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.694 ' HB2' HD11 ' A' ' 84' ' ' LEU . 30.4 p -70.74 -25.84 63.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 110.841 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -77.74 0.3 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.946 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.686 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -77.54 -14.42 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 75.530000000000001 110.886 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -91.39 102.03 14.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.864 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.06 7.75 12.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.43 110.877 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.3 m-30 -59.03 -70.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 70.150000000000006 110.853 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.85 178.03 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 75.540000000000006 110.884 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -1.84 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 110.908 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.889 HG21 ' CD1' ' A' ' 25' ' ' LEU . 37.3 p -95.0 -50.33 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 111.147 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.723 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -80.66 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 71.400000000000006 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -87.01 -179.52 6.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 111.148 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.694 HD11 ' HB2' ' A' ' 73' ' ' SER . 2.5 mt -67.36 131.51 45.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 64.209999999999994 110.938 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.08 168.43 9.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 73.540000000000006 111.129 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.25 -169.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 55.409999999999997 110.867 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -44.22 172.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 74.329999999999998 111.127 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.4 t-20 -52.01 106.78 0.7 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 74.109999999999999 110.89 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.547 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.7 -4.03 13.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.678 2.252 . . . . 74.150000000000006 112.34 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 2.5 t -51.98 110.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 54.229999999999997 110.838 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -15.69 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 72.329999999999998 110.921 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.89 -128.92 1.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 62.100000000000001 112.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.59 65.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 74.519999999999996 111.142 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.49 101.98 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 53.219999999999999 110.902 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -99.75 141.29 32.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 75.450000000000003 110.939 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.547 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 15.9 m-85 -93.14 147.76 34.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 75.299999999999997 110.896 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.4 4.08 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 72.239999999999995 112.289 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.47 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 27.9 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 75.310000000000002 110.878 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.662 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 70.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 75.219999999999999 110.825 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.662 ' CE3' ' C ' ' A' ' 12' ' ' SER . 7.2 m-90 -152.94 107.06 3.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.956 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -72.87 105.59 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 65.230000000000004 110.853 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.556 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.8 m -158.88 154.82 23.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.647 0.736 . . . . 73.209999999999994 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.527 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.78 118.43 5.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 72.140000000000001 112.329 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.98 110.16 1.74 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.714 . . . . 71.420000000000002 110.89 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 79.65 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.705 2.27 . . . . 42.439999999999998 112.356 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 159.41 58.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 41.009999999999998 112.484 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.839 ' CG2' HD11 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -158.26 177.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 60.310000000000002 111.105 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 2.4 m -51.97 116.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 52.32 110.878 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -40.94 -66.22 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 110.887 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.33 -27.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.824 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' SER . 21.8 tt0 -63.54 -52.45 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 110.908 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.839 HD11 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -71.65 -51.14 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 64.109999999999999 110.903 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.597 ' OG1' HG11 ' A' ' 54' ' ' VAL . 25.7 m -45.5 -43.86 12.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 72.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.4 -30.49 2.05 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 72.239999999999995 112.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -64.37 -66.68 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 110.876 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 57' ' ' HIS . 37.1 mt -38.21 -49.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.178 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.442 ' OD1' ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -52.14 -44.84 64.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.030000000000001 110.873 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -74.05 -54.6 7.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 110.937 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -51.57 -38.89 56.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 44.009999999999998 111.088 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -12.66 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.299999999999997 110.874 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -115.2 18.04 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 110.844 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 1.8 mm100 -93.02 -52.02 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.918 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 161.72 -91.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 65.129999999999995 112.482 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.451 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.55 17.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 53.009999999999998 111.132 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -85.41 -60.68 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 71.150000000000006 110.869 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.88 110.06 8.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 63.520000000000003 110.924 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.65 -70.99 0.46 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 63.420000000000002 112.486 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.558 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.75 8.1 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.691 2.26 . . . . 71.099999999999994 112.309 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.682 HD12 ' CD2' ' A' ' 57' ' ' HIS . 20.2 pt -82.32 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 64.150000000000006 111.142 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -82.85 122.56 78.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 65.329999999999998 110.926 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 168.53 21.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 71.430000000000007 112.303 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.56 -35.45 1.08 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 44.340000000000003 112.503 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.57 -19.42 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 42.420000000000002 112.519 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 -68.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 74.209999999999994 111.089 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -117.98 12.75 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 75.209999999999994 110.914 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.524 ' CE1' ' CB ' ' A' ' 52' ' ' ASN . 2.1 t80 -56.97 -47.37 80.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 110.863 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.57 129.12 33.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.652 0.739 . . . . 74.239999999999995 110.909 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.76 150.54 90.33 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 -1.8 . . . . 61.299999999999997 112.367 0.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.524 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -114.5 118.2 33.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.010000000000005 110.936 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.82 170.18 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 72.409999999999997 111.156 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.597 HG11 ' OG1' ' A' ' 26' ' ' THR . 50.3 t -64.4 -52.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.230000000000004 111.134 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.527 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.73 13.63 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 65.310000000000002 110.873 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.99 -43.06 60.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.349999999999994 111.098 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.682 ' CD2' HD12 ' A' ' 42' ' ' ILE . 61.8 m80 -55.2 -46.97 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 72.319999999999993 110.834 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.592 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -59.67 -37.53 79.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 52.310000000000002 111.098 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.34 80.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 54.340000000000003 111.12 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.558 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -68.74 -61.19 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 74.120000000000005 110.915 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -54.79 -45.36 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 75.109999999999999 111.145 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -46.07 -21.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 65.310000000000002 110.876 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HB3' HD23 ' A' ' 64' ' ' LEU . 10.9 t30 -69.41 -59.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.510000000000005 110.906 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -76.74 -47.18 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 72.120000000000005 110.938 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t80 -46.52 -40.11 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.929 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 6.3 t80 -60.47 -31.07 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 110.956 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -96.3 -4.32 42.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 72.109999999999999 110.888 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -50.4 45.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 110.863 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.812 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -68.01 -57.84 5.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 22.350000000000001 111.09 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.14 25.09 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 73.450000000000003 112.501 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.01 35.82 17.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 70.439999999999998 110.888 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.476 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.2 m-80 -102.84 169.69 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.9 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.562 ' HB2' HD11 ' A' ' 84' ' ' LEU . 56.5 p -71.72 -22.49 61.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 61.329999999999998 110.83 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.66 0.82 32.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 74.109999999999999 110.892 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.812 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -10.28 59.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 65.230000000000004 110.906 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HE1' ' A' ' 62' ' ' MET . 0.5 OUTLIER -90.66 103.33 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.049999999999997 110.917 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -118.03 2.23 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.879 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.592 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 2.8 m-85 -58.94 -71.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 110.924 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.35 177.97 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 110.895 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -65.41 -2.48 3.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.540000000000006 110.922 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.1 p -98.02 -48.43 5.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 61.219999999999999 111.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -80.42 23.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 111.137 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -84.98 -176.69 6.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.209 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 73' ' ' SER . 2.0 mt -66.21 107.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 64.219999999999999 110.901 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -78.14 168.97 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 111.147 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' THR . 75.3 m-20 -53.54 -168.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 110.907 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 10.2 t -44.46 171.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 55.210000000000001 111.145 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.01 106.27 0.63 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.636 0.732 . . . . 73.239999999999995 110.872 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.72 -1.6 8.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.701 2.268 . . . . 75.040000000000006 112.385 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -52.01 108.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.901 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.579 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 4.1 p90 -82.82 -18.14 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 62.140000000000001 110.914 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 -114.48 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 65.209999999999994 112.5 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -36.92 85.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 73.349999999999994 111.049 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.579 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -79.41 101.98 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.91 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -100.08 147.82 25.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 62.329999999999998 110.908 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -93.1 156.41 40.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 75.340000000000003 110.904 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 125.95 12.69 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.262 . . . . 74.109999999999999 112.291 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.483 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 1.2 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.510000000000005 110.843 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.879 0.371 . . . . 71.140000000000001 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -148.4 132.31 8.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.613 0.72 . . . . 73.209999999999994 111.13 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 118.54 5.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.646 2.231 . . . . 74.540000000000006 112.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -110.39 141.59 24.27 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.63 0.728 . . . . 62.219999999999999 111.131 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.67 20.82 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.652 2.234 . . . . 64.219999999999999 112.381 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -121.23 141.9 34.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.566 0.698 . . . . 50.310000000000002 111.139 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -163.69 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 72.319999999999993 112.351 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -109.01 131.02 55.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 110.859 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.6 158.72 30.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.114 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.66 154.13 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 63.43 111.098 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.97 -64.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 71.409999999999997 112.487 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.589 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -152.21 158.22 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.847 0.356 . . . . 54.030000000000001 110.876 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CE3' ' C ' ' A' ' 12' ' ' SER . 2.5 m-90 -138.08 120.86 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 72.420000000000002 110.93 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.81 102.09 14.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 63.009999999999998 110.871 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.99 152.43 26.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 71.209999999999994 111.166 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.74 127.78 15.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.664 2.243 . . . . 71.129999999999995 112.329 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -52.02 118.23 11.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 73.129999999999995 110.911 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 73.299999999999997 112.312 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.28 -25.61 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.748 . . . . 74.319999999999993 112.461 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.766 ' HB ' HD11 ' A' ' 25' ' ' LEU . 13.2 t -59.1 166.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 74.109999999999999 111.104 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.836 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.3 m -56.44 113.19 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.811 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 21' ' ' SER . 24.3 m-20 -36.57 -59.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 65.439999999999998 110.898 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -36.43 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.030000000000001 110.891 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -63.72 -48.51 76.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.458 . . . . 65.200000000000003 110.899 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -70.98 -30.46 66.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.430000000000007 110.877 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.52 ' OG1' HG11 ' A' ' 54' ' ' VAL . 9.8 m -55.8 -30.24 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 60.25 111.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.13 58.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 62.109999999999999 112.532 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 4.6 m-20 -64.14 -68.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.328 . . . . 73.319999999999993 110.901 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 84.9 mt -43.82 -43.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.117 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -46.99 83.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.409999999999997 110.886 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 1.2 t80 -73.95 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 61.130000000000003 110.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.92 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -51.15 -43.19 61.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 65.519999999999996 111.097 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 35.5 t -53.37 -14.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 64.209999999999994 110.939 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.87 14.5 19.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 63.420000000000002 110.901 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -46.48 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 71.230000000000004 110.94 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.65 -62.41 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 34.340000000000003 112.493 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -82.32 5.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 73.209999999999994 111.159 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.92 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 6.0 m-20 -82.86 -63.81 1.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 53.140000000000001 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.11 126.19 30.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.901 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.85 -70.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 62.219999999999999 112.471 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.616 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.82 4.85 1.98 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.694 2.263 . . . . 62.119999999999997 112.319 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.772 HD12 ' CG ' ' A' ' 57' ' ' HIS . 27.3 pt -83.35 18.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 63.439999999999998 111.113 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -74.12 129.28 84.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 73.230000000000004 110.92 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 161.24 46.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 72.099999999999994 112.352 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.87 -35.33 2.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 63.009999999999998 112.435 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.13 -26.1 5.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 75.450000000000003 112.487 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.1 -68.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 73.129999999999995 111.12 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' A' ' 49' ' ' PHE . 28.8 m -118.07 -4.36 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.450000000000003 110.866 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.7 t80 -34.28 -54.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.33 124.76 41.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 71.150000000000006 110.909 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.15 88.13 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 -1.811 . . . . 70.140000000000001 112.345 0.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.43 ' CA ' ' O ' ' A' ' 49' ' ' PHE . 13.7 p-10 -106.03 127.08 52.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.319999999999993 110.882 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 59.1 p -83.5 166.8 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 54.399999999999999 111.16 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.52 HG11 ' OG1' ' A' ' 26' ' ' THR . 41.0 t -65.8 -57.84 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 111.123 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -78.97 13.94 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 45.119999999999997 110.923 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -51.3 -48.42 62.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.230000000000004 111.084 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.772 ' CG ' HD12 ' A' ' 42' ' ' ILE . 34.7 m170 -50.33 -50.41 51.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 73.310000000000002 110.828 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.711 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -56.66 -37.55 70.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.219999999999999 111.106 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.34 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 71.150000000000006 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 6.8 t80 -68.27 -63.11 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 70.129999999999995 110.951 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 65' ' ' TYR . 2.6 p -54.82 -33.39 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 111.147 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.46 ' HE3' ' CD1' ' A' ' 78' ' ' PHE . 1.5 mmt -45.54 -24.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 65.299999999999997 110.862 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 99' ' ' GLY . 8.4 t30 -68.87 -58.15 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 63.109999999999999 110.905 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.673 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -74.86 -50.73 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 61.409999999999997 110.933 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.658 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.4 t80 -46.3 -50.02 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.030000000000001 110.936 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.553 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 31.4 t80 -53.53 -36.78 62.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 73.219999999999999 110.939 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 99' ' ' GLY . 15.8 mt-30 -94.09 -2.68 52.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.5 110.91 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.55 -42.62 58.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.150000000000006 110.879 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.988 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.48 -60.9 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 51.399999999999999 111.098 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.02 19.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 41.240000000000002 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.98 32.08 9.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 70.040000000000006 110.866 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.553 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 1.9 m-80 -104.75 166.38 10.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 45.130000000000003 110.857 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.575 ' HB3' HD21 ' A' ' 84' ' ' LEU . 57.8 p -68.06 -23.15 64.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 60.329999999999998 110.852 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.13 2.23 28.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.439999999999998 110.914 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.988 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -13.45 61.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 55.299999999999997 110.911 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.73 101.98 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 8.6 m-20 -118.0 7.63 12.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.868 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.3 m-30 -59.08 -68.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.040000000000006 110.907 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.91 178.04 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 63.350000000000001 110.87 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -1.94 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.833 HG21 ' CD1' ' A' ' 25' ' ' LEU . 72.2 p -93.17 -52.52 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 111.132 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -82.43 102.01 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 70.230000000000004 111.132 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -148.94 178.06 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 111.117 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 73' ' ' SER . 6.2 mp -66.32 126.75 29.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 65.230000000000004 110.947 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -106.38 169.36 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 62.140000000000001 111.121 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' THR . 33.4 m-80 -54.06 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 61.130000000000003 110.921 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -45.13 175.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 65.319999999999993 111.185 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 5.8 t-20 -51.97 105.96 0.59 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.626 0.727 . . . . 71.010000000000005 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.4 Cg_endo -69.79 -16.44 37.42 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.254 . . . . 65.310000000000002 112.31 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 29.8 t -51.97 110.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 64.349999999999994 110.848 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -77.2 -15.71 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.932 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 168.65 -122.43 1.02 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.748 -0.739 . . . . 41.109999999999999 112.501 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -40.09 -42.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 52.420000000000002 111.045 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.64 102.26 7.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 62.520000000000003 110.859 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -99.0 130.85 45.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 75.120000000000005 110.921 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 20.8 m-85 -83.93 144.38 44.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.659 0.742 . . . . 70.010000000000005 110.886 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 120.34 7.14 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.236 . . . . 61.200000000000003 112.369 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 52.6 p -110.23 2.96 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 62.009999999999998 110.828 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.526 ' O ' ' NE2' ' A' ' 67' ' ' GLN . . . 124.75 -43.42 1.39 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 71.329999999999998 112.513 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 m -77.84 141.15 39.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 61.350000000000001 110.862 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 110.871 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.837 0.351 . . . . 50.200000000000003 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.7 p -146.42 150.48 40.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 72.109999999999999 111.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 136.66 33.42 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.716 2.277 . . . . 63.240000000000002 112.29 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.2 p -138.41 143.46 38.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.583 0.706 . . . . 72.400000000000006 111.129 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 133.95 26.7 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 63.140000000000001 112.342 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.8 p -105.95 148.78 37.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.539 0.685 . . . . 64.209999999999994 111.137 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -173.83 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 73.140000000000001 112.349 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 115.74 14.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 61.030000000000001 110.905 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.38 166.41 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 63.520000000000003 111.12 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 163.55 7.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 111.125 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.634 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 58.66 105.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.749 . . . . 45.439999999999998 112.494 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.63 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.6 OUTLIER -157.95 125.87 5.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 41.219999999999999 110.852 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.634 ' CZ3' ' C ' ' A' ' 11' ' ' GLY . 1.6 m-90 -134.29 111.69 10.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.118 -0.492 . . . . 64.349999999999994 110.93 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -82.42 101.99 11.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.86 152.42 26.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 72.329999999999998 111.124 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.74 129.17 17.15 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 75.540000000000006 112.355 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 115.93 7.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 74.340000000000003 110.883 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 84.49 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 41.130000000000003 112.371 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.74 -25.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.745 -0.741 . . . . 61.329999999999998 112.457 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.8 t -59.1 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.073 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.696 ' O ' HD22 ' A' ' 25' ' ' LEU . 14.8 m -52.06 109.2 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.099999999999994 110.836 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 21' ' ' SER . 42.8 m-20 -33.87 -64.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 63.25 110.878 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.34 -40.53 2.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.883 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.9 tp60 -58.13 -51.38 69.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 43.329999999999998 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.794 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -71.68 -27.04 62.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.877 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.809 ' OG1' HG11 ' A' ' 54' ' ' VAL . 11.0 m -62.89 -6.88 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 60.119999999999997 111.14 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -25.8 45.21 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 61.399999999999999 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.39 -67.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 63.43 110.879 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 80.7 mt -39.21 -44.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 72.150000000000006 111.112 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.52 -47.6 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.53 -58.12 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 110.889 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.89 -41.16 61.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 13.3 t -56.84 -9.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 65.409999999999997 110.851 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.05 18.0 19.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.453 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 13.6 mm-40 -94.46 -50.57 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 71.230000000000004 110.916 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.83 -81.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 72.310000000000002 112.446 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.76 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.3 pt -81.6 17.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 74.340000000000003 111.128 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -89.44 -61.13 1.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 74.0 110.872 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -74.47 124.58 26.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.409999999999997 110.892 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.19 -69.77 0.42 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 65.540000000000006 112.512 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.666 2.244 . . . . 74.109999999999999 112.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 38' ' ' ASP . 21.6 pt -82.53 17.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.099999999999994 111.117 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.75 138.65 62.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 75.230000000000004 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.74 145.9 58.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 61.140000000000001 112.336 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.3 -29.94 4.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 74.310000000000002 112.463 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.15 -13.1 7.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 54.450000000000003 112.536 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 -68.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 74.420000000000002 111.114 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 m -118.05 11.11 13.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.549999999999997 110.914 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 1.5 t80 -54.92 -57.39 11.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 75.310000000000002 110.909 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.588 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -100.53 127.09 33.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 73.430000000000007 110.887 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.73 153.92 93.04 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 -1.797 . . . . 64.340000000000003 112.367 -0.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -101.58 119.31 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.877 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 56.5 p -83.19 171.43 13.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 74.450000000000003 111.163 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.809 HG11 ' OG1' ' A' ' 26' ' ' THR . 69.1 t -65.84 -61.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 34.299999999999997 111.125 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.55 16.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 72.129999999999995 110.911 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -51.47 -47.5 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.106 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.642 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.8 m80 -50.15 -50.25 49.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.831 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.681 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.93 -33.14 68.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 51.030000000000001 111.109 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.14 86.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 111.083 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.589 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -68.32 -60.65 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.349999999999994 110.961 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -55.26 -34.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 71.120000000000005 111.152 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.574 ' HE2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -50.67 -29.99 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.846 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -65.38 -67.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.893 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.82 -53.35 41.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.908 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.76 ' HA ' HD11 ' A' ' 37' ' ' ILE . 3.3 t80 -46.94 -45.79 20.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.299999999999997 110.907 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 35.6 t80 -58.76 -26.41 63.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 72.400000000000006 110.9 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.489 ' NE2' ' HA2' ' A' ' 99' ' ' GLY . 41.9 mt-30 -103.29 -1.89 28.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 74.019999999999996 110.921 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -70.17 -42.19 72.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 73.010000000000005 110.852 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.638 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.63 -56.09 4.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 111.121 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.42 24.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 62.109999999999999 112.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 52.04 46.57 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 74.319999999999993 110.85 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -112.71 168.23 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 71.430000000000007 110.902 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.514 ' HA ' HD11 ' A' ' 84' ' ' LEU . 73.2 p -71.2 -24.59 62.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 50.43 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -78.87 1.35 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 74.430000000000007 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -22.47 59.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 110.888 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.407 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.3 m -82.31 102.0 10.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 110.906 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.0 8.81 12.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 70.209999999999994 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.681 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -58.54 -68.67 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.867 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -172.07 178.01 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 65.140000000000001 110.819 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -65.7 -1.52 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 72.540000000000006 110.939 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.583 HG21 ' CD1' ' A' ' 25' ' ' LEU . 64.9 p -92.91 -52.62 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 53.420000000000002 111.157 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.34 102.33 11.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.409999999999997 111.092 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 t -148.78 178.01 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 70.200000000000003 111.162 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -66.65 112.06 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 65.230000000000004 110.958 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -89.23 168.18 12.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 64.140000000000001 111.107 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' THR . 72.1 m-20 -54.39 -167.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.6 t -44.46 173.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 65.349999999999994 111.138 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.8 t-20 -52.11 106.92 0.72 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 65.329999999999998 110.86 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.73 -2.77 10.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 72.150000000000006 112.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.402 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 11.7 t -51.99 105.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.887 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -74.6 -16.39 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 73.049999999999997 110.931 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.08 -113.25 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 51.210000000000001 112.52 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.31 79.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 72.209999999999994 111.08 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 63.32 110.876 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -99.36 140.16 33.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.530000000000001 110.894 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.543 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.07 151.14 40.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 74.519999999999996 110.841 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.623 2.215 . . . . 62.32 112.371 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 6.0 p -113.35 -0.18 14.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 73.340000000000003 110.842 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.489 ' HA2' ' NE2' ' A' ' 67' ' ' GLN . . . 39.77 42.98 2.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 53.509999999999998 112.503 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.08 168.15 11.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 51.109999999999999 110.863 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 74.109999999999999 110.889 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.872 0.367 . . . . 65.040000000000006 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.479 ' CG2' ' HD2' ' A' ' 3' ' ' PRO . 4.9 m -95.87 136.44 22.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.6 0.714 . . . . 74.439999999999998 111.175 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' ' CG2' ' A' ' 2' ' ' THR . 53.9 Cg_endo -69.77 99.14 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.707 2.272 . . . . 73.219999999999999 112.35 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -74.8 149.72 85.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.574 0.702 . . . . 55.420000000000002 111.147 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 154.75 67.34 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.662 2.242 . . . . 65.420000000000002 112.367 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.6 p -70.56 148.47 95.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 53.32 111.104 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -168.93 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 74.340000000000003 112.317 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -101.76 118.67 37.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.400000000000006 110.908 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.4 111.71 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 62.140000000000001 111.11 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.08 171.67 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.121 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . -80.12 142.75 24.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 32.5 112.522 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -153.55 126.43 8.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 72.219999999999999 110.891 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.4 m-90 -125.98 116.52 21.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 74.040000000000006 110.926 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.92 106.24 18.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 70.420000000000002 110.859 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -155.4 152.43 24.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.585 0.707 . . . . 74.420000000000002 111.133 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 Cg_endo -69.75 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 73.340000000000003 112.336 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -51.97 113.55 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.601 0.715 . . . . 61.350000000000001 110.903 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' HZ3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.77 79.93 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.732 2.288 . . . . 73.420000000000002 112.325 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -26.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 71.430000000000007 112.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.811 ' HB ' HD11 ' A' ' 25' ' ' LEU . 3.3 t -58.96 167.73 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.239999999999995 111.131 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.763 ' O ' HD22 ' A' ' 25' ' ' LEU . 3.6 m -53.89 111.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 41.399999999999999 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 21' ' ' SER . 23.1 m-20 -34.96 -61.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.888 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.28 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.319999999999993 110.889 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.1 tp60 -60.34 -50.25 74.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.400000000000006 110.919 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.891 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.93 -23.78 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.530000000000001 110.88 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.418 HG23 ' CG1' ' A' ' 54' ' ' VAL . 3.1 m -66.35 0.08 2.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.109999999999999 111.134 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.43 -35.64 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 65.120000000000005 112.517 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 7.9 p30 -55.15 -45.37 75.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 74.010000000000005 110.916 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 55' ' ' LYS . 63.6 mt -59.24 -59.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 72.439999999999998 111.162 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -44.63 -40.0 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 71.319999999999993 110.93 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -73.94 -60.7 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.299999999999997 110.905 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -52.17 -26.46 11.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 60.229999999999997 111.083 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -70.59 1.65 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.887 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.15 9.39 32.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.851 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.03 -44.63 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 62.020000000000003 110.857 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.6 -51.95 0.84 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 74.349999999999994 112.482 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.654 HD12 HD12 ' A' ' 64' ' ' LEU . 2.5 pt -82.18 8.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 72.540000000000006 111.12 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.1 t70 -89.1 -60.71 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.230000000000004 110.886 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.62 119.01 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 63.350000000000001 110.857 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.22 -67.86 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 50.420000000000002 112.474 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -69.72 -1.05 7.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 55.25 112.377 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.699 HD12 ' CG ' ' A' ' 57' ' ' HIS . 17.4 pt -82.87 14.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 71.030000000000001 111.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -76.75 126.54 85.72 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.637 0.732 . . . . 73.019999999999996 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.67 10.61 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 72.540000000000006 112.337 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.29 -38.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.773 -0.727 . . . . 23.52 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.92 -34.36 2.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 75.319999999999993 112.465 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.06 -68.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 73.409999999999997 111.078 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.98 15.76 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 75.150000000000006 110.876 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 50' ' ' GLU . 2.5 t80 -51.85 -66.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.837 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.1 136.66 35.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.749 . . . . 65.310000000000002 110.853 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.73 146.13 81.25 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 -1.799 . . . . 73.099999999999994 112.385 -0.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 9.0 p-10 -104.8 134.04 48.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 p -95.12 169.11 10.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 61.210000000000001 111.128 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' CG1' HG23 ' A' ' 26' ' ' THR . 59.4 t -65.18 -56.98 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 111.093 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -78.67 13.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 73.530000000000001 110.931 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -51.64 -46.96 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.209999999999994 111.104 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.699 ' CG ' HD12 ' A' ' 42' ' ' ILE . 38.9 m80 -50.46 -59.67 3.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 75.540000000000006 110.83 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.746 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -47.75 -38.01 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.106 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 56' ' ' ALA . . . -57.84 -42.06 83.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 65.230000000000004 111.062 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.604 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 2.7 t80 -67.31 -57.78 6.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 72.329999999999998 110.934 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 65' ' ' TYR . 3.6 p -55.22 -38.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 64.200000000000003 111.153 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.585 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 36.3 mtp -46.22 -25.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 54.520000000000003 110.91 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.475 ' OD1' ' CA ' ' A' ' 99' ' ' GLY . 1.1 t30 -66.41 -60.36 2.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 70.219999999999999 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.654 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -73.46 -45.69 52.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 55.100000000000001 110.936 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.65 ' HA ' HD11 ' A' ' 37' ' ' ILE . 2.4 t80 -51.4 -54.2 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 61.240000000000002 110.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 26.4 t80 -50.95 -36.15 37.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 110.924 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -94.49 -3.64 49.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 44.310000000000002 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.93 -42.56 60.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.83 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.003 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.2 -62.05 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.349999999999994 111.052 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.42 20.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 45.350000000000001 112.546 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.99 37.44 21.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 74.129999999999995 110.891 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -108.84 168.26 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 75.230000000000004 110.899 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.594 ' CB ' HD11 ' A' ' 84' ' ' LEU . 89.2 p -69.03 -24.93 64.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -80.22 1.17 29.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 71.030000000000001 110.922 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 1.003 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -26.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 70.239999999999995 110.9 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.5 m -82.47 102.04 11.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 63.409999999999997 110.9 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.03 14.24 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.149 -0.478 . . . . 55.329999999999998 110.873 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.746 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.3 m-30 -58.92 -67.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 110.908 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.64 178.02 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 110.834 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -64.88 -2.33 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.891 HG21 ' CD1' ' A' ' 25' ' ' LEU . 50.9 p -93.36 -51.77 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 65.310000000000002 111.135 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.11 104.82 12.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.099 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 t -154.82 178.01 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.164 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD11 ' CB ' ' A' ' 73' ' ' SER . 37.6 mt -67.29 127.7 33.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.9 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.6 t -106.3 167.58 9.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 72.530000000000001 111.12 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 87' ' ' THR . 50.2 m-80 -53.85 -168.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.913 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.85 172.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 74.340000000000003 111.153 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.08 106.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 71.219999999999999 110.862 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -1.09 7.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.010000000000005 112.34 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 14.9 t -51.97 108.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.430000000000007 110.861 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -75.12 -17.11 60.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 70.310000000000002 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.71 -111.38 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 75.200000000000003 112.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.93 85.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 72.219999999999999 111.114 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 102.09 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 63.100000000000001 110.899 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.82 151.65 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 110.864 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.1 m-85 -92.41 148.93 37.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.628 0.728 . . . . 71.120000000000005 110.854 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 124.43 11.06 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.665 2.243 . . . . 74.25 112.34 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.556 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 13.1 p -117.26 14.81 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 75.230000000000004 110.909 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.475 ' CA ' ' OD1' ' A' ' 63' ' ' ASN . . . 100.22 -22.58 39.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 62.329999999999998 112.435 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.7 p -150.67 167.36 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 71.209999999999994 110.859 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 75.230000000000004 110.862 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.91 0.386 . . . . 70.349999999999994 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -128.74 141.83 42.94 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.639 0.733 . . . . 74.209999999999994 111.109 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 112.83 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.272 . . . . 73.140000000000001 112.33 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.9 m -69.0 122.84 86.64 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.559 0.695 . . . . 74.200000000000003 111.154 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 94.75 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 73.150000000000006 112.336 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.681 HG23 ' HD2' ' A' ' 7' ' ' PRO . 84.3 m -90.85 139.14 26.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.569 0.7 . . . . 61.039999999999999 111.156 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 6' ' ' THR . 53.8 Cg_endo -69.77 -173.76 0.78 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.672 2.248 . . . . 73.099999999999994 112.327 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 110.22 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 65.319999999999993 110.882 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 164.89 18.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 51.539999999999999 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.52 163.33 3.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.077 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.592 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 70.4 122.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 72.239999999999995 112.469 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.607 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 36.0 m -157.98 120.54 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 73.5 110.844 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 4.6 m-90 -133.33 116.14 15.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 74.439999999999998 110.883 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -87.36 101.99 14.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 71.319999999999993 110.904 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.436 HG21 ' CE2' ' A' ' 96' ' ' PHE . 2.9 m -148.9 153.54 38.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 64.439999999999998 111.135 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.75 126.17 13.01 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.672 2.248 . . . . 73.299999999999997 112.336 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -51.98 107.07 0.74 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.576 0.703 . . . . 73.310000000000002 110.909 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 53.7 Cg_endo -69.74 79.81 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.717 2.278 . . . . 74.040000000000006 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 163.43 55.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 52.009999999999998 112.476 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 25' ' ' LEU . 1.2 m -158.59 177.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 72.329999999999998 111.108 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -52.01 119.05 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 63.450000000000003 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 52.0 m-20 -52.2 -37.02 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 44.109999999999999 110.877 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -20.53 55.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 70.420000000000002 110.845 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -77.79 -48.43 16.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 65.019999999999996 110.919 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.836 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.67 -53.03 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 70.420000000000002 110.924 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.569 HG23 ' N ' ' A' ' 27' ' ' GLY . 14.2 t -37.49 -47.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.310000000000002 111.135 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.569 ' N ' HG23 ' A' ' 26' ' ' THR . . . -46.4 -41.73 12.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 55.340000000000003 112.479 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -47.18 -69.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 72.439999999999998 110.866 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 70.1 mt -40.08 -57.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 75.329999999999998 111.139 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -46.12 -42.68 14.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.150000000000006 110.869 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 78' ' ' PHE . 4.6 t80 -73.86 -58.37 3.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 110.909 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -51.09 -24.78 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 70.430000000000007 111.101 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.08 2.27 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.140000000000001 110.859 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 5.73 37.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.409999999999997 110.818 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.04 -42.75 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.89 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.48 -46.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 44.210000000000001 112.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.1 pt -82.34 5.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 72.030000000000001 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.74 ' O ' HG23 ' A' ' 42' ' ' ILE . 16.4 t70 -89.36 -58.06 2.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 110.855 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.73 119.34 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.881 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.36 -70.84 0.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 74.129999999999995 112.465 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.5 Cg_endo -69.8 -0.84 7.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.655 2.236 . . . . 75.030000000000001 112.313 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.771 HD12 ' CG ' ' A' ' 57' ' ' HIS . 14.2 pt -83.08 17.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 54.530000000000001 111.13 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.93 137.97 69.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 64.109999999999999 110.876 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 173.92 10.3 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.221 . . . . 64.0 112.375 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.76 -35.35 1.07 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 41.409999999999997 112.462 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.13 -27.75 5.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 74.25 112.498 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 -68.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.824 0.345 . . . . 61.009999999999998 111.061 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.98 18.06 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.89 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.9 t80 -56.84 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.885 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -94.8 129.02 37.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 75.109999999999999 110.89 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.72 148.01 85.75 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.655 -1.81 . . . . 63.229999999999997 112.376 -0.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.39 142.27 34.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.897 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 19.8 p -92.39 167.32 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.109999999999999 111.163 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG11 ' HB ' ' A' ' 26' ' ' THR . 84.5 t -65.61 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 73.140000000000001 111.081 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.19 17.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.888 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.76 -42.84 58.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 111.076 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.771 ' CG ' HD12 ' A' ' 42' ' ' ILE . 41.3 m170 -54.49 -56.59 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.020000000000003 110.832 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -49.99 -36.57 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.109999999999999 111.099 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 35.43 111.068 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -67.86 -58.53 4.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 71.349999999999994 110.91 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 65' ' ' TYR . 3.5 p -55.06 -36.56 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 64.019999999999996 111.095 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.622 ' HE2' ' CZ ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER -46.7 -23.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.130000000000003 110.858 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -69.41 -62.35 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.120000000000005 110.896 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -70.8 -45.28 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 110.928 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.634 ' HA ' HD11 ' A' ' 37' ' ' ILE . 2.4 t80 -53.45 -50.82 64.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 110.953 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 58.2 t80 -53.02 -29.13 27.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 63.409999999999997 110.892 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -99.28 -4.02 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 73.420000000000002 110.933 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -71.51 -42.2 68.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.874 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.04 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.019999999999996 111.085 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 23.19 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 55.340000000000003 112.477 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.0 39.36 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 54.5 110.903 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.609 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 4.7 m-80 -110.94 171.94 7.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.883 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.53 ' HA ' HD11 ' A' ' 84' ' ' LEU . 79.4 p -71.86 -23.56 61.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 70.420000000000002 110.85 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.78 2.48 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 73.150000000000006 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.866 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -24.69 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 110.844 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.4 m -82.32 101.95 10.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 64.340000000000003 110.845 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -117.96 11.31 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.892 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.716 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.0 m-30 -58.47 -68.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 72.019999999999996 110.867 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.69 177.98 3.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 53.299999999999997 110.849 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.33 -1.96 2.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.493 . . . . 72.439999999999998 110.968 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 25' ' ' LEU . 61.1 p -92.53 -52.91 4.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.15 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.47 106.06 14.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 70.310000000000002 111.102 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.5 t -154.7 178.02 10.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 74.409999999999997 111.113 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 73' ' ' SER . 1.4 mt -67.37 123.32 20.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 73.310000000000002 110.913 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -103.82 168.62 9.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' THR . 66.6 m-20 -54.16 -167.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 63.240000000000002 110.873 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.24 170.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 64.450000000000003 111.133 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.4 t-20 -51.97 107.03 0.73 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.624 0.726 . . . . 51.32 110.894 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.3 Cg_endo -69.82 2.55 3.46 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.653 2.235 . . . . 75.439999999999998 112.32 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 44.5 t -52.02 106.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 64.200000000000003 110.883 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 94' ' ' CYS . 11.2 p90 -78.62 -16.21 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 64.549999999999997 110.903 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -113.49 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 62.210000000000001 112.518 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.74 83.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 64.209999999999994 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -76.34 102.66 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 70.439999999999998 110.862 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -98.14 140.48 32.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.928 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 15' ' ' VAL . 6.6 m-85 -92.48 158.02 39.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 61.520000000000003 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 113.82 3.51 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 74.409999999999997 112.337 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.54 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 26.1 p -91.23 2.7 56.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 61.5 110.88 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.97 32.82 47.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.665 -0.779 . . . . 75.420000000000002 112.484 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.9 106.87 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 73.430000000000007 110.852 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.7 t30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 70.040000000000006 110.857 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.819 0.342 . . . . 72.329999999999998 111.108 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p -100.8 152.11 37.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.57 0.7 . . . . 74.420000000000002 111.122 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -7.69 21.68 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.664 2.243 . . . . 54.450000000000003 112.395 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.8 p -82.57 153.23 67.91 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.541 0.686 . . . . 63.340000000000003 111.154 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.7 18.05 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 51.539999999999999 112.33 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.9 p -52.17 151.62 6.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 74.230000000000004 111.191 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.726 2.284 . . . . 41.509999999999998 112.333 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -108.62 110.04 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 71.299999999999997 110.917 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.68 167.48 26.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 74.129999999999995 111.112 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.16 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 51.049999999999997 111.114 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -66.29 -159.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 63.130000000000003 112.543 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.473 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -151.15 140.65 21.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 74.140000000000001 110.82 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.7 m-90 -137.52 115.75 11.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.01 102.05 12.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 65.150000000000006 110.867 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -152.65 152.02 27.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.731 . . . . 74.120000000000005 111.099 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.83 124.66 11.26 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.659 2.239 . . . . 70.420000000000002 112.304 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.8 mmtm -52.0 119.57 14.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 74.329999999999998 110.863 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 80.72 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 54.310000000000002 112.308 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -25.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 72.219999999999999 112.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 21' ' ' SER . 2.5 t -59.0 173.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 64.209999999999994 111.144 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.882 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.69 115.28 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 74.329999999999998 110.857 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' HA ' HD23 ' A' ' 25' ' ' LEU . 53.2 m-20 -40.73 -47.81 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 75.340000000000003 110.85 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -57.76 -34.38 69.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.140000000000001 110.872 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 14.1 mm100 -69.04 -46.12 68.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.959 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.882 HD22 ' O ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -70.29 -56.54 6.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 110.947 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 27' ' ' GLY . 11.3 t -41.05 -45.25 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.144 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 26' ' ' THR . . . -39.39 -37.8 0.84 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 72.109999999999999 112.43 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 29' ' ' ILE . 3.7 m-20 -56.14 -68.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 62.210000000000001 110.86 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 55' ' ' LYS . 76.9 mt -35.31 -44.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.200000000000003 111.076 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -56.12 -49.18 74.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 62.450000000000003 110.89 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' ASN . 1.1 t80 -74.46 -54.43 7.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.912 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.92 -40.3 60.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 74.299999999999997 111.154 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.5 t -56.75 -10.04 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 55.219999999999999 110.839 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 m -112.55 18.1 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 71.430000000000007 110.845 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.471 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 10.5 mm-40 -93.9 -50.93 5.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 63.020000000000003 110.911 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.82 -85.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 70.519999999999996 112.473 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 64' ' ' LEU . 2.6 pt -81.38 17.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 74.109999999999999 111.115 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.623 ' HA ' HG21 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -85.38 -61.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 63.119999999999997 110.851 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.02 122.43 23.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 50.340000000000003 110.819 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.49 -67.42 0.51 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 63.210000000000001 112.477 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.71 1.98 3.92 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 64.040000000000006 112.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.683 HD12 ' CD2' ' A' ' 57' ' ' HIS . 24.7 pt -84.54 17.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.122 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -85.85 127.29 63.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.72 . . . . 64.430000000000007 110.912 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.75 156.45 63.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.717 2.278 . . . . 63.25 112.337 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.43 -47.13 1.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 74.420000000000002 112.457 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.04 -0.94 2.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.784 -0.722 . . . . 52.119999999999997 112.508 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.27 -68.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 73.430000000000007 111.11 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -117.94 9.86 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.925 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.5 t80 -56.21 -60.3 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 71.010000000000005 110.891 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 mt-10 -96.72 128.93 34.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.643 0.735 . . . . 61.210000000000001 110.89 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.81 145.09 78.59 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 -1.804 . . . . 72.319999999999993 112.372 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 1.2 p30 -107.23 151.74 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.129999999999995 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 39.7 p -99.92 170.87 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 71.129999999999995 111.172 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 26' ' ' THR . 72.0 t -65.43 -62.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 71.340000000000003 111.081 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.78 18.04 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.209999999999994 110.914 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.23 -40.91 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 65.109999999999999 111.064 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.3 m80 -53.19 -52.65 58.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 71.230000000000004 110.875 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.47 -38.14 74.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 62.130000000000003 111.086 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.04 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 52.310000000000002 111.124 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 10.5 t80 -61.58 -65.08 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 110.945 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 38' ' ' ASP . 2.7 p -55.2 -34.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 74.030000000000001 111.088 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.485 ' HE3' ' HD3' ' A' ' 16' ' ' PRO . 2.7 mtm -44.89 -26.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.040000000000006 110.908 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -67.25 -60.74 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.54 -52.3 18.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 110.91 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.604 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.7 t80 -46.46 -44.59 17.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 73.0 110.928 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 12.6 t80 -58.96 -28.43 66.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 70.230000000000004 110.903 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -99.56 -4.79 30.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 70.319999999999993 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -41.67 69.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 110.881 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.846 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.17 -58.12 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 51.310000000000002 111.094 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 23.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 13.199999999999999 112.487 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.02 43.79 30.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 73.439999999999998 110.852 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.504 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.5 m-80 -114.4 169.92 8.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 75.230000000000004 110.932 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.414 ' CB ' HD11 ' A' ' 84' ' ' LEU . 78.4 p -71.7 -23.19 61.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 52.520000000000003 110.873 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.06 1.89 26.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 74.530000000000001 110.907 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.846 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -24.32 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 52.020000000000003 110.916 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -82.55 102.02 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.857 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -118.03 11.83 13.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 54.439999999999998 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.73 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.7 m-30 -59.04 -68.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.895 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.46 178.02 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 43.530000000000001 110.824 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -65.9 -1.78 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 75.510000000000005 110.963 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 25' ' ' LEU . 73.3 p -91.81 -50.01 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 111.118 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.14 102.01 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.076 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 t -147.37 178.47 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 63.149999999999999 111.124 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.414 HD11 ' CB ' ' A' ' 73' ' ' SER . 35.7 mt -66.16 122.9 18.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.914 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -99.57 168.03 10.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.159 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.96 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 52.450000000000003 110.867 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.0 t -44.46 172.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 111.067 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.3 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 63.329999999999998 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.8 -2.37 10.09 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 63.020000000000003 112.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.4 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 8.0 t -52.04 108.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 62.329999999999998 110.845 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 5.9 p90 -81.57 -15.28 55.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 74.310000000000002 110.947 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.97 -115.12 0.5 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 74.219999999999999 112.566 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.96 89.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 73.120000000000005 111.142 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -76.45 102.03 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 62.32 110.867 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -99.5 142.84 30.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 61.229999999999997 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 10.0 m-85 -92.08 150.87 41.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.671 0.748 . . . . 70.209999999999994 110.839 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.23 11.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 51.409999999999997 112.37 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 9.1 p -106.91 -5.69 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 61.32 110.877 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.78 52.8 7.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 74.239999999999995 112.512 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.08 164.11 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.040000000000006 110.873 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 71.310000000000002 110.896 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.863 0.363 . . . . 64.099999999999994 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 t -150.61 133.69 8.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.619 0.724 . . . . 72.040000000000006 111.128 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.679 2.252 . . . . 64.450000000000003 112.352 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 p -53.53 155.22 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 73.230000000000004 111.113 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 72.310000000000002 112.375 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 p -141.85 153.19 64.1 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.566 0.698 . . . . 73.129999999999995 111.137 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -173.88 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 53.229999999999997 112.374 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.56 109.01 5.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.874 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.96 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 61.210000000000001 111.096 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 166.39 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 73.25 111.04 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.429 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . -38.02 157.96 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.736 -0.745 . . . . 75.519999999999996 112.513 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.529 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 25.2 m -158.0 139.73 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 71.340000000000003 110.806 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.0 m-90 -137.75 119.52 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 74.540000000000006 110.927 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 101.98 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 65.299999999999997 110.884 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -151.84 152.6 30.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 75.310000000000002 111.091 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.77 127.76 15.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.682 2.255 . . . . 60.530000000000001 112.327 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -52.02 113.44 4.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 65.450000000000003 110.912 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 91.4 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.678 2.252 . . . . 63.020000000000003 112.393 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.13 -27.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 40.140000000000001 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 25' ' ' LEU . 3.1 t -59.01 165.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 71.219999999999999 111.17 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.6 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -52.12 114.51 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.855 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 21' ' ' SER . 6.0 m-20 -33.65 -65.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 72.400000000000006 110.822 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.2 -39.17 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 63.439999999999998 110.872 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.7 tp-100 -58.36 -50.87 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 110.91 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.723 HD11 ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 65.519999999999996 110.926 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.603 ' OG1' HG11 ' A' ' 54' ' ' VAL . 1.7 m -59.54 -31.48 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 71.5 111.154 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.77 -30.66 56.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 45.32 112.47 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' ILE . 1.1 m-20 -61.86 -68.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 74.310000000000002 110.867 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 67.6 mt -37.09 -48.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 111.073 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.06 -47.37 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 110.91 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.1 -53.65 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.479 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.12 -43.13 61.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 54.149999999999999 111.116 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -11.58 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.120000000000005 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -109.06 18.03 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.821 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.49 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 15.5 mm-40 -97.86 -49.96 4.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.420000000000002 110.887 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.65 -82.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 72.310000000000002 112.47 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.771 HD12 HD12 ' A' ' 64' ' ' LEU . 3.6 pt -80.97 17.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 64.140000000000001 111.123 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.56 -59.86 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 52.439999999999998 110.843 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.475 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.71 122.35 23.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.129999999999995 110.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.47 -71.34 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 71.400000000000006 112.463 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.601 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.77 4.24 2.31 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.684 2.256 . . . . 74.219999999999999 112.316 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 38' ' ' ASP . 9.6 pt -82.87 18.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.239999999999995 111.136 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -80.31 148.36 66.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 70.140000000000001 110.886 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.1 Cg_endo -69.79 152.61 69.18 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.709 2.273 . . . . 71.439999999999998 112.351 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.83 -47.9 2.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 55.109999999999999 112.483 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.83 3.08 2.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 72.019999999999996 112.484 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 64.120000000000005 111.106 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.0 7.85 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.898 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -43.27 -59.0 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.875 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.562 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 2.4 mm-40 -96.72 131.02 28.89 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.671 0.748 . . . . 70.329999999999998 110.826 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.75 153.61 92.98 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 -1.801 . . . . 65.219999999999999 112.32 -0.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 10.4 p30 -101.73 130.55 48.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.876 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.78 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 41.2 p -82.97 169.99 15.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 72.310000000000002 111.163 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.603 HG11 ' OG1' ' A' ' 26' ' ' THR . 51.8 t -67.1 -58.9 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 63.229999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -87.91 18.04 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 73.530000000000001 110.901 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.78 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -49.7 -51.88 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 111.092 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.618 ' ND1' HD12 ' A' ' 42' ' ' ILE . 63.1 m170 -43.65 -58.16 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 65.120000000000005 110.841 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -52.22 -39.8 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 62.439999999999998 111.145 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.15 74.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 75.319999999999993 111.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 11.2 t80 -68.57 -63.45 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.931 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 65' ' ' TYR . 2.3 p -54.9 -33.47 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 61.539999999999999 111.132 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.63 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 3.8 mtt -45.61 -27.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.882 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.63 -61.68 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 63.130000000000003 110.842 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.771 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -70.29 -49.33 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 64.420000000000002 110.918 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.596 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.5 t80 -50.29 -47.0 55.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 110.926 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 30.4 t80 -55.88 -28.57 57.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 62.049999999999997 110.915 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -99.93 -4.59 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 70.049999999999997 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.11 -40.33 65.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.861 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.949 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -59.39 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 111.101 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.29 22.03 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 62.130000000000003 112.508 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.01 41.07 29.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 71.209999999999994 110.841 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.8 m-80 -114.11 169.12 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.863 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.408 ' HB2' ' CD1' ' A' ' 84' ' ' LEU . 96.5 p -70.28 -23.14 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 70.209999999999994 110.849 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -81.02 2.2 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 75.219999999999999 110.943 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.949 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -20.62 60.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 70.120000000000005 110.887 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.46 102.01 11.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 72.430000000000007 110.859 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.02 10.68 13.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 110.847 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.63 ' CD2' ' HE2' ' A' ' 62' ' ' MET . 2.7 m-30 -58.32 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.917 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.62 178.01 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 61.009999999999998 110.897 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -2.2 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.119999999999997 110.9 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.544 ' HB ' HD12 ' A' ' 25' ' ' LEU . 65.4 p -92.15 -52.37 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.310000000000002 111.175 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.52 102.15 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.114 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -148.64 178.02 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 111.154 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 12' ' ' SER . 6.2 mp -65.57 127.2 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.874 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.04 167.76 9.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 71.219999999999999 111.179 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 87' ' ' THR . 10.4 m120 -54.03 -168.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 74.329999999999998 110.884 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.99 173.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 111.17 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.7 t-20 -51.97 106.33 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.653 0.739 . . . . 73.329999999999998 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.78 -4.39 13.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 61.329999999999998 112.353 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -52.02 112.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 54.32 110.81 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 94' ' ' CYS . 1.8 p90 -79.8 -16.62 55.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 110.926 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.85 -123.83 0.94 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.439999999999998 112.454 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.35 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 43.039999999999999 111.08 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -76.35 104.16 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 62.140000000000001 110.882 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.0 129.24 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.329999999999998 110.919 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.545 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.1 m-85 -78.42 154.97 79.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.655 0.74 . . . . 72.409999999999997 110.876 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.75 108.08 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.647 2.231 . . . . 54.219999999999999 112.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 54.6 p -80.55 -10.78 59.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.842 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.66 37.89 27.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 73.409999999999997 112.505 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -157.97 141.95 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 74.219999999999999 110.849 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 110.851 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.817 0.342 . . . . 75.200000000000003 111.066 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.9 m -103.31 121.46 48.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 74.430000000000007 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 164.52 34.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 72.230000000000004 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.1 p -111.52 113.55 53.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.633 0.73 . . . . 74.140000000000001 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -171.18 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 71.299999999999997 112.331 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 81.5 p -130.49 103.0 16.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.5 111.107 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 6' ' ' THR . 53.9 Cg_endo -69.79 -167.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.675 2.25 . . . . 64.230000000000004 112.384 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.51 128.89 50.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 73.150000000000006 110.942 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 130.92 45.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 70.340000000000003 111.076 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.1 177.96 5.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 111.111 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 81.43 175.21 49.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 71.120000000000005 112.465 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.52 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -148.51 138.55 22.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 73.510000000000005 110.836 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.594 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.0 m-90 -136.03 123.06 21.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 110.913 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 102.01 13.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 74.209999999999994 110.836 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -154.58 153.06 27.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 54.219999999999999 111.09 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.4 Cg_endo -69.82 129.34 17.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 71.019999999999996 112.383 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 118.12 11.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.522 0.677 . . . . 75.219999999999999 110.947 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 79.87 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.686 2.257 . . . . 73.140000000000001 112.324 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.58 -24.3 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 72.099999999999994 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 25' ' ' LEU . 4.8 t -59.0 166.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.328 . . . . 71.450000000000003 111.164 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.779 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.01 107.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 52.119999999999997 110.849 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 54' ' ' VAL . 72.9 m-20 -33.36 -63.41 0.24 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 73.129999999999995 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.99 -39.74 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 75.150000000000006 110.862 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -58.34 -50.93 71.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 53.340000000000003 110.875 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.782 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -71.49 -29.65 65.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 71.510000000000005 110.883 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.434 ' OG1' HG11 ' A' ' 54' ' ' VAL . 97.1 m -52.13 -26.53 11.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 54.25 111.129 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.36 -24.77 72.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 21.120000000000001 112.49 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.27 -51.4 63.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 65.439999999999998 110.864 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 55' ' ' LYS . 73.1 mt -62.53 -52.46 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 62.340000000000003 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -50.25 -43.63 53.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.16 -58.11 3.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 110.934 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.786 ' HB1' ' CG ' ' A' ' 38' ' ' ASP . . . -51.46 -31.65 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 63.210000000000001 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.91 -11.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.883 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 18.0 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 41.299999999999997 110.855 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -92.17 -52.1 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.219999999999999 110.887 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.38 -92.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.786 -0.721 . . . . 75.310000000000002 112.512 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.41 4.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 75.439999999999998 111.138 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.88 ' HA ' HG21 ' A' ' 61' ' ' VAL . 2.5 m-20 -66.66 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.84 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -76.07 134.92 39.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 52.130000000000003 110.88 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.94 -72.3 0.33 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 61.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.78 6.47 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.674 2.25 . . . . 72.510000000000005 112.358 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.626 HD12 ' CG ' ' A' ' 57' ' ' HIS . 22.9 pt -82.44 18.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.450000000000003 111.141 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -80.16 123.75 83.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 75.030000000000001 110.895 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.32 38.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 71.510000000000005 112.315 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.34 -32.99 1.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 62.109999999999999 112.514 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.49 -31.22 3.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 72.420000000000002 112.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.05 -68.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 111.126 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' PHE . 13.7 t -113.05 -13.77 13.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.430000000000007 110.926 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -34.46 -44.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 64.209999999999994 110.849 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.41 125.75 38.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 64.299999999999997 110.88 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.5 Cg_endo -69.75 151.89 91.82 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.726 -1.781 . . . . 44.140000000000001 112.317 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.38 120.02 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 63.100000000000001 110.875 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.76 168.59 16.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 71.030000000000001 111.115 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.631 HG21 ' HB3' ' A' ' 22' ' ' ASP . 91.8 t -65.79 -56.79 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 61.32 111.147 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HG3' ' CG ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.24 17.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 64.450000000000003 110.85 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.63 -42.29 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 64.5 111.061 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.626 ' CG ' HD12 ' A' ' 42' ' ' ILE . 67.5 m80 -52.28 -54.78 27.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.839 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.779 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -56.72 -37.74 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 62.310000000000002 111.105 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.14 -30.6 71.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 72.099999999999994 111.094 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 12.2 t80 -67.86 -66.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 110.902 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.88 HG21 ' HA ' ' A' ' 38' ' ' ASP . 7.5 p -55.24 -29.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 74.420000000000002 111.165 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 1.6 mmt -45.53 -22.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.845 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -71.95 -56.61 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -76.14 -53.13 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 110.948 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.4 t80 -45.72 -48.2 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 63.100000000000001 110.953 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.606 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 33.8 t80 -58.51 -26.86 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 72.219999999999999 110.93 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -100.04 -2.78 33.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 74.319999999999993 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -40.09 52.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 71.099999999999994 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.898 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -55.41 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 111.082 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.35 24.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 54.530000000000001 112.496 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 49.2 31.98 3.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 72.430000000000007 110.912 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.606 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 5.2 m-80 -102.81 168.59 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 65.040000000000006 110.864 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.8 p -70.93 -21.97 62.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.827 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.437 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.08 2.03 29.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.902 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.898 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.57 -18.94 61.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 72.140000000000001 110.898 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 102.05 11.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 71.450000000000003 110.87 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 8.93 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 64.120000000000005 110.886 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.779 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -58.51 -68.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 73.140000000000001 110.844 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -171.93 178.06 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.450000000000003 110.875 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -65.8 -0.99 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 65.540000000000006 110.895 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.735 HG21 ' CD1' ' A' ' 25' ' ' LEU . 62.3 p -92.84 -52.1 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 111.143 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.86 106.37 13.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 71.400000000000006 111.09 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.9 t -150.64 177.98 9.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 63.439999999999998 111.162 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.03 149.85 49.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 110.947 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -133.77 168.55 18.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.319999999999993 111.156 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 87' ' ' THR . 14.4 m-20 -53.63 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.889 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.9 t -44.36 174.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 111.104 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.594 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 72.239999999999995 110.877 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 88' ' ' ASN . 53.3 Cg_endo -69.85 -0.15 6.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.303 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.404 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 12.9 t -52.04 106.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 110.834 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.65 -16.33 59.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.918 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.74 -115.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 55.520000000000003 112.472 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.34 69.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 62.039999999999999 111.108 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.37 102.03 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 52.219999999999999 110.886 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -99.97 137.95 37.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.150000000000006 110.903 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.26 146.52 32.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.637 0.732 . . . . 75.430000000000007 110.9 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.02 12.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 73.400000000000006 112.334 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.454 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 2.0 p -113.7 0.25 14.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.099999999999994 110.806 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 62.4 -122.83 29.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 45.520000000000003 112.421 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -91.71 115.25 27.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 54.119999999999997 110.816 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 74.219999999999999 110.908 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.831 0.348 . . . . 52.130000000000003 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.5 p -144.76 148.37 39.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.558 0.694 . . . . 65.340000000000003 111.158 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 111.69 2.86 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.291 . . . . 75.120000000000005 112.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -79.7 114.33 44.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.578 0.704 . . . . 70.239999999999995 111.18 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 156.74 62.55 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 71.329999999999998 112.354 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -98.8 156.98 34.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.569 0.7 . . . . 73.450000000000003 111.147 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -173.89 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.676 2.251 . . . . 72.120000000000005 112.316 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -104.27 103.6 13.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 73.150000000000006 110.893 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 170.79 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 55.409999999999997 111.102 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.56 120.61 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 55.439999999999998 111.118 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.568 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . 74.42 175.92 34.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 55.439999999999998 112.502 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.44 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 9.3 m -149.16 136.31 19.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 73.129999999999995 110.898 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.568 ' CH2' ' HA3' ' A' ' 11' ' ' GLY . 4.2 m-90 -135.67 109.65 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 72.25 110.905 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 102.17 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 72.230000000000004 110.832 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.66 152.43 24.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 73.120000000000005 111.131 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.71 123.55 10.23 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.686 2.257 . . . . 72.040000000000006 112.336 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -51.98 122.42 22.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.551 0.691 . . . . 74.030000000000001 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 88.06 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 74.319999999999993 112.353 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.37 -20.79 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 31.219999999999999 112.497 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 25' ' ' LEU . 11.0 t -63.62 158.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 74.430000000000007 111.133 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 24' ' ' GLN . 1.8 m -52.09 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 71.040000000000006 110.817 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 21' ' ' SER . 85.9 m-20 -33.5 -68.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 75.230000000000004 110.873 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.4 -39.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 73.150000000000006 110.86 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 25.4 tt0 -58.11 -51.3 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 110.938 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.841 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -70.96 -36.18 72.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.914 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.417 ' OG1' HG11 ' A' ' 54' ' ' VAL . 25.7 m -52.2 -15.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.98 -35.48 57.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 65.129999999999995 112.493 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -57.19 -68.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 75.319999999999993 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 55' ' ' LYS . 73.6 mt -37.49 -47.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 70.400000000000006 111.121 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.42 -47.76 72.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 71.349999999999994 110.849 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -73.55 -56.1 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 44.450000000000003 110.942 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . . . -51.95 -35.7 46.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 54.109999999999999 111.102 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.5 t -56.39 -12.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.109999999999999 110.875 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.75 18.02 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 110.828 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -89.8 -52.82 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 72.349999999999994 110.899 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 165.19 -94.81 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 64.310000000000002 112.503 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.517 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -81.96 17.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 72.109999999999999 111.118 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.563 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -83.08 -59.95 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 64.519999999999996 110.902 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 122.31 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 71.5 110.902 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.14 -67.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 63.119999999999997 112.474 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 4.51 2.14 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.246 . . . . 73.109999999999999 112.339 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.604 HD12 ' CD2' ' A' ' 57' ' ' HIS . 19.4 pt -82.77 17.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 70.420000000000002 111.112 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -84.48 125.15 72.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.623 0.725 . . . . 75.439999999999998 110.899 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.525 ' CB ' ' CD1' ' A' ' 49' ' ' PHE . 53.7 Cg_endo -69.74 154.58 67.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.668 2.245 . . . . 64.129999999999995 112.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.88 -40.08 1.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 32.43 112.495 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.47 -23.51 3.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.74 . . . . 61.210000000000001 112.494 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.06 -68.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 111.089 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -118.04 -11.28 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 54.509999999999998 110.873 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CD1' ' CB ' ' A' ' 44' ' ' PRO . 2.6 t80 -33.92 -52.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 71.120000000000005 110.897 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -99.57 127.97 32.73 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.623 0.725 . . . . 73.200000000000003 110.87 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.51 88.72 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 -1.806 . . . . 54.130000000000003 112.329 -0.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -107.98 152.75 24.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 63.149999999999999 110.891 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 43.5 p -106.69 172.38 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 111.153 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.417 HG11 ' OG1' ' A' ' 26' ' ' THR . 98.0 t -66.21 -64.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.420000000000002 111.143 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.25 18.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.897 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.91 -38.9 52.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 44.420000000000002 111.054 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.604 ' CD2' HD12 ' A' ' 42' ' ' ILE . 60.2 m80 -54.08 -52.72 60.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 110.855 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.709 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.27 -37.53 72.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 72.329999999999998 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.34 74.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 44.100000000000001 111.131 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 3.0 t80 -68.45 -57.96 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.891 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.484 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 1.8 p -54.57 -37.44 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 71.439999999999998 111.164 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.661 ' HE2' ' CE2' ' A' ' 78' ' ' PHE . 9.7 mtt -49.09 -20.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.030000000000001 110.912 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.533 ' HB3' HD23 ' A' ' 64' ' ' LEU . 44.9 t30 -69.16 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 110.896 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -74.93 -52.25 11.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 44.140000000000001 110.927 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.6 t80 -45.7 -49.55 14.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 71.519999999999996 110.87 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 2.8 t80 -58.42 -27.38 64.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.923 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.505 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 42.5 mt-30 -101.11 -2.26 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.120000000000005 110.918 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -74.04 -41.43 61.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.864 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.15 -55.51 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 44.520000000000003 111.095 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.85 24.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.040000000000006 112.508 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 51.1 44.17 28.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 70.120000000000005 110.872 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.546 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.9 m-80 -109.89 172.44 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.913 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -74.22 -24.78 59.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 52.450000000000003 110.908 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -79.67 2.0 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 75.319999999999993 110.91 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.733 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.78 -23.26 59.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.329999999999998 110.912 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.37 101.96 10.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 54.329999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.0 10.1 12.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 110.847 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.0 m-30 -58.84 -68.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.84 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 t -172.0 178.01 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.399999999999999 110.836 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.51 -2.48 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 64.310000000000002 110.926 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 25' ' ' LEU . 66.4 p -91.54 -50.57 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 63.539999999999999 111.149 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.479 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.71 102.09 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.108 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 t -148.81 178.01 9.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.43 111.11 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.67 114.0 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -89.71 167.47 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 63.210000000000001 111.168 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.84 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 62.409999999999997 110.905 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.24 172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.549999999999997 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 9.5 t-20 -51.98 106.66 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 63.520000000000003 110.907 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.19 3.74 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.743 2.295 . . . . 54.149999999999999 112.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.411 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 23.0 t -52.03 106.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.783 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -17.04 61.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 54.299999999999997 110.941 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.44 -111.24 0.42 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.94 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 111.06 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.85 102.0 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 73.019999999999996 110.879 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -99.0 151.73 20.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 61.210000000000001 110.883 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.7 m-85 -92.35 154.07 42.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.669 0.747 . . . . 74.129999999999995 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 114.21 3.62 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 72.099999999999994 112.356 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.528 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 12.1 p -88.81 -11.71 44.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 65.219999999999999 110.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.71 -105.62 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 74.310000000000002 112.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.3 p -92.93 161.24 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 62.130000000000003 110.861 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.120000000000005 110.839 -179.942 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.881 0.372 . . . . 54.009999999999998 111.122 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.1 p -107.19 143.29 26.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.526 0.679 . . . . 64.400000000000006 111.184 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.37 60.08 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 70.019999999999996 112.338 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -119.54 111.46 36.31 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.608 0.718 . . . . 72.430000000000007 111.144 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 174.49 9.38 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.685 2.257 . . . . 74.439999999999998 112.347 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -99.16 121.34 55.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.109999999999999 111.118 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -173.6 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.688 2.259 . . . . 62.43 112.361 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.5 102.11 5.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 61.310000000000002 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.72 166.07 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 111.125 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.15 177.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 111.122 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.561 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 67.41 105.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 73.129999999999995 112.471 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.571 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -158.02 122.22 4.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 71.209999999999994 110.846 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.5 m-90 -129.74 116.55 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 62.340000000000003 110.922 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.21 102.05 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 71.439999999999998 110.946 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -152.83 152.55 28.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 70.219999999999999 111.108 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 127.62 14.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.645 2.23 . . . . 72.140000000000001 112.327 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.06 118.15 11.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 74.040000000000006 110.939 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 92.12 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.673 2.248 . . . . 63.32 112.334 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.78 -26.78 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 42.240000000000002 112.488 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.72 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.3 t -59.0 168.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 72.140000000000001 111.174 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.878 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -54.52 111.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 43.130000000000003 110.829 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' HG21 ' A' ' 54' ' ' VAL . 24.2 m-20 -38.94 -55.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 63.100000000000001 110.888 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.21 -33.98 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 110.846 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' SER . 6.6 tp60 -68.31 -46.48 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.868 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.878 HD22 ' O ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -70.01 -54.06 14.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 72.299999999999997 110.955 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 27' ' ' GLY . 16.8 m -41.14 -48.35 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.400000000000006 111.169 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' THR . . . -34.91 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 23.219999999999999 112.502 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 31' ' ' TYR . 10.3 m-20 -59.5 -64.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 72.030000000000001 110.909 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.91 HG23 ' CG ' ' A' ' 57' ' ' HIS . 72.7 mt -36.58 -41.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 111.163 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.59 -45.6 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' ASN . 3.4 t80 -73.55 -58.28 3.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.140000000000001 110.887 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.947 ' HB1' ' CG ' ' A' ' 38' ' ' ASP . . . -48.1 -50.05 29.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 64.129999999999995 111.072 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.79 -22.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.929 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -80.52 13.33 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 70.430000000000007 110.861 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -45.79 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.942 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.9 -43.91 1.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 71.400000000000006 112.5 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.658 HD13 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -101.54 2.29 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.346 . . . . 54.310000000000002 111.129 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.947 ' CG ' ' HB1' ' A' ' 32' ' ' ALA . 1.4 m-20 -74.99 -70.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 74.150000000000006 110.823 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -80.4 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 110.862 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.11 -68.78 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 74.319999999999993 112.466 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.61 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.71 6.97 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 70.140000000000001 112.36 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.791 HD13 ' HB2' ' A' ' 57' ' ' HIS . 8.0 pt -82.14 17.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 74.409999999999997 111.136 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.25 121.69 85.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.628 0.728 . . . . 44.329999999999998 110.912 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -169.46 0.33 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 71.299999999999997 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.99 -28.74 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 73.540000000000006 112.5 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.08 -26.23 8.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 61.409999999999997 112.461 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.37 -68.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 72.5 111.138 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 13.8 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 60.049999999999997 110.843 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.578 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 10.9 t80 -47.88 -60.52 2.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.944 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 28.5 mt-10 -92.56 142.39 25.77 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.697 0.761 . . . . 74.409999999999997 110.844 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.75 146.86 83.35 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 -1.796 . . . . 73.109999999999999 112.332 -0.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -99.91 142.21 31.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 54.140000000000001 110.901 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -97.86 160.06 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 64.200000000000003 111.184 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 ' OD1' ' A' ' 22' ' ' ASP . 40.9 t -65.87 -56.43 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 71.340000000000003 111.156 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.48 17.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 65.019999999999996 110.937 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -49.64 -55.29 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.239999999999995 111.112 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.91 ' CG ' HG23 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -35.23 -51.34 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 71.230000000000004 110.873 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.786 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -63.97 -42.14 97.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 111.126 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.46 -49.54 77.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 70.129999999999995 111.076 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -54.21 -63.42 1.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 110.932 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.796 HG11 ' OD1' ' A' ' 38' ' ' ASP . 3.5 p -54.85 -35.63 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.549999999999997 111.159 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.475 ' HE2' ' HA ' ' A' ' 62' ' ' MET . 0.0 OUTLIER -44.92 -21.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 64.420000000000002 110.872 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 61' ' ' VAL . 33.0 t-20 -72.56 -44.25 62.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.942 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -90.71 -49.06 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.954 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.732 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -47.0 -46.26 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 73.340000000000003 110.937 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.9 t80 -57.14 -30.71 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 110.904 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -97.25 -5.14 37.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 72.310000000000002 110.911 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -40.96 62.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.847 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.991 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.38 -59.98 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.094 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.85 21.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.713 -0.756 . . . . 55.109999999999999 112.499 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 51.69 32.01 8.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 75.209999999999994 110.903 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.56 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.2 m-80 -105.55 167.1 9.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 72.299999999999997 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.8 p -68.73 -22.75 64.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 71.219999999999999 110.856 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.84 2.41 26.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.869 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.991 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.36 -16.89 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.439999999999998 110.894 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 0.8 OUTLIER -82.8 102.04 11.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 75.310000000000002 110.846 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -117.98 8.73 12.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 75.420000000000002 110.899 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.786 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.4 m-30 -58.98 -69.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 110.858 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -172.01 177.99 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 45.350000000000001 110.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -2.56 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 63.409999999999997 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.598 HG21 HD13 ' A' ' 25' ' ' LEU . 70.4 p -91.62 -51.44 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 111.139 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -83.75 102.02 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.219999999999999 111.064 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 t -147.93 178.0 8.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 62.219999999999999 111.174 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.61 127.26 31.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 62.340000000000003 110.923 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -106.07 168.98 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 41.539999999999999 111.158 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 87' ' ' THR . 15.5 m120 -53.68 -168.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 110.894 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' ASN . 5.0 t -45.06 174.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.165 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.5 t-20 -51.99 107.24 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 75.450000000000003 110.882 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.75 0.89 4.97 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.714 2.276 . . . . 61.109999999999999 112.324 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.412 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 21.8 t -52.06 108.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 54.310000000000002 110.854 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -72.18 -16.44 61.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.040000000000006 110.909 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.407 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 174.41 -109.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 64.209999999999994 112.511 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.53 79.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 63.539999999999999 111.124 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 102.06 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 72.109999999999999 110.838 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 149.42 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 64.239999999999995 110.896 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.543 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -90.34 154.84 46.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 65.219999999999999 110.932 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.66 3.78 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 71.409999999999997 112.35 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.482 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 83.7 p -91.31 -9.78 43.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.852 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.84 19.3 55.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 55.310000000000002 112.485 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.96 107.16 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 64.409999999999997 110.872 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 73.109999999999999 110.871 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.863 0.363 . . . . 73.140000000000001 111.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.487 HG23 ' HD2' ' A' ' 3' ' ' PRO . 99.3 m -119.85 134.77 23.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.569 0.699 . . . . 74.519999999999996 111.131 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HD2' HG23 ' A' ' 2' ' ' THR . 53.6 Cg_endo -69.7 106.82 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.729 2.286 . . . . 63.509999999999998 112.326 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -140.45 148.54 54.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.523 0.678 . . . . 70.219999999999999 111.188 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 139.72 40.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.705 2.27 . . . . 75.209999999999994 112.33 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -112.83 143.32 28.83 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.708 . . . . 63.350000000000001 111.147 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 4.87 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 2.234 . . . . 74.439999999999998 112.392 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -51.96 102.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 110.92 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 164.52 12.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.549999999999997 111.101 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 11' ' ' GLY . . . -80.06 138.51 37.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 54.310000000000002 111.097 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 35.71 91.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 71.340000000000003 112.458 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 3.0 m -157.99 127.47 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.843 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CH2' ' HA2' ' A' ' 11' ' ' GLY . 3.8 m-90 -133.16 123.36 25.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.907 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.96 102.01 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.130000000000003 110.916 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.11 152.2 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 75.349999999999994 111.191 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' CE ' ' A' ' 62' ' ' MET . 54.1 Cg_endo -69.76 129.92 18.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.637 2.225 . . . . 72.329999999999998 112.39 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -52.0 120.94 17.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 74.400000000000006 110.879 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 80.7 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.668 2.245 . . . . 75.319999999999993 112.281 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.43 -27.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 74.209999999999994 112.516 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.656 ' HB ' HD11 ' A' ' 25' ' ' LEU . 19.7 t -59.15 164.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 65.239999999999995 111.158 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.89 ' O ' HD22 ' A' ' 25' ' ' LEU . 31.3 m -55.7 114.83 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 63.109999999999999 110.885 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.52 -67.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 74.129999999999995 110.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -39.59 -42.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 54.240000000000002 110.896 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -48.7 80.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.941 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.89 HD22 ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -71.11 -27.9 63.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.88 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 54' ' ' VAL . 12.6 m -60.77 -41.46 95.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 73.319999999999993 111.109 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.18 28.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 53.140000000000001 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -55.8 -44.94 78.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 51.43 110.823 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.852 HG23 ' CG ' ' A' ' 57' ' ' HIS . 90.4 mt -60.1 -64.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.010000000000005 111.093 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -37.6 -41.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 63.109999999999999 110.886 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 4.6 t80 -75.03 -68.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.329999999999998 110.946 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -47.95 -19.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 71.219999999999999 111.107 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 4.4 t -70.52 1.59 4.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.549999999999997 110.914 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.36 17.9 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 71.519999999999996 110.862 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.72 -48.81 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.109999999999999 110.954 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.8 -61.47 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 33.119999999999997 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -82.13 12.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 74.439999999999998 111.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.838 ' OD1' HG11 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -88.93 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.450000000000003 110.883 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -80.02 119.37 22.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 62.299999999999997 110.879 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.4 -68.84 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 72.25 112.46 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.628 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.1 Cg_endo -69.75 6.3 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.726 2.284 . . . . 54.310000000000002 112.316 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.1 pt -82.06 17.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 65.230000000000004 111.107 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -73.94 124.6 90.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.711 . . . . 65.209999999999994 110.905 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.9 Cg_endo -69.75 -179.37 2.86 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.723 2.282 . . . . 75.439999999999998 112.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.02 -36.15 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 63.43 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.1 -27.18 5.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 73.329999999999998 112.483 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.18 -68.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 63.509999999999998 111.146 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.3 t -117.86 -5.78 11.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 64.049999999999997 110.918 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 52' ' ' ASN . 2.6 t80 -40.69 -53.07 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.299999999999997 110.861 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.74 130.32 28.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 70.120000000000005 110.94 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.8 151.83 91.88 Favored 'Cis proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 -1.793 . . . . 55.020000000000003 112.327 0.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 7.2 p-10 -101.69 144.32 30.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 70.200000000000003 110.907 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.9 p -94.97 160.3 14.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 72.040000000000006 111.143 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 26' ' ' THR . 88.8 t -66.14 -52.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 62.020000000000003 111.128 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.617 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.97 17.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 74.510000000000005 110.881 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.34 -56.43 11.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 111.131 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.955 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -35.55 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.818 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.688 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -65.01 -38.39 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 64.209999999999994 111.125 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.74 -53.96 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 63.0 111.101 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -54.49 -63.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 73.540000000000006 110.953 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 57' ' ' HIS . 1.6 p -53.73 -37.09 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 71.120000000000005 111.153 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.495 ' CE ' ' HD3' ' A' ' 16' ' ' PRO . 2.5 mtm -45.96 -21.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 61.43 110.888 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.504 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 10.3 t-20 -71.89 -54.53 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.540000000000006 110.866 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -79.0 -45.88 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 110.927 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.545 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -48.91 -49.63 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.883 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.6 t80 -55.32 -32.2 62.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 99' ' ' GLY . 26.9 mt-30 -96.12 -4.91 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.883 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.401 ' HB3' ' O ' ' A' ' 65' ' ' TYR . 7.3 t60 -74.79 -40.68 61.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 73.230000000000004 110.86 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.983 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.76 -61.57 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 54.340000000000003 111.135 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.94 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.677 -0.773 . . . . 75.209999999999994 112.484 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.94 33.3 11.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 63.350000000000001 110.94 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -106.57 167.71 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 63.409999999999997 110.878 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.469 ' CB ' HD11 ' A' ' 84' ' ' LEU . 75.4 p -69.09 -23.01 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 74.129999999999995 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.28 2.85 26.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 75.319999999999993 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.983 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.4 -24.37 60.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.540000000000006 110.881 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.95 102.0 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.200000000000003 110.901 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -118.0 11.36 13.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.299999999999997 110.848 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.688 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.8 m-30 -57.75 -68.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 75.299999999999997 110.876 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -171.9 178.01 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.040000000000006 110.872 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -65.61 -2.13 3.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 71.040000000000006 110.943 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 25' ' ' LEU . 72.4 p -91.76 -51.77 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 52.210000000000001 111.107 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.72 107.42 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 71.439999999999998 111.146 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -152.49 177.99 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 64.25 111.126 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -66.36 153.73 41.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.926 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -133.69 167.27 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 63.030000000000001 111.148 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' THR . 6.5 m120 -53.66 -168.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 73.340000000000003 110.86 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.24 174.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 73.120000000000005 111.168 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.572 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.0 t-20 -52.06 107.0 0.73 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.73 . . . . 63.409999999999997 110.895 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -0.6 7.12 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 75.019999999999996 112.369 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 5.3 t -52.0 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 42.530000000000001 110.827 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -79.71 -17.23 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.497 . . . . 75.409999999999997 110.914 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.421 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 177.58 -112.48 0.38 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 71.430000000000007 112.487 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.45 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 75.510000000000005 111.127 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.35 101.99 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 71.030000000000001 110.867 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.89 142.07 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 60.25 110.873 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.05 140.88 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.716 0.77 . . . . 55.229999999999997 110.896 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 132.05 22.43 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.635 2.224 . . . . 64.430000000000007 112.368 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.498 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 3.1 t -117.95 -2.37 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 70.049999999999997 110.869 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.541 ' O ' ' NE2' ' A' ' 67' ' ' GLN . . . 118.21 -36.86 3.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 32.130000000000003 112.506 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 106.96 4.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 51.039999999999999 110.855 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 72.25 110.873 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.874 0.369 . . . . 74.329999999999998 111.073 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.5 m -140.88 120.91 8.62 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.621 0.724 . . . . 74.219999999999999 111.077 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -177.99 2.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.669 2.246 . . . . 73.109999999999999 112.304 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -66.87 146.92 99.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 31.309999999999999 111.133 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' O ' HG23 ' A' ' 6' ' ' THR . 53.2 Cg_endo -69.8 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.651 2.234 . . . . 61.140000000000001 112.335 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 5' ' ' PRO . 29.1 p -156.79 154.04 25.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.569 0.7 . . . . 73.439999999999998 111.135 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 9.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.634 2.222 . . . . 75.400000000000006 112.341 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 6' ' ' THR . 6.6 ttmm -52.01 106.28 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.120000000000005 110.906 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 178.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 62.520000000000003 111.115 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.723 ' HB1' ' CZ2' ' A' ' 13' ' ' TRP . . . -159.12 174.74 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 63.409999999999997 111.117 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.584 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 153.38 -29.23 0.78 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 61.130000000000003 112.496 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.488 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 7.0 m -143.97 139.95 29.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 73.340000000000003 110.839 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.723 ' CZ2' ' HB1' ' A' ' 10' ' ' ALA . 4.1 m-90 -134.82 124.97 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 71.209999999999994 110.912 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.48 102.05 13.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 75.030000000000001 110.883 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.492 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -150.65 153.87 34.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 75.430000000000007 111.074 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.9 Cg_endo -69.74 126.3 13.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 70.150000000000006 112.376 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.08 113.42 4.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 64.329999999999998 110.868 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 79.59 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 71.450000000000003 112.351 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.492 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 161.14 61.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.792 -0.718 . . . . 63.100000000000001 112.487 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.762 ' CG2' HD11 ' A' ' 25' ' ' LEU . 1.7 m -157.56 178.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 72.319999999999993 111.122 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' HD22 ' A' ' 25' ' ' LEU . 48.9 m -52.04 114.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 63.5 110.827 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.56 -53.67 5.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 75.140000000000001 110.841 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -50.73 -30.09 13.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.899 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -51.35 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 71.230000000000004 110.939 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.42 -32.06 67.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 62.100000000000001 110.905 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' THR . 11.9 m -66.72 -1.0 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 62.340000000000003 111.121 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.29 -38.13 6.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.474 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 3.3 p30 -57.68 -56.39 22.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 65.439999999999998 110.894 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' HB3' ' A' ' 57' ' ' HIS . 40.6 mt -43.52 -45.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 53.439999999999998 111.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.96 -50.88 33.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.129999999999995 110.877 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -74.77 -52.43 11.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.906 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 35' ' ' GLN . . . -46.55 -57.15 5.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 111.108 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.41 -20.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.864 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -81.41 12.55 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 70.530000000000001 110.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.16 5.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 110.901 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.38 -53.1 0.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 63.140000000000001 112.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.698 HD12 HD12 ' A' ' 64' ' ' LEU . 1.2 pt -82.06 5.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 73.430000000000007 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.799 ' OD1' HG21 ' A' ' 61' ' ' VAL . 6.9 m-20 -87.64 -56.71 3.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 72.530000000000001 110.878 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.2 OUTLIER -78.29 120.03 22.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.88 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.19 -67.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.75 -0.738 . . . . 64.129999999999995 112.492 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.62 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.72 4.81 1.96 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.722 2.281 . . . . 62.329999999999998 112.367 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.7 pt -82.41 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.112 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.29 125.73 90.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 74.200000000000003 110.913 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.78 7.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 75.109999999999999 112.344 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.37 -31.74 1.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 33.520000000000003 112.497 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.84 -31.91 5.17 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 53.25 112.499 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.61 -68.25 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 45.539999999999999 111.123 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.19 2.81 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 110.876 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.1 t80 -39.99 -58.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.914 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mm-40 -98.24 131.45 26.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 64.230000000000004 110.866 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.67 148.98 87.63 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 -1.795 . . . . 62.229999999999997 112.368 -0.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -102.98 134.27 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.9 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.428 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 43.3 p -79.92 155.57 27.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.152 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.07 -53.58 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 61.210000000000001 111.136 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.636 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.61 18.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.849 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.4 -55.25 11.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.450000000000003 111.105 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.741 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -33.75 -53.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.869 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.784 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -66.23 -38.88 88.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 61.100000000000001 111.118 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.11 -42.45 94.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 73.329999999999998 111.086 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.1 t80 -66.32 -60.48 2.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.886 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.799 HG21 ' OD1' ' A' ' 38' ' ' ASP . 2.1 p -54.11 -34.77 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.086 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.6 ' HE2' ' CZ ' ' A' ' 78' ' ' PHE . 1.2 mmt -45.77 -25.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 53.109999999999999 110.885 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 19.0 t-20 -65.6 -63.56 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 110.848 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.698 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -72.5 -53.18 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 74.400000000000006 110.961 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.675 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -39.22 -57.5 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 62.399999999999999 110.914 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.583 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 16.7 t80 -50.45 -38.1 41.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.481 . . . . 64.120000000000005 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.44 ' OE1' ' C ' ' A' ' 99' ' ' GLY . 9.0 mt-30 -92.27 -4.22 54.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 75.099999999999994 110.929 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.539 ' CD2' HD13 ' A' ' 37' ' ' ILE . 2.3 t60 -74.88 -41.94 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 62.310000000000002 110.844 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.022 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.67 -63.17 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 111.099 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.03 18.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 71.219999999999999 112.538 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.94 35.7 16.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 75.319999999999993 110.891 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.2 m-80 -107.31 167.84 9.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.953 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.504 ' CB ' HD11 ' A' ' 84' ' ' LEU . 72.1 p -68.98 -24.25 64.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 73.040000000000006 110.846 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -81.1 2.17 28.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.907 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 1.022 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -23.52 59.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.140000000000001 110.892 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.14 102.03 10.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 75.310000000000002 110.864 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.03 11.31 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 110.845 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.784 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.9 m-30 -57.96 -68.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.835 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.13 177.99 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.310000000000002 110.833 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -65.53 -1.61 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 72.019999999999996 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 69.8 p -92.79 -53.16 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 71.430000000000007 111.112 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.95 103.43 11.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 111.05 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 t -148.45 178.02 8.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 70.019999999999996 111.096 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD11 ' CB ' ' A' ' 73' ' ' SER . 1.3 mt -66.69 152.4 45.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 54.439999999999998 110.872 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -133.75 167.32 20.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 87' ' ' THR . 61.8 m-80 -53.53 -168.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.140000000000001 110.867 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 86' ' ' ASN . 7.2 t -45.23 175.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.200000000000003 111.155 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.8 t-20 -51.98 108.26 1.03 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 72.239999999999995 110.911 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.591 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.74 -2.89 10.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.709 2.273 . . . . 65.530000000000001 112.368 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.405 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.0 106.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.854 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -73.15 -15.85 61.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.915 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.2 -111.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 72.400000000000006 112.499 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.44 -31.56 67.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 53.439999999999998 111.101 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 102.04 7.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 54.240000000000002 110.859 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.3 139.84 34.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 65.120000000000005 110.911 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.591 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.4 m-85 -85.84 157.63 57.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 71.409999999999997 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.492 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.81 106.26 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.647 2.231 . . . . 53.119999999999997 112.32 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.497 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 74.3 p -81.15 -11.48 59.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.520000000000003 110.866 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 67' ' ' GLN . . . 35.14 36.34 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 62.130000000000003 112.456 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.89 149.8 24.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.852 0.358 . . . . 74.040000000000006 110.879 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.898 0.38 . . . . 75.010000000000005 111.129 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.52 163.15 7.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 70.129999999999995 111.174 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 3.09 2.97 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.744 2.296 . . . . 70.340000000000003 112.345 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.5 p -52.06 151.95 6.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.537 0.684 . . . . 63.020000000000003 111.188 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 136.4 33.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.683 2.255 . . . . 64.329999999999998 112.347 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.5 p -114.37 154.25 46.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 70.239999999999995 111.1 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -172.05 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 73.099999999999994 112.35 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 126.03 42.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.019999999999996 110.872 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.25 127.8 33.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 73.25 111.069 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.1 136.9 52.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 111.069 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.58 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 91.64 63.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.721 . . . . 54.030000000000001 112.484 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' HD23 ' A' ' 84' ' ' LEU . 41.4 m -158.02 126.9 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.372 . . . . 73.319999999999993 110.857 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CH2' ' HA2' ' A' ' 11' ' ' GLY . 5.7 m-90 -129.29 122.64 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.915 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 62' ' ' MET . 1.1 t -95.47 107.56 19.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 73.430000000000007 110.897 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 3.9 m -152.64 154.81 32.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 60.109999999999999 111.136 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.74 131.37 21.13 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.701 2.267 . . . . 65.540000000000006 112.339 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 110.77 2.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.575 0.702 . . . . 74.230000000000004 110.929 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 96.79 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.252 . . . . 72.209999999999994 112.352 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.15 -32.31 2.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 43.399999999999999 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 21' ' ' SER . 3.6 p -58.67 -178.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.344 . . . . 54.450000000000003 111.127 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.853 ' H ' HG22 ' A' ' 20' ' ' VAL . 3.2 m -52.05 113.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 64.239999999999995 110.881 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.22 -56.71 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 63.140000000000001 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 26' ' ' THR . 0.4 OUTLIER -52.4 -15.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.906 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.31 -46.21 16.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 74.530000000000001 110.892 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -70.41 -50.23 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.140000000000001 110.906 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' ASP . 12.3 t -36.89 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 63.530000000000001 111.16 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . -66.34 -44.93 89.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.7 -0.762 . . . . 54.299999999999997 112.488 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' LEU . 14.5 m-20 -41.87 -48.82 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 74.450000000000003 110.883 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.805 HG23 ' CG ' ' A' ' 57' ' ' HIS . 82.1 mt -55.63 -42.46 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 75.340000000000003 111.133 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.32 -46.05 80.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 54.439999999999998 110.886 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.15 -61.5 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 54.119999999999997 110.93 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.708 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -50.06 -46.87 53.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 61.5 111.083 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 40.4 t -50.33 -17.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 71.099999999999994 110.866 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -93.03 17.96 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.817 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.415 ' C ' ' CD ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -96.98 -48.95 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.230000000000004 110.935 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.7 -63.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 63.219999999999999 112.445 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.669 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.36 4.66 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 72.239999999999995 111.164 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.838 ' OD1' HG11 ' A' ' 61' ' ' VAL . 2.3 m-20 -78.08 -68.2 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 35.439999999999998 110.869 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.15 129.02 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.340000000000003 110.876 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.57 -72.69 0.39 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 71.349999999999994 112.496 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.75 8.29 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.675 2.25 . . . . 71.219999999999999 112.364 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.71 HD13 ' HD2' ' A' ' 57' ' ' HIS . 29.8 pt -82.12 17.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 53.450000000000003 111.106 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -76.06 125.27 88.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.559 0.695 . . . . 75.120000000000005 110.91 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 161.62 45.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.24 . . . . 53.100000000000001 112.327 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.4 -40.62 1.47 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 70.140000000000001 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.71 17.34 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 64.420000000000002 112.535 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.79 -68.42 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.356 . . . . 71.109999999999999 111.099 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -117.89 11.67 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 110.898 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 13.0 t80 -55.32 -52.42 63.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.109999999999999 110.881 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 83.1 mt-10 -98.31 129.17 31.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.696 0.76 . . . . 61.340000000000003 110.869 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.79 153.48 93.04 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 -1.81 . . . . 64.400000000000006 112.361 -0.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -99.41 141.55 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 55.310000000000002 110.85 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.489 ' CG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -98.19 158.38 15.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 70.450000000000003 111.138 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.76 -55.17 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 111.146 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.07 18.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.519999999999996 110.903 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.9 -58.08 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 71.329999999999998 111.114 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.805 ' CG ' HG23 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -33.8 -48.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 60.32 110.842 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.688 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -64.53 -46.19 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 111.106 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -56.28 -46.96 79.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.150000000000006 111.093 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.6 t80 -59.77 -64.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.92 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.838 HG11 ' OD1' ' A' ' 38' ' ' ASP . 5.7 p -54.52 -36.21 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 64.540000000000006 111.116 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.476 ' CE ' ' SG ' ' A' ' 76' ' ' CYS . 8.6 mtp -45.49 -21.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.859 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.537 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 57.9 t-20 -71.85 -52.36 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 75.299999999999997 110.84 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.669 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -81.14 -45.13 16.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 65.430000000000007 110.943 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.634 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -50.79 -45.93 59.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.882 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 19.3 t80 -58.9 -32.2 69.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 72.120000000000005 110.929 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 38.5 mt-30 -95.95 -4.92 42.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 63.409999999999997 110.902 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -73.42 -41.81 62.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.992 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.19 -60.73 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.130000000000003 111.117 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.15 22.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.694 -0.765 . . . . 75.340000000000003 112.457 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.03 36.42 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 73.239999999999995 110.857 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.564 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.5 m-80 -108.81 165.55 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 74.219999999999999 110.842 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.413 ' HB3' HD21 ' A' ' 84' ' ' LEU . 11.5 p -68.34 -22.67 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 74.530000000000001 110.841 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.471 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -80.78 2.16 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 73.25 110.902 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.992 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -23.69 59.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 42.039999999999999 110.867 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' CE ' ' A' ' 62' ' ' MET . 4.1 m -82.48 102.01 11.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.887 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.03 12.89 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.868 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.688 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.2 m-30 -58.8 -68.26 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.73 177.99 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 53.229999999999997 110.86 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -1.94 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 110.921 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.622 HG21 ' CD1' ' A' ' 25' ' ' LEU . 68.2 p -92.01 -52.03 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.209999999999994 111.145 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.476 ' HB1' ' CE ' ' A' ' 62' ' ' MET . . . -82.51 101.98 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 53.310000000000002 111.087 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -148.86 178.08 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 111.156 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 84' ' ' LEU . 4.2 mp -66.89 154.15 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.450000000000003 110.871 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -133.92 169.22 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 111.169 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.06 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 65.340000000000003 110.892 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.47 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.16 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.577 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.5 t-20 -52.04 106.55 0.67 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 74.530000000000001 110.855 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.0 Cg_endo -69.76 0.59 5.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.641 2.228 . . . . 71.200000000000003 112.357 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.428 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.01 108.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 74.439999999999998 110.86 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 1.3 p90 -80.99 -16.29 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 74.310000000000002 110.963 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.26 -119.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.540000000000006 112.444 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.63 71.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 45.420000000000002 111.118 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.2 m -78.77 101.95 7.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.892 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -98.79 136.56 38.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.510000000000005 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.8 m-85 -85.27 147.22 46.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.72 . . . . 74.420000000000002 110.888 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 135.77 31.42 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 73.120000000000005 112.335 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 10.6 t -115.83 -8.32 11.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 64.239999999999995 110.878 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.511 ' HA2' ' NE2' ' A' ' 67' ' ' GLN . . . 78.31 39.39 22.81 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 71.409999999999997 112.482 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.8 t -93.06 135.71 33.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 72.340000000000003 110.844 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 64.400000000000006 110.892 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.86 0.362 . . . . 40.409999999999997 111.069 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.1 p -141.48 146.26 41.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.549 0.69 . . . . 70.109999999999999 111.164 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.701 2.267 . . . . 61.009999999999998 112.339 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.9 p -143.92 123.39 7.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.722 . . . . 74.319999999999993 111.113 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.34 9.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 64.040000000000006 112.33 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 p -147.91 148.82 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.558 0.694 . . . . 72.140000000000001 111.17 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -171.89 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 62.310000000000002 112.345 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.42 116.95 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 71.099999999999994 110.89 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.03 160.11 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 111.067 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 175.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 54.100000000000001 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.499 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 155.92 41.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 64.140000000000001 112.474 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.0 124.0 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 74.030000000000001 110.854 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.8 m-90 -125.41 118.37 25.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 73.25 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -94.06 102.05 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 63.310000000000002 110.879 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 2.7 m -151.9 153.34 31.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 73.329999999999998 111.095 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.5 Cg_endo -69.82 127.94 15.26 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.655 2.236 . . . . 71.430000000000007 112.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -51.96 114.71 5.65 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.583 0.706 . . . . 75.439999999999998 110.952 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.76 15.3 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 71.129999999999995 112.371 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 20' ' ' VAL . . . -131.65 62.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.709 -0.758 . . . . 54.329999999999998 112.499 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 25' ' ' LEU . 2.2 m -158.49 178.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 75.510000000000005 111.077 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.604 ' O ' HD22 ' A' ' 25' ' ' LEU . 34.3 m -55.84 127.45 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.826 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.55 -49.4 67.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 73.319999999999993 110.833 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -28.03 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.839 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.03 -49.57 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 110.905 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -71.05 -41.33 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 72.329999999999998 110.917 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 m -46.29 -43.39 15.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.219999999999999 111.131 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.62 -29.57 25.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 71.439999999999998 112.513 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -59.97 -68.15 0.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 44.219999999999999 110.946 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.643 HG23 ' CG ' ' A' ' 57' ' ' HIS . 97.2 mt -40.9 -68.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 74.409999999999997 111.123 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 29' ' ' ILE . 5.6 t30 -34.1 -44.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.838 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -75.72 -68.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 110.932 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB1' ' OD2' ' A' ' 38' ' ' ASP . . . -45.18 -21.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 73.409999999999997 111.082 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -71.96 5.16 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.876 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -110.04 15.2 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 110.857 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.2 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 51.43 110.866 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.19 -55.78 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 70.140000000000001 112.46 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.704 HG21 ' NE2' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.21 9.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 51.5 111.141 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.771 ' OD2' ' HB1' ' A' ' 32' ' ' ALA . 1.6 m-20 -88.1 -63.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 110.868 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 114.93 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 63.130000000000003 110.88 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.77 -69.67 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 31.219999999999999 112.485 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.8 7.5 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.200000000000003 112.313 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.3 pt -82.22 16.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 111.145 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -73.62 123.74 89.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 61.130000000000003 110.932 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 171.25 14.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.719 2.28 . . . . 73.420000000000002 112.316 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.83 -33.89 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 12.01 112.485 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.09 5.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 63.32 112.498 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -68.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 53.219999999999999 111.082 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.87 2.18 18.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 72.219999999999999 110.9 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 6.1 t80 -40.99 -60.07 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.409999999999997 110.877 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.14 134.12 22.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.731 . . . . 73.340000000000003 110.905 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.71 150.67 90.38 Favored 'Cis proline' 0 C--N 1.341 0.145 0 C-N-CA 122.7 -1.792 . . . . 53.5 112.313 -0.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -100.47 122.22 42.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' NZ ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -85.68 157.48 20.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 54.149999999999999 111.146 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.92 -49.33 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 111.105 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' NZ ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -81.28 18.07 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 65.340000000000003 110.882 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.43 -54.18 23.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 62.450000000000003 111.076 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.946 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -37.25 -50.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.861 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.812 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -65.3 -39.48 92.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 65.230000000000004 111.098 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.09 -55.85 29.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 62.200000000000003 111.105 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.3 t80 -52.6 -62.35 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 110.919 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.946 HG12 ' O ' ' A' ' 57' ' ' HIS . 1.5 p -54.38 -37.44 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 73.120000000000005 111.137 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.417 ' SD ' ' SG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -45.71 -21.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 110.875 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -71.37 -52.08 20.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 72.329999999999998 110.923 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.665 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -83.53 -46.39 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 110.899 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.626 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -46.33 -45.29 17.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 53.520000000000003 110.947 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CE1' ' O ' ' A' ' 72' ' ' ASN . 58.7 t80 -60.45 -34.91 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 63.240000000000002 110.939 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -93.07 -4.22 52.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 64.349999999999994 110.96 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.704 ' NE2' HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -70.83 -44.58 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 54.420000000000002 110.833 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.907 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.6 -59.53 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 65.099999999999994 111.064 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.79 24.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 74.420000000000002 112.466 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.01 32.43 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 110.846 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.627 ' O ' ' CE1' ' A' ' 66' ' ' TYR . 5.9 m-80 -100.71 163.63 12.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.400000000000006 110.891 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.523 ' CB ' HD11 ' A' ' 84' ' ' LEU . 83.8 p -67.55 -21.87 65.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.420000000000002 110.885 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.489 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.71 3.5 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.875 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.907 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -76.53 -26.71 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 110.873 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.417 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 93.1 m -82.4 102.01 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -118.01 11.05 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 64.409999999999997 110.904 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.812 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.9 m-30 -57.72 -68.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 75.049999999999997 110.917 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.75 178.0 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 110.851 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -2.06 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 110.907 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.523 HG21 ' CD1' ' A' ' 25' ' ' LEU . 67.2 p -91.88 -53.58 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 60.210000000000001 111.104 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.49 102.01 11.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.030000000000001 111.107 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.3 t -152.88 178.03 10.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.209999999999994 111.141 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.559 HD23 ' SG ' ' A' ' 14' ' ' CYS . 18.8 mt -65.8 123.69 20.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 73.010000000000005 110.949 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.472 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -106.17 168.63 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.049999999999997 111.132 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.8 m120 -53.88 -167.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 110.895 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.7 t -45.06 175.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 43.149999999999999 111.125 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.2 t-20 -51.95 107.09 0.75 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.701 . . . . 61.43 110.9 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.78 3.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 73.140000000000001 112.35 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.42 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 19.8 t -52.04 109.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 110.824 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -70.36 -16.86 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 74.209999999999994 110.967 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 175.16 -110.54 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 63.229999999999997 112.474 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.81 73.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 62.409999999999997 111.085 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.32 104.66 14.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 110.886 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -98.64 149.86 22.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 65.129999999999995 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.534 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.4 m-85 -90.71 159.87 39.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.652 0.739 . . . . 74.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 104.35 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.261 . . . . 55.229999999999997 112.334 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.578 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 40.6 p -73.83 -15.96 61.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 64.230000000000004 110.89 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 45.0 52.78 7.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.666 -0.778 . . . . 52.219999999999999 112.516 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.59 167.0 19.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 64.340000000000003 110.866 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 75.340000000000003 110.87 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.864 0.364 . . . . 62.509999999999998 111.081 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -52.43 141.56 32.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.541 0.686 . . . . 65.439999999999998 111.172 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 118.34 5.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.673 2.248 . . . . 73.439999999999998 112.34 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.48 HG23 ' HD2' ' A' ' 5' ' ' PRO . 21.6 m -79.26 136.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.578 0.704 . . . . 71.120000000000005 111.129 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 4' ' ' THR . 53.7 Cg_endo -69.81 84.33 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.22 . . . . 64.310000000000002 112.347 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.13 159.97 66.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.608 0.718 . . . . 72.120000000000005 111.112 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -173.86 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.274 . . . . 73.549999999999997 112.335 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' HZ2' ' HA ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -130.59 122.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.140000000000001 110.892 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.82 155.03 33.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 111.093 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 132.91 54.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 54.210000000000001 111.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 108.09 83.77 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 72.230000000000004 112.439 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.71 ' HB3' HD22 ' A' ' 84' ' ' LEU . 58.1 m -157.77 138.4 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 53.299999999999997 110.84 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.684 ' HB2' HG22 ' A' ' 85' ' ' THR . 10.9 m-90 -145.56 113.24 6.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 75.120000000000005 110.932 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.435 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -83.64 108.45 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 110.896 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.53 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.4 m -158.63 153.99 22.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.109999999999999 111.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.522 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.77 122.85 9.52 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.707 2.272 . . . . 60.43 112.36 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -51.92 116.97 8.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 74.530000000000001 110.927 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 86.85 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 65.25 112.324 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 -27.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 70.409999999999997 112.487 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 21' ' ' SER . 2.6 t -59.03 170.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 52.340000000000003 111.12 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.885 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.97 118.37 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 53.240000000000002 110.826 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -42.98 -66.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 71.209999999999994 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -41.23 -40.62 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.01 -50.4 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 52.100000000000001 110.904 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -71.31 -31.17 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 54.149999999999999 110.947 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.2 m -64.66 -30.03 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 111.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.72 -23.3 70.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 71.129999999999995 112.466 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 57.5 m-20 -63.83 -58.64 6.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 72.239999999999995 110.912 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 55' ' ' LYS . 95.9 mt -47.14 -47.86 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 72.329999999999998 111.11 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -51.65 -44.24 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.439999999999998 110.865 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.12 -56.56 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.881 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -47.85 -43.84 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 74.519999999999996 111.089 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -28.31 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 110.891 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -81.46 15.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 70.200000000000003 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.597 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.95 -46.8 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 61.210000000000001 110.932 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -62.43 0.64 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 54.399999999999999 112.512 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.79 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -83.07 11.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.094 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.863 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.6 t70 -86.98 -56.6 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.897 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.452 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.3 m -74.85 120.59 20.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.873 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.33 -69.44 0.43 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 75.530000000000001 112.477 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.81 1.28 4.61 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 63.329999999999998 112.337 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 38' ' ' ASP . 33.3 pt -83.2 18.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 111.109 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -86.75 135.69 35.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.638 0.733 . . . . 72.200000000000003 110.907 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 174.12 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.281 . . . . 63.439999999999998 112.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.09 -33.73 0.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 73.239999999999995 112.463 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.18 -21.4 6.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 72.519999999999996 112.478 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.44 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 60.200000000000003 111.078 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.2 m -117.91 -2.27 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.400000000000006 110.914 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.3 t80 -36.42 -51.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.867 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.582 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 19.1 mm-40 -99.72 129.56 28.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.59 0.71 . . . . 64.530000000000001 110.901 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.77 147.85 85.51 Favored 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.69 -1.796 . . . . 60.299999999999997 112.366 0.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.531 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 5.5 p-10 -104.17 133.4 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 70.530000000000001 110.934 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.51 166.4 12.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 70.329999999999998 111.131 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.35 -56.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 111.095 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.08 14.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 75.140000000000001 110.877 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.38 53.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 41.020000000000003 111.109 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.733 ' CD2' HD12 ' A' ' 42' ' ' ILE . 64.8 m80 -51.95 -52.3 51.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 71.409999999999997 110.864 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -55.35 -43.02 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 111.108 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.73 68.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -68.38 -64.71 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 70.430000000000007 110.927 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 65' ' ' TYR . 7.1 p -55.5 -33.7 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 73.25 111.136 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.514 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -45.85 -27.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 65.319999999999993 110.843 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -66.16 -60.51 2.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 63.399999999999999 110.835 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.79 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -71.4 -47.85 53.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.932 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.597 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 3.0 t80 -45.55 -48.24 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.955 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.4 t80 -62.37 -31.89 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 71.230000000000004 110.943 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.64 -4.64 44.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 71.439999999999998 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.29 -42.89 68.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 70.530000000000001 110.869 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.904 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.45 -60.61 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 71.420000000000002 111.098 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.19 23.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 72.239999999999995 112.494 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 7.7 mtp180 52.07 43.18 30.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 74.439999999999998 110.856 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.3 m-80 -109.19 166.95 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 40.520000000000003 110.941 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.475 ' HB2' HD11 ' A' ' 84' ' ' LEU . 32.6 p -71.15 -24.93 62.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 41.43 110.819 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -78.52 -1.1 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 64.409999999999997 110.907 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.904 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.82 -22.07 59.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 72.549999999999997 110.879 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -82.78 102.05 11.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.510000000000005 110.855 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -117.98 6.88 12.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.868 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.3 m-30 -58.96 -71.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 64.209999999999994 110.89 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.16 178.01 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.807 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -2.78 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 63.200000000000003 110.904 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.643 HG21 ' CD1' ' A' ' 25' ' ' LEU . 29.1 p -97.99 -46.68 5.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 75.349999999999994 111.148 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -80.97 24.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.130000000000003 111.062 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -84.47 -178.18 6.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 62.149999999999999 111.141 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 12' ' ' SER . 1.6 mt -66.89 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.229999999999997 110.906 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.684 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.2 t -106.2 169.06 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.164 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 87' ' ' THR . 13.1 m-80 -53.25 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 70.019999999999996 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.08 173.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 75.140000000000001 111.159 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 6.6 t-20 -52.07 106.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 74.109999999999999 110.889 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.72 -13.21 34.44 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 60.219999999999999 112.378 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -52.06 105.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 62.420000000000002 110.847 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -16.7 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.310000000000002 110.908 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.56 -115.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 63.229999999999997 112.504 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.27 86.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 111.082 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 101.99 5.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 110.918 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.57 139.18 36.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 61.049999999999997 110.892 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 20.0 m-85 -93.01 141.18 23.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 74.120000000000005 110.879 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 129.02 16.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 74.310000000000002 112.331 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 36.8 p -110.03 -6.4 15.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.519999999999996 110.898 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 46.43 30.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 12.33 112.478 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 p -155.69 125.24 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.39 . . . . 65.230000000000004 110.83 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 65.439999999999998 110.864 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.872 0.368 . . . . 73.109999999999999 111.119 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.4 p -88.01 137.97 31.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.587 0.708 . . . . 64.519999999999996 111.128 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 165.35 31.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.68 2.253 . . . . 71.129999999999995 112.369 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.2 p -142.15 127.36 10.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 111.153 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 157.73 59.33 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 74.420000000000002 112.353 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 8' ' ' LYS . 3.1 m -142.74 101.95 5.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.599 0.714 . . . . 64.420000000000002 111.161 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 6' ' ' THR . 53.6 Cg_endo -69.71 3.47 2.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.237 . . . . 73.200000000000003 112.397 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.73 ' HB2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -52.12 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.310000000000002 110.894 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.75 168.56 17.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 42.149999999999999 111.151 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.63 177.98 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.510000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -125.77 -8.69 5.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 63.020000000000003 112.469 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB3' HD22 ' A' ' 84' ' ' LEU . 3.7 m -141.9 148.23 38.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 64.230000000000004 110.867 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.558 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 9.2 m-90 -142.85 115.16 8.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 71.310000000000002 110.893 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.79 108.62 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 62.109999999999999 110.885 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG21 ' CD2' ' A' ' 96' ' ' PHE . 3.2 m -158.56 154.16 22.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 72.519999999999996 111.124 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.542 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.78 120.75 7.48 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 75.049999999999997 112.334 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.01 117.7 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.617 0.722 . . . . 74.340000000000003 110.877 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.723 2.282 . . . . 50.219999999999999 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.06 -21.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 65.549999999999997 112.409 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.826 ' HB ' HD11 ' A' ' 25' ' ' LEU . 2.3 t -59.07 164.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 65.030000000000001 111.155 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.769 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.0 m -53.63 111.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 53.310000000000002 110.854 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.7 m-20 -33.78 -64.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 61.130000000000003 110.884 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.24 -40.73 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.871 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.4 tp-100 -58.33 -50.44 73.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 70.019999999999996 110.896 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.926 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.9 -29.28 65.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.901 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -66.53 -0.24 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 111.168 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.92 -38.5 5.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 45.340000000000003 112.498 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.4 p30 -53.6 -43.1 68.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 62.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 55' ' ' LYS . 64.1 mt -59.11 -46.94 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 70.040000000000006 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -44.31 38.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 63.43 110.884 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.7 -49.03 27.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.92 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -51.7 -45.13 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 73.299999999999997 111.093 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' CA ' ' OD2' ' A' ' 38' ' ' ASP . 9.0 t -57.44 -12.16 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 51.109999999999999 110.863 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.13 6.69 47.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 64.019999999999996 110.831 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.468 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.96 -43.09 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.957 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.96 -47.09 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 64.230000000000004 112.428 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 HD12 ' A' ' 64' ' ' LEU . 1.5 pt -89.74 8.21 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 73.049999999999997 111.132 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 42' ' ' ILE . 9.3 t70 -86.87 -61.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 70.430000000000007 110.871 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 3.8 m -75.95 124.62 27.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.812 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.28 -74.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 64.099999999999994 112.433 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' C ' ' A' ' 39' ' ' CYS . 53.3 Cg_endo -69.81 4.14 2.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 74.109999999999999 112.325 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 38' ' ' ASP . 5.9 pt -82.93 17.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 111.111 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -79.16 144.33 62.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.608 0.718 . . . . 64.150000000000006 110.891 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.595 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.2 Cg_endo -69.74 148.13 64.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 64.519999999999996 112.388 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.64 -39.28 3.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.5 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.69 15.18 2.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.74 . . . . 72.239999999999995 112.52 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.89 -68.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 60.219999999999999 111.149 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' PHE . 21.1 t -117.93 -6.73 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.310000000000002 110.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 3.0 t80 -34.34 -56.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 71.109999999999999 110.878 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 9.7 mm-40 -99.6 125.84 39.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 61.25 110.913 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.82 150.71 90.73 Favored 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 -1.813 . . . . 72.319999999999993 112.337 0.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -111.29 133.52 53.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 72.230000000000004 110.852 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.81 176.63 6.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 64.420000000000002 111.098 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.32 -54.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.120000000000005 111.114 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.71 17.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.862 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.28 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 73.150000000000006 111.101 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.719 ' CG ' HD12 ' A' ' 42' ' ' ILE . 26.8 m170 -57.25 -57.77 11.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 72.140000000000001 110.893 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.667 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -50.02 -36.52 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 74.040000000000006 111.086 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.31 92.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 111.059 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 5.7 t80 -68.01 -59.09 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 74.219999999999999 110.904 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 65' ' ' TYR . 7.5 p -55.1 -35.97 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 73.150000000000006 111.152 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.633 ' HE3' ' HA ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -46.46 -29.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.892 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.38 -65.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.935 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.53 -47.87 74.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.902 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.527 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -49.71 -47.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.929 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.1 t80 -60.6 -30.62 69.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.129999999999995 110.882 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -98.87 3.34 47.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 73.310000000000002 110.881 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.535 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -75.41 -48.8 21.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.878 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -70.16 -54.55 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.240000000000002 111.065 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.67 26.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 62.240000000000002 112.489 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.97 47.96 23.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 72.409999999999997 110.847 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.563 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 4.1 m-80 -114.19 162.07 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 62.119999999999997 110.928 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.577 ' HB2' HD11 ' A' ' 84' ' ' LEU . 59.5 p -67.96 -24.43 65.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 62.109999999999999 110.818 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -80.04 1.19 28.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 75.400000000000006 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.667 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -77.46 -19.79 55.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.919 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -83.54 102.08 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 41.229999999999997 110.833 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.04 7.56 12.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 72.239999999999995 110.898 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.667 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.3 m-30 -59.27 -71.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 110.913 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.71 177.97 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.883 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -65.5 -1.99 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 72.409999999999997 110.931 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.926 HG21 ' CD1' ' A' ' 25' ' ' LEU . 26.9 p -97.92 -47.48 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 53.310000000000002 111.157 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.03 26.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 44.130000000000003 111.088 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.6 t -86.75 -177.83 6.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 63.329999999999998 111.158 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 73' ' ' SER . 14.5 mt -67.04 130.51 43.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.442 . . . . 64.519999999999996 110.899 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.5 t -106.02 169.51 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 64.519999999999996 111.139 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.0 m120 -53.15 -169.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 61.310000000000002 110.883 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.5 t -44.66 172.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 61.130000000000003 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.558 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 15.7 t-20 -52.09 106.79 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.662 0.744 . . . . 75.209999999999994 110.869 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.555 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.74 -3.7 12.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 73.439999999999998 112.353 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 1.9 t -52.02 104.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 61.100000000000001 110.889 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -17.83 25.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.899 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.08 -117.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 51.130000000000003 112.519 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.8 -26.79 65.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 72.329999999999998 111.07 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 t -76.13 102.02 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 53.549999999999997 110.87 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.77 127.94 45.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.555 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 25.6 m-85 -92.45 141.15 24.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 63.229999999999997 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.24 25.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.688 2.259 . . . . 75.530000000000001 112.361 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 99' ' ' GLY . 18.4 p -106.1 -14.34 15.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.859 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 98' ' ' SER . . . 35.49 38.77 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 63.049999999999997 112.472 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.1 p -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 71.140000000000001 110.826 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 73.530000000000001 110.877 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.857 0.361 . . . . 54.310000000000002 111.087 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.0 p -94.48 132.99 27.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.638 0.733 . . . . 75.209999999999994 111.141 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -176.28 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 71.439999999999998 112.346 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.7 p -156.44 147.45 16.51 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.604 0.716 . . . . 74.040000000000006 111.105 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.42 6.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.707 2.271 . . . . 61.229999999999997 112.356 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.0 p -100.34 143.55 26.74 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.589 0.709 . . . . 72.439999999999998 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -172.85 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.687 2.258 . . . . 63.32 112.372 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -114.52 126.67 55.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 71.25 110.904 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' N ' ' HD3' ' A' ' 8' ' ' LYS . . . -56.01 113.32 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 111.093 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.53 177.96 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 111.088 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.569 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -59.78 -177.15 1.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 74.409999999999997 112.44 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.656 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -146.3 153.92 41.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 71.430000000000007 110.856 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.656 ' CE3' ' C ' ' A' ' 12' ' ' SER . 8.6 m-90 -153.4 112.2 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 75.310000000000002 110.908 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -79.41 110.76 15.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 110.927 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.505 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 5.6 m -159.96 155.88 22.92 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.668 0.747 . . . . 74.439999999999998 111.078 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.77 122.9 9.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 74.439999999999998 112.331 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -52.02 114.53 5.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.525 0.678 . . . . 71.400000000000006 110.918 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 99.89 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 74.010000000000005 112.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.63 -28.28 2.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 72.530000000000001 112.474 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.882 HG11 HD11 ' A' ' 25' ' ' LEU . 5.8 p -58.89 173.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 42.450000000000003 111.155 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.701 ' H ' HG22 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.0 109.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.853 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.77 -68.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 50.340000000000003 110.861 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -41.22 -27.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 65.340000000000003 110.894 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 21' ' ' SER . 6.1 tm0? -63.99 -51.49 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 73.299999999999997 110.915 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.882 HD11 HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -70.24 -33.41 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 43.100000000000001 110.915 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 m -51.01 -18.84 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 62.009999999999998 111.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.97 -27.65 49.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 71.420000000000002 112.493 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 78.7 m-20 -59.81 -46.51 88.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 51.43 110.917 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 54' ' ' VAL . 65.2 mt -62.96 -53.24 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 62.030000000000001 111.117 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -52.43 -47.21 66.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.239999999999995 110.873 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -69.37 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 63.140000000000001 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.69 -33.36 33.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.081 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 43.8 t -57.27 -11.3 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 63.539999999999999 110.859 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 17.99 14.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 70.030000000000001 110.863 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -90.84 -51.83 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 62.43 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 168.02 -97.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 73.109999999999999 112.471 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.796 HG12 HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -81.99 18.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 64.530000000000001 111.121 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -75.09 -62.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 65.439999999999998 110.89 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.37 126.14 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 51.240000000000002 110.83 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.13 -70.06 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 63.25 112.467 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' CG ' ' O ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.81 6.0 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.683 2.255 . . . . 64.129999999999995 112.325 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.653 HD12 ' CG ' ' A' ' 57' ' ' HIS . 22.6 pt -82.63 18.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 111.135 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -79.89 129.51 70.31 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.922 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 170.1 17.46 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.678 2.252 . . . . 75.0 112.299 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.6 -41.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 61.439999999999998 112.48 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.35 -17.49 5.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 61.149999999999999 112.505 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.14 -68.64 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 72.209999999999994 111.132 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.05 6.29 12.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 64.329999999999998 110.859 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.573 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 3.7 t80 -40.87 -68.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 45.32 110.885 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -93.24 137.74 23.45 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.617 0.722 . . . . 73.109999999999999 110.913 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.555 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.2 Cg_endo -69.75 139.87 57.18 Favored 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.712 -1.786 . . . . 74.25 112.317 -0.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.73 133.66 52.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.438 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -86.93 174.24 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.479 . . . . 74.129999999999995 111.129 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 29' ' ' ILE . 56.4 t -65.76 -55.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.162 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HZ2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -78.42 13.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 110.904 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.579 ' N ' ' HZ2' ' A' ' 55' ' ' LYS . . . -51.15 -48.89 61.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 41.530000000000001 111.112 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.653 ' CG ' HD12 ' A' ' 42' ' ' ILE . 65.5 m80 -49.04 -48.13 44.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 74.340000000000003 110.847 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB1' ' HE2' ' A' ' 78' ' ' PHE . . . -57.66 -38.06 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 61.439999999999998 111.116 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.54 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 34.43 111.119 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.607 ' CE1' HD21 ' A' ' 64' ' ' LEU . 3.4 t80 -68.53 -59.14 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 63.439999999999998 110.905 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 2.0 p -54.71 -39.19 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 73.219999999999999 111.125 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.706 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 5.0 mtm -45.96 -32.62 2.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 71.129999999999995 110.858 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -64.63 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 62.340000000000003 110.862 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.796 HD12 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.69 -59.5 4.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 71.329999999999998 110.911 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.436 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 4.4 t80 -39.65 -43.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.901 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.0 t80 -61.15 -41.34 96.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 63.439999999999998 110.927 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 99' ' ' GLY . 29.2 mt-30 -91.62 -3.82 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 64.209999999999994 110.931 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.3 t60 -75.26 -40.68 58.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 74.140000000000001 110.89 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.998 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -75.76 -60.6 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 111.081 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.62 20.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 72.510000000000005 112.51 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 51.96 33.91 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 72.530000000000001 110.887 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.9 m-80 -102.98 167.24 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.109999999999999 110.897 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.655 ' HB2' HD11 ' A' ' 84' ' ' LEU . 93.7 p -71.26 -24.3 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.319999999999993 110.858 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.436 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -78.19 0.52 24.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 75.129999999999995 110.927 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.998 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -6.17 45.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.925 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -94.28 102.21 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.319999999999993 110.85 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.03 5.29 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 44.119999999999997 110.819 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.0 m-30 -59.31 -71.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 62.329999999999998 110.879 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.37 177.99 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.86 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.37 -2.84 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.936 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.49 HG21 ' CD1' ' A' ' 25' ' ' LEU . 27.5 p -98.04 -47.25 5.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 111.103 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.706 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -81.44 24.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 64.030000000000001 111.06 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 t -85.05 -177.29 6.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 70.439999999999998 111.173 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 73' ' ' SER . 15.4 mt -66.86 125.28 25.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.140000000000001 110.875 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.7 t -98.01 169.39 9.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 73.140000000000001 111.161 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 85' ' ' THR . 51.8 m-80 -52.95 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 110.901 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 1.6 t -44.39 170.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 63.039999999999999 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.563 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.3 t-20 -52.01 106.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.643 0.735 . . . . 62.240000000000002 110.902 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -3.09 11.28 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 71.450000000000003 112.323 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 3.5 t -51.97 107.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.450000000000003 110.857 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -17.88 45.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 110.913 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.56 -113.59 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 72.510000000000005 112.471 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.18 -38.16 90.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 61.439999999999998 111.103 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 101.99 5.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 110.905 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.51 144.97 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 55.299999999999997 110.906 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 8.6 m-85 -92.45 150.35 39.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.657 0.741 . . . . 74.010000000000005 110.924 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 115.97 4.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 72.209999999999994 112.333 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 8.5 p -109.42 16.58 22.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 53.030000000000001 110.876 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.465 ' O ' ' NE2' ' A' ' 67' ' ' GLN . . . 68.04 -80.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 75.219999999999999 112.509 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 106.69 15.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 71.349999999999994 110.852 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 63.109999999999999 110.86 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.874 0.369 . . . . 64.439999999999998 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.7 m -98.03 119.66 61.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.558 0.694 . . . . 73.150000000000006 111.154 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 161.9 44.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 44.340000000000003 112.359 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.8 p -80.32 115.91 58.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 64.329999999999998 111.157 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 177.91 5.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 54.25 112.356 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 p -97.81 102.69 14.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.597 0.713 . . . . 64.209999999999994 111.11 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -173.85 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.643 2.229 . . . . 65.219999999999999 112.327 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -88.07 123.97 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 62.020000000000003 110.871 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.55 163.56 2.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 72.109999999999999 111.063 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -160.47 177.43 10.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 111.09 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.99 -134.66 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 73.140000000000001 112.51 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.571 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -154.71 154.57 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 73.319999999999993 110.836 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.574 ' CD1' ' HB3' ' A' ' 98' ' ' SER . 7.6 m-90 -146.7 105.24 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 63.119999999999997 110.929 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.428 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -72.28 105.34 4.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 53.43 110.867 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.519 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.2 m -158.77 153.62 21.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 63.130000000000003 111.098 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.76 120.27 7.08 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 50.25 112.371 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.0 119.37 14.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 75.239999999999995 110.904 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 85.3 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.725 2.283 . . . . 62.100000000000001 112.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.42 -22.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 70.439999999999998 112.457 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 21' ' ' SER . 24.4 t -65.81 164.13 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 62.039999999999999 111.123 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.582 ' N ' HG12 ' A' ' 20' ' ' VAL . 5.4 m -54.0 103.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 62.020000000000003 110.88 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 21' ' ' SER . 34.8 m-20 -34.06 -65.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 110.876 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . 35.2 m-20 -36.21 -41.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.895 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -62.62 -46.91 86.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 64.209999999999994 110.911 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.794 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.1 OUTLIER -70.27 -33.54 71.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.299999999999997 110.93 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 m -56.6 -35.0 67.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 32.420000000000002 111.145 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.9 -26.63 67.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 73.099999999999994 112.509 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -63.46 -43.2 98.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 73.109999999999999 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 57' ' ' HIS . 24.9 mt -62.38 -51.63 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.010000000000005 111.102 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -54.07 -45.41 71.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -68.95 -58.07 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 110.895 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.894 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -49.94 -47.03 52.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 75.310000000000002 111.127 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -50.77 -17.43 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 54.25 110.863 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -88.0 13.58 10.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 52.340000000000003 110.897 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.03 -46.06 6.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 72.0 110.918 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 136.53 -55.57 0.7 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.714 -0.755 . . . . 55.32 112.457 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.3 pt -88.13 4.1 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 60.100000000000001 111.135 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.894 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 1.9 m-20 -80.6 -58.98 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 75.510000000000005 110.857 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -75.37 127.31 32.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 75.25 110.874 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.17 -73.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 40.409999999999997 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.602 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.8 3.61 2.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.686 2.257 . . . . 62.450000000000003 112.336 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 38' ' ' ASP . 12.7 pt -83.1 17.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 54.240000000000002 111.08 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.52 135.54 53.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 64.420000000000002 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 176.56 6.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.695 2.263 . . . . 71.0 112.381 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.95 -35.43 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 71.439999999999998 112.466 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.1 -25.86 9.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 53.340000000000003 112.471 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.78 -68.14 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 63.240000000000002 111.108 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.09 -8.96 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.219999999999999 110.866 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -37.49 -48.44 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.519999999999996 110.842 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.32 126.97 37.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 74.519999999999996 110.858 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.72 148.26 86.26 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 -1.789 . . . . 61.439999999999998 112.335 -0.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 41.2 t30 -103.14 150.63 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 53.030000000000001 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.4 ' CB ' ' HE2' ' A' ' 55' ' ' LYS . 27.9 p -106.46 163.82 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 71.319999999999993 111.119 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.8 -56.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 53.509999999999998 111.122 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.609 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.49 16.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.864 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -51.24 -47.89 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.0 111.127 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.724 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.2 m80 -45.34 -58.97 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 110.84 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.696 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -51.46 -38.81 55.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.096 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 56' ' ' ALA . . . -55.89 -40.42 72.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.200000000000003 111.111 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.602 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 9.4 t80 -68.13 -63.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.040000000000006 110.923 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.881 HG11 ' OD1' ' A' ' 38' ' ' ASP . 7.4 p -55.12 -33.56 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 73.129999999999995 111.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.686 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 mmt -46.13 -29.66 1.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 110.885 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.37 -65.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 64.310000000000002 110.858 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.569 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.87 -51.03 62.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 62.530000000000001 110.901 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.561 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.8 t80 -44.64 -43.71 8.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 74.030000000000001 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 3.7 t80 -64.08 -30.71 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.936 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 99' ' ' GLY . 24.1 mt-30 -98.21 -2.33 39.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 74.329999999999998 110.928 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -72.99 -48.18 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 75.109999999999999 110.85 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.937 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -68.82 -57.06 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 111.136 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.7 24.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 74.109999999999999 112.482 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 52.0 35.61 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 70.230000000000004 110.839 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -103.14 166.3 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 35.399999999999999 110.846 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -71.3 -23.24 61.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 65.530000000000001 110.81 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.44 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -79.29 0.26 29.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.468 . . . . 74.340000000000003 110.936 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.937 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -23.19 59.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.299999999999997 110.891 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -84.11 102.11 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 61.009999999999998 110.846 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -118.08 8.44 12.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.828 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.696 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -59.46 -70.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.876 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.75 177.98 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.129999999999995 110.803 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -65.33 -2.35 3.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 71.400000000000006 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.794 HG21 ' CD1' ' A' ' 25' ' ' LEU . 29.0 p -97.96 -46.46 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 111.17 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.67 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.66 25.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 111.077 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 t -86.56 -177.6 6.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 74.519999999999996 111.18 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 12' ' ' SER . 16.7 mt -66.89 106.9 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 53.130000000000003 110.915 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.2 t -77.98 167.55 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 64.099999999999994 111.152 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 17.2 m-20 -53.27 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.65 173.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 73.400000000000006 111.099 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 21.5 t-20 -52.0 106.0 0.6 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.647 0.737 . . . . 54.520000000000003 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.2 Cg_endo -69.74 -23.03 31.33 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.272 . . . . 70.299999999999997 112.298 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.1 t -52.0 106.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 71.219999999999999 110.832 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -80.03 -15.3 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 73.129999999999995 110.917 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.01 -124.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 74.329999999999998 112.474 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -37.86 -43.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 73.450000000000003 111.088 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 62.219999999999999 110.852 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.84 133.83 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 110.907 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.546 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 23.8 m-85 -92.71 146.48 32.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.678 0.751 . . . . 74.5 110.869 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 117.13 4.89 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.674 2.249 . . . . 70.129999999999995 112.345 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 91.9 p -102.6 -1.36 30.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 63.299999999999997 110.87 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' NE2' ' A' ' 67' ' ' GLN . . . 104.87 -88.04 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 43.020000000000003 112.509 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -77.47 124.11 27.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 70.120000000000005 110.895 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 43.420000000000002 110.894 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.897 0.38 . . . . 64.030000000000001 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.9 p -118.0 143.5 32.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 75.209999999999994 111.175 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.249 . . . . 73.409999999999997 112.343 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p -103.26 145.11 29.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.699 . . . . 72.420000000000002 111.148 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -175.5 1.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.234 . . . . 73.329999999999998 112.353 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 p -90.64 119.75 68.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.693 . . . . 74.219999999999999 111.176 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -173.05 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 71.5 112.333 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.31 124.93 19.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 110.884 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.67 160.25 31.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.530000000000001 111.123 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.85 168.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 73.010000000000005 111.153 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.45 36.65 1.29 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 64.010000000000005 112.544 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.665 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 58.8 m -159.79 152.05 20.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 71.5 110.836 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.665 ' CE3' ' C ' ' A' ' 12' ' ' SER . 9.2 m-90 -152.8 123.19 7.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.299999999999997 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.48 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -90.7 111.72 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.120000000000005 110.886 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.488 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.2 m -160.09 154.89 20.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.450000000000003 111.133 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HD3' ' HE1' ' A' ' 62' ' ' MET . 53.5 Cg_endo -69.75 125.59 12.33 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.717 2.278 . . . . 63.32 112.35 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 110.13 1.73 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.512 0.672 . . . . 71.299999999999997 110.882 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 97.58 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 74.310000000000002 112.29 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.83 -33.73 2.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 54.229999999999997 112.483 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 21' ' ' SER . 2.8 p -58.98 178.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 64.040000000000006 111.136 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.775 ' H ' HG22 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -52.0 128.46 24.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.838 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 24' ' ' GLN . 72.9 m-20 -58.26 -67.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.854 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' HA ' HG22 ' A' ' 26' ' ' THR . 1.1 m-20 -41.81 -23.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 70.510000000000005 110.834 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 22' ' ' ASP . 1.0 OUTLIER -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 53.450000000000003 110.904 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.654 HD11 ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -70.89 -56.67 5.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.898 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 23' ' ' ASP . 12.0 t -44.9 -20.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 70.310000000000002 111.108 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 25' ' ' LEU . . . -69.15 -37.93 82.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 73.200000000000003 112.48 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.88 -56.24 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.782 0.325 . . . . 74.510000000000005 110.916 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 57' ' ' HIS . 23.4 mt -46.44 -41.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 62.109999999999999 111.128 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -56.66 -48.08 78.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.13 -56.18 5.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 62.539999999999999 110.967 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.878 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -51.05 -43.47 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 75.219999999999999 111.099 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 37.4 t -52.75 -15.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.510000000000005 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.32 15.87 16.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 60.020000000000003 110.886 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.98 -48.04 5.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 73.230000000000004 110.922 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.73 -64.14 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.748 . . . . 34.200000000000003 112.486 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.115 HD12 HD12 ' A' ' 64' ' ' LEU . 3.4 pt -82.3 14.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 71.349999999999994 111.121 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.878 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 3.2 m-20 -89.5 -65.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 73.519999999999996 110.846 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.4 m -76.08 124.49 27.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.858 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.45 -74.58 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 71.239999999999995 112.499 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD2' ' C ' ' A' ' 39' ' ' CYS . 53.5 Cg_endo -69.78 5.73 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 62.25 112.322 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 38' ' ' ASP . 5.1 pt -85.23 17.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 70.019999999999996 111.105 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -76.69 135.49 68.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.722 . . . . 75.409999999999997 110.93 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 170.66 16.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.625 2.216 . . . . 74.099999999999994 112.318 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.78 -38.83 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 71.329999999999998 112.444 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.57 -26.16 4.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 45.299999999999997 112.434 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.83 -68.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 63.420000000000002 111.093 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.96 14.43 14.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 44.100000000000001 110.897 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 3.1 t80 -56.48 -50.9 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.899 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -97.52 128.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.699 0.762 . . . . 72.430000000000007 110.853 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 150.84 90.87 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.68 -1.8 . . . . 74.540000000000006 112.37 -0.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.553 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 16.2 t-20 -99.74 131.62 45.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.329999999999998 110.86 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.545 ' HB ' ' HZ3' ' A' ' 55' ' ' LYS . 65.7 p -90.9 167.31 12.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 52.119999999999997 111.193 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.2 -59.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 71.400000000000006 111.141 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.49 17.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 110.929 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -48.55 -41.12 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.400000000000006 111.043 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.596 ' CD2' HD12 ' A' ' 42' ' ' ILE . 47.2 m80 -54.76 -55.26 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 74.140000000000001 110.874 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.497 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -50.57 -41.93 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 34.399999999999999 111.106 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' HE3' ' A' ' 62' ' ' MET . . . -57.43 -40.23 77.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 111.101 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 6.3 t80 -68.92 -57.0 6.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 73.329999999999998 110.972 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.513 HG21 ' OD1' ' A' ' 38' ' ' ASP . 3.3 p -54.39 -43.79 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 72.319999999999993 111.134 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.563 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 2.8 ttm -45.76 -29.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 75.400000000000006 110.863 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.502 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 32.8 t30 -59.3 -62.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.540000000000006 110.855 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.115 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.58 -46.22 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 73.319999999999993 110.93 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.469 ' HB2' HG22 ' A' ' 61' ' ' VAL . 3.4 t80 -47.43 -54.59 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 72.329999999999998 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.599 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.0 t80 -55.59 -30.55 61.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 74.120000000000005 110.905 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 49.4 mt-30 -95.41 -4.51 45.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 73.409999999999997 110.895 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.706 ' CD2' ' C ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -68.4 -44.14 75.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 54.399999999999999 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.978 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.42 -60.23 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 111.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.82 23.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 32.509999999999998 112.475 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.563 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.02 37.24 20.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.0 110.858 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.599 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 2.4 m-80 -100.97 164.76 11.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.230000000000004 110.913 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 p -68.38 -25.57 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 110.825 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -79.55 1.78 24.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 71.319999999999993 110.951 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.978 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -79.92 -3.93 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 43.420000000000002 110.868 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -101.57 102.01 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 44.039999999999999 110.888 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -117.96 9.54 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.904 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.638 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.6 m-30 -58.33 -70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.929 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.78 178.01 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 61.100000000000001 110.868 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -3.07 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 74.420000000000002 110.937 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 25' ' ' LEU . 26.5 p -97.95 -49.01 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 44.340000000000003 111.146 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.73 25.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.139 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -86.3 -178.5 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 71.430000000000007 111.16 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 12' ' ' SER . 2.9 mm? -66.91 130.89 44.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 63.539999999999999 110.899 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.05 167.85 9.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 73.019999999999996 111.149 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.9 m-20 -53.71 -168.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 71.310000000000002 110.878 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -44.53 171.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 111.163 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.557 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 13.6 t-20 -51.95 105.94 0.59 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.329999999999998 110.878 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.79 -1.27 8.21 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 72.439999999999998 112.347 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.456 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 4.9 t -51.98 110.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.450000000000003 110.874 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -86.98 -18.06 31.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 64.230000000000004 110.918 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.44 -120.72 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 64.430000000000007 112.452 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.98 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.349999999999994 110.854 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.03 140.32 33.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 110.891 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.5 m-85 -92.11 146.03 31.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 74.430000000000007 110.865 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 122.83 9.49 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 74.200000000000003 112.37 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 25.7 p -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 74.420000000000002 110.866 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 -57.0 2.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 50.530000000000001 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 t -88.99 176.17 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 53.210000000000001 110.86 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 65.030000000000001 110.885 -179.974 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.9 0.381 . . . . 54.329999999999998 111.048 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.673 HG23 ' HD2' ' A' ' 3' ' ' PRO . 95.6 m -68.39 139.03 91.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.565 0.698 . . . . 74.310000000000002 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HD2' HG23 ' A' ' 2' ' ' THR . 54.0 Cg_endo -69.73 -177.28 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 53.340000000000003 112.376 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.6 p -53.93 129.54 57.05 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.624 0.726 . . . . 75.209999999999994 111.112 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -179.45 2.94 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.647 2.231 . . . . 73.420000000000002 112.326 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 p -53.92 156.07 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 74.230000000000004 111.149 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -174.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.687 2.258 . . . . 73.420000000000002 112.324 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 121.0 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 52.149999999999999 110.902 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.23 171.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.430000000000007 111.109 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 125.46 23.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 111.129 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -41.12 121.37 2.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 70.010000000000005 112.539 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.651 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 2.7 m -157.92 129.68 6.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 73.400000000000006 110.874 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.651 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 6.4 m-90 -141.07 114.14 8.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 63.409999999999997 110.916 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.0 110.67 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 74.200000000000003 110.861 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.51 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 m -159.59 154.34 21.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.626 0.727 . . . . 75.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 54.1 Cg_endo -69.8 123.28 9.94 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 63.119999999999997 112.326 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.98 114.3 5.18 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 74.420000000000002 110.871 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 92.37 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.715 2.277 . . . . 72.140000000000001 112.37 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.74 -24.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 52.200000000000003 112.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.636 ' HB ' HD21 ' A' ' 25' ' ' LEU . 44.3 t -59.05 165.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 64.340000000000003 111.142 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.632 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.2 m -52.08 108.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.450000000000003 110.877 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 21' ' ' SER . 5.5 m-20 -32.99 -65.27 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.140000000000001 110.853 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.02 -40.68 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.905 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -60.26 -49.17 78.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 73.25 110.907 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.22 -29.04 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 61.520000000000003 110.945 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.778 ' OG1' HG11 ' A' ' 54' ' ' VAL . 17.3 m -67.11 0.07 2.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 73.519999999999996 111.166 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.92 -40.34 5.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 65.129999999999995 112.506 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.3 p30 -50.47 -44.3 55.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.367 . . . . 74.25 110.883 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 55' ' ' LYS . 61.6 mt -58.21 -49.05 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 74.049999999999997 111.142 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.19 -41.07 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.9 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.15 -52.68 11.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 110.967 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 38' ' ' ASP . . . -52.82 -41.6 64.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 70.299999999999997 111.099 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.42 -9.69 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 60.509999999999998 110.9 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.19 3.89 40.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.019999999999996 110.848 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.18 -36.48 6.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 110.923 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 -31.18 7.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 34.130000000000003 112.506 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.728 ' CD1' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -83.22 -11.41 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 74.430000000000007 111.168 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.726 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.65 -63.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.876 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 62.9 m -75.83 129.57 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 41.210000000000001 110.834 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.7 -85.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 54.310000000000002 112.51 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 7.02 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.242 . . . . 74.340000000000003 112.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.697 HD12 ' CG ' ' A' ' 57' ' ' HIS . 5.1 pt -82.62 17.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.540000000000006 111.16 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -79.53 132.85 60.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.601 0.715 . . . . 64.430000000000007 110.916 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 171.52 14.33 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.686 2.258 . . . . 61.530000000000001 112.323 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 63.130000000000003 112.492 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.36 -25.72 3.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.349999999999994 112.449 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.41 -68.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 61.039999999999999 111.12 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.95 14.88 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 51.420000000000002 110.907 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.591 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 2.9 t80 -51.66 -56.55 13.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 71.109999999999999 110.847 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.591 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 1.3 mm-40 -96.41 133.18 25.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 65.450000000000003 110.879 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 157.04 92.57 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.705 -1.79 . . . . 65.299999999999997 112.33 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -117.24 142.22 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 60.149999999999999 110.912 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.0 p -106.84 172.82 6.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 111.118 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.778 HG11 ' OG1' ' A' ' 26' ' ' THR . 43.9 t -65.73 -54.73 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 71.430000000000007 111.153 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -79.7 17.23 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.893 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.3 -45.44 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.340000000000003 111.115 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.697 ' CG ' HD12 ' A' ' 42' ' ' ILE . 32.9 m170 -53.79 -60.18 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 71.549999999999997 110.843 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.497 ' C ' ' HE2' ' A' ' 62' ' ' MET . . . -43.97 -47.21 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 44.310000000000002 111.1 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.35 49.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 75.140000000000001 111.134 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 8.9 t80 -69.33 -65.01 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.947 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.664 HG23 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -54.42 -26.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 75.019999999999996 111.127 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.723 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 1.5 mtm -52.26 -20.38 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.889 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.07 -65.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 61.340000000000003 110.877 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.728 HD12 ' CD1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -63.74 -41.77 97.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.908 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 3.4 t80 -58.51 -45.11 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.916 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 4.6 t80 -65.21 -30.43 71.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.409999999999997 110.926 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -96.21 -3.71 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 71.010000000000005 110.949 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -45.74 74.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 71.530000000000001 110.83 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.686 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -75.82 -57.75 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.071 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.11 25.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 71.299999999999997 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.04 47.09 25.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 72.010000000000005 110.897 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.6 m-80 -110.27 165.6 11.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.230000000000004 110.886 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.694 ' HB2' HD11 ' A' ' 84' ' ' LEU . 30.4 p -70.74 -25.84 63.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 110.841 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -77.74 0.3 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.946 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.686 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -77.54 -14.42 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 75.530000000000001 110.886 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -91.39 102.03 14.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.864 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.06 7.75 12.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.43 110.877 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.3 m-30 -59.03 -70.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 70.150000000000006 110.853 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.85 178.03 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 75.540000000000006 110.884 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -1.84 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 110.908 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.889 HG21 ' CD1' ' A' ' 25' ' ' LEU . 37.3 p -95.0 -50.33 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 111.147 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.723 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -80.66 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 71.400000000000006 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -87.01 -179.52 6.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 111.148 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.694 HD11 ' HB2' ' A' ' 73' ' ' SER . 2.5 mt -67.36 131.51 45.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 64.209999999999994 110.938 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.08 168.43 9.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 73.540000000000006 111.129 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.25 -169.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 55.409999999999997 110.867 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -44.22 172.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 74.329999999999998 111.127 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.4 t-20 -52.01 106.78 0.7 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 74.109999999999999 110.89 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.547 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.7 -4.03 13.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.678 2.252 . . . . 74.150000000000006 112.34 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 2.5 t -51.98 110.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 54.229999999999997 110.838 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -15.69 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 72.329999999999998 110.921 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.89 -128.92 1.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 62.100000000000001 112.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.59 65.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 74.519999999999996 111.142 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.49 101.98 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 53.219999999999999 110.902 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -99.75 141.29 32.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 75.450000000000003 110.939 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.547 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 15.9 m-85 -93.14 147.76 34.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 75.299999999999997 110.896 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.4 4.08 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 72.239999999999995 112.289 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.47 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 27.9 p -95.08 -6.8 41.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 75.310000000000002 110.878 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.39 -83.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.757 . . . . 71.430000000000007 112.488 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.59 120.76 34.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 73.129999999999995 110.853 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 74.219999999999999 110.827 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 41.229999999999997 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.2 p -116.12 145.88 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.641 0.734 . . . . 53.43 111.099 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.09 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 75.129999999999995 112.318 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 p -95.96 144.22 27.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.711 . . . . 54.25 111.138 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -166.38 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.728 2.285 . . . . 74.030000000000001 112.357 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -74.46 141.97 77.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.611 0.72 . . . . 61.100000000000001 111.118 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.81 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.726 2.284 . . . . 60.140000000000001 112.343 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 124.19 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.85 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.58 42.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 111.079 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.32 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 65.319999999999993 111.139 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.36 8.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 64.230000000000004 112.515 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.662 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 70.8 m -150.32 161.52 42.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 75.219999999999999 110.825 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.662 ' CE3' ' C ' ' A' ' 12' ' ' SER . 7.2 m-90 -152.94 107.06 3.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.956 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -72.87 105.59 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 65.230000000000004 110.853 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.556 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.8 m -158.88 154.82 23.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.647 0.736 . . . . 73.209999999999994 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.78 118.43 5.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 72.140000000000001 112.329 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.98 110.16 1.74 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.714 . . . . 71.420000000000002 110.89 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 79.65 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.705 2.27 . . . . 42.439999999999998 112.356 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 159.41 58.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 41.009999999999998 112.484 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.839 ' CG2' HD11 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -158.26 177.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 60.310000000000002 111.105 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 2.4 m -51.97 116.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 52.32 110.878 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -40.94 -66.22 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 110.887 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.33 -27.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.824 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' SER . 21.8 tt0 -63.54 -52.45 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 110.908 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.839 HD11 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -71.65 -51.14 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 64.109999999999999 110.903 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.597 ' OG1' HG11 ' A' ' 54' ' ' VAL . 25.7 m -45.5 -43.86 12.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 72.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.4 -30.49 2.05 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 72.239999999999995 112.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -64.37 -66.68 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 110.876 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 57' ' ' HIS . 37.1 mt -38.21 -49.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.178 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.442 ' OD1' ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -52.14 -44.84 64.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.030000000000001 110.873 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -74.05 -54.6 7.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 110.937 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -51.57 -38.89 56.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 44.009999999999998 111.088 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -12.66 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.299999999999997 110.874 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -115.2 18.04 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 110.844 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 1.8 mm100 -93.02 -52.02 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.918 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 161.72 -91.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 65.129999999999995 112.482 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.451 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.55 17.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 53.009999999999998 111.132 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -85.41 -60.68 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 71.150000000000006 110.869 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.88 110.06 8.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 63.520000000000003 110.924 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.65 -70.99 0.46 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 63.420000000000002 112.486 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.558 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.75 8.1 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.691 2.26 . . . . 71.099999999999994 112.309 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.682 HD12 ' CD2' ' A' ' 57' ' ' HIS . 20.2 pt -82.32 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 64.150000000000006 111.142 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -82.85 122.56 78.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 65.329999999999998 110.926 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 168.53 21.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 71.430000000000007 112.303 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.56 -35.45 1.08 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 44.340000000000003 112.503 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.57 -19.42 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 42.420000000000002 112.519 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 -68.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 74.209999999999994 111.089 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -117.98 12.75 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 75.209999999999994 110.914 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.524 ' CE1' ' CB ' ' A' ' 52' ' ' ASN . 2.1 t80 -56.97 -47.37 80.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 110.863 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.57 129.12 33.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.652 0.739 . . . . 74.239999999999995 110.909 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.76 150.54 90.33 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 -1.8 . . . . 61.299999999999997 112.367 0.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.524 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -114.5 118.2 33.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.010000000000005 110.936 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.82 170.18 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 72.409999999999997 111.156 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.597 HG11 ' OG1' ' A' ' 26' ' ' THR . 50.3 t -64.4 -52.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.230000000000004 111.134 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.527 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.73 13.63 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 65.310000000000002 110.873 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.99 -43.06 60.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.349999999999994 111.098 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.682 ' CD2' HD12 ' A' ' 42' ' ' ILE . 61.8 m80 -55.2 -46.97 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 72.319999999999993 110.834 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.592 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -59.67 -37.53 79.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 52.310000000000002 111.098 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.34 80.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 54.340000000000003 111.12 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.558 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -68.74 -61.19 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 74.120000000000005 110.915 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -54.79 -45.36 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 75.109999999999999 111.145 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -46.07 -21.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 65.310000000000002 110.876 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HB3' HD23 ' A' ' 64' ' ' LEU . 10.9 t30 -69.41 -59.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.510000000000005 110.906 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -76.74 -47.18 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 72.120000000000005 110.938 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t80 -46.52 -40.11 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.929 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 6.3 t80 -60.47 -31.07 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 110.956 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -96.3 -4.32 42.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 72.109999999999999 110.888 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -50.4 45.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 110.863 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.812 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -68.01 -57.84 5.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 22.350000000000001 111.09 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.14 25.09 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 73.450000000000003 112.501 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.01 35.82 17.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 70.439999999999998 110.888 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.476 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.2 m-80 -102.84 169.69 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.9 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.562 ' HB2' HD11 ' A' ' 84' ' ' LEU . 56.5 p -71.72 -22.49 61.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 61.329999999999998 110.83 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.66 0.82 32.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 74.109999999999999 110.892 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.812 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -10.28 59.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 65.230000000000004 110.906 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HE1' ' A' ' 62' ' ' MET . 0.5 OUTLIER -90.66 103.33 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.049999999999997 110.917 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -118.03 2.23 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.879 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.592 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 2.8 m-85 -58.94 -71.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 110.924 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.35 177.97 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 110.895 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -65.41 -2.48 3.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.540000000000006 110.922 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.1 p -98.02 -48.43 5.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 61.219999999999999 111.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -80.42 23.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 111.137 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -84.98 -176.69 6.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.209 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 73' ' ' SER . 2.0 mt -66.21 107.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 64.219999999999999 110.901 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -78.14 168.97 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 111.147 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' THR . 75.3 m-20 -53.54 -168.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 110.907 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 10.2 t -44.46 171.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 55.210000000000001 111.145 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.01 106.27 0.63 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.636 0.732 . . . . 73.239999999999995 110.872 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.72 -1.6 8.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.701 2.268 . . . . 75.040000000000006 112.385 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -52.01 108.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.901 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.579 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 4.1 p90 -82.82 -18.14 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 62.140000000000001 110.914 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 -114.48 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 65.209999999999994 112.5 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -36.92 85.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 73.349999999999994 111.049 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.579 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -79.41 101.98 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.91 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -100.08 147.82 25.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 62.329999999999998 110.908 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -93.1 156.41 40.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 75.340000000000003 110.904 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 125.95 12.69 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.262 . . . . 74.109999999999999 112.291 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.483 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 1.2 p -117.57 5.24 12.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.510000000000005 110.843 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.88 -142.68 25.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 71.109999999999999 112.53 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 m -81.56 113.71 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 70.430000000000007 110.866 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 73.239999999999995 110.905 -179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.589 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.847 0.356 . . . . 54.030000000000001 110.876 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CE3' ' C ' ' A' ' 12' ' ' SER . 2.5 m-90 -138.08 120.86 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 72.420000000000002 110.93 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.81 102.09 14.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 63.009999999999998 110.871 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.99 152.43 26.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 71.209999999999994 111.166 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.74 127.78 15.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.664 2.243 . . . . 71.129999999999995 112.329 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -52.02 118.23 11.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 73.129999999999995 110.911 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 73.299999999999997 112.312 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.28 -25.61 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.748 . . . . 74.319999999999993 112.461 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.766 ' HB ' HD11 ' A' ' 25' ' ' LEU . 13.2 t -59.1 166.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 74.109999999999999 111.104 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.836 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.3 m -56.44 113.19 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.811 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 21' ' ' SER . 24.3 m-20 -36.57 -59.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 65.439999999999998 110.898 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -36.43 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.030000000000001 110.891 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -63.72 -48.51 76.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.458 . . . . 65.200000000000003 110.899 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -70.98 -30.46 66.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.430000000000007 110.877 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.52 ' OG1' HG11 ' A' ' 54' ' ' VAL . 9.8 m -55.8 -30.24 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 60.25 111.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.13 58.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 62.109999999999999 112.532 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 4.6 m-20 -64.14 -68.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.328 . . . . 73.319999999999993 110.901 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 84.9 mt -43.82 -43.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.117 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -46.99 83.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.409999999999997 110.886 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 1.2 t80 -73.95 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 61.130000000000003 110.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.92 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -51.15 -43.19 61.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 65.519999999999996 111.097 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 35.5 t -53.37 -14.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 64.209999999999994 110.939 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.87 14.5 19.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 63.420000000000002 110.901 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -46.48 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 71.230000000000004 110.94 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.65 -62.41 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 34.340000000000003 112.493 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -82.32 5.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 73.209999999999994 111.159 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.92 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 6.0 m-20 -82.86 -63.81 1.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 53.140000000000001 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.45 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.11 126.19 30.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.901 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.85 -70.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 62.219999999999999 112.471 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.616 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.82 4.85 1.98 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.694 2.263 . . . . 62.119999999999997 112.319 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.772 HD12 ' CG ' ' A' ' 57' ' ' HIS . 27.3 pt -83.35 18.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 63.439999999999998 111.113 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -74.12 129.28 84.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 73.230000000000004 110.92 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 161.24 46.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 72.099999999999994 112.352 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.87 -35.33 2.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 63.009999999999998 112.435 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.13 -26.1 5.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 75.450000000000003 112.487 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.1 -68.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 73.129999999999995 111.12 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' A' ' 49' ' ' PHE . 28.8 m -118.07 -4.36 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.450000000000003 110.866 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.7 t80 -34.28 -54.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.33 124.76 41.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 71.150000000000006 110.909 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.15 88.13 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 -1.811 . . . . 70.140000000000001 112.345 0.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.43 ' CA ' ' O ' ' A' ' 49' ' ' PHE . 13.7 p-10 -106.03 127.08 52.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.319999999999993 110.882 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 59.1 p -83.5 166.8 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 54.399999999999999 111.16 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.52 HG11 ' OG1' ' A' ' 26' ' ' THR . 41.0 t -65.8 -57.84 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 111.123 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -78.97 13.94 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 45.119999999999997 110.923 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -51.3 -48.42 62.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.230000000000004 111.084 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.772 ' CG ' HD12 ' A' ' 42' ' ' ILE . 34.7 m170 -50.33 -50.41 51.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 73.310000000000002 110.828 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.711 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -56.66 -37.55 70.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.219999999999999 111.106 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.34 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 71.150000000000006 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 6.8 t80 -68.27 -63.11 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 70.129999999999995 110.951 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 65' ' ' TYR . 2.6 p -54.82 -33.39 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 111.147 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.46 ' HE3' ' CD1' ' A' ' 78' ' ' PHE . 1.5 mmt -45.54 -24.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 65.299999999999997 110.862 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -68.87 -58.15 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 63.109999999999999 110.905 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.673 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -74.86 -50.73 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 61.409999999999997 110.933 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.658 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.4 t80 -46.3 -50.02 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.030000000000001 110.936 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.553 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 31.4 t80 -53.53 -36.78 62.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 73.219999999999999 110.939 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -94.09 -2.68 52.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.5 110.91 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.55 -42.62 58.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.150000000000006 110.879 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.988 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.48 -60.9 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 51.399999999999999 111.098 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.02 19.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 41.240000000000002 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.98 32.08 9.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 70.040000000000006 110.866 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.553 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 1.9 m-80 -104.75 166.38 10.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 45.130000000000003 110.857 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.575 ' HB3' HD21 ' A' ' 84' ' ' LEU . 57.8 p -68.06 -23.15 64.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 60.329999999999998 110.852 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.13 2.23 28.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.439999999999998 110.914 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.988 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -13.45 61.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 55.299999999999997 110.911 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.73 101.98 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 8.6 m-20 -118.0 7.63 12.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.868 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.3 m-30 -59.08 -68.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.040000000000006 110.907 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.91 178.04 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 63.350000000000001 110.87 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -1.94 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.833 HG21 ' CD1' ' A' ' 25' ' ' LEU . 72.2 p -93.17 -52.52 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 111.132 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -82.43 102.01 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 70.230000000000004 111.132 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -148.94 178.06 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 111.117 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 73' ' ' SER . 6.2 mp -66.32 126.75 29.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 65.230000000000004 110.947 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -106.38 169.36 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 62.140000000000001 111.121 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' THR . 33.4 m-80 -54.06 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 61.130000000000003 110.921 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -45.13 175.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 65.319999999999993 111.185 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 5.8 t-20 -51.97 105.96 0.59 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.626 0.727 . . . . 71.010000000000005 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.4 Cg_endo -69.79 -16.44 37.42 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.254 . . . . 65.310000000000002 112.31 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 29.8 t -51.97 110.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 64.349999999999994 110.848 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -77.2 -15.71 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.932 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 168.65 -122.43 1.02 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.748 -0.739 . . . . 41.109999999999999 112.501 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -40.09 -42.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 52.420000000000002 111.045 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.64 102.26 7.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 62.520000000000003 110.859 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.0 130.85 45.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 75.120000000000005 110.921 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 20.8 m-85 -83.93 144.38 44.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.659 0.742 . . . . 70.010000000000005 110.886 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 120.34 7.14 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.236 . . . . 61.200000000000003 112.369 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 52.6 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 62.009999999999998 110.828 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.63 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.854 0.359 . . . . 41.219999999999999 110.852 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.63 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 1.6 m-90 -134.29 111.69 10.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.118 -0.492 . . . . 64.349999999999994 110.93 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -82.42 101.99 11.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.86 152.42 26.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 72.329999999999998 111.124 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.74 129.17 17.15 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 75.540000000000006 112.355 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 115.93 7.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 74.340000000000003 110.883 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 84.49 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 41.130000000000003 112.371 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.74 -25.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.745 -0.741 . . . . 61.329999999999998 112.457 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.8 t -59.1 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.073 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.696 ' O ' HD22 ' A' ' 25' ' ' LEU . 14.8 m -52.06 109.2 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.099999999999994 110.836 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 21' ' ' SER . 42.8 m-20 -33.87 -64.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 63.25 110.878 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.34 -40.53 2.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.883 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.9 tp60 -58.13 -51.38 69.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 43.329999999999998 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.794 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -71.68 -27.04 62.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.877 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.809 ' OG1' HG11 ' A' ' 54' ' ' VAL . 11.0 m -62.89 -6.88 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 60.119999999999997 111.14 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -25.8 45.21 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 61.399999999999999 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.39 -67.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 63.43 110.879 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 80.7 mt -39.21 -44.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 72.150000000000006 111.112 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.52 -47.6 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.53 -58.12 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 110.889 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.89 -41.16 61.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 13.3 t -56.84 -9.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 65.409999999999997 110.851 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.05 18.0 19.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.453 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 4.9 mm100 -94.46 -50.57 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 71.230000000000004 110.916 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.83 -81.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 72.310000000000002 112.446 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.76 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.3 pt -81.6 17.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 74.340000000000003 111.128 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -89.44 -61.13 1.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 74.0 110.872 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.454 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -74.47 124.58 26.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.409999999999997 110.892 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.19 -69.77 0.42 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 65.540000000000006 112.512 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.589 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.666 2.244 . . . . 74.109999999999999 112.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 38' ' ' ASP . 21.6 pt -82.53 17.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.099999999999994 111.117 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.75 138.65 62.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 75.230000000000004 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.74 145.9 58.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 61.140000000000001 112.336 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.3 -29.94 4.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 74.310000000000002 112.463 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.15 -13.1 7.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 54.450000000000003 112.536 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 -68.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 74.420000000000002 111.114 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 m -118.05 11.11 13.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.549999999999997 110.914 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 1.5 t80 -54.92 -57.39 11.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 75.310000000000002 110.909 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.588 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -100.53 127.09 33.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 73.430000000000007 110.887 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.73 153.92 93.04 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 -1.797 . . . . 64.340000000000003 112.367 -0.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -101.58 119.31 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.877 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 56.5 p -83.19 171.43 13.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 74.450000000000003 111.163 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.809 HG11 ' OG1' ' A' ' 26' ' ' THR . 69.1 t -65.84 -61.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 34.299999999999997 111.125 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.55 16.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 72.129999999999995 110.911 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -51.47 -47.5 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.106 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.642 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.8 m80 -50.15 -50.25 49.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.831 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.681 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.93 -33.14 68.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 51.030000000000001 111.109 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.14 86.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 111.083 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.589 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -68.32 -60.65 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.349999999999994 110.961 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -55.26 -34.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 71.120000000000005 111.152 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.574 ' HE2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -50.67 -29.99 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.846 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -65.38 -67.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.893 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.82 -53.35 41.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.908 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.76 ' HA ' HD11 ' A' ' 37' ' ' ILE . 3.3 t80 -46.94 -45.79 20.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.299999999999997 110.907 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 35.6 t80 -58.76 -26.41 63.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 72.400000000000006 110.9 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -103.29 -1.89 28.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 74.019999999999996 110.921 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -70.17 -42.19 72.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 73.010000000000005 110.852 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.638 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.63 -56.09 4.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 111.121 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.42 24.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 62.109999999999999 112.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 52.04 46.57 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 74.319999999999993 110.85 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -112.71 168.23 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 71.430000000000007 110.902 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.514 ' HA ' HD11 ' A' ' 84' ' ' LEU . 73.2 p -71.2 -24.59 62.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 50.43 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -78.87 1.35 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 74.430000000000007 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -22.47 59.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 110.888 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.407 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.3 m -82.31 102.0 10.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 110.906 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.0 8.81 12.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 70.209999999999994 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.681 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -58.54 -68.67 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.867 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -172.07 178.01 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 65.140000000000001 110.819 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -65.7 -1.52 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 72.540000000000006 110.939 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.583 HG21 ' CD1' ' A' ' 25' ' ' LEU . 64.9 p -92.91 -52.62 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 53.420000000000002 111.157 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.34 102.33 11.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.409999999999997 111.092 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 t -148.78 178.01 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 70.200000000000003 111.162 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -66.65 112.06 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 65.230000000000004 110.958 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -89.23 168.18 12.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 64.140000000000001 111.107 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' THR . 72.1 m-20 -54.39 -167.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.6 t -44.46 173.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 65.349999999999994 111.138 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.8 t-20 -52.11 106.92 0.72 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 65.329999999999998 110.86 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.73 -2.77 10.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 72.150000000000006 112.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.402 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 11.7 t -51.99 105.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.887 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -74.6 -16.39 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 73.049999999999997 110.931 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.08 -113.25 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 51.210000000000001 112.52 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.31 79.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 72.209999999999994 111.08 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 63.32 110.876 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -99.36 140.16 33.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.530000000000001 110.894 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.543 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.07 151.14 40.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 74.519999999999996 110.841 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.623 2.215 . . . . 62.32 112.371 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 6.0 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 73.340000000000003 110.842 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.819 0.342 . . . . 72.219999999999999 110.891 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.4 m-90 -125.98 116.52 21.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 74.040000000000006 110.926 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.92 106.24 18.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 70.420000000000002 110.859 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -155.4 152.43 24.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.585 0.707 . . . . 74.420000000000002 111.133 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 Cg_endo -69.75 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 73.340000000000003 112.336 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -51.97 113.55 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.601 0.715 . . . . 61.350000000000001 110.903 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' HZ3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.77 79.93 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.732 2.288 . . . . 73.420000000000002 112.325 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -26.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 71.430000000000007 112.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.811 ' HB ' HD11 ' A' ' 25' ' ' LEU . 3.3 t -58.96 167.73 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.239999999999995 111.131 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.763 ' O ' HD22 ' A' ' 25' ' ' LEU . 3.6 m -53.89 111.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 41.399999999999999 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 21' ' ' SER . 23.1 m-20 -34.96 -61.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.888 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.28 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.319999999999993 110.889 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.1 tp60 -60.34 -50.25 74.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.400000000000006 110.919 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.891 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.93 -23.78 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.530000000000001 110.88 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.418 HG23 ' CG1' ' A' ' 54' ' ' VAL . 3.1 m -66.35 0.08 2.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.109999999999999 111.134 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.43 -35.64 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 65.120000000000005 112.517 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 7.9 p30 -55.15 -45.37 75.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 74.010000000000005 110.916 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 55' ' ' LYS . 63.6 mt -59.24 -59.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 72.439999999999998 111.162 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -44.63 -40.0 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 71.319999999999993 110.93 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -73.94 -60.7 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.299999999999997 110.905 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -52.17 -26.46 11.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 60.229999999999997 111.083 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -70.59 1.65 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.887 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.15 9.39 32.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.851 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.03 -44.63 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 62.020000000000003 110.857 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.6 -51.95 0.84 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 74.349999999999994 112.482 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.654 HD12 HD12 ' A' ' 64' ' ' LEU . 2.5 pt -82.18 8.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 72.540000000000006 111.12 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.1 t70 -89.1 -60.71 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.230000000000004 110.886 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.62 119.01 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 63.350000000000001 110.857 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.22 -67.86 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 50.420000000000002 112.474 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -69.72 -1.05 7.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 55.25 112.377 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.699 HD12 ' CG ' ' A' ' 57' ' ' HIS . 17.4 pt -82.87 14.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 71.030000000000001 111.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -76.75 126.54 85.72 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.637 0.732 . . . . 73.019999999999996 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.67 10.61 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 72.540000000000006 112.337 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.29 -38.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.773 -0.727 . . . . 23.52 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.92 -34.36 2.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 75.319999999999993 112.465 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.06 -68.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 73.409999999999997 111.078 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.98 15.76 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 75.150000000000006 110.876 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 50' ' ' GLU . 2.5 t80 -51.85 -66.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.837 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.1 136.66 35.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.749 . . . . 65.310000000000002 110.853 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.73 146.13 81.25 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 -1.799 . . . . 73.099999999999994 112.385 -0.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 3.1 p30 -104.8 134.04 48.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 p -95.12 169.11 10.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 61.210000000000001 111.128 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' CG1' HG23 ' A' ' 26' ' ' THR . 59.4 t -65.18 -56.98 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 111.093 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -78.67 13.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 73.530000000000001 110.931 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -51.64 -46.96 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.209999999999994 111.104 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.699 ' CG ' HD12 ' A' ' 42' ' ' ILE . 38.9 m80 -50.46 -59.67 3.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 75.540000000000006 110.83 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.746 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -47.75 -38.01 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.106 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 56' ' ' ALA . . . -57.84 -42.06 83.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 65.230000000000004 111.062 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.604 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 2.7 t80 -67.31 -57.78 6.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 72.329999999999998 110.934 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 65' ' ' TYR . 3.6 p -55.22 -38.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 64.200000000000003 111.153 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.585 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 36.3 mtp -46.22 -25.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 54.520000000000003 110.91 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -66.41 -60.36 2.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 70.219999999999999 110.873 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.654 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -73.46 -45.69 52.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 55.100000000000001 110.936 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.65 ' HA ' HD11 ' A' ' 37' ' ' ILE . 2.4 t80 -51.4 -54.2 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 61.240000000000002 110.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 26.4 t80 -50.95 -36.15 37.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 110.924 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.49 -3.64 49.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 44.310000000000002 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.93 -42.56 60.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.83 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.003 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.2 -62.05 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.349999999999994 111.052 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.42 20.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 45.350000000000001 112.546 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.99 37.44 21.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 74.129999999999995 110.891 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -108.84 168.26 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 75.230000000000004 110.899 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.594 ' CB ' HD11 ' A' ' 84' ' ' LEU . 89.2 p -69.03 -24.93 64.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -80.22 1.17 29.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 71.030000000000001 110.922 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 1.003 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -26.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 70.239999999999995 110.9 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.5 m -82.47 102.04 11.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 63.409999999999997 110.9 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.03 14.24 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.149 -0.478 . . . . 55.329999999999998 110.873 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.746 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.3 m-30 -58.92 -67.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 110.908 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.64 178.02 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 110.834 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -64.88 -2.33 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.891 HG21 ' CD1' ' A' ' 25' ' ' LEU . 50.9 p -93.36 -51.77 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 65.310000000000002 111.135 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.11 104.82 12.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.099 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 t -154.82 178.01 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.164 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD11 ' CB ' ' A' ' 73' ' ' SER . 37.6 mt -67.29 127.7 33.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.9 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.6 t -106.3 167.58 9.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 72.530000000000001 111.12 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 87' ' ' THR . 50.2 m-80 -53.85 -168.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.913 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.85 172.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 74.340000000000003 111.153 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.08 106.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 71.219999999999999 110.862 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -1.09 7.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.010000000000005 112.34 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 14.9 t -51.97 108.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.430000000000007 110.861 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -75.12 -17.11 60.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 70.310000000000002 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.71 -111.38 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 75.200000000000003 112.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.93 85.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 72.219999999999999 111.114 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 102.09 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 63.100000000000001 110.899 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -98.82 151.65 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 110.864 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.1 m-85 -92.41 148.93 37.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.628 0.728 . . . . 71.120000000000005 110.854 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 124.43 11.06 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.665 2.243 . . . . 74.25 112.34 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.556 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 13.1 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 75.230000000000004 110.909 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.607 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 36.0 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.807 0.337 . . . . 73.5 110.844 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 4.6 m-90 -133.33 116.14 15.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 74.439999999999998 110.883 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -87.36 101.99 14.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 71.319999999999993 110.904 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.436 HG21 ' CE2' ' A' ' 96' ' ' PHE . 2.9 m -148.9 153.54 38.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 64.439999999999998 111.135 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.75 126.17 13.01 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.672 2.248 . . . . 73.299999999999997 112.336 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -51.98 107.07 0.74 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.576 0.703 . . . . 73.310000000000002 110.909 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 53.7 Cg_endo -69.74 79.81 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.717 2.278 . . . . 74.040000000000006 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 163.43 55.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 52.009999999999998 112.476 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 25' ' ' LEU . 1.2 m -158.59 177.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 72.329999999999998 111.108 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -52.01 119.05 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 63.450000000000003 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 52.0 m-20 -52.2 -37.02 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 44.109999999999999 110.877 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -20.53 55.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 70.420000000000002 110.845 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -77.79 -48.43 16.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 65.019999999999996 110.919 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.836 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.67 -53.03 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 70.420000000000002 110.924 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.569 HG23 ' N ' ' A' ' 27' ' ' GLY . 14.2 t -37.49 -47.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.310000000000002 111.135 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.569 ' N ' HG23 ' A' ' 26' ' ' THR . . . -46.4 -41.73 12.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 55.340000000000003 112.479 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -47.18 -69.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 72.439999999999998 110.866 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 70.1 mt -40.08 -57.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 75.329999999999998 111.139 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -46.12 -42.68 14.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.150000000000006 110.869 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 78' ' ' PHE . 4.6 t80 -73.86 -58.37 3.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 110.909 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -51.09 -24.78 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 70.430000000000007 111.101 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.08 2.27 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.140000000000001 110.859 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 5.73 37.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.409999999999997 110.818 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.04 -42.75 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.89 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.48 -46.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 44.210000000000001 112.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.1 pt -82.34 5.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 72.030000000000001 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.74 ' O ' HG23 ' A' ' 42' ' ' ILE . 16.4 t70 -89.36 -58.06 2.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 110.855 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.73 119.34 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.881 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.36 -70.84 0.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 74.129999999999995 112.465 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.5 Cg_endo -69.8 -0.84 7.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.655 2.236 . . . . 75.030000000000001 112.313 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.771 HD12 ' CG ' ' A' ' 57' ' ' HIS . 14.2 pt -83.08 17.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 54.530000000000001 111.13 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.93 137.97 69.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 64.109999999999999 110.876 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 173.92 10.3 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.221 . . . . 64.0 112.375 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.76 -35.35 1.07 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 41.409999999999997 112.462 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.13 -27.75 5.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 74.25 112.498 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 -68.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.824 0.345 . . . . 61.009999999999998 111.061 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.98 18.06 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.89 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.9 t80 -56.84 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.885 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -94.8 129.02 37.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 75.109999999999999 110.89 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.72 148.01 85.75 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.655 -1.81 . . . . 63.229999999999997 112.376 -0.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.39 142.27 34.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.897 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 19.8 p -92.39 167.32 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.109999999999999 111.163 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG11 ' HB ' ' A' ' 26' ' ' THR . 84.5 t -65.61 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 73.140000000000001 111.081 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.508 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.19 17.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.888 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.76 -42.84 58.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 111.076 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.771 ' CG ' HD12 ' A' ' 42' ' ' ILE . 41.3 m170 -54.49 -56.59 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.020000000000003 110.832 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -49.99 -36.57 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.109999999999999 111.099 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 35.43 111.068 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -67.86 -58.53 4.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 71.349999999999994 110.91 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 65' ' ' TYR . 3.5 p -55.06 -36.56 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 64.019999999999996 111.095 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.622 ' HE2' ' CZ ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER -46.7 -23.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.130000000000003 110.858 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -69.41 -62.35 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.120000000000005 110.896 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -70.8 -45.28 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 110.928 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.634 ' HA ' HD11 ' A' ' 37' ' ' ILE . 2.4 t80 -53.45 -50.82 64.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 110.953 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 58.2 t80 -53.02 -29.13 27.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 63.409999999999997 110.892 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -99.28 -4.02 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 73.420000000000002 110.933 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -71.51 -42.2 68.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.874 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.04 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.019999999999996 111.085 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 23.19 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 55.340000000000003 112.477 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.0 39.36 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 54.5 110.903 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.609 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 4.7 m-80 -110.94 171.94 7.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.883 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.53 ' HA ' HD11 ' A' ' 84' ' ' LEU . 79.4 p -71.86 -23.56 61.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 70.420000000000002 110.85 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.78 2.48 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 73.150000000000006 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.866 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -24.69 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 110.844 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.4 m -82.32 101.95 10.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 64.340000000000003 110.845 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -117.96 11.31 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.892 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.716 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.0 m-30 -58.47 -68.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 72.019999999999996 110.867 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.69 177.98 3.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 53.299999999999997 110.849 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.33 -1.96 2.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.493 . . . . 72.439999999999998 110.968 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 25' ' ' LEU . 61.1 p -92.53 -52.91 4.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.15 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.47 106.06 14.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 70.310000000000002 111.102 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.5 t -154.7 178.02 10.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 74.409999999999997 111.113 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 73' ' ' SER . 1.4 mt -67.37 123.32 20.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 73.310000000000002 110.913 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -103.82 168.62 9.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' THR . 66.6 m-20 -54.16 -167.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 63.240000000000002 110.873 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.24 170.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 64.450000000000003 111.133 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.4 t-20 -51.97 107.03 0.73 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.624 0.726 . . . . 51.32 110.894 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.3 Cg_endo -69.82 2.55 3.46 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.653 2.235 . . . . 75.439999999999998 112.32 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 44.5 t -52.02 106.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 64.200000000000003 110.883 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 94' ' ' CYS . 11.2 p90 -78.62 -16.21 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 64.549999999999997 110.903 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -113.49 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 62.210000000000001 112.518 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.74 83.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 64.209999999999994 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -76.34 102.66 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 70.439999999999998 110.862 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -98.14 140.48 32.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.928 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 15' ' ' VAL . 6.6 m-85 -92.48 158.02 39.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 61.520000000000003 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 113.82 3.51 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 74.409999999999997 112.337 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.54 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 26.1 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 61.5 110.88 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.473 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.876 0.369 . . . . 74.140000000000001 110.82 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.7 m-90 -137.52 115.75 11.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.01 102.05 12.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 65.150000000000006 110.867 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -152.65 152.02 27.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.731 . . . . 74.120000000000005 111.099 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.83 124.66 11.26 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.659 2.239 . . . . 70.420000000000002 112.304 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.8 mmtm -52.0 119.57 14.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 74.329999999999998 110.863 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 80.72 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 54.310000000000002 112.308 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -25.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 72.219999999999999 112.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 21' ' ' SER . 2.5 t -59.0 173.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 64.209999999999994 111.144 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.882 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.69 115.28 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 74.329999999999998 110.857 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' HA ' HD23 ' A' ' 25' ' ' LEU . 53.2 m-20 -40.73 -47.81 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 75.340000000000003 110.85 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -57.76 -34.38 69.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.140000000000001 110.872 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 14.1 mm100 -69.04 -46.12 68.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.959 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.882 HD22 ' O ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -70.29 -56.54 6.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 110.947 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 27' ' ' GLY . 11.3 t -41.05 -45.25 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.144 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 26' ' ' THR . . . -39.39 -37.8 0.84 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 72.109999999999999 112.43 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 29' ' ' ILE . 3.7 m-20 -56.14 -68.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 62.210000000000001 110.86 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 55' ' ' LYS . 76.9 mt -35.31 -44.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.200000000000003 111.076 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -56.12 -49.18 74.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 62.450000000000003 110.89 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' ASN . 1.1 t80 -74.46 -54.43 7.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.912 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.92 -40.3 60.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 74.299999999999997 111.154 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.5 t -56.75 -10.04 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 55.219999999999999 110.839 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 m -112.55 18.1 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 71.430000000000007 110.845 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.471 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 4.4 mm100 -93.9 -50.93 5.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 63.020000000000003 110.911 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.82 -85.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 70.519999999999996 112.473 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 64' ' ' LEU . 2.6 pt -81.38 17.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 74.109999999999999 111.115 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.623 ' HA ' HG21 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -85.38 -61.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 63.119999999999997 110.851 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.02 122.43 23.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 50.340000000000003 110.819 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.49 -67.42 0.51 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 63.210000000000001 112.477 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.71 1.98 3.92 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 64.040000000000006 112.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.683 HD12 ' CD2' ' A' ' 57' ' ' HIS . 24.7 pt -84.54 17.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.122 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -85.85 127.29 63.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.72 . . . . 64.430000000000007 110.912 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.75 156.45 63.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.717 2.278 . . . . 63.25 112.337 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.43 -47.13 1.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 74.420000000000002 112.457 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.04 -0.94 2.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.784 -0.722 . . . . 52.119999999999997 112.508 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.27 -68.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 73.430000000000007 111.11 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -117.94 9.86 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.925 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.5 t80 -56.21 -60.3 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 71.010000000000005 110.891 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 mt-10 -96.72 128.93 34.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.643 0.735 . . . . 61.210000000000001 110.89 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.81 145.09 78.59 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 -1.804 . . . . 72.319999999999993 112.372 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 1.2 p30 -107.23 151.74 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.129999999999995 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 39.7 p -99.92 170.87 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 71.129999999999995 111.172 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 26' ' ' THR . 72.0 t -65.43 -62.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 71.340000000000003 111.081 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.78 18.04 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.209999999999994 110.914 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.23 -40.91 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 65.109999999999999 111.064 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.3 m80 -53.19 -52.65 58.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 71.230000000000004 110.875 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.47 -38.14 74.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 62.130000000000003 111.086 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.04 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 52.310000000000002 111.124 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 10.5 t80 -61.58 -65.08 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 110.945 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 38' ' ' ASP . 2.7 p -55.2 -34.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 74.030000000000001 111.088 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.485 ' HE3' ' HD3' ' A' ' 16' ' ' PRO . 2.7 mtm -44.89 -26.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.040000000000006 110.908 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -67.25 -60.74 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.54 -52.3 18.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 110.91 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.604 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.7 t80 -46.46 -44.59 17.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 73.0 110.928 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 12.6 t80 -58.96 -28.43 66.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 70.230000000000004 110.903 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -99.56 -4.79 30.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 70.319999999999993 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -41.67 69.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 110.881 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.846 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.17 -58.12 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 51.310000000000002 111.094 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 23.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 13.199999999999999 112.487 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.02 43.79 30.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 73.439999999999998 110.852 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.504 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.5 m-80 -114.4 169.92 8.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 75.230000000000004 110.932 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.414 ' CB ' HD11 ' A' ' 84' ' ' LEU . 78.4 p -71.7 -23.19 61.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 52.520000000000003 110.873 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.06 1.89 26.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 74.530000000000001 110.907 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.846 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -24.32 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 52.020000000000003 110.916 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -82.55 102.02 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.857 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -118.03 11.83 13.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 54.439999999999998 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.73 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.7 m-30 -59.04 -68.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.895 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.46 178.02 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 43.530000000000001 110.824 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -65.9 -1.78 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 75.510000000000005 110.963 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 25' ' ' LEU . 73.3 p -91.81 -50.01 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 111.118 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.14 102.01 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.076 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 t -147.37 178.47 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 63.149999999999999 111.124 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD11 ' CB ' ' A' ' 73' ' ' SER . 35.7 mt -66.16 122.9 18.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.914 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -99.57 168.03 10.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.159 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.96 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 52.450000000000003 110.867 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.0 t -44.46 172.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 111.067 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.3 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 63.329999999999998 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.8 -2.37 10.09 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 63.020000000000003 112.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.4 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 8.0 t -52.04 108.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 62.329999999999998 110.845 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 5.9 p90 -81.57 -15.28 55.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 74.310000000000002 110.947 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.97 -115.12 0.5 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 74.219999999999999 112.566 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.96 89.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 73.120000000000005 111.142 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -76.45 102.03 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 62.32 110.867 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.5 142.84 30.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 61.229999999999997 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 10.0 m-85 -92.08 150.87 41.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.671 0.748 . . . . 70.209999999999994 110.839 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.23 11.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 51.409999999999997 112.37 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 9.1 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 61.32 110.877 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.529 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 25.2 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.915 0.388 . . . . 71.340000000000003 110.806 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.0 m-90 -137.75 119.52 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 74.540000000000006 110.927 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 101.98 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 65.299999999999997 110.884 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -151.84 152.6 30.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 75.310000000000002 111.091 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.77 127.76 15.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.682 2.255 . . . . 60.530000000000001 112.327 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -52.02 113.44 4.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 65.450000000000003 110.912 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 91.4 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.678 2.252 . . . . 63.020000000000003 112.393 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.13 -27.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 40.140000000000001 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 25' ' ' LEU . 3.1 t -59.01 165.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 71.219999999999999 111.17 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.6 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -52.12 114.51 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.855 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 21' ' ' SER . 6.0 m-20 -33.65 -65.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 72.400000000000006 110.822 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.2 -39.17 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 63.439999999999998 110.872 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.7 tp-100 -58.36 -50.87 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 110.91 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.723 HD11 ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 65.519999999999996 110.926 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.603 ' OG1' HG11 ' A' ' 54' ' ' VAL . 1.7 m -59.54 -31.48 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 71.5 111.154 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.77 -30.66 56.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 45.32 112.47 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' ILE . 1.1 m-20 -61.86 -68.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 74.310000000000002 110.867 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 67.6 mt -37.09 -48.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 111.073 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.06 -47.37 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 110.91 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.1 -53.65 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.479 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.12 -43.13 61.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 54.149999999999999 111.116 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -11.58 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.120000000000005 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -109.06 18.03 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.821 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.49 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 5.1 mm100 -97.86 -49.96 4.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.420000000000002 110.887 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.65 -82.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 72.310000000000002 112.47 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.771 HD12 HD12 ' A' ' 64' ' ' LEU . 3.6 pt -80.97 17.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 64.140000000000001 111.123 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.56 -59.86 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 52.439999999999998 110.843 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.475 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.71 122.35 23.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.129999999999995 110.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.47 -71.34 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 71.400000000000006 112.463 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.601 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.77 4.24 2.31 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.684 2.256 . . . . 74.219999999999999 112.316 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 38' ' ' ASP . 9.6 pt -82.87 18.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.239999999999995 111.136 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -80.31 148.36 66.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 70.140000000000001 110.886 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.1 Cg_endo -69.79 152.61 69.18 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.709 2.273 . . . . 71.439999999999998 112.351 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.83 -47.9 2.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 55.109999999999999 112.483 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.83 3.08 2.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 72.019999999999996 112.484 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 64.120000000000005 111.106 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.0 7.85 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.898 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -43.27 -59.0 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.875 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.562 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 2.4 mm-40 -96.72 131.02 28.89 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.671 0.748 . . . . 70.329999999999998 110.826 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.75 153.61 92.98 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 -1.801 . . . . 65.219999999999999 112.32 -0.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 10.4 p30 -101.73 130.55 48.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.876 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.78 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 41.2 p -82.97 169.99 15.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 72.310000000000002 111.163 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.603 HG11 ' OG1' ' A' ' 26' ' ' THR . 51.8 t -67.1 -58.9 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 63.229999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -87.91 18.04 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 73.530000000000001 110.901 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.78 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -49.7 -51.88 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 111.092 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.618 ' ND1' HD12 ' A' ' 42' ' ' ILE . 63.1 m170 -43.65 -58.16 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 65.120000000000005 110.841 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -52.22 -39.8 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 62.439999999999998 111.145 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.15 74.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 75.319999999999993 111.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 11.2 t80 -68.57 -63.45 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.931 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 65' ' ' TYR . 2.3 p -54.9 -33.47 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 61.539999999999999 111.132 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.63 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 3.8 mtt -45.61 -27.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.882 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.63 -61.68 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 63.130000000000003 110.842 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.771 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -70.29 -49.33 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 64.420000000000002 110.918 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.596 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.5 t80 -50.29 -47.0 55.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 110.926 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 30.4 t80 -55.88 -28.57 57.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 62.049999999999997 110.915 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -99.93 -4.59 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 70.049999999999997 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.11 -40.33 65.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.861 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.949 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -59.39 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 111.101 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.29 22.03 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 62.130000000000003 112.508 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.01 41.07 29.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 71.209999999999994 110.841 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.8 m-80 -114.11 169.12 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.863 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.408 ' HB2' ' CD1' ' A' ' 84' ' ' LEU . 96.5 p -70.28 -23.14 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 70.209999999999994 110.849 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -81.02 2.2 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 75.219999999999999 110.943 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.949 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -20.62 60.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 70.120000000000005 110.887 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.46 102.01 11.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 72.430000000000007 110.859 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.02 10.68 13.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 110.847 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.63 ' CD2' ' HE2' ' A' ' 62' ' ' MET . 2.7 m-30 -58.32 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.917 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.62 178.01 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 61.009999999999998 110.897 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -2.2 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.119999999999997 110.9 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.544 ' HB ' HD12 ' A' ' 25' ' ' LEU . 65.4 p -92.15 -52.37 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.310000000000002 111.175 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.52 102.15 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.114 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -148.64 178.02 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 111.154 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 12' ' ' SER . 6.2 mp -65.57 127.2 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.874 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.04 167.76 9.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 71.219999999999999 111.179 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 87' ' ' THR . 11.3 m-80 -54.03 -168.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 74.329999999999998 110.884 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.99 173.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 111.17 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.7 t-20 -51.97 106.33 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.653 0.739 . . . . 73.329999999999998 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.78 -4.39 13.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 61.329999999999998 112.353 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -52.02 112.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 54.32 110.81 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 94' ' ' CYS . 1.8 p90 -79.8 -16.62 55.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 110.926 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.85 -123.83 0.94 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.439999999999998 112.454 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.35 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 43.039999999999999 111.08 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -76.35 104.16 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 62.140000000000001 110.882 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.0 129.24 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.329999999999998 110.919 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.545 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.1 m-85 -78.42 154.97 79.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.655 0.74 . . . . 72.409999999999997 110.876 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.75 108.08 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.647 2.231 . . . . 54.219999999999999 112.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 54.6 p . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.842 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.52 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.915 0.388 . . . . 73.510000000000005 110.836 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.594 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.0 m-90 -136.03 123.06 21.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 110.913 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 102.01 13.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 74.209999999999994 110.836 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -154.58 153.06 27.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 54.219999999999999 111.09 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.4 Cg_endo -69.82 129.34 17.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 71.019999999999996 112.383 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 118.12 11.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.522 0.677 . . . . 75.219999999999999 110.947 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 79.87 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.686 2.257 . . . . 73.140000000000001 112.324 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.58 -24.3 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 72.099999999999994 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 25' ' ' LEU . 4.8 t -59.0 166.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.328 . . . . 71.450000000000003 111.164 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.779 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.01 107.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 52.119999999999997 110.849 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 54' ' ' VAL . 72.9 m-20 -33.36 -63.41 0.24 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 73.129999999999995 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.99 -39.74 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 75.150000000000006 110.862 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -58.34 -50.93 71.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 53.340000000000003 110.875 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.782 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -71.49 -29.65 65.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 71.510000000000005 110.883 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.434 ' OG1' HG11 ' A' ' 54' ' ' VAL . 97.1 m -52.13 -26.53 11.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 54.25 111.129 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.36 -24.77 72.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 21.120000000000001 112.49 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.27 -51.4 63.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 65.439999999999998 110.864 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 55' ' ' LYS . 73.1 mt -62.53 -52.46 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 62.340000000000003 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -50.25 -43.63 53.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.16 -58.11 3.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 110.934 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.786 ' HB1' ' CG ' ' A' ' 38' ' ' ASP . . . -51.46 -31.65 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 63.210000000000001 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.91 -11.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.883 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 18.0 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 41.299999999999997 110.855 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -92.17 -52.1 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.219999999999999 110.887 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.38 -92.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.786 -0.721 . . . . 75.310000000000002 112.512 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.41 4.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 75.439999999999998 111.138 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.88 ' HA ' HG21 ' A' ' 61' ' ' VAL . 2.5 m-20 -66.66 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.84 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -76.07 134.92 39.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 52.130000000000003 110.88 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.94 -72.3 0.33 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 61.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.597 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.78 6.47 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.674 2.25 . . . . 72.510000000000005 112.358 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.626 HD12 ' CG ' ' A' ' 57' ' ' HIS . 22.9 pt -82.44 18.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.450000000000003 111.141 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -80.16 123.75 83.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 75.030000000000001 110.895 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.32 38.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 71.510000000000005 112.315 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.34 -32.99 1.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 62.109999999999999 112.514 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.49 -31.22 3.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 72.420000000000002 112.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.05 -68.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 111.126 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' PHE . 13.7 t -113.05 -13.77 13.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.430000000000007 110.926 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -34.46 -44.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 64.209999999999994 110.849 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.41 125.75 38.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 64.299999999999997 110.88 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.5 Cg_endo -69.75 151.89 91.82 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.726 -1.781 . . . . 44.140000000000001 112.317 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.38 120.02 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 63.100000000000001 110.875 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.76 168.59 16.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 71.030000000000001 111.115 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.631 HG21 ' HB3' ' A' ' 22' ' ' ASP . 91.8 t -65.79 -56.79 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 61.32 111.147 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HG3' ' CG ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.24 17.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 64.450000000000003 110.85 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.63 -42.29 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 64.5 111.061 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.626 ' CG ' HD12 ' A' ' 42' ' ' ILE . 67.5 m80 -52.28 -54.78 27.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.839 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.779 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -56.72 -37.74 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 62.310000000000002 111.105 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.14 -30.6 71.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 72.099999999999994 111.094 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 12.2 t80 -67.86 -66.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 110.902 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.88 HG21 ' HA ' ' A' ' 38' ' ' ASP . 7.5 p -55.24 -29.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 74.420000000000002 111.165 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 1.6 mmt -45.53 -22.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.845 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -71.95 -56.61 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -76.14 -53.13 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 110.948 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.4 t80 -45.72 -48.2 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 63.100000000000001 110.953 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.606 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 33.8 t80 -58.51 -26.86 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 72.219999999999999 110.93 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -100.04 -2.78 33.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 74.319999999999993 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -40.09 52.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 71.099999999999994 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.898 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -55.41 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 111.082 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.35 24.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 54.530000000000001 112.496 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 49.2 31.98 3.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 72.430000000000007 110.912 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.606 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 5.2 m-80 -102.81 168.59 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 65.040000000000006 110.864 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.8 p -70.93 -21.97 62.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.827 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.437 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.08 2.03 29.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.902 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.898 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.57 -18.94 61.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 72.140000000000001 110.898 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 102.05 11.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 71.450000000000003 110.87 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 8.93 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 64.120000000000005 110.886 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.779 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -58.51 -68.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 73.140000000000001 110.844 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -171.93 178.06 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.450000000000003 110.875 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -65.8 -0.99 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 65.540000000000006 110.895 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.735 HG21 ' CD1' ' A' ' 25' ' ' LEU . 62.3 p -92.84 -52.1 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 111.143 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.86 106.37 13.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 71.400000000000006 111.09 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.9 t -150.64 177.98 9.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 63.439999999999998 111.162 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.03 149.85 49.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 110.947 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -133.77 168.55 18.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.319999999999993 111.156 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 87' ' ' THR . 14.4 m-20 -53.63 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.889 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.9 t -44.36 174.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 111.104 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.594 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 72.239999999999995 110.877 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 88' ' ' ASN . 53.3 Cg_endo -69.85 -0.15 6.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.303 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.404 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 12.9 t -52.04 106.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 110.834 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.65 -16.33 59.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.918 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.74 -115.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 55.520000000000003 112.472 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.34 69.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 62.039999999999999 111.108 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.37 102.03 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 52.219999999999999 110.886 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -99.97 137.95 37.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.150000000000006 110.903 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.26 146.52 32.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.637 0.732 . . . . 75.430000000000007 110.9 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.02 12.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 73.400000000000006 112.334 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.454 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 2.0 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.099999999999994 110.806 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.44 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 9.3 m . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.881 0.372 . . . . 73.129999999999995 110.898 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.2 m-90 -135.67 109.65 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 72.25 110.905 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 102.17 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 72.230000000000004 110.832 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.66 152.43 24.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 73.120000000000005 111.131 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.71 123.55 10.23 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.686 2.257 . . . . 72.040000000000006 112.336 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -51.98 122.42 22.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.551 0.691 . . . . 74.030000000000001 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 88.06 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 74.319999999999993 112.353 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.37 -20.79 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 31.219999999999999 112.497 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 25' ' ' LEU . 11.0 t -63.62 158.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 74.430000000000007 111.133 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 24' ' ' GLN . 1.8 m -52.09 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 71.040000000000006 110.817 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 21' ' ' SER . 85.9 m-20 -33.5 -68.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 75.230000000000004 110.873 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.4 -39.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 73.150000000000006 110.86 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 25.4 tt0 -58.11 -51.3 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 110.938 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.841 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -70.96 -36.18 72.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.914 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.417 ' OG1' HG11 ' A' ' 54' ' ' VAL . 25.7 m -52.2 -15.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.98 -35.48 57.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 65.129999999999995 112.493 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -57.19 -68.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 75.319999999999993 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 55' ' ' LYS . 73.6 mt -37.49 -47.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 70.400000000000006 111.121 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.42 -47.76 72.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 71.349999999999994 110.849 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -73.55 -56.1 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 44.450000000000003 110.942 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . . . -51.95 -35.7 46.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 54.109999999999999 111.102 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.5 t -56.39 -12.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.109999999999999 110.875 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.75 18.02 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 110.828 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -89.8 -52.82 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 72.349999999999994 110.899 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 165.19 -94.81 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 64.310000000000002 112.503 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.517 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -81.96 17.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 72.109999999999999 111.118 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.563 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -83.08 -59.95 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 64.519999999999996 110.902 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 122.31 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 71.5 110.902 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.14 -67.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 63.119999999999997 112.474 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 4.51 2.14 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.246 . . . . 73.109999999999999 112.339 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.604 HD12 ' CD2' ' A' ' 57' ' ' HIS . 19.4 pt -82.77 17.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 70.420000000000002 111.112 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -84.48 125.15 72.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.623 0.725 . . . . 75.439999999999998 110.899 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.525 ' CB ' ' CD1' ' A' ' 49' ' ' PHE . 53.7 Cg_endo -69.74 154.58 67.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.668 2.245 . . . . 64.129999999999995 112.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.88 -40.08 1.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 32.43 112.495 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.47 -23.51 3.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.74 . . . . 61.210000000000001 112.494 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.06 -68.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 111.089 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -118.04 -11.28 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 54.509999999999998 110.873 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CD1' ' CB ' ' A' ' 44' ' ' PRO . 2.6 t80 -33.92 -52.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 71.120000000000005 110.897 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -99.57 127.97 32.73 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.623 0.725 . . . . 73.200000000000003 110.87 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.51 88.72 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 -1.806 . . . . 54.130000000000003 112.329 -0.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.98 152.75 24.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 63.149999999999999 110.891 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 43.5 p -106.69 172.38 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 111.153 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.417 HG11 ' OG1' ' A' ' 26' ' ' THR . 98.0 t -66.21 -64.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.420000000000002 111.143 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.25 18.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.897 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.91 -38.9 52.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 44.420000000000002 111.054 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.604 ' CD2' HD12 ' A' ' 42' ' ' ILE . 60.2 m80 -54.08 -52.72 60.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 110.855 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.709 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.27 -37.53 72.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 72.329999999999998 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.34 74.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 44.100000000000001 111.131 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 3.0 t80 -68.45 -57.96 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.891 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.484 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 1.8 p -54.57 -37.44 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 71.439999999999998 111.164 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.661 ' HE2' ' CE2' ' A' ' 78' ' ' PHE . 9.7 mtt -49.09 -20.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.030000000000001 110.912 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.533 ' HB3' HD23 ' A' ' 64' ' ' LEU . 44.9 t30 -69.16 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 110.896 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -74.93 -52.25 11.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 44.140000000000001 110.927 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.6 t80 -45.7 -49.55 14.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 71.519999999999996 110.87 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 2.8 t80 -58.42 -27.38 64.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.923 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.401 ' OE1' ' O ' ' A' ' 63' ' ' ASN . 29.0 mt-30 -101.11 -2.26 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.120000000000005 110.918 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -74.04 -41.43 61.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.864 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.15 -55.51 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 44.520000000000003 111.095 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.85 24.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.040000000000006 112.508 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 51.1 44.17 28.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 70.120000000000005 110.872 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.546 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.9 m-80 -109.89 172.44 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.913 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -74.22 -24.78 59.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 52.450000000000003 110.908 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -79.67 2.0 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 75.319999999999993 110.91 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.733 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.78 -23.26 59.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.329999999999998 110.912 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.37 101.96 10.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 54.329999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.0 10.1 12.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 110.847 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.0 m-30 -58.84 -68.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.84 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 t -172.0 178.01 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.399999999999999 110.836 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.51 -2.48 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 64.310000000000002 110.926 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 25' ' ' LEU . 66.4 p -91.54 -50.57 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 63.539999999999999 111.149 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.479 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.71 102.09 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.108 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 t -148.81 178.01 9.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.43 111.11 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.67 114.0 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -89.71 167.47 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 63.210000000000001 111.168 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.84 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 62.409999999999997 110.905 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.24 172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.549999999999997 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 9.5 t-20 -51.98 106.66 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 63.520000000000003 110.907 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.19 3.74 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.743 2.295 . . . . 54.149999999999999 112.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.411 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 23.0 t -52.03 106.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.783 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -17.04 61.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 54.299999999999997 110.941 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.44 -111.24 0.42 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.94 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 111.06 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.85 102.0 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 73.019999999999996 110.879 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -99.0 151.73 20.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 61.210000000000001 110.883 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.7 m-85 -92.35 154.07 42.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.669 0.747 . . . . 74.129999999999995 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 114.21 3.62 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 72.099999999999994 112.356 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.528 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 12.1 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 65.219999999999999 110.836 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.571 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.835 0.35 . . . . 71.209999999999994 110.846 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.5 m-90 -129.74 116.55 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 62.340000000000003 110.922 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.21 102.05 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 71.439999999999998 110.946 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -152.83 152.55 28.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 70.219999999999999 111.108 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 127.62 14.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.645 2.23 . . . . 72.140000000000001 112.327 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.06 118.15 11.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 74.040000000000006 110.939 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 92.12 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.673 2.248 . . . . 63.32 112.334 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.78 -26.78 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 42.240000000000002 112.488 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.72 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.3 t -59.0 168.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 72.140000000000001 111.174 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.878 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -54.52 111.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 43.130000000000003 110.829 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' HG21 ' A' ' 54' ' ' VAL . 24.2 m-20 -38.94 -55.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 63.100000000000001 110.888 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.21 -33.98 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 110.846 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' SER . 6.6 tp60 -68.31 -46.48 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.868 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.878 HD22 ' O ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -70.01 -54.06 14.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 72.299999999999997 110.955 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 27' ' ' GLY . 16.8 m -41.14 -48.35 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.400000000000006 111.169 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' THR . . . -34.91 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 23.219999999999999 112.502 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 31' ' ' TYR . 10.3 m-20 -59.5 -64.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 72.030000000000001 110.909 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.91 HG23 ' CG ' ' A' ' 57' ' ' HIS . 72.7 mt -36.58 -41.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 111.163 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.59 -45.6 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' ASN . 3.4 t80 -73.55 -58.28 3.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.140000000000001 110.887 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.947 ' HB1' ' CG ' ' A' ' 38' ' ' ASP . . . -48.1 -50.05 29.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 64.129999999999995 111.072 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.79 -22.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.929 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -80.52 13.33 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 70.430000000000007 110.861 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.498 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -97.96 -45.79 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.942 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.9 -43.91 1.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 71.400000000000006 112.5 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.658 HD13 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -101.54 2.29 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.346 . . . . 54.310000000000002 111.129 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.947 ' CG ' ' HB1' ' A' ' 32' ' ' ALA . 1.4 m-20 -74.99 -70.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 74.150000000000006 110.823 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -80.4 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 110.862 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.11 -68.78 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 74.319999999999993 112.466 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.61 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.71 6.97 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 70.140000000000001 112.36 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.791 HD13 ' HB2' ' A' ' 57' ' ' HIS . 8.0 pt -82.14 17.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 74.409999999999997 111.136 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.25 121.69 85.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.628 0.728 . . . . 44.329999999999998 110.912 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -169.46 0.33 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 71.299999999999997 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.99 -28.74 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 73.540000000000006 112.5 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.08 -26.23 8.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 61.409999999999997 112.461 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.37 -68.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 72.5 111.138 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 13.8 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 60.049999999999997 110.843 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.578 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 10.9 t80 -47.88 -60.52 2.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.944 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 28.5 mt-10 -92.56 142.39 25.77 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.697 0.761 . . . . 74.409999999999997 110.844 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.75 146.86 83.35 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 -1.796 . . . . 73.109999999999999 112.332 -0.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -99.91 142.21 31.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 54.140000000000001 110.901 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -97.86 160.06 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 64.200000000000003 111.184 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 ' OD1' ' A' ' 22' ' ' ASP . 40.9 t -65.87 -56.43 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 71.340000000000003 111.156 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.48 17.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 65.019999999999996 110.937 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -49.64 -55.29 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.239999999999995 111.112 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.91 ' CG ' HG23 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -35.23 -51.34 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 71.230000000000004 110.873 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.786 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -63.97 -42.14 97.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 111.126 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.46 -49.54 77.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 70.129999999999995 111.076 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -54.21 -63.42 1.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 110.932 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.796 HG11 ' OD1' ' A' ' 38' ' ' ASP . 3.5 p -54.85 -35.63 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.549999999999997 111.159 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.475 ' HE2' ' HA ' ' A' ' 62' ' ' MET . 0.0 OUTLIER -44.92 -21.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 64.420000000000002 110.872 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 61' ' ' VAL . 33.0 t-20 -72.56 -44.25 62.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.942 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -90.71 -49.06 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.954 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.732 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -47.0 -46.26 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 73.340000000000003 110.937 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.9 t80 -57.14 -30.71 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 110.904 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -97.25 -5.14 37.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 72.310000000000002 110.911 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -40.96 62.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.847 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.991 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.38 -59.98 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.094 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.85 21.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.713 -0.756 . . . . 55.109999999999999 112.499 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 51.69 32.01 8.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 75.209999999999994 110.903 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.56 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.2 m-80 -105.55 167.1 9.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 72.299999999999997 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.8 p -68.73 -22.75 64.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 71.219999999999999 110.856 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.84 2.41 26.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.869 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.991 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.36 -16.89 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.439999999999998 110.894 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 0.8 OUTLIER -82.8 102.04 11.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 75.310000000000002 110.846 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -117.98 8.73 12.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 75.420000000000002 110.899 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.786 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.4 m-30 -58.98 -69.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 110.858 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -172.01 177.99 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 45.350000000000001 110.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -2.56 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 63.409999999999997 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.598 HG21 HD13 ' A' ' 25' ' ' LEU . 70.4 p -91.62 -51.44 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 111.139 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -83.75 102.02 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.219999999999999 111.064 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 t -147.93 178.0 8.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 62.219999999999999 111.174 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.61 127.26 31.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 62.340000000000003 110.923 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -106.07 168.98 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 41.539999999999999 111.158 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 87' ' ' THR . 15.5 m120 -53.68 -168.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 110.894 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' ASN . 5.0 t -45.06 174.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.165 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.5 t-20 -51.99 107.24 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 75.450000000000003 110.882 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.75 0.89 4.97 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.714 2.276 . . . . 61.109999999999999 112.324 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.412 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 21.8 t -52.06 108.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 54.310000000000002 110.854 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -72.18 -16.44 61.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.040000000000006 110.909 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.407 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 174.41 -109.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 64.209999999999994 112.511 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.53 79.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 63.539999999999999 111.124 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 102.06 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 72.109999999999999 110.838 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 149.42 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 64.239999999999995 110.896 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.543 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -90.34 154.84 46.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 65.219999999999999 110.932 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.66 3.78 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 71.409999999999997 112.35 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.482 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 83.7 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.852 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 3.0 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.843 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.573 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 3.8 m-90 -133.16 123.36 25.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.907 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.96 102.01 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.130000000000003 110.916 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.11 152.2 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 75.349999999999994 111.191 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' CE ' ' A' ' 62' ' ' MET . 54.1 Cg_endo -69.76 129.92 18.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.637 2.225 . . . . 72.329999999999998 112.39 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -52.0 120.94 17.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 74.400000000000006 110.879 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 80.7 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.668 2.245 . . . . 75.319999999999993 112.281 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.43 -27.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 74.209999999999994 112.516 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.656 ' HB ' HD11 ' A' ' 25' ' ' LEU . 19.7 t -59.15 164.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 65.239999999999995 111.158 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.89 ' O ' HD22 ' A' ' 25' ' ' LEU . 31.3 m -55.7 114.83 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 63.109999999999999 110.885 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.52 -67.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 74.129999999999995 110.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -39.59 -42.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 54.240000000000002 110.896 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -48.7 80.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.941 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.89 HD22 ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -71.11 -27.9 63.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.88 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 54' ' ' VAL . 12.6 m -60.77 -41.46 95.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 73.319999999999993 111.109 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.18 28.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 53.140000000000001 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -55.8 -44.94 78.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 51.43 110.823 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.852 HG23 ' CG ' ' A' ' 57' ' ' HIS . 90.4 mt -60.1 -64.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.010000000000005 111.093 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -37.6 -41.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 63.109999999999999 110.886 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 4.6 t80 -75.03 -68.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.329999999999998 110.946 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -47.95 -19.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 71.219999999999999 111.107 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 4.4 t -70.52 1.59 4.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.549999999999997 110.914 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.36 17.9 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 71.519999999999996 110.862 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.72 -48.81 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.109999999999999 110.954 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.8 -61.47 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 33.119999999999997 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -82.13 12.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 74.439999999999998 111.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.838 ' OD1' HG11 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -88.93 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.450000000000003 110.883 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -80.02 119.37 22.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 62.299999999999997 110.879 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.4 -68.84 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 72.25 112.46 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.628 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.1 Cg_endo -69.75 6.3 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.726 2.284 . . . . 54.310000000000002 112.316 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.1 pt -82.06 17.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 65.230000000000004 111.107 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -73.94 124.6 90.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.711 . . . . 65.209999999999994 110.905 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.9 Cg_endo -69.75 -179.37 2.86 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.723 2.282 . . . . 75.439999999999998 112.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.02 -36.15 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 63.43 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.1 -27.18 5.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 73.329999999999998 112.483 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.18 -68.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 63.509999999999998 111.146 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.3 t -117.86 -5.78 11.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 64.049999999999997 110.918 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 52' ' ' ASN . 2.6 t80 -40.69 -53.07 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.299999999999997 110.861 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.74 130.32 28.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 70.120000000000005 110.94 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.8 151.83 91.88 Favored 'Cis proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 -1.793 . . . . 55.020000000000003 112.327 0.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 7.2 p-10 -101.69 144.32 30.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 70.200000000000003 110.907 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.9 p -94.97 160.3 14.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 72.040000000000006 111.143 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 26' ' ' THR . 88.8 t -66.14 -52.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 62.020000000000003 111.128 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.617 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.97 17.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 74.510000000000005 110.881 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.34 -56.43 11.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 111.131 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.955 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -35.55 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.818 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.688 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -65.01 -38.39 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 64.209999999999994 111.125 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.74 -53.96 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 63.0 111.101 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -54.49 -63.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 73.540000000000006 110.953 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 57' ' ' HIS . 1.6 p -53.73 -37.09 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 71.120000000000005 111.153 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.495 ' CE ' ' HD3' ' A' ' 16' ' ' PRO . 2.5 mtm -45.96 -21.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 61.43 110.888 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 10.3 t-20 -71.89 -54.53 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.540000000000006 110.866 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -79.0 -45.88 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 110.927 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.545 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -48.91 -49.63 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.883 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.6 t80 -55.32 -32.2 62.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -96.12 -4.91 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.883 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.401 ' HB3' ' O ' ' A' ' 65' ' ' TYR . 7.3 t60 -74.79 -40.68 61.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 73.230000000000004 110.86 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.983 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.76 -61.57 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 54.340000000000003 111.135 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.94 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.677 -0.773 . . . . 75.209999999999994 112.484 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.94 33.3 11.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 63.350000000000001 110.94 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -106.57 167.71 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 63.409999999999997 110.878 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.469 ' CB ' HD11 ' A' ' 84' ' ' LEU . 75.4 p -69.09 -23.01 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 74.129999999999995 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.28 2.85 26.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 75.319999999999993 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.983 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.4 -24.37 60.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.540000000000006 110.881 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.95 102.0 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.200000000000003 110.901 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -118.0 11.36 13.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.299999999999997 110.848 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.688 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.8 m-30 -57.75 -68.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 75.299999999999997 110.876 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -171.9 178.01 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.040000000000006 110.872 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -65.61 -2.13 3.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 71.040000000000006 110.943 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 25' ' ' LEU . 72.4 p -91.76 -51.77 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 52.210000000000001 111.107 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.72 107.42 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 71.439999999999998 111.146 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -152.49 177.99 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 64.25 111.126 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -66.36 153.73 41.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.926 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -133.69 167.27 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 63.030000000000001 111.148 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' THR . 6.5 m120 -53.66 -168.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 73.340000000000003 110.86 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.24 174.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 73.120000000000005 111.168 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.572 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.0 t-20 -52.06 107.0 0.73 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.73 . . . . 63.409999999999997 110.895 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -0.6 7.12 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 75.019999999999996 112.369 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 5.3 t -52.0 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 42.530000000000001 110.827 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -79.71 -17.23 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.497 . . . . 75.409999999999997 110.914 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.421 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 177.58 -112.48 0.38 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 71.430000000000007 112.487 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.45 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 75.510000000000005 111.127 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.35 101.99 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 71.030000000000001 110.867 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.89 142.07 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 60.25 110.873 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.05 140.88 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.716 0.77 . . . . 55.229999999999997 110.896 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 132.05 22.43 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.635 2.224 . . . . 64.430000000000007 112.368 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.498 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 3.1 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 70.049999999999997 110.869 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.488 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 7.0 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.872 0.368 . . . . 73.340000000000003 110.839 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.57 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.1 m-90 -134.82 124.97 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 71.209999999999994 110.912 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.48 102.05 13.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 75.030000000000001 110.883 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.492 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -150.65 153.87 34.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 75.430000000000007 111.074 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.9 Cg_endo -69.74 126.3 13.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 70.150000000000006 112.376 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.08 113.42 4.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 64.329999999999998 110.868 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 79.59 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 71.450000000000003 112.351 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.492 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 161.14 61.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.792 -0.718 . . . . 63.100000000000001 112.487 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.762 ' CG2' HD11 ' A' ' 25' ' ' LEU . 1.7 m -157.56 178.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 72.319999999999993 111.122 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' HD22 ' A' ' 25' ' ' LEU . 48.9 m -52.04 114.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 63.5 110.827 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.56 -53.67 5.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 75.140000000000001 110.841 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -50.73 -30.09 13.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.899 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -51.35 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 71.230000000000004 110.939 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.42 -32.06 67.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 62.100000000000001 110.905 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' THR . 11.9 m -66.72 -1.0 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 62.340000000000003 111.121 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.29 -38.13 6.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.474 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 3.3 p30 -57.68 -56.39 22.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 65.439999999999998 110.894 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' HB3' ' A' ' 57' ' ' HIS . 40.6 mt -43.52 -45.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 53.439999999999998 111.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.96 -50.88 33.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.129999999999995 110.877 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -74.77 -52.43 11.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.906 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 35' ' ' GLN . . . -46.55 -57.15 5.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 111.108 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.41 -20.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.864 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -81.41 12.55 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 70.530000000000001 110.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.16 5.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 110.901 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.38 -53.1 0.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 63.140000000000001 112.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.698 HD12 HD12 ' A' ' 64' ' ' LEU . 1.2 pt -82.06 5.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 73.430000000000007 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.799 ' OD1' HG21 ' A' ' 61' ' ' VAL . 6.9 m-20 -87.64 -56.71 3.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 72.530000000000001 110.878 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.2 OUTLIER -78.29 120.03 22.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.88 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.19 -67.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.75 -0.738 . . . . 64.129999999999995 112.492 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.62 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.72 4.81 1.96 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.722 2.281 . . . . 62.329999999999998 112.367 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.7 pt -82.41 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.112 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.29 125.73 90.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 74.200000000000003 110.913 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.78 7.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 75.109999999999999 112.344 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.37 -31.74 1.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 33.520000000000003 112.497 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.84 -31.91 5.17 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 53.25 112.499 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.61 -68.25 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 45.539999999999999 111.123 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.19 2.81 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 110.876 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.1 t80 -39.99 -58.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.914 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mm-40 -98.24 131.45 26.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 64.230000000000004 110.866 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.67 148.98 87.63 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 -1.795 . . . . 62.229999999999997 112.368 -0.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.98 134.27 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.9 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.428 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 43.3 p -79.92 155.57 27.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.152 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.07 -53.58 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 61.210000000000001 111.136 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.636 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.61 18.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.849 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.4 -55.25 11.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.450000000000003 111.105 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.741 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -33.75 -53.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.869 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.784 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -66.23 -38.88 88.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 61.100000000000001 111.118 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.11 -42.45 94.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 73.329999999999998 111.086 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.1 t80 -66.32 -60.48 2.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.886 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.799 HG21 ' OD1' ' A' ' 38' ' ' ASP . 2.1 p -54.11 -34.77 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.086 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.6 ' HE2' ' CZ ' ' A' ' 78' ' ' PHE . 1.2 mmt -45.77 -25.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 53.109999999999999 110.885 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 19.0 t-20 -65.6 -63.56 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 110.848 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.698 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -72.5 -53.18 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 74.400000000000006 110.961 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.675 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -39.22 -57.5 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 62.399999999999999 110.914 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.583 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 16.7 t80 -50.45 -38.1 41.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.481 . . . . 64.120000000000005 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.434 ' HA ' ' CG ' ' A' ' 71' ' ' ARG . 9.0 mt-30 -92.27 -4.22 54.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 75.099999999999994 110.929 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.539 ' CD2' HD13 ' A' ' 37' ' ' ILE . 2.3 t60 -74.88 -41.94 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 62.310000000000002 110.844 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.022 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.67 -63.17 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 111.099 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.03 18.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 71.219999999999999 112.538 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.94 35.7 16.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 75.319999999999993 110.891 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.2 m-80 -107.31 167.84 9.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.953 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.504 ' CB ' HD11 ' A' ' 84' ' ' LEU . 72.1 p -68.98 -24.25 64.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 73.040000000000006 110.846 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -81.1 2.17 28.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.907 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 1.022 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -23.52 59.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.140000000000001 110.892 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.14 102.03 10.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 75.310000000000002 110.864 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.03 11.31 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 110.845 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.784 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.9 m-30 -57.96 -68.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.835 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.13 177.99 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.310000000000002 110.833 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -65.53 -1.61 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 72.019999999999996 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 69.8 p -92.79 -53.16 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 71.430000000000007 111.112 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.95 103.43 11.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 111.05 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 t -148.45 178.02 8.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 70.019999999999996 111.096 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD11 ' CB ' ' A' ' 73' ' ' SER . 1.3 mt -66.69 152.4 45.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 54.439999999999998 110.872 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -133.75 167.32 20.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 87' ' ' THR . 61.8 m-80 -53.53 -168.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.140000000000001 110.867 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 86' ' ' ASN . 7.2 t -45.23 175.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.200000000000003 111.155 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.8 t-20 -51.98 108.26 1.03 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 72.239999999999995 110.911 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.591 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.74 -2.89 10.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.709 2.273 . . . . 65.530000000000001 112.368 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.405 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.0 106.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.854 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -73.15 -15.85 61.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.915 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.2 -111.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 72.400000000000006 112.499 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.44 -31.56 67.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 53.439999999999998 111.101 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 102.04 7.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 54.240000000000002 110.859 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.3 139.84 34.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 65.120000000000005 110.911 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.591 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.4 m-85 -85.84 157.63 57.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 71.409999999999997 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.492 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.81 106.26 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.647 2.231 . . . . 53.119999999999997 112.32 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.497 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 74.3 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.520000000000003 110.866 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' HD23 ' A' ' 84' ' ' LEU . 41.4 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.882 0.372 . . . . 73.319999999999993 110.857 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.577 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 5.7 m-90 -129.29 122.64 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.915 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 62' ' ' MET . 1.1 t -95.47 107.56 19.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 73.430000000000007 110.897 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.437 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 3.9 m -152.64 154.81 32.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 60.109999999999999 111.136 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.74 131.37 21.13 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.701 2.267 . . . . 65.540000000000006 112.339 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 110.77 2.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.575 0.702 . . . . 74.230000000000004 110.929 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 96.79 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.252 . . . . 72.209999999999994 112.352 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.15 -32.31 2.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 43.399999999999999 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 21' ' ' SER . 3.6 p -58.67 -178.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.344 . . . . 54.450000000000003 111.127 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.853 ' H ' HG22 ' A' ' 20' ' ' VAL . 3.2 m -52.05 113.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 64.239999999999995 110.881 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.22 -56.71 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 63.140000000000001 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 26' ' ' THR . 0.4 OUTLIER -52.4 -15.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.906 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.31 -46.21 16.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 74.530000000000001 110.892 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -70.41 -50.23 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.140000000000001 110.906 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' ASP . 12.3 t -36.89 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 63.530000000000001 111.16 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . -66.34 -44.93 89.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.7 -0.762 . . . . 54.299999999999997 112.488 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' LEU . 14.5 m-20 -41.87 -48.82 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 74.450000000000003 110.883 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.805 HG23 ' CG ' ' A' ' 57' ' ' HIS . 82.1 mt -55.63 -42.46 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 75.340000000000003 111.133 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.32 -46.05 80.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 54.439999999999998 110.886 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.15 -61.5 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 54.119999999999997 110.93 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.708 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -50.06 -46.87 53.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 61.5 111.083 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 40.4 t -50.33 -17.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 71.099999999999994 110.866 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -93.03 17.96 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.817 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -96.98 -48.95 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.230000000000004 110.935 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.7 -63.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 63.219999999999999 112.445 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.669 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.36 4.66 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 72.239999999999995 111.164 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.838 ' OD1' HG11 ' A' ' 61' ' ' VAL . 2.3 m-20 -78.08 -68.2 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 35.439999999999998 110.869 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.15 129.02 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.340000000000003 110.876 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.57 -72.69 0.39 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 71.349999999999994 112.496 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.75 8.29 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.675 2.25 . . . . 71.219999999999999 112.364 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.71 HD13 ' HD2' ' A' ' 57' ' ' HIS . 29.8 pt -82.12 17.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 53.450000000000003 111.106 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -76.06 125.27 88.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.559 0.695 . . . . 75.120000000000005 110.91 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 161.62 45.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.24 . . . . 53.100000000000001 112.327 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.4 -40.62 1.47 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 70.140000000000001 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.71 17.34 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 64.420000000000002 112.535 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.79 -68.42 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.356 . . . . 71.109999999999999 111.099 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -117.89 11.67 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 110.898 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 13.0 t80 -55.32 -52.42 63.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.109999999999999 110.881 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 83.1 mt-10 -98.31 129.17 31.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.696 0.76 . . . . 61.340000000000003 110.869 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.79 153.48 93.04 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 -1.81 . . . . 64.400000000000006 112.361 -0.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -99.41 141.55 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 55.310000000000002 110.85 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.489 ' CG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -98.19 158.38 15.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 70.450000000000003 111.138 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.76 -55.17 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 111.146 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.07 18.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.519999999999996 110.903 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.9 -58.08 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 71.329999999999998 111.114 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.805 ' CG ' HG23 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -33.8 -48.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 60.32 110.842 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.688 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -64.53 -46.19 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 111.106 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -56.28 -46.96 79.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.150000000000006 111.093 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.6 t80 -59.77 -64.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.92 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.838 HG11 ' OD1' ' A' ' 38' ' ' ASP . 5.7 p -54.52 -36.21 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 64.540000000000006 111.116 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.476 ' CE ' ' SG ' ' A' ' 76' ' ' CYS . 8.6 mtp -45.49 -21.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.859 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -71.85 -52.36 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 75.299999999999997 110.84 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.669 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -81.14 -45.13 16.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 65.430000000000007 110.943 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.634 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -50.79 -45.93 59.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.882 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 19.3 t80 -58.9 -32.2 69.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 72.120000000000005 110.929 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -95.95 -4.92 42.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 63.409999999999997 110.902 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -73.42 -41.81 62.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.992 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.19 -60.73 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.130000000000003 111.117 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.15 22.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.694 -0.765 . . . . 75.340000000000003 112.457 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.03 36.42 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 73.239999999999995 110.857 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.564 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.5 m-80 -108.81 165.55 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 74.219999999999999 110.842 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.413 ' HB3' HD21 ' A' ' 84' ' ' LEU . 11.5 p -68.34 -22.67 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 74.530000000000001 110.841 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.471 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -80.78 2.16 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 73.25 110.902 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.992 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -23.69 59.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 42.039999999999999 110.867 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' CE ' ' A' ' 62' ' ' MET . 4.1 m -82.48 102.01 11.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.887 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.03 12.89 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.868 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.688 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.2 m-30 -58.8 -68.26 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.73 177.99 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 53.229999999999997 110.86 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -1.94 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 110.921 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.622 HG21 ' CD1' ' A' ' 25' ' ' LEU . 68.2 p -92.01 -52.03 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.209999999999994 111.145 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.476 ' HB1' ' CE ' ' A' ' 62' ' ' MET . . . -82.51 101.98 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 53.310000000000002 111.087 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -148.86 178.08 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 111.156 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 84' ' ' LEU . 4.2 mp -66.89 154.15 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.450000000000003 110.871 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -133.92 169.22 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 111.169 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.06 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 65.340000000000003 110.892 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.47 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.16 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.577 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.5 t-20 -52.04 106.55 0.67 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 74.530000000000001 110.855 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.0 Cg_endo -69.76 0.59 5.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.641 2.228 . . . . 71.200000000000003 112.357 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.428 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.01 108.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 74.439999999999998 110.86 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 1.3 p90 -80.99 -16.29 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 74.310000000000002 110.963 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.26 -119.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.540000000000006 112.444 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.63 71.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 45.420000000000002 111.118 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.2 m -78.77 101.95 7.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.892 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -98.79 136.56 38.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.510000000000005 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.8 m-85 -85.27 147.22 46.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.72 . . . . 74.420000000000002 110.888 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 135.77 31.42 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 73.120000000000005 112.335 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 10.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 64.239999999999995 110.878 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.855 0.36 . . . . 74.030000000000001 110.854 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.8 m-90 -125.41 118.37 25.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 73.25 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -94.06 102.05 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 63.310000000000002 110.879 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 2.7 m -151.9 153.34 31.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 73.329999999999998 111.095 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.5 Cg_endo -69.82 127.94 15.26 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.655 2.236 . . . . 71.430000000000007 112.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -51.96 114.71 5.65 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.583 0.706 . . . . 75.439999999999998 110.952 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.76 15.3 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 71.129999999999995 112.371 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 20' ' ' VAL . . . -131.65 62.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.709 -0.758 . . . . 54.329999999999998 112.499 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 25' ' ' LEU . 2.2 m -158.49 178.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 75.510000000000005 111.077 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.604 ' O ' HD22 ' A' ' 25' ' ' LEU . 34.3 m -55.84 127.45 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.826 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.55 -49.4 67.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 73.319999999999993 110.833 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -28.03 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.839 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.03 -49.57 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 110.905 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -71.05 -41.33 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 72.329999999999998 110.917 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 m -46.29 -43.39 15.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.219999999999999 111.131 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.62 -29.57 25.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 71.439999999999998 112.513 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -59.97 -68.15 0.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 44.219999999999999 110.946 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.643 HG23 ' CG ' ' A' ' 57' ' ' HIS . 97.2 mt -40.9 -68.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 74.409999999999997 111.123 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 29' ' ' ILE . 5.6 t30 -34.1 -44.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.838 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -75.72 -68.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 110.932 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB1' ' OD2' ' A' ' 38' ' ' ASP . . . -45.18 -21.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 73.409999999999997 111.082 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -71.96 5.16 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.876 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -110.04 15.2 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 110.857 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.2 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 51.43 110.866 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.19 -55.78 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 70.140000000000001 112.46 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.904 HG21 ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.21 9.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 51.5 111.141 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.771 ' OD2' ' HB1' ' A' ' 32' ' ' ALA . 1.6 m-20 -88.1 -63.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 110.868 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 114.93 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 63.130000000000003 110.88 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.77 -69.67 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 31.219999999999999 112.485 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.614 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.8 7.5 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.200000000000003 112.313 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.3 pt -82.22 16.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 111.145 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -73.62 123.74 89.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 61.130000000000003 110.932 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 171.25 14.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.719 2.28 . . . . 73.420000000000002 112.316 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.83 -33.89 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 12.01 112.485 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.09 5.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 63.32 112.498 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -68.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 53.219999999999999 111.082 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.87 2.18 18.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 72.219999999999999 110.9 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 6.1 t80 -40.99 -60.07 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.409999999999997 110.877 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.14 134.12 22.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.731 . . . . 73.340000000000003 110.905 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.71 150.67 90.38 Favored 'Cis proline' 0 C--N 1.341 0.145 0 C-N-CA 122.7 -1.792 . . . . 53.5 112.313 -0.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -100.47 122.22 42.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' NZ ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -85.68 157.48 20.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 54.149999999999999 111.146 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.92 -49.33 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 111.105 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' NZ ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -81.28 18.07 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 65.340000000000003 110.882 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.43 -54.18 23.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 62.450000000000003 111.076 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.946 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -37.25 -50.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.861 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.812 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -65.3 -39.48 92.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 65.230000000000004 111.098 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.09 -55.85 29.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 62.200000000000003 111.105 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.3 t80 -52.6 -62.35 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 110.919 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.946 HG12 ' O ' ' A' ' 57' ' ' HIS . 1.5 p -54.38 -37.44 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 73.120000000000005 111.137 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.417 ' SD ' ' SG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -45.71 -21.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 110.875 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -71.37 -52.08 20.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 72.329999999999998 110.923 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.665 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -83.53 -46.39 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 110.899 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.626 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -46.33 -45.29 17.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 53.520000000000003 110.947 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CE1' ' O ' ' A' ' 72' ' ' ASN . 58.7 t80 -60.45 -34.91 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 63.240000000000002 110.939 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -93.07 -4.22 52.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 64.349999999999994 110.96 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.904 ' CE1' HG21 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -70.83 -44.58 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 54.420000000000002 110.833 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.907 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.6 -59.53 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 65.099999999999994 111.064 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.79 24.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 74.420000000000002 112.466 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.01 32.43 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 110.846 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.627 ' O ' ' CE1' ' A' ' 66' ' ' TYR . 5.9 m-80 -100.71 163.63 12.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.400000000000006 110.891 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.523 ' CB ' HD11 ' A' ' 84' ' ' LEU . 83.8 p -67.55 -21.87 65.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.420000000000002 110.885 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.489 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.71 3.5 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.875 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.907 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -76.53 -26.71 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 110.873 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.417 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 93.1 m -82.4 102.01 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -118.01 11.05 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 64.409999999999997 110.904 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.812 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.9 m-30 -57.72 -68.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 75.049999999999997 110.917 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.75 178.0 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 110.851 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -2.06 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 110.907 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.523 HG21 ' CD1' ' A' ' 25' ' ' LEU . 67.2 p -91.88 -53.58 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 60.210000000000001 111.104 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.49 102.01 11.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.030000000000001 111.107 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.3 t -152.88 178.03 10.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.209999999999994 111.141 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.559 HD23 ' SG ' ' A' ' 14' ' ' CYS . 18.8 mt -65.8 123.69 20.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 73.010000000000005 110.949 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.472 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -106.17 168.63 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.049999999999997 111.132 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.8 m120 -53.88 -167.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 110.895 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.7 t -45.06 175.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 43.149999999999999 111.125 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.2 t-20 -51.95 107.09 0.75 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.701 . . . . 61.43 110.9 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.78 3.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 73.140000000000001 112.35 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.42 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 19.8 t -52.04 109.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 110.824 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -70.36 -16.86 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 74.209999999999994 110.967 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.455 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 175.16 -110.54 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 63.229999999999997 112.474 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.81 73.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 62.409999999999997 111.085 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.32 104.66 14.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 110.886 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -98.64 149.86 22.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 65.129999999999995 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.534 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.4 m-85 -90.71 159.87 39.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.652 0.739 . . . . 74.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 104.35 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.261 . . . . 55.229999999999997 112.334 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.578 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 40.6 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 64.230000000000004 110.89 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.71 ' HB3' HD22 ' A' ' 84' ' ' LEU . 58.1 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.837 0.351 . . . . 53.299999999999997 110.84 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.684 ' HB2' HG22 ' A' ' 85' ' ' THR . 10.9 m-90 -145.56 113.24 6.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 75.120000000000005 110.932 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.435 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -83.64 108.45 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 110.896 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.53 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.4 m -158.63 153.99 22.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.109999999999999 111.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.522 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.77 122.85 9.52 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.707 2.272 . . . . 60.43 112.36 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -51.92 116.97 8.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 74.530000000000001 110.927 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 86.85 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 65.25 112.324 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 -27.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 70.409999999999997 112.487 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 21' ' ' SER . 2.6 t -59.03 170.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 52.340000000000003 111.12 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.885 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.97 118.37 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 53.240000000000002 110.826 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -42.98 -66.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 71.209999999999994 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -41.23 -40.62 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.01 -50.4 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 52.100000000000001 110.904 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -71.31 -31.17 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 54.149999999999999 110.947 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.2 m -64.66 -30.03 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 111.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.72 -23.3 70.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 71.129999999999995 112.466 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 57.5 m-20 -63.83 -58.64 6.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 72.239999999999995 110.912 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 55' ' ' LYS . 95.9 mt -47.14 -47.86 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 72.329999999999998 111.11 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -51.65 -44.24 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.439999999999998 110.865 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.12 -56.56 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.881 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -47.85 -43.84 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 74.519999999999996 111.089 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -28.31 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 110.891 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -81.46 15.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 70.200000000000003 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.597 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.95 -46.8 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 61.210000000000001 110.932 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -62.43 0.64 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 54.399999999999999 112.512 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.79 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -83.07 11.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.094 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.863 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.6 t70 -86.98 -56.6 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.897 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.452 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.3 m -74.85 120.59 20.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.873 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.33 -69.44 0.43 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 75.530000000000001 112.477 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.81 1.28 4.61 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 63.329999999999998 112.337 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 38' ' ' ASP . 33.3 pt -83.2 18.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 111.109 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -86.75 135.69 35.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.638 0.733 . . . . 72.200000000000003 110.907 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 174.12 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.281 . . . . 63.439999999999998 112.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.09 -33.73 0.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 73.239999999999995 112.463 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.18 -21.4 6.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 72.519999999999996 112.478 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.44 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 60.200000000000003 111.078 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.2 m -117.91 -2.27 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.400000000000006 110.914 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.3 t80 -36.42 -51.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.867 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.582 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 19.1 mm-40 -99.72 129.56 28.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.59 0.71 . . . . 64.530000000000001 110.901 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.77 147.85 85.51 Favored 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.69 -1.796 . . . . 60.299999999999997 112.366 0.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.531 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 6.4 p30 -104.17 133.4 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 70.530000000000001 110.934 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.51 166.4 12.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 70.329999999999998 111.131 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.35 -56.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 111.095 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.08 14.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 75.140000000000001 110.877 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.38 53.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 41.020000000000003 111.109 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.733 ' CD2' HD12 ' A' ' 42' ' ' ILE . 64.8 m80 -51.95 -52.3 51.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 71.409999999999997 110.864 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -55.35 -43.02 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 111.108 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.73 68.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -68.38 -64.71 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 70.430000000000007 110.927 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 65' ' ' TYR . 7.1 p -55.5 -33.7 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 73.25 111.136 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.514 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -45.85 -27.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 65.319999999999993 110.843 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -66.16 -60.51 2.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 63.399999999999999 110.835 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.79 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -71.4 -47.85 53.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.932 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.597 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 3.0 t80 -45.55 -48.24 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.955 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.4 t80 -62.37 -31.89 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 71.230000000000004 110.943 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.64 -4.64 44.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 71.439999999999998 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.29 -42.89 68.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 70.530000000000001 110.869 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.904 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.45 -60.61 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 71.420000000000002 111.098 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.19 23.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 72.239999999999995 112.494 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 7.7 mtp180 52.07 43.18 30.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 74.439999999999998 110.856 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.3 m-80 -109.19 166.95 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 40.520000000000003 110.941 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.475 ' HB2' HD11 ' A' ' 84' ' ' LEU . 32.6 p -71.15 -24.93 62.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 41.43 110.819 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -78.52 -1.1 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 64.409999999999997 110.907 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.904 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.82 -22.07 59.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 72.549999999999997 110.879 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -82.78 102.05 11.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.510000000000005 110.855 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -117.98 6.88 12.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.868 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.3 m-30 -58.96 -71.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 64.209999999999994 110.89 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.16 178.01 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.807 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -2.78 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 63.200000000000003 110.904 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.643 HG21 ' CD1' ' A' ' 25' ' ' LEU . 29.1 p -97.99 -46.68 5.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 75.349999999999994 111.148 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -80.97 24.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.130000000000003 111.062 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -84.47 -178.18 6.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 62.149999999999999 111.141 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 12' ' ' SER . 1.6 mt -66.89 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.229999999999997 110.906 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.684 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.2 t -106.2 169.06 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.164 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 87' ' ' THR . 13.1 m-80 -53.25 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 70.019999999999996 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.08 173.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 75.140000000000001 111.159 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 6.6 t-20 -52.07 106.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 74.109999999999999 110.889 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.72 -13.21 34.44 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 60.219999999999999 112.378 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -52.06 105.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 62.420000000000002 110.847 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -16.7 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.310000000000002 110.908 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.56 -115.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 63.229999999999997 112.504 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.27 86.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 111.082 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 101.99 5.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 110.918 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.57 139.18 36.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 61.049999999999997 110.892 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 20.0 m-85 -93.01 141.18 23.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 74.120000000000005 110.879 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 129.02 16.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 74.310000000000002 112.331 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 36.8 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.519999999999996 110.898 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB3' HD22 ' A' ' 84' ' ' LEU . 3.7 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.854 0.359 . . . . 64.230000000000004 110.867 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.558 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 9.2 m-90 -142.85 115.16 8.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 71.310000000000002 110.893 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.79 108.62 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 62.109999999999999 110.885 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG21 ' CD2' ' A' ' 96' ' ' PHE . 3.2 m -158.56 154.16 22.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 72.519999999999996 111.124 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.542 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.78 120.75 7.48 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 75.049999999999997 112.334 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.01 117.7 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.617 0.722 . . . . 74.340000000000003 110.877 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.723 2.282 . . . . 50.219999999999999 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.06 -21.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 65.549999999999997 112.409 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.826 ' HB ' HD11 ' A' ' 25' ' ' LEU . 2.3 t -59.07 164.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 65.030000000000001 111.155 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.769 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.0 m -53.63 111.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 53.310000000000002 110.854 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.7 m-20 -33.78 -64.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 61.130000000000003 110.884 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.24 -40.73 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.871 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.4 tp-100 -58.33 -50.44 73.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 70.019999999999996 110.896 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.926 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.9 -29.28 65.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.901 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -66.53 -0.24 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 111.168 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.92 -38.5 5.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 45.340000000000003 112.498 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.4 p30 -53.6 -43.1 68.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 62.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 55' ' ' LYS . 64.1 mt -59.11 -46.94 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 70.040000000000006 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -44.31 38.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 63.43 110.884 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.7 -49.03 27.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.92 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -51.7 -45.13 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 73.299999999999997 111.093 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.443 ' CA ' ' OD2' ' A' ' 38' ' ' ASP . 9.0 t -57.44 -12.16 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 51.109999999999999 110.863 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.13 6.69 47.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 64.019999999999996 110.831 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.468 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.96 -43.09 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.957 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.96 -47.09 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 64.230000000000004 112.428 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 HD12 ' A' ' 64' ' ' LEU . 1.5 pt -89.74 8.21 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 73.049999999999997 111.132 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 42' ' ' ILE . 9.3 t70 -86.87 -61.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 70.430000000000007 110.871 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 3.8 m -75.95 124.62 27.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.812 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.28 -74.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 64.099999999999994 112.433 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' C ' ' A' ' 39' ' ' CYS . 53.3 Cg_endo -69.81 4.14 2.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 74.109999999999999 112.325 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 38' ' ' ASP . 5.9 pt -82.93 17.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 111.111 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -79.16 144.33 62.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.608 0.718 . . . . 64.150000000000006 110.891 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.595 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.2 Cg_endo -69.74 148.13 64.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 64.519999999999996 112.388 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.64 -39.28 3.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.5 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.69 15.18 2.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.74 . . . . 72.239999999999995 112.52 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.89 -68.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 60.219999999999999 111.149 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' PHE . 21.1 t -117.93 -6.73 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.310000000000002 110.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 3.0 t80 -34.34 -56.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 71.109999999999999 110.878 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 9.7 mm-40 -99.6 125.84 39.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 61.25 110.913 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.82 150.71 90.73 Favored 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 -1.813 . . . . 72.319999999999993 112.337 0.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -111.29 133.52 53.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 72.230000000000004 110.852 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.81 176.63 6.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 64.420000000000002 111.098 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.32 -54.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.120000000000005 111.114 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.71 17.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.862 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.28 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 73.150000000000006 111.101 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.719 ' CG ' HD12 ' A' ' 42' ' ' ILE . 26.8 m170 -57.25 -57.77 11.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 72.140000000000001 110.893 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.667 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -50.02 -36.52 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 74.040000000000006 111.086 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.31 92.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 111.059 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 5.7 t80 -68.01 -59.09 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 74.219999999999999 110.904 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 65' ' ' TYR . 7.5 p -55.1 -35.97 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 73.150000000000006 111.152 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.633 ' HE3' ' HA ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -46.46 -29.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.892 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.38 -65.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.935 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.53 -47.87 74.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.902 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.527 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -49.71 -47.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.929 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.1 t80 -60.6 -30.62 69.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.129999999999995 110.882 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -98.87 3.34 47.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 73.310000000000002 110.881 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.535 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -75.41 -48.8 21.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.878 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -70.16 -54.55 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.240000000000002 111.065 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.67 26.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 62.240000000000002 112.489 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.97 47.96 23.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 72.409999999999997 110.847 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.563 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 4.1 m-80 -114.19 162.07 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 62.119999999999997 110.928 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.577 ' HB2' HD11 ' A' ' 84' ' ' LEU . 59.5 p -67.96 -24.43 65.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 62.109999999999999 110.818 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -80.04 1.19 28.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 75.400000000000006 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.667 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -77.46 -19.79 55.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.919 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -83.54 102.08 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 41.229999999999997 110.833 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.04 7.56 12.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 72.239999999999995 110.898 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.667 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.3 m-30 -59.27 -71.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 110.913 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.71 177.97 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.883 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -65.5 -1.99 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 72.409999999999997 110.931 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.926 HG21 ' CD1' ' A' ' 25' ' ' LEU . 26.9 p -97.92 -47.48 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 53.310000000000002 111.157 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.03 26.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 44.130000000000003 111.088 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.6 t -86.75 -177.83 6.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 63.329999999999998 111.158 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 73' ' ' SER . 14.5 mt -67.04 130.51 43.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.442 . . . . 64.519999999999996 110.899 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.5 t -106.02 169.51 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 64.519999999999996 111.139 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.0 m120 -53.15 -169.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 61.310000000000002 110.883 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.5 t -44.66 172.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 61.130000000000003 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.558 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 15.7 t-20 -52.09 106.79 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.662 0.744 . . . . 75.209999999999994 110.869 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.555 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.74 -3.7 12.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 73.439999999999998 112.353 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 1.9 t -52.02 104.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 61.100000000000001 110.889 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -17.83 25.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.899 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.08 -117.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 51.130000000000003 112.519 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.8 -26.79 65.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 72.329999999999998 111.07 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 t -76.13 102.02 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 53.549999999999997 110.87 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.77 127.94 45.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.555 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 25.6 m-85 -92.45 141.15 24.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 63.229999999999997 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.24 25.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.688 2.259 . . . . 75.530000000000001 112.361 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.417 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 18.4 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.859 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.656 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.892 0.377 . . . . 71.430000000000007 110.856 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.656 ' CE3' ' C ' ' A' ' 12' ' ' SER . 8.6 m-90 -153.4 112.2 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 75.310000000000002 110.908 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -79.41 110.76 15.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 110.927 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.505 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 5.6 m -159.96 155.88 22.92 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.668 0.747 . . . . 74.439999999999998 111.078 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.77 122.9 9.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 74.439999999999998 112.331 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -52.02 114.53 5.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.525 0.678 . . . . 71.400000000000006 110.918 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 99.89 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 74.010000000000005 112.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.63 -28.28 2.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 72.530000000000001 112.474 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.882 HG11 HD11 ' A' ' 25' ' ' LEU . 5.8 p -58.89 173.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 42.450000000000003 111.155 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.701 ' H ' HG22 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.0 109.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.853 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.77 -68.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 50.340000000000003 110.861 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -41.22 -27.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 65.340000000000003 110.894 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 21' ' ' SER . 6.1 tm0? -63.99 -51.49 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 73.299999999999997 110.915 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.882 HD11 HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -70.24 -33.41 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 43.100000000000001 110.915 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 m -51.01 -18.84 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 62.009999999999998 111.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.97 -27.65 49.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 71.420000000000002 112.493 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 78.7 m-20 -59.81 -46.51 88.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 51.43 110.917 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 54' ' ' VAL . 65.2 mt -62.96 -53.24 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 62.030000000000001 111.117 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -52.43 -47.21 66.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.239999999999995 110.873 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -69.37 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 63.140000000000001 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.69 -33.36 33.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.081 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 43.8 t -57.27 -11.3 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 63.539999999999999 110.859 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 17.99 14.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 70.030000000000001 110.863 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -90.84 -51.83 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 62.43 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 168.02 -97.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 73.109999999999999 112.471 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.796 HG12 HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -81.99 18.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 64.530000000000001 111.121 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -75.09 -62.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 65.439999999999998 110.89 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.37 126.14 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 51.240000000000002 110.83 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.13 -70.06 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 63.25 112.467 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' CG ' ' O ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.81 6.0 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.683 2.255 . . . . 64.129999999999995 112.325 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.653 HD12 ' CG ' ' A' ' 57' ' ' HIS . 22.6 pt -82.63 18.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 111.135 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -79.89 129.51 70.31 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.922 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 170.1 17.46 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.678 2.252 . . . . 75.0 112.299 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.6 -41.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 61.439999999999998 112.48 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.35 -17.49 5.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 61.149999999999999 112.505 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.14 -68.64 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 72.209999999999994 111.132 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.05 6.29 12.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 64.329999999999998 110.859 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.573 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 3.7 t80 -40.87 -68.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 45.32 110.885 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -93.24 137.74 23.45 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.617 0.722 . . . . 73.109999999999999 110.913 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.555 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.2 Cg_endo -69.75 139.87 57.18 Favored 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.712 -1.786 . . . . 74.25 112.317 -0.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.73 133.66 52.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.438 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -86.93 174.24 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.479 . . . . 74.129999999999995 111.129 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 29' ' ' ILE . 56.4 t -65.76 -55.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.162 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HZ2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -78.42 13.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 110.904 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.579 ' N ' ' HZ2' ' A' ' 55' ' ' LYS . . . -51.15 -48.89 61.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 41.530000000000001 111.112 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.653 ' CG ' HD12 ' A' ' 42' ' ' ILE . 65.5 m80 -49.04 -48.13 44.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 74.340000000000003 110.847 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB1' ' HE2' ' A' ' 78' ' ' PHE . . . -57.66 -38.06 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 61.439999999999998 111.116 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.54 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 34.43 111.119 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.607 ' CE1' HD21 ' A' ' 64' ' ' LEU . 3.4 t80 -68.53 -59.14 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 63.439999999999998 110.905 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 2.0 p -54.71 -39.19 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 73.219999999999999 111.125 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.706 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 5.0 mtm -45.96 -32.62 2.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 71.129999999999995 110.858 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 62.340000000000003 110.862 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.796 HD12 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.69 -59.5 4.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 71.329999999999998 110.911 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.436 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 4.4 t80 -39.65 -43.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.901 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.0 t80 -61.15 -41.34 96.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 63.439999999999998 110.927 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 64' ' ' LEU . 29.2 mt-30 -91.62 -3.82 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 64.209999999999994 110.931 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.3 t60 -75.26 -40.68 58.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 74.140000000000001 110.89 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.998 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -75.76 -60.6 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 111.081 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.62 20.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 72.510000000000005 112.51 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 51.96 33.91 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 72.530000000000001 110.887 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.9 m-80 -102.98 167.24 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.109999999999999 110.897 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.655 ' HB2' HD11 ' A' ' 84' ' ' LEU . 93.7 p -71.26 -24.3 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.319999999999993 110.858 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.436 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -78.19 0.52 24.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 75.129999999999995 110.927 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.998 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -6.17 45.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.925 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -94.28 102.21 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.319999999999993 110.85 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.03 5.29 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 44.119999999999997 110.819 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.0 m-30 -59.31 -71.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 62.329999999999998 110.879 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.37 177.99 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.86 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.37 -2.84 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.936 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.49 HG21 ' CD1' ' A' ' 25' ' ' LEU . 27.5 p -98.04 -47.25 5.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 111.103 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.706 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -81.44 24.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 64.030000000000001 111.06 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 t -85.05 -177.29 6.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 70.439999999999998 111.173 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 73' ' ' SER . 15.4 mt -66.86 125.28 25.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.140000000000001 110.875 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.7 t -98.01 169.39 9.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 73.140000000000001 111.161 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 85' ' ' THR . 51.8 m-80 -52.95 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 110.901 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 1.6 t -44.39 170.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 63.039999999999999 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.563 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.3 t-20 -52.01 106.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.643 0.735 . . . . 62.240000000000002 110.902 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -3.09 11.28 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 71.450000000000003 112.323 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 3.5 t -51.97 107.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.450000000000003 110.857 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -17.88 45.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 110.913 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.56 -113.59 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 72.510000000000005 112.471 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.18 -38.16 90.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 61.439999999999998 111.103 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 101.99 5.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 110.905 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.51 144.97 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 55.299999999999997 110.906 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 8.6 m-85 -92.45 150.35 39.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.657 0.741 . . . . 74.010000000000005 110.924 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 115.97 4.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 72.209999999999994 112.333 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 8.5 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 53.030000000000001 110.876 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.571 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.885 0.374 . . . . 73.319999999999993 110.836 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.574 ' CD1' ' HB3' ' A' ' 98' ' ' SER . 7.6 m-90 -146.7 105.24 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 63.119999999999997 110.929 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.428 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -72.28 105.34 4.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 53.43 110.867 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.519 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.2 m -158.77 153.62 21.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 63.130000000000003 111.098 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.76 120.27 7.08 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 50.25 112.371 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.0 119.37 14.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 75.239999999999995 110.904 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 85.3 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.725 2.283 . . . . 62.100000000000001 112.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.42 -22.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 70.439999999999998 112.457 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 21' ' ' SER . 24.4 t -65.81 164.13 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 62.039999999999999 111.123 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.582 ' N ' HG12 ' A' ' 20' ' ' VAL . 5.4 m -54.0 103.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 62.020000000000003 110.88 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 21' ' ' SER . 34.8 m-20 -34.06 -65.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 110.876 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . 35.2 m-20 -36.21 -41.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.895 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -62.62 -46.91 86.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 64.209999999999994 110.911 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.794 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.1 OUTLIER -70.27 -33.54 71.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.299999999999997 110.93 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 m -56.6 -35.0 67.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 32.420000000000002 111.145 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.9 -26.63 67.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 73.099999999999994 112.509 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -63.46 -43.2 98.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 73.109999999999999 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 57' ' ' HIS . 24.9 mt -62.38 -51.63 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.010000000000005 111.102 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -54.07 -45.41 71.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -68.95 -58.07 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 110.895 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.894 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -49.94 -47.03 52.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 75.310000000000002 111.127 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -50.77 -17.43 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 54.25 110.863 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -88.0 13.58 10.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 52.340000000000003 110.897 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.03 -46.06 6.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 72.0 110.918 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 136.53 -55.57 0.7 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.714 -0.755 . . . . 55.32 112.457 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.3 pt -88.13 4.1 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 60.100000000000001 111.135 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.894 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 1.9 m-20 -80.6 -58.98 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 75.510000000000005 110.857 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -75.37 127.31 32.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 75.25 110.874 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.17 -73.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 40.409999999999997 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.602 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.8 3.61 2.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.686 2.257 . . . . 62.450000000000003 112.336 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 38' ' ' ASP . 12.7 pt -83.1 17.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 54.240000000000002 111.08 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.52 135.54 53.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 64.420000000000002 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 176.56 6.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.695 2.263 . . . . 71.0 112.381 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.95 -35.43 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 71.439999999999998 112.466 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.1 -25.86 9.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 53.340000000000003 112.471 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.78 -68.14 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 63.240000000000002 111.108 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.09 -8.96 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.219999999999999 110.866 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -37.49 -48.44 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.519999999999996 110.842 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.32 126.97 37.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 74.519999999999996 110.858 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.72 148.26 86.26 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 -1.789 . . . . 61.439999999999998 112.335 -0.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 8.7 t-20 -103.14 150.63 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 53.030000000000001 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.4 ' CB ' ' HE2' ' A' ' 55' ' ' LYS . 27.9 p -106.46 163.82 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 71.319999999999993 111.119 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.8 -56.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 53.509999999999998 111.122 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.609 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.49 16.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.864 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -51.24 -47.89 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.0 111.127 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.724 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.2 m80 -45.34 -58.97 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 110.84 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.696 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -51.46 -38.81 55.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.096 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 56' ' ' ALA . . . -55.89 -40.42 72.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.200000000000003 111.111 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.602 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 9.4 t80 -68.13 -63.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.040000000000006 110.923 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.881 HG11 ' OD1' ' A' ' 38' ' ' ASP . 7.4 p -55.12 -33.56 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 73.129999999999995 111.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.686 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 mmt -46.13 -29.66 1.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 110.885 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.37 -65.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 64.310000000000002 110.858 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.569 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.87 -51.03 62.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 62.530000000000001 110.901 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.561 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.8 t80 -44.64 -43.71 8.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 74.030000000000001 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 3.7 t80 -64.08 -30.71 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.936 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -98.21 -2.33 39.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 74.329999999999998 110.928 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -72.99 -48.18 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 75.109999999999999 110.85 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.937 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -68.82 -57.06 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 111.136 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.7 24.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 74.109999999999999 112.482 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 52.0 35.61 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 70.230000000000004 110.839 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -103.14 166.3 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 35.399999999999999 110.846 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -71.3 -23.24 61.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 65.530000000000001 110.81 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.44 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -79.29 0.26 29.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.468 . . . . 74.340000000000003 110.936 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.937 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -23.19 59.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.299999999999997 110.891 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -84.11 102.11 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 61.009999999999998 110.846 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -118.08 8.44 12.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.828 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.696 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -59.46 -70.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.876 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.75 177.98 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.129999999999995 110.803 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -65.33 -2.35 3.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 71.400000000000006 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.794 HG21 ' CD1' ' A' ' 25' ' ' LEU . 29.0 p -97.96 -46.46 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 111.17 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.67 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.66 25.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 111.077 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 t -86.56 -177.6 6.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 74.519999999999996 111.18 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 12' ' ' SER . 16.7 mt -66.89 106.9 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 53.130000000000003 110.915 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.2 t -77.98 167.55 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 64.099999999999994 111.152 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 17.2 m-20 -53.27 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.65 173.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 73.400000000000006 111.099 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 21.5 t-20 -52.0 106.0 0.6 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.647 0.737 . . . . 54.520000000000003 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.2 Cg_endo -69.74 -23.03 31.33 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.272 . . . . 70.299999999999997 112.298 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.1 t -52.0 106.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 71.219999999999999 110.832 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -80.03 -15.3 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 73.129999999999995 110.917 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.01 -124.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 74.329999999999998 112.474 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -37.86 -43.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 73.450000000000003 111.088 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 62.219999999999999 110.852 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.84 133.83 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 110.907 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.546 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 23.8 m-85 -92.71 146.48 32.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.678 0.751 . . . . 74.5 110.869 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 117.13 4.89 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.674 2.249 . . . . 70.129999999999995 112.345 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 91.9 p . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 63.299999999999997 110.87 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.665 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 58.8 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.856 0.36 . . . . 71.5 110.836 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.665 ' CE3' ' C ' ' A' ' 12' ' ' SER . 9.2 m-90 -152.8 123.19 7.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.299999999999997 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.48 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -90.7 111.72 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.120000000000005 110.886 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.488 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.2 m -160.09 154.89 20.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.450000000000003 111.133 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HD3' ' HE1' ' A' ' 62' ' ' MET . 53.5 Cg_endo -69.75 125.59 12.33 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.717 2.278 . . . . 63.32 112.35 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 110.13 1.73 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.512 0.672 . . . . 71.299999999999997 110.882 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 97.58 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 74.310000000000002 112.29 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.83 -33.73 2.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 54.229999999999997 112.483 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 21' ' ' SER . 2.8 p -58.98 178.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 64.040000000000006 111.136 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.775 ' H ' HG22 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -52.0 128.46 24.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.838 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 24' ' ' GLN . 72.9 m-20 -58.26 -67.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.854 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' HA ' HG22 ' A' ' 26' ' ' THR . 1.1 m-20 -41.81 -23.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 70.510000000000005 110.834 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 22' ' ' ASP . 1.0 OUTLIER -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 53.450000000000003 110.904 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.654 HD11 ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -70.89 -56.67 5.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.898 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 23' ' ' ASP . 12.0 t -44.9 -20.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 70.310000000000002 111.108 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 25' ' ' LEU . . . -69.15 -37.93 82.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 73.200000000000003 112.48 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.88 -56.24 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.782 0.325 . . . . 74.510000000000005 110.916 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 57' ' ' HIS . 23.4 mt -46.44 -41.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 62.109999999999999 111.128 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -56.66 -48.08 78.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.13 -56.18 5.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 62.539999999999999 110.967 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.878 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -51.05 -43.47 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 75.219999999999999 111.099 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 37.4 t -52.75 -15.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.510000000000005 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.32 15.87 16.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 60.020000000000003 110.886 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.445 ' HA ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -97.98 -48.04 5.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 73.230000000000004 110.922 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.73 -64.14 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.748 . . . . 34.200000000000003 112.486 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.115 HD12 HD12 ' A' ' 64' ' ' LEU . 3.4 pt -82.3 14.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 71.349999999999994 111.121 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.878 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 3.2 m-20 -89.5 -65.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 73.519999999999996 110.846 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.4 m -76.08 124.49 27.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.858 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.45 -74.58 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 71.239999999999995 112.499 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD2' ' C ' ' A' ' 39' ' ' CYS . 53.5 Cg_endo -69.78 5.73 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 62.25 112.322 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 38' ' ' ASP . 5.1 pt -85.23 17.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 70.019999999999996 111.105 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -76.69 135.49 68.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.722 . . . . 75.409999999999997 110.93 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 170.66 16.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.625 2.216 . . . . 74.099999999999994 112.318 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.78 -38.83 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 71.329999999999998 112.444 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.57 -26.16 4.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 45.299999999999997 112.434 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.83 -68.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 63.420000000000002 111.093 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.96 14.43 14.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 44.100000000000001 110.897 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 3.1 t80 -56.48 -50.9 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.899 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -97.52 128.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.699 0.762 . . . . 72.430000000000007 110.853 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 150.84 90.87 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.68 -1.8 . . . . 74.540000000000006 112.37 -0.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.553 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 4.1 t30 -99.74 131.62 45.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.329999999999998 110.86 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.545 ' HB ' ' HZ3' ' A' ' 55' ' ' LYS . 65.7 p -90.9 167.31 12.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 52.119999999999997 111.193 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.2 -59.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 71.400000000000006 111.141 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.49 17.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 110.929 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -48.55 -41.12 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.400000000000006 111.043 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.596 ' CD2' HD12 ' A' ' 42' ' ' ILE . 47.2 m80 -54.76 -55.26 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 74.140000000000001 110.874 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.497 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -50.57 -41.93 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 34.399999999999999 111.106 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' HE3' ' A' ' 62' ' ' MET . . . -57.43 -40.23 77.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 111.101 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 6.3 t80 -68.92 -57.0 6.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 73.329999999999998 110.972 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.513 HG21 ' OD1' ' A' ' 38' ' ' ASP . 3.3 p -54.39 -43.79 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 72.319999999999993 111.134 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.563 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 2.8 ttm -45.76 -29.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 75.400000000000006 110.863 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.502 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 32.8 t30 -59.3 -62.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.540000000000006 110.855 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.115 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.58 -46.22 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 73.319999999999993 110.93 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 3.4 t80 -47.43 -54.59 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 72.329999999999998 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.599 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.0 t80 -55.59 -30.55 61.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 74.120000000000005 110.905 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 49.4 mt-30 -95.41 -4.51 45.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 73.409999999999997 110.895 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -68.4 -44.14 75.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 54.399999999999999 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.978 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.42 -60.23 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 111.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.82 23.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 32.509999999999998 112.475 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.563 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.02 37.24 20.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.0 110.858 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.599 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 2.4 m-80 -100.97 164.76 11.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.230000000000004 110.913 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 p -68.38 -25.57 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 110.825 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -79.55 1.78 24.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 71.319999999999993 110.951 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.978 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -79.92 -3.93 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 43.420000000000002 110.868 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -101.57 102.01 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 44.039999999999999 110.888 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -117.96 9.54 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.904 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.638 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.6 m-30 -58.33 -70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.929 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.78 178.01 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 61.100000000000001 110.868 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -3.07 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 74.420000000000002 110.937 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 25' ' ' LEU . 26.5 p -97.95 -49.01 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 44.340000000000003 111.146 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.73 25.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.139 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -86.3 -178.5 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 71.430000000000007 111.16 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 12' ' ' SER . 2.9 mm? -66.91 130.89 44.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 63.539999999999999 110.899 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.05 167.85 9.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 73.019999999999996 111.149 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.9 m-20 -53.71 -168.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 71.310000000000002 110.878 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -44.53 171.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 111.163 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.557 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 13.6 t-20 -51.95 105.94 0.59 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.329999999999998 110.878 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.79 -1.27 8.21 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 72.439999999999998 112.347 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.456 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 4.9 t -51.98 110.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.450000000000003 110.874 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -86.98 -18.06 31.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 64.230000000000004 110.918 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.44 -120.72 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 64.430000000000007 112.452 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.98 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.349999999999994 110.854 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.03 140.32 33.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 110.891 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.5 m-85 -92.11 146.03 31.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 74.430000000000007 110.865 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 122.83 9.49 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 74.200000000000003 112.37 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 25.7 p . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 74.420000000000002 110.866 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.651 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 2.7 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.833 0.349 . . . . 73.400000000000006 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.651 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 6.4 m-90 -141.07 114.14 8.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 63.409999999999997 110.916 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.0 110.67 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 74.200000000000003 110.861 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.51 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 m -159.59 154.34 21.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.626 0.727 . . . . 75.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.527 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 54.1 Cg_endo -69.8 123.28 9.94 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 63.119999999999997 112.326 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.98 114.3 5.18 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 74.420000000000002 110.871 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 92.37 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.715 2.277 . . . . 72.140000000000001 112.37 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.74 -24.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 52.200000000000003 112.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.636 ' HB ' HD21 ' A' ' 25' ' ' LEU . 44.3 t -59.05 165.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 64.340000000000003 111.142 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.632 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.2 m -52.08 108.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.450000000000003 110.877 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 21' ' ' SER . 5.5 m-20 -32.99 -65.27 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.140000000000001 110.853 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.02 -40.68 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.905 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -60.26 -49.17 78.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 73.25 110.907 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.22 -29.04 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 61.520000000000003 110.945 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.778 ' OG1' HG11 ' A' ' 54' ' ' VAL . 17.3 m -67.11 0.07 2.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 73.519999999999996 111.166 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.92 -40.34 5.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 65.129999999999995 112.506 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.3 p30 -50.47 -44.3 55.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.367 . . . . 74.25 110.883 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 55' ' ' LYS . 61.6 mt -58.21 -49.05 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 74.049999999999997 111.142 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.19 -41.07 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.9 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.15 -52.68 11.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 110.967 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 38' ' ' ASP . . . -52.82 -41.6 64.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 70.299999999999997 111.099 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.42 -9.69 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 60.509999999999998 110.9 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.19 3.89 40.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.019999999999996 110.848 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.18 -36.48 6.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 110.923 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 -31.18 7.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 34.130000000000003 112.506 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.728 ' CD1' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -83.22 -11.41 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 74.430000000000007 111.168 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.726 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.65 -63.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.876 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 62.9 m -75.83 129.57 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 41.210000000000001 110.834 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.7 -85.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 54.310000000000002 112.51 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 7.02 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.242 . . . . 74.340000000000003 112.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.697 HD12 ' CG ' ' A' ' 57' ' ' HIS . 5.1 pt -82.62 17.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.540000000000006 111.16 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -79.53 132.85 60.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.601 0.715 . . . . 64.430000000000007 110.916 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 171.52 14.33 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.686 2.258 . . . . 61.530000000000001 112.323 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 63.130000000000003 112.492 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.36 -25.72 3.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.349999999999994 112.449 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.41 -68.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 61.039999999999999 111.12 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.95 14.88 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 51.420000000000002 110.907 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.591 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 2.9 t80 -51.66 -56.55 13.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 71.109999999999999 110.847 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.591 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 1.3 mm-40 -96.41 133.18 25.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 65.450000000000003 110.879 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 157.04 92.57 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.705 -1.79 . . . . 65.299999999999997 112.33 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -117.24 142.22 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 60.149999999999999 110.912 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.0 p -106.84 172.82 6.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 111.118 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.778 HG11 ' OG1' ' A' ' 26' ' ' THR . 43.9 t -65.73 -54.73 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 71.430000000000007 111.153 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -79.7 17.23 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.893 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.3 -45.44 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.340000000000003 111.115 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.697 ' CG ' HD12 ' A' ' 42' ' ' ILE . 32.9 m170 -53.79 -60.18 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 71.549999999999997 110.843 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.497 ' C ' ' HE2' ' A' ' 62' ' ' MET . . . -43.97 -47.21 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 44.310000000000002 111.1 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.35 49.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 75.140000000000001 111.134 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 8.9 t80 -69.33 -65.01 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.947 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.664 HG23 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -54.42 -26.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 75.019999999999996 111.127 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.723 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 1.5 mtm -52.26 -20.38 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.889 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.07 -65.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 61.340000000000003 110.877 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.728 HD12 ' CD1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -63.74 -41.77 97.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.908 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 3.4 t80 -58.51 -45.11 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.916 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 4.6 t80 -65.21 -30.43 71.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.409999999999997 110.926 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -96.21 -3.71 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 71.010000000000005 110.949 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -45.74 74.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 71.530000000000001 110.83 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.686 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -75.82 -57.75 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.071 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.11 25.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 71.299999999999997 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.04 47.09 25.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 72.010000000000005 110.897 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.6 m-80 -110.27 165.6 11.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.230000000000004 110.886 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.694 ' HB2' HD11 ' A' ' 84' ' ' LEU . 30.4 p -70.74 -25.84 63.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 110.841 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -77.74 0.3 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.946 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.686 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -77.54 -14.42 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 75.530000000000001 110.886 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -91.39 102.03 14.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.864 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.06 7.75 12.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.43 110.877 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.3 m-30 -59.03 -70.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 70.150000000000006 110.853 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.85 178.03 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 75.540000000000006 110.884 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -1.84 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 110.908 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.889 HG21 ' CD1' ' A' ' 25' ' ' LEU . 37.3 p -95.0 -50.33 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 111.147 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.723 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -80.66 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 71.400000000000006 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -87.01 -179.52 6.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 111.148 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.694 HD11 ' HB2' ' A' ' 73' ' ' SER . 2.5 mt -67.36 131.51 45.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 64.209999999999994 110.938 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.08 168.43 9.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 73.540000000000006 111.129 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.25 -169.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 55.409999999999997 110.867 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -44.22 172.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 74.329999999999998 111.127 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.4 t-20 -52.01 106.78 0.7 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 74.109999999999999 110.89 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.547 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.7 -4.03 13.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.678 2.252 . . . . 74.150000000000006 112.34 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 2.5 t -51.98 110.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 54.229999999999997 110.838 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -15.69 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 72.329999999999998 110.921 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.89 -128.92 1.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 62.100000000000001 112.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.59 65.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 74.519999999999996 111.142 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.49 101.98 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 53.219999999999999 110.902 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -99.75 141.29 32.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 75.450000000000003 110.939 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.547 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 15.9 m-85 -93.14 147.76 34.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 75.299999999999997 110.896 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.4 4.08 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 72.239999999999995 112.289 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.47 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 27.9 p . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 75.310000000000002 110.878 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.662 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 70.8 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.896 0.379 . . . . 75.219999999999999 110.825 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.662 ' CE3' ' C ' ' A' ' 12' ' ' SER . 7.2 m-90 -152.94 107.06 3.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.956 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -72.87 105.59 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 65.230000000000004 110.853 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.556 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.8 m -158.88 154.82 23.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.647 0.736 . . . . 73.209999999999994 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.527 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.78 118.43 5.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 72.140000000000001 112.329 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.98 110.16 1.74 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.714 . . . . 71.420000000000002 110.89 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 79.65 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.705 2.27 . . . . 42.439999999999998 112.356 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 159.41 58.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 41.009999999999998 112.484 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.839 ' CG2' HD11 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -158.26 177.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 60.310000000000002 111.105 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 2.4 m -51.97 116.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 52.32 110.878 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -40.94 -66.22 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 110.887 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.33 -27.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.824 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' SER . 21.8 tt0 -63.54 -52.45 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 110.908 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.839 HD11 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -71.65 -51.14 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 64.109999999999999 110.903 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.597 ' OG1' HG11 ' A' ' 54' ' ' VAL . 25.7 m -45.5 -43.86 12.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 72.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.4 -30.49 2.05 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 72.239999999999995 112.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -64.37 -66.68 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 110.876 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 57' ' ' HIS . 37.1 mt -38.21 -49.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.178 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.442 ' OD1' ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -52.14 -44.84 64.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.030000000000001 110.873 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -74.05 -54.6 7.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 110.937 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -51.57 -38.89 56.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 44.009999999999998 111.088 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -12.66 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.299999999999997 110.874 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -115.2 18.04 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 110.844 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 1.8 mm100 -93.02 -52.02 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.918 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 161.72 -91.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 65.129999999999995 112.482 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.451 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.55 17.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 53.009999999999998 111.132 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -85.41 -60.68 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 71.150000000000006 110.869 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.88 110.06 8.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 63.520000000000003 110.924 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.65 -70.99 0.46 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 63.420000000000002 112.486 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.558 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.75 8.1 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.691 2.26 . . . . 71.099999999999994 112.309 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.682 HD12 ' CD2' ' A' ' 57' ' ' HIS . 20.2 pt -82.32 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 64.150000000000006 111.142 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -82.85 122.56 78.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 65.329999999999998 110.926 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 168.53 21.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 71.430000000000007 112.303 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.56 -35.45 1.08 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 44.340000000000003 112.503 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.57 -19.42 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 42.420000000000002 112.519 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 -68.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 74.209999999999994 111.089 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -117.98 12.75 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 75.209999999999994 110.914 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.524 ' CE1' ' CB ' ' A' ' 52' ' ' ASN . 2.1 t80 -56.97 -47.37 80.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 110.863 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.57 129.12 33.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.652 0.739 . . . . 74.239999999999995 110.909 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.76 150.54 90.33 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 -1.8 . . . . 61.299999999999997 112.367 0.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.524 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -114.5 118.2 33.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.010000000000005 110.936 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.82 170.18 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 72.409999999999997 111.156 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.597 HG11 ' OG1' ' A' ' 26' ' ' THR . 50.3 t -64.4 -52.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.230000000000004 111.134 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.527 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.73 13.63 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 65.310000000000002 110.873 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.99 -43.06 60.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.349999999999994 111.098 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.682 ' CD2' HD12 ' A' ' 42' ' ' ILE . 61.8 m80 -55.2 -46.97 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 72.319999999999993 110.834 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.592 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -59.67 -37.53 79.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 52.310000000000002 111.098 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.34 80.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 54.340000000000003 111.12 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.558 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -68.74 -61.19 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 74.120000000000005 110.915 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -54.79 -45.36 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 75.109999999999999 111.145 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -46.07 -21.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 65.310000000000002 110.876 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HB3' HD23 ' A' ' 64' ' ' LEU . 10.9 t30 -69.41 -59.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.510000000000005 110.906 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -76.74 -47.18 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 72.120000000000005 110.938 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t80 -46.52 -40.11 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.929 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 6.3 t80 -60.47 -31.07 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 110.956 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -96.3 -4.32 42.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 72.109999999999999 110.888 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -50.4 45.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 110.863 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.812 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -68.01 -57.84 5.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 22.350000000000001 111.09 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.14 25.09 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 73.450000000000003 112.501 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.01 35.82 17.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 70.439999999999998 110.888 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.476 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.2 m-80 -102.84 169.69 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.9 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.562 ' HB2' HD11 ' A' ' 84' ' ' LEU . 56.5 p -71.72 -22.49 61.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 61.329999999999998 110.83 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.66 0.82 32.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 74.109999999999999 110.892 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.812 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -10.28 59.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 65.230000000000004 110.906 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HE1' ' A' ' 62' ' ' MET . 0.5 OUTLIER -90.66 103.33 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.049999999999997 110.917 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -118.03 2.23 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.879 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.592 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 2.8 m-85 -58.94 -71.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 110.924 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.35 177.97 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 110.895 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -65.41 -2.48 3.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.540000000000006 110.922 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.1 p -98.02 -48.43 5.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 61.219999999999999 111.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -80.42 23.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 111.137 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -84.98 -176.69 6.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.209 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 73' ' ' SER . 2.0 mt -66.21 107.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 64.219999999999999 110.901 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -78.14 168.97 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 111.147 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' THR . 75.3 m-20 -53.54 -168.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 110.907 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 10.2 t -44.46 171.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 55.210000000000001 111.145 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.01 106.27 0.63 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.636 0.732 . . . . 73.239999999999995 110.872 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.72 -1.6 8.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.701 2.268 . . . . 75.040000000000006 112.385 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -52.01 108.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.901 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.579 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 4.1 p90 -82.82 -18.14 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 62.140000000000001 110.914 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 -114.48 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 65.209999999999994 112.5 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -36.92 85.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 73.349999999999994 111.049 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.579 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -79.41 101.98 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.91 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.08 147.82 25.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 62.329999999999998 110.908 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -93.1 156.41 40.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 75.340000000000003 110.904 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 125.95 12.69 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.262 . . . . 74.109999999999999 112.291 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.483 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 1.2 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.510000000000005 110.843 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.879 0.371 . . . . 71.140000000000001 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -148.4 132.31 8.54 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.613 0.72 . . . . 73.209999999999994 111.13 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 118.54 5.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.646 2.231 . . . . 74.540000000000006 112.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -110.39 141.59 24.27 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.63 0.728 . . . . 62.219999999999999 111.131 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 168.67 20.82 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.652 2.234 . . . . 64.219999999999999 112.381 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -121.23 141.9 34.01 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.566 0.698 . . . . 50.310000000000002 111.139 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -163.69 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 72.319999999999993 112.351 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -109.01 131.02 55.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 110.859 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.6 158.72 30.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.25 111.114 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.66 154.13 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 63.43 111.098 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.97 -64.63 0.5 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 71.409999999999997 112.487 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.589 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -152.21 158.22 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.847 0.356 . . . . 54.030000000000001 110.876 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CE3' ' C ' ' A' ' 12' ' ' SER . 2.5 m-90 -138.08 120.86 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 72.420000000000002 110.93 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.81 102.09 14.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 63.009999999999998 110.871 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.99 152.43 26.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 71.209999999999994 111.166 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.74 127.78 15.1 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.664 2.243 . . . . 71.129999999999995 112.329 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -52.02 118.23 11.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.566 0.698 . . . . 73.129999999999995 110.911 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 82.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.726 2.284 . . . . 73.299999999999997 112.312 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.28 -25.61 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.73 -0.748 . . . . 74.319999999999993 112.461 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.766 ' HB ' HD11 ' A' ' 25' ' ' LEU . 13.2 t -59.1 166.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.865 0.364 . . . . 74.109999999999999 111.104 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.836 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.3 m -56.44 113.19 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 110.811 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 21' ' ' SER . 24.3 m-20 -36.57 -59.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 65.439999999999998 110.898 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -36.43 28.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 74.030000000000001 110.891 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -63.72 -48.51 76.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.458 . . . . 65.200000000000003 110.899 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.836 HD22 ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -70.98 -30.46 66.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.430000000000007 110.877 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.52 ' OG1' HG11 ' A' ' 54' ' ' VAL . 9.8 m -55.8 -30.24 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 60.25 111.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.78 -23.13 58.46 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.699 -0.762 . . . . 62.109999999999999 112.532 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 4.6 m-20 -64.14 -68.67 0.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.328 . . . . 73.319999999999993 110.901 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 84.9 mt -43.82 -43.68 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 73.439999999999998 111.117 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -57.52 -46.99 83.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.409999999999997 110.886 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 1.2 t80 -73.95 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 61.130000000000003 110.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.92 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -51.15 -43.19 61.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 65.519999999999996 111.097 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 35.5 t -53.37 -14.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 64.209999999999994 110.939 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.87 14.5 19.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 63.420000000000002 110.901 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.96 -46.48 5.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 71.230000000000004 110.94 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.65 -62.41 0.57 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 34.340000000000003 112.493 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.673 HD12 HD12 ' A' ' 64' ' ' LEU . 1.0 OUTLIER -82.32 5.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 73.209999999999994 111.159 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.92 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 6.0 m-20 -82.86 -63.81 1.29 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.133 -0.485 . . . . 53.140000000000001 110.877 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.45 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.11 126.19 30.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.32 110.901 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.85 -70.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 62.219999999999999 112.471 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.616 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.82 4.85 1.98 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.694 2.263 . . . . 62.119999999999997 112.319 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.772 HD12 ' CG ' ' A' ' 57' ' ' HIS . 27.3 pt -83.35 18.04 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 63.439999999999998 111.113 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -74.12 129.28 84.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.57 0.7 . . . . 73.230000000000004 110.92 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 161.24 46.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 72.099999999999994 112.352 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.87 -35.33 2.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.694 -0.765 . . . . 63.009999999999998 112.435 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.13 -26.1 5.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 75.450000000000003 112.487 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.1 -68.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 73.129999999999995 111.12 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' A' ' 49' ' ' PHE . 28.8 m -118.07 -4.36 11.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 72.450000000000003 110.866 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 48' ' ' CYS . 1.7 t80 -34.28 -54.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.129999999999995 110.863 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.33 124.76 41.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.73 . . . . 71.150000000000006 110.909 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.15 88.13 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 -1.811 . . . . 70.140000000000001 112.345 0.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.43 ' CA ' ' O ' ' A' ' 49' ' ' PHE . 13.7 p-10 -106.03 127.08 52.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.319999999999993 110.882 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 59.1 p -83.5 166.8 17.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 54.399999999999999 111.16 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.52 HG11 ' OG1' ' A' ' 26' ' ' THR . 41.0 t -65.8 -57.84 9.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 111.123 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -78.97 13.94 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 45.119999999999997 110.923 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -51.3 -48.42 62.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.230000000000004 111.084 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.772 ' CG ' HD12 ' A' ' 42' ' ' ILE . 34.7 m170 -50.33 -50.41 51.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 73.310000000000002 110.828 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.711 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -56.66 -37.55 70.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.219999999999999 111.106 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.34 75.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 71.150000000000006 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 6.8 t80 -68.27 -63.11 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 70.129999999999995 110.951 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.658 HG22 ' HB2' ' A' ' 65' ' ' TYR . 2.6 p -54.82 -33.39 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 111.147 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.46 ' HE3' ' CD1' ' A' ' 78' ' ' PHE . 1.5 mmt -45.54 -24.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 65.299999999999997 110.862 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 99' ' ' GLY . 8.4 t30 -68.87 -58.15 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 63.109999999999999 110.905 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.673 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -74.86 -50.73 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 61.409999999999997 110.933 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.658 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.4 t80 -46.3 -50.02 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.030000000000001 110.936 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.553 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 31.4 t80 -53.53 -36.78 62.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 73.219999999999999 110.939 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -94.09 -2.68 52.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.485 . . . . 75.5 110.91 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -74.55 -42.62 58.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.150000000000006 110.879 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.988 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.48 -60.9 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 51.399999999999999 111.098 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.02 19.95 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 41.240000000000002 112.455 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.98 32.08 9.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 70.040000000000006 110.866 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.553 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 1.9 m-80 -104.75 166.38 10.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.453 . . . . 45.130000000000003 110.857 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.575 ' HB3' HD21 ' A' ' 84' ' ' LEU . 57.8 p -68.06 -23.15 64.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 60.329999999999998 110.852 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.427 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.13 2.23 28.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 65.439999999999998 110.914 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.988 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -13.45 61.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 55.299999999999997 110.911 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -82.73 101.98 11.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 63.439999999999998 110.943 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' O ' ' CE2' ' A' ' 31' ' ' TYR . 8.6 m-20 -118.0 7.63 12.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.868 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.3 m-30 -59.08 -68.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.040000000000006 110.907 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.91 178.04 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 63.350000000000001 110.87 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -1.94 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.833 HG21 ' CD1' ' A' ' 25' ' ' LEU . 72.2 p -93.17 -52.52 4.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 111.132 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -82.43 102.01 11.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 70.230000000000004 111.132 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -148.94 178.06 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 111.117 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.575 HD21 ' HB3' ' A' ' 73' ' ' SER . 6.2 mp -66.32 126.75 29.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 65.230000000000004 110.947 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -106.38 169.36 8.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 62.140000000000001 111.121 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 87' ' ' THR . 33.4 m-80 -54.06 -167.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 61.130000000000003 110.921 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.2 t -45.13 175.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 65.319999999999993 111.185 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.582 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 5.8 t-20 -51.97 105.96 0.59 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.626 0.727 . . . . 71.010000000000005 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.503 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.4 Cg_endo -69.79 -16.44 37.42 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.254 . . . . 65.310000000000002 112.31 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 29.8 t -51.97 110.54 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 64.349999999999994 110.848 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -77.2 -15.71 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.932 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 168.65 -122.43 1.02 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.748 -0.739 . . . . 41.109999999999999 112.501 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -40.09 -42.79 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 52.420000000000002 111.045 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.64 102.26 7.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 62.520000000000003 110.859 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.0 130.85 45.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 75.120000000000005 110.921 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.503 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 20.8 m-85 -83.93 144.38 44.69 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.659 0.742 . . . . 70.010000000000005 110.886 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 120.34 7.14 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.655 2.236 . . . . 61.200000000000003 112.369 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 52.6 p -110.23 2.96 19.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 62.009999999999998 110.828 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.47 ' O ' ' ND2' ' A' ' 63' ' ' ASN . . . 124.75 -43.42 1.39 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.783 -0.722 . . . . 71.329999999999998 112.513 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.6 m -77.84 141.15 39.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 61.350000000000001 110.862 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 110.871 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.837 0.351 . . . . 50.200000000000003 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.7 p -146.42 150.48 40.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 72.109999999999999 111.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 136.66 33.42 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.716 2.277 . . . . 63.240000000000002 112.29 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.2 p -138.41 143.46 38.7 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.583 0.706 . . . . 72.400000000000006 111.129 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 133.95 26.7 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 63.140000000000001 112.342 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.8 p -105.95 148.78 37.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.539 0.685 . . . . 64.209999999999994 111.137 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -173.83 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.689 2.259 . . . . 73.140000000000001 112.349 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 115.74 14.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 61.030000000000001 110.905 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.38 166.41 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 63.520000000000003 111.12 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 163.55 7.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 111.125 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.634 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 58.66 105.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.728 -0.749 . . . . 45.439999999999998 112.494 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.63 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.6 OUTLIER -157.95 125.87 5.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 41.219999999999999 110.852 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.634 ' CZ3' ' C ' ' A' ' 11' ' ' GLY . 1.6 m-90 -134.29 111.69 10.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.118 -0.492 . . . . 64.349999999999994 110.93 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -82.42 101.99 11.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 74.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -153.86 152.42 26.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 72.329999999999998 111.124 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.74 129.17 17.15 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 75.540000000000006 112.355 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 115.93 7.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.617 0.722 . . . . 74.340000000000003 110.883 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 84.49 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 41.130000000000003 112.371 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.74 -25.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.745 -0.741 . . . . 61.329999999999998 112.457 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.635 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.8 t -59.1 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.073 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.696 ' O ' HD22 ' A' ' 25' ' ' LEU . 14.8 m -52.06 109.2 0.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.099999999999994 110.836 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 21' ' ' SER . 42.8 m-20 -33.87 -64.91 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 63.25 110.878 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.34 -40.53 2.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.883 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.9 tp60 -58.13 -51.38 69.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 43.329999999999998 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.794 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -71.68 -27.04 62.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.877 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.809 ' OG1' HG11 ' A' ' 54' ' ' VAL . 11.0 m -62.89 -6.88 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 60.119999999999997 111.14 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.58 -25.8 45.21 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 61.399999999999999 112.492 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.39 -67.96 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 63.43 110.879 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 33' ' ' CYS . 80.7 mt -39.21 -44.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 72.150000000000006 111.112 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.52 -47.6 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.239999999999995 110.868 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.53 -58.12 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 110.889 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.89 -41.16 61.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 111.114 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 13.3 t -56.84 -9.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 65.409999999999997 110.851 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.05 18.0 19.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.453 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 4.9 mm100 -94.46 -50.57 5.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 71.230000000000004 110.916 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.83 -81.13 0.17 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 72.310000000000002 112.446 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.76 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.3 pt -81.6 17.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 74.340000000000003 111.128 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.703 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -89.44 -61.13 1.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 74.0 110.872 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.454 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -74.47 124.58 26.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.409999999999997 110.892 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.19 -69.77 0.42 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 65.540000000000006 112.512 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.77 6.01 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.666 2.244 . . . . 74.109999999999999 112.371 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.703 HG23 ' O ' ' A' ' 38' ' ' ASP . 21.6 pt -82.53 17.95 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.099999999999994 111.117 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.75 138.65 62.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 75.230000000000004 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.74 145.9 58.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.701 2.267 . . . . 61.140000000000001 112.336 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.3 -29.94 4.32 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 74.310000000000002 112.463 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.15 -13.1 7.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 54.450000000000003 112.536 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 -68.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 74.420000000000002 111.114 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.2 m -118.05 11.11 13.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.549999999999997 110.914 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 1.5 t80 -54.92 -57.39 11.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 75.310000000000002 110.909 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.588 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -100.53 127.09 33.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 73.430000000000007 110.887 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.73 153.92 93.04 Favored 'Cis proline' 0 C--N 1.342 0.188 0 C-N-CA 122.687 -1.797 . . . . 64.340000000000003 112.367 -0.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -101.58 119.31 38.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.877 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 56.5 p -83.19 171.43 13.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 74.450000000000003 111.163 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.809 HG11 ' OG1' ' A' ' 26' ' ' THR . 69.1 t -65.84 -61.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 34.299999999999997 111.125 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.55 16.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 72.129999999999995 110.911 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -51.47 -47.5 63.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.106 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.642 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.8 m80 -50.15 -50.25 49.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.831 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.681 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.93 -33.14 68.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 51.030000000000001 111.109 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.3 -37.14 86.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 111.083 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.589 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -68.32 -60.65 2.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.349999999999994 110.961 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -55.26 -34.72 33.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 71.120000000000005 111.152 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.574 ' HE2' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -50.67 -29.99 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.846 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -65.38 -67.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.893 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.82 -53.35 41.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.908 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.76 ' HA ' HD11 ' A' ' 37' ' ' ILE . 3.3 t80 -46.94 -45.79 20.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.299999999999997 110.907 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.607 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 35.6 t80 -58.76 -26.41 63.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 72.400000000000006 110.9 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.489 ' NE2' ' HA2' ' A' ' 99' ' ' GLY . 41.9 mt-30 -103.29 -1.89 28.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 74.019999999999996 110.921 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -70.17 -42.19 72.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.466 . . . . 73.010000000000005 110.852 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.638 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.63 -56.09 4.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 111.121 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.42 24.57 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 62.109999999999999 112.484 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 52.04 46.57 26.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.812 0.339 . . . . 74.319999999999993 110.85 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.607 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -112.71 168.23 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 71.430000000000007 110.902 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.514 ' HA ' HD11 ' A' ' 84' ' ' LEU . 73.2 p -71.2 -24.59 62.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 50.43 110.865 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -78.87 1.35 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 74.430000000000007 110.938 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -22.47 59.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 110.888 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.407 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.3 m -82.31 102.0 10.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 110.906 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.0 8.81 12.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 70.209999999999994 110.87 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.681 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -58.54 -68.67 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.867 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.3 t -172.07 178.01 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 65.140000000000001 110.819 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -65.7 -1.52 2.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 72.540000000000006 110.939 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.583 HG21 ' CD1' ' A' ' 25' ' ' LEU . 64.9 p -92.91 -52.62 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 53.420000000000002 111.157 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.34 102.33 11.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.409999999999997 111.092 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 t -148.78 178.01 9.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.431 . . . . 70.200000000000003 111.162 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -66.65 112.06 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 65.230000000000004 110.958 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -89.23 168.18 12.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 64.140000000000001 111.107 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' THR . 72.1 m-20 -54.39 -167.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.908 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.6 t -44.46 173.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 65.349999999999994 111.138 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.8 t-20 -52.11 106.92 0.72 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.624 0.726 . . . . 65.329999999999998 110.86 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.73 -2.77 10.71 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.672 2.248 . . . . 72.150000000000006 112.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.402 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 11.7 t -51.99 105.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.887 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -74.6 -16.39 60.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 73.049999999999997 110.931 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.08 -113.25 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.737 . . . . 51.210000000000001 112.52 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.31 79.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 72.209999999999994 111.08 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 63.32 110.876 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -99.36 140.16 33.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 62.530000000000001 110.894 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.543 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.07 151.14 40.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 74.519999999999996 110.841 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 126.23 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.623 2.215 . . . . 62.32 112.371 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.497 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 6.0 p -113.35 -0.18 14.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 73.340000000000003 110.842 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.489 ' HA2' ' NE2' ' A' ' 67' ' ' GLN . . . 39.77 42.98 2.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 53.509999999999998 112.503 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.08 168.15 11.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 51.109999999999999 110.863 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 74.109999999999999 110.889 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.872 0.367 . . . . 65.040000000000006 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.479 ' CG2' ' HD2' ' A' ' 3' ' ' PRO . 4.9 m -95.87 136.44 22.24 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.6 0.714 . . . . 74.439999999999998 111.175 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' HD2' ' CG2' ' A' ' 2' ' ' THR . 53.9 Cg_endo -69.77 99.14 0.73 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.707 2.272 . . . . 73.219999999999999 112.35 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -74.8 149.72 85.85 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.574 0.702 . . . . 55.420000000000002 111.147 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 154.75 67.34 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.662 2.242 . . . . 65.420000000000002 112.367 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.6 p -70.56 148.47 95.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 53.32 111.104 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -168.93 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.264 . . . . 74.340000000000003 112.317 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -101.76 118.67 37.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.400000000000006 110.908 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.4 111.71 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 62.140000000000001 111.11 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.08 171.67 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.121 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . -80.12 142.75 24.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.759 -0.734 . . . . 32.5 112.522 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -153.55 126.43 8.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.819 0.342 . . . . 72.219999999999999 110.891 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.569 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.4 m-90 -125.98 116.52 21.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 74.040000000000006 110.926 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.92 106.24 18.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 70.420000000000002 110.859 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -155.4 152.43 24.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.585 0.707 . . . . 74.420000000000002 111.133 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.8 Cg_endo -69.75 127.29 14.38 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 73.340000000000003 112.336 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -51.97 113.55 4.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.601 0.715 . . . . 61.350000000000001 110.903 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' HZ3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.77 79.93 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.732 2.288 . . . . 73.420000000000002 112.325 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -26.25 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 71.430000000000007 112.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.811 ' HB ' HD11 ' A' ' 25' ' ' LEU . 3.3 t -58.96 167.73 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.239999999999995 111.131 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.763 ' O ' HD22 ' A' ' 25' ' ' LEU . 3.6 m -53.89 111.77 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 41.399999999999999 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 21' ' ' SER . 23.1 m-20 -34.96 -61.09 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.888 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.28 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.319999999999993 110.889 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.1 tp60 -60.34 -50.25 74.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 74.400000000000006 110.919 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.891 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.93 -23.78 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.530000000000001 110.88 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.418 HG23 ' CG1' ' A' ' 54' ' ' VAL . 3.1 m -66.35 0.08 2.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.109999999999999 111.134 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.43 -35.64 6.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 65.120000000000005 112.517 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 7.9 p30 -55.15 -45.37 75.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 74.010000000000005 110.916 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 55' ' ' LYS . 63.6 mt -59.24 -59.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 72.439999999999998 111.162 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -44.63 -40.0 5.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 71.319999999999993 110.93 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -73.94 -60.7 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 62.299999999999997 110.905 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.5 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -52.17 -26.46 11.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 60.229999999999997 111.083 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -70.59 1.65 4.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.887 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.15 9.39 32.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.851 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.03 -44.63 6.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 62.020000000000003 110.857 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.6 -51.95 0.84 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 74.349999999999994 112.482 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.654 HD12 HD12 ' A' ' 64' ' ' LEU . 2.5 pt -82.18 8.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.833 0.349 . . . . 72.540000000000006 111.12 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.1 t70 -89.1 -60.71 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.230000000000004 110.886 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.62 119.01 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 63.350000000000001 110.857 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.22 -67.86 0.48 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.762 . . . . 50.420000000000002 112.474 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.2 Cg_endo -69.72 -1.05 7.78 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.672 2.248 . . . . 55.25 112.377 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.699 HD12 ' CG ' ' A' ' 57' ' ' HIS . 17.4 pt -82.87 14.9 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 71.030000000000001 111.09 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -76.75 126.54 85.72 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.637 0.732 . . . . 73.019999999999996 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 173.67 10.61 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 72.540000000000006 112.337 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.29 -38.92 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.773 -0.727 . . . . 23.52 112.452 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.92 -34.36 2.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.686 -0.768 . . . . 75.319999999999993 112.465 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.06 -68.57 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 73.409999999999997 111.078 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.98 15.76 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 75.150000000000006 110.876 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 50' ' ' GLU . 2.5 t80 -51.85 -66.81 0.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.25 110.837 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -86.1 136.66 35.76 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.749 . . . . 65.310000000000002 110.853 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.73 146.13 81.25 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 -1.799 . . . . 73.099999999999994 112.385 -0.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 3.1 p30 -104.8 134.04 48.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.8 p -95.12 169.11 10.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.187 -0.461 . . . . 61.210000000000001 111.128 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' CG1' HG23 ' A' ' 26' ' ' THR . 59.4 t -65.18 -56.98 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 111.093 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -78.67 13.63 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 73.530000000000001 110.931 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -51.64 -46.96 63.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 71.209999999999994 111.104 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.699 ' CG ' HD12 ' A' ' 42' ' ' ILE . 38.9 m80 -50.46 -59.67 3.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 75.540000000000006 110.83 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.746 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -47.75 -38.01 14.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.106 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 56' ' ' ALA . . . -57.84 -42.06 83.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 65.230000000000004 111.062 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.604 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 2.7 t80 -67.31 -57.78 6.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.414 . . . . 72.329999999999998 110.934 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 65' ' ' TYR . 3.6 p -55.22 -38.88 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 64.200000000000003 111.153 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.585 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 36.3 mtp -46.22 -25.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 54.520000000000003 110.91 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.475 ' OD1' ' CA ' ' A' ' 99' ' ' GLY . 1.1 t30 -66.41 -60.36 2.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 70.219999999999999 110.873 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.654 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -73.46 -45.69 52.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 55.100000000000001 110.936 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.65 ' HA ' HD11 ' A' ' 37' ' ' ILE . 2.4 t80 -51.4 -54.2 29.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 61.240000000000002 110.906 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 26.4 t80 -50.95 -36.15 37.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 110.924 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.49 -3.64 49.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 44.310000000000002 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -73.93 -42.56 60.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.83 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.003 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.2 -62.05 1.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 74.349999999999994 111.052 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -167.42 20.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.718 . . . . 45.350000000000001 112.546 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.99 37.44 21.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 74.129999999999995 110.891 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.0 m-80 -108.84 168.26 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 75.230000000000004 110.899 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.594 ' CB ' HD11 ' A' ' 84' ' ' LEU . 89.2 p -69.03 -24.93 64.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 110.866 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -80.22 1.17 29.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 71.030000000000001 110.922 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 1.003 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.65 -26.24 60.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 70.239999999999995 110.9 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.5 m -82.47 102.04 11.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 63.409999999999997 110.9 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -118.03 14.24 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.149 -0.478 . . . . 55.329999999999998 110.873 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.746 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.3 m-30 -58.92 -67.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 110.908 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.64 178.02 3.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 110.834 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -64.88 -2.33 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.938 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.891 HG21 ' CD1' ' A' ' 25' ' ' LEU . 50.9 p -93.36 -51.77 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 65.310000000000002 111.135 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.585 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.11 104.82 12.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.099 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 t -154.82 178.01 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.164 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD11 ' CB ' ' A' ' 73' ' ' SER . 37.6 mt -67.29 127.7 33.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.9 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.6 t -106.3 167.58 9.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 72.530000000000001 111.12 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' A' ' 87' ' ' THR . 50.2 m-80 -53.85 -168.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 71.329999999999998 110.913 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.85 172.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 74.340000000000003 111.153 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.569 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.08 106.86 0.71 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 71.219999999999999 110.862 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -1.09 7.85 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.010000000000005 112.34 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.406 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 14.9 t -51.97 108.93 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.430000000000007 110.861 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -75.12 -17.11 60.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 70.310000000000002 110.914 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.71 -111.38 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 75.200000000000003 112.495 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.93 85.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 72.219999999999999 111.114 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 102.09 11.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 63.100000000000001 110.899 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -98.82 151.65 20.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 110.864 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.1 m-85 -92.41 148.93 37.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.628 0.728 . . . . 71.120000000000005 110.854 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 124.43 11.06 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.665 2.243 . . . . 74.25 112.34 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.556 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 13.1 p -117.26 14.81 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 75.230000000000004 110.909 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.475 ' CA ' ' OD1' ' A' ' 63' ' ' ASN . . . 100.22 -22.58 39.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 62.329999999999998 112.435 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.7 p -150.67 167.36 27.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 71.209999999999994 110.859 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 75.230000000000004 110.862 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.91 0.386 . . . . 70.349999999999994 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 t -128.74 141.83 42.94 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.639 0.733 . . . . 74.209999999999994 111.109 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 112.83 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.272 . . . . 73.140000000000001 112.33 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.9 m -69.0 122.84 86.64 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.559 0.695 . . . . 74.200000000000003 111.154 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 94.75 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.672 2.248 . . . . 73.150000000000006 112.336 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.681 HG23 ' HD2' ' A' ' 7' ' ' PRO . 84.3 m -90.85 139.14 26.01 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.569 0.7 . . . . 61.039999999999999 111.156 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 6' ' ' THR . 53.8 Cg_endo -69.77 -173.76 0.78 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.672 2.248 . . . . 73.099999999999994 112.327 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.1 110.22 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 65.319999999999993 110.882 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.94 164.89 18.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 51.539999999999999 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.52 163.33 3.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.077 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.592 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 70.4 122.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.748 -0.739 . . . . 72.239999999999995 112.469 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.607 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 36.0 m -157.98 120.54 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.807 0.337 . . . . 73.5 110.844 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.607 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 4.6 m-90 -133.33 116.14 15.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.481 . . . . 74.439999999999998 110.883 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -87.36 101.99 14.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 71.319999999999993 110.904 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.436 HG21 ' CE2' ' A' ' 96' ' ' PHE . 2.9 m -148.9 153.54 38.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 64.439999999999998 111.135 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.75 126.17 13.01 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.672 2.248 . . . . 73.299999999999997 112.336 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -51.98 107.07 0.74 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.576 0.703 . . . . 73.310000000000002 110.909 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 17' ' ' LYS . 53.7 Cg_endo -69.74 79.81 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.717 2.278 . . . . 74.040000000000006 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 163.43 55.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 52.009999999999998 112.476 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 25' ' ' LEU . 1.2 m -158.59 177.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.879 0.371 . . . . 72.329999999999998 111.108 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -52.01 119.05 3.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 63.450000000000003 110.906 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.479 ' HA ' ' CD2' ' A' ' 25' ' ' LEU . 52.0 m-20 -52.2 -37.02 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 44.109999999999999 110.877 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -20.53 55.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 70.420000000000002 110.845 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -77.79 -48.43 16.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 65.019999999999996 110.919 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.836 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.67 -53.03 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.461 . . . . 70.420000000000002 110.924 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.569 HG23 ' N ' ' A' ' 27' ' ' GLY . 14.2 t -37.49 -47.89 0.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 72.310000000000002 111.135 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.569 ' N ' HG23 ' A' ' 26' ' ' THR . . . -46.4 -41.73 12.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 55.340000000000003 112.479 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -47.18 -69.48 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 72.439999999999998 110.866 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 70.1 mt -40.08 -57.56 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 75.329999999999998 111.139 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -46.12 -42.68 14.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 70.150000000000006 110.869 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.4 ' CD2' ' HA ' ' A' ' 78' ' ' PHE . 4.6 t80 -73.86 -58.37 3.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 110.909 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' ASP . . . -51.09 -24.78 4.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 70.430000000000007 111.101 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.08 2.27 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.140000000000001 110.859 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.47 5.73 37.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 62.409999999999997 110.818 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.04 -42.75 7.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.89 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 123.48 -46.43 1.1 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 44.210000000000001 112.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.634 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.1 pt -82.34 5.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 72.030000000000001 111.115 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.74 ' O ' HG23 ' A' ' 42' ' ' ILE . 16.4 t70 -89.36 -58.06 2.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 110.855 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.8 OUTLIER -75.73 119.34 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.881 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.36 -70.84 0.41 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.727 -0.749 . . . . 74.129999999999995 112.465 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.5 Cg_endo -69.8 -0.84 7.54 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.655 2.236 . . . . 75.030000000000001 112.313 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.771 HD12 ' CG ' ' A' ' 57' ' ' HIS . 14.2 pt -83.08 17.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 54.530000000000001 111.13 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -75.93 137.97 69.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 64.109999999999999 110.876 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 173.92 10.3 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.221 . . . . 64.0 112.375 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.76 -35.35 1.07 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 41.409999999999997 112.462 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 124.13 -27.75 5.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 74.25 112.498 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.2 -68.29 0.24 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.824 0.345 . . . . 61.009999999999998 111.061 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -115.98 18.06 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.230000000000004 110.89 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.568 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.9 t80 -56.84 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 71.209999999999994 110.885 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -94.8 129.02 37.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.613 0.72 . . . . 75.109999999999999 110.89 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.72 148.01 85.75 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.655 -1.81 . . . . 63.229999999999997 112.376 -0.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -103.39 142.27 34.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.897 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 19.8 p -92.39 167.32 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.109999999999999 111.163 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG11 ' HB ' ' A' ' 26' ' ' THR . 84.5 t -65.61 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 73.140000000000001 111.081 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.508 ' CG ' ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -81.19 17.96 1.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.888 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.76 -42.84 58.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 111.076 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.771 ' CG ' HD12 ' A' ' 42' ' ' ILE . 41.3 m170 -54.49 -56.59 17.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 63.020000000000003 110.832 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -49.99 -36.57 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 55.109999999999999 111.099 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 35.43 111.068 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.592 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -67.86 -58.53 4.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 71.349999999999994 110.91 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' A' ' 65' ' ' TYR . 3.5 p -55.06 -36.56 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.074 -0.512 . . . . 64.019999999999996 111.095 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.622 ' HE2' ' CZ ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER -46.7 -23.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.130000000000003 110.858 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -69.41 -62.35 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.120000000000005 110.896 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -70.8 -45.28 64.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 110.928 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.634 ' HA ' HD11 ' A' ' 37' ' ' ILE . 2.4 t80 -53.45 -50.82 64.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 110.953 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.609 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 58.2 t80 -53.02 -29.13 27.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.096 -0.502 . . . . 63.409999999999997 110.892 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.537 ' NE2' ' C ' ' A' ' 99' ' ' GLY . 23.7 mt-30 -99.28 -4.02 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 73.420000000000002 110.933 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -71.51 -42.2 68.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 74.25 110.874 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.866 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.04 -59.8 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.019999999999996 111.085 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 23.19 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 55.340000000000003 112.477 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.0 39.36 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 54.5 110.903 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.609 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 4.7 m-80 -110.94 171.94 7.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.883 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.53 ' HA ' HD11 ' A' ' 84' ' ' LEU . 79.4 p -71.86 -23.56 61.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 70.420000000000002 110.85 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.78 2.48 26.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 73.150000000000006 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.866 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -24.69 59.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 110.844 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 1.4 m -82.32 101.95 10.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 64.340000000000003 110.845 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -117.96 11.31 13.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.892 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.716 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.0 m-30 -58.47 -68.12 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 72.019999999999996 110.867 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.69 177.98 3.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 53.299999999999997 110.849 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.33 -1.96 2.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.493 . . . . 72.439999999999998 110.968 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.437 HG21 ' CD1' ' A' ' 25' ' ' LEU . 61.1 p -92.53 -52.91 4.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.15 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.47 106.06 14.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 70.310000000000002 111.102 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.5 t -154.7 178.02 10.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 74.409999999999997 111.113 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 73' ' ' SER . 1.4 mt -67.37 123.32 20.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 73.310000000000002 110.913 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.5 t -103.82 168.62 9.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 111.138 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' THR . 66.6 m-20 -54.16 -167.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 63.240000000000002 110.873 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.24 170.98 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.129 -0.487 . . . . 64.450000000000003 111.133 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.4 t-20 -51.97 107.03 0.73 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.624 0.726 . . . . 51.32 110.894 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.424 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.3 Cg_endo -69.82 2.55 3.46 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.653 2.235 . . . . 75.439999999999998 112.32 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 44.5 t -52.02 106.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 64.200000000000003 110.883 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 94' ' ' CYS . 11.2 p90 -78.62 -16.21 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 64.549999999999997 110.903 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.5 -113.49 0.48 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 62.210000000000001 112.518 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.47 -36.74 83.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 64.209999999999994 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -76.34 102.66 6.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 70.439999999999998 110.862 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -98.14 140.48 32.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.928 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 15' ' ' VAL . 6.6 m-85 -92.48 158.02 39.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 61.520000000000003 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 113.82 3.51 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.665 2.244 . . . . 74.409999999999997 112.337 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.54 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 26.1 p -91.23 2.7 56.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 61.5 110.88 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.537 ' C ' ' NE2' ' A' ' 67' ' ' GLN . . . 76.97 32.82 47.93 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.665 -0.779 . . . . 75.420000000000002 112.484 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.9 106.87 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 73.430000000000007 110.852 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.7 t30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 70.040000000000006 110.857 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.819 0.342 . . . . 72.329999999999998 111.108 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p -100.8 152.11 37.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.57 0.7 . . . . 74.420000000000002 111.122 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -7.69 21.68 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.664 2.243 . . . . 54.450000000000003 112.395 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.8 p -82.57 153.23 67.91 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.541 0.686 . . . . 63.340000000000003 111.154 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.7 18.05 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.676 2.251 . . . . 51.539999999999999 112.33 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.9 p -52.17 151.62 6.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 74.230000000000004 111.191 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -165.98 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.726 2.284 . . . . 41.509999999999998 112.333 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -108.62 110.04 21.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 71.299999999999997 110.917 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.68 167.48 26.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 74.129999999999995 111.112 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.19 171.16 3.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 51.049999999999997 111.114 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -66.29 -159.91 0.79 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.735 -0.745 . . . . 63.130000000000003 112.543 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.473 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -151.15 140.65 21.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.876 0.369 . . . . 74.140000000000001 110.82 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.7 m-90 -137.52 115.75 11.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.874 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.01 102.05 12.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 65.150000000000006 110.867 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -152.65 152.02 27.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.636 0.731 . . . . 74.120000000000005 111.099 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.83 124.66 11.26 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.659 2.239 . . . . 70.420000000000002 112.304 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' O ' HG23 ' A' ' 20' ' ' VAL . 5.8 mmtm -52.0 119.57 14.53 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.578 0.704 . . . . 74.329999999999998 110.863 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 80.72 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.705 2.27 . . . . 54.310000000000002 112.308 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -25.48 0.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.71 -0.757 . . . . 72.219999999999999 112.46 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 21' ' ' SER . 2.5 t -59.0 173.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.363 . . . . 64.209999999999994 111.144 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.882 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.69 115.28 4.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 74.329999999999998 110.857 -179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' HA ' HD23 ' A' ' 25' ' ' LEU . 53.2 m-20 -40.73 -47.81 2.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 75.340000000000003 110.85 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -57.76 -34.38 69.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.140000000000001 110.872 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 14.1 mm100 -69.04 -46.12 68.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.959 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.882 HD22 ' O ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -70.29 -56.54 6.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 110.947 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 27' ' ' GLY . 11.3 t -41.05 -45.25 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.144 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 26' ' ' THR . . . -39.39 -37.8 0.84 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 72.109999999999999 112.43 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 29' ' ' ILE . 3.7 m-20 -56.14 -68.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 62.210000000000001 110.86 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 55' ' ' LYS . 76.9 mt -35.31 -44.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 73.200000000000003 111.076 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -56.12 -49.18 74.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 62.450000000000003 110.89 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' ASN . 1.1 t80 -74.46 -54.43 7.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.912 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.92 -40.3 60.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 74.299999999999997 111.154 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 34.5 t -56.75 -10.04 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 55.219999999999999 110.839 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 m -112.55 18.1 18.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 71.430000000000007 110.845 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.471 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 4.4 mm100 -93.9 -50.93 5.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 63.020000000000003 110.911 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.82 -85.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.694 -0.765 . . . . 70.519999999999996 112.473 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 64' ' ' LEU . 2.6 pt -81.38 17.39 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.81 0.338 . . . . 74.109999999999999 111.115 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.623 ' HA ' HG21 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -85.38 -61.29 1.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 63.119999999999997 110.851 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -75.02 122.43 23.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 50.340000000000003 110.819 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.49 -67.42 0.51 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 63.210000000000001 112.477 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.71 1.98 3.92 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.237 . . . . 64.040000000000006 112.363 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.683 HD12 ' CD2' ' A' ' 57' ' ' HIS . 24.7 pt -84.54 17.98 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.122 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -85.85 127.29 63.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.72 . . . . 64.430000000000007 110.912 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.8 Cg_endo -69.75 156.45 63.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.717 2.278 . . . . 63.25 112.337 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.43 -47.13 1.15 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 74.420000000000002 112.457 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.04 -0.94 2.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.784 -0.722 . . . . 52.119999999999997 112.508 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.27 -68.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 73.430000000000007 111.11 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -117.94 9.86 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.925 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 4.5 t80 -56.21 -60.3 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 71.010000000000005 110.891 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 mt-10 -96.72 128.93 34.2 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.643 0.735 . . . . 61.210000000000001 110.89 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.81 145.09 78.59 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 -1.804 . . . . 72.319999999999993 112.372 0.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 1.2 p30 -107.23 151.74 25.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 72.129999999999995 110.88 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 39.7 p -99.92 170.87 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 71.129999999999995 111.172 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 26' ' ' THR . 72.0 t -65.43 -62.61 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 71.340000000000003 111.081 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.78 18.04 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.209999999999994 110.914 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.23 -40.91 48.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 65.109999999999999 111.064 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.3 m80 -53.19 -52.65 58.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 71.230000000000004 110.875 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.47 -38.14 74.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 62.130000000000003 111.086 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.04 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 52.310000000000002 111.124 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 10.5 t80 -61.58 -65.08 0.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 110.945 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 38' ' ' ASP . 2.7 p -55.2 -34.74 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 74.030000000000001 111.088 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.485 ' HE3' ' HD3' ' A' ' 16' ' ' PRO . 2.7 mtm -44.89 -26.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.040000000000006 110.908 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -67.25 -60.74 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.310000000000002 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.54 -52.3 18.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 110.91 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.604 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.7 t80 -46.46 -44.59 17.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 73.0 110.928 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 12.6 t80 -58.96 -28.43 66.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 70.230000000000004 110.903 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -99.56 -4.79 30.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 70.319999999999993 110.927 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.24 -41.67 69.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 110.881 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.846 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.17 -58.12 3.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 51.310000000000002 111.094 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 23.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 13.199999999999999 112.487 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.02 43.79 30.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.864 0.364 . . . . 73.439999999999998 110.852 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.504 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.5 m-80 -114.4 169.92 8.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 75.230000000000004 110.932 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.414 ' CB ' HD11 ' A' ' 84' ' ' LEU . 78.4 p -71.7 -23.19 61.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 52.520000000000003 110.873 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -80.06 1.89 26.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 74.530000000000001 110.907 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.846 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -24.32 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 52.020000000000003 110.916 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -82.55 102.02 11.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.857 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -118.03 11.83 13.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 54.439999999999998 110.844 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.73 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.7 m-30 -59.04 -68.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.895 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.46 178.02 3.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 43.530000000000001 110.824 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -65.9 -1.78 3.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 75.510000000000005 110.963 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.587 HG21 HD13 ' A' ' 25' ' ' LEU . 73.3 p -91.81 -50.01 5.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 111.118 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.14 102.01 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 111.076 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.1 t -147.37 178.47 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 63.149999999999999 111.124 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.414 HD11 ' CB ' ' A' ' 73' ' ' SER . 35.7 mt -66.16 122.9 18.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.914 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -99.57 168.03 10.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.159 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.96 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 52.450000000000003 110.867 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.0 t -44.46 172.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 111.067 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.3 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.625 0.726 . . . . 63.329999999999998 110.915 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.8 -2.37 10.09 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 63.020000000000003 112.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.4 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 8.0 t -52.04 108.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 62.329999999999998 110.845 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 5.9 p90 -81.57 -15.28 55.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 74.310000000000002 110.947 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.97 -115.12 0.5 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 74.219999999999999 112.566 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.96 89.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 73.120000000000005 111.142 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.577 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -76.45 102.03 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 62.32 110.867 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.5 142.84 30.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 61.229999999999997 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.544 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 10.0 m-85 -92.08 150.87 41.2 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.671 0.748 . . . . 70.209999999999994 110.839 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 125.23 11.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 51.409999999999997 112.37 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 9.1 p -106.91 -5.69 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 61.32 110.877 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.78 52.8 7.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 74.239999999999995 112.512 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -162.08 164.11 28.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.906 0.384 . . . . 74.040000000000006 110.873 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 71.310000000000002 110.896 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.863 0.363 . . . . 64.099999999999994 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 t -150.61 133.69 8.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.619 0.724 . . . . 72.040000000000006 111.128 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -170.78 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.679 2.252 . . . . 64.450000000000003 112.352 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 p -53.53 155.22 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 73.230000000000004 111.113 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 80.02 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 72.310000000000002 112.375 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 p -141.85 153.19 64.1 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.566 0.698 . . . . 73.129999999999995 111.137 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -173.88 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 53.229999999999997 112.374 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.56 109.01 5.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.874 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.96 127.77 34.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 61.210000000000001 111.096 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 166.39 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 73.25 111.04 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.429 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . -38.02 157.96 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.736 -0.745 . . . . 75.519999999999996 112.513 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.529 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 25.2 m -158.0 139.73 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.915 0.388 . . . . 71.340000000000003 110.806 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.0 m-90 -137.75 119.52 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 74.540000000000006 110.927 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -89.21 101.98 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 65.299999999999997 110.884 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -151.84 152.6 30.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.647 0.737 . . . . 75.310000000000002 111.091 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.77 127.76 15.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.682 2.255 . . . . 60.530000000000001 112.327 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -52.02 113.44 4.22 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.553 0.692 . . . . 65.450000000000003 110.912 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 91.4 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.678 2.252 . . . . 63.020000000000003 112.393 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.13 -27.78 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.709 -0.758 . . . . 40.140000000000001 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 25' ' ' LEU . 3.1 t -59.01 165.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 71.219999999999999 111.17 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.6 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -52.12 114.51 1.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.855 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 21' ' ' SER . 6.0 m-20 -33.65 -65.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 72.400000000000006 110.822 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.2 -39.17 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 63.439999999999998 110.872 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 21' ' ' SER . 1.7 tp-100 -58.36 -50.87 72.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 110.91 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.723 HD11 ' HB ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 65.519999999999996 110.926 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.603 ' OG1' HG11 ' A' ' 54' ' ' VAL . 1.7 m -59.54 -31.48 69.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 71.5 111.154 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.77 -30.66 56.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 45.32 112.47 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 29' ' ' ILE . 1.1 m-20 -61.86 -68.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.832 0.349 . . . . 74.310000000000002 110.867 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.478 ' CD1' ' HA ' ' A' ' 55' ' ' LYS . 67.6 mt -37.09 -48.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 111.073 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.06 -47.37 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 71.140000000000001 110.91 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -72.1 -53.65 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.895 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.479 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.12 -43.13 61.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 54.149999999999999 111.116 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -54.81 -11.58 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.120000000000005 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -109.06 18.03 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.821 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.49 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 5.1 mm100 -97.86 -49.96 4.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 75.420000000000002 110.887 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.65 -82.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 72.310000000000002 112.47 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.771 HD12 HD12 ' A' ' 64' ' ' LEU . 3.6 pt -80.97 17.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.815 0.341 . . . . 64.140000000000001 111.123 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.783 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -89.56 -59.86 2.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 52.439999999999998 110.843 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.475 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.71 122.35 23.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.129999999999995 110.88 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.47 -71.34 0.33 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 71.400000000000006 112.463 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.601 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.7 Cg_endo -69.77 4.24 2.31 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.684 2.256 . . . . 74.219999999999999 112.316 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.783 HG23 ' O ' ' A' ' 38' ' ' ASP . 9.6 pt -82.87 18.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 71.239999999999995 111.136 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -80.31 148.36 66.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.578 0.704 . . . . 70.140000000000001 110.886 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.592 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.1 Cg_endo -69.79 152.61 69.18 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.709 2.273 . . . . 71.439999999999998 112.351 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.83 -47.9 2.02 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 55.109999999999999 112.483 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.83 3.08 2.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 72.019999999999996 112.484 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.55 -69.11 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.829 0.347 . . . . 64.120000000000005 111.106 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.0 7.85 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.898 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -43.27 -59.0 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.875 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.562 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 2.4 mm-40 -96.72 131.02 28.89 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.671 0.748 . . . . 70.329999999999998 110.826 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.75 153.61 92.98 Favored 'Cis proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 -1.801 . . . . 65.219999999999999 112.32 -0.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 10.4 p30 -101.73 130.55 48.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 110.876 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.78 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 41.2 p -82.97 169.99 15.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 72.310000000000002 111.163 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.603 HG11 ' OG1' ' A' ' 26' ' ' THR . 51.8 t -67.1 -58.9 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 63.229999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.478 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -87.91 18.04 4.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 73.530000000000001 110.901 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.78 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -49.7 -51.88 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 111.092 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.618 ' ND1' HD12 ' A' ' 42' ' ' ILE . 63.1 m170 -43.65 -58.16 2.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 65.120000000000005 110.841 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -52.22 -39.8 60.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 62.439999999999998 111.145 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.15 74.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 75.319999999999993 111.129 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.601 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 11.2 t80 -68.57 -63.45 1.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.931 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 65' ' ' TYR . 2.3 p -54.9 -33.47 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 61.539999999999999 111.132 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.63 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 3.8 mtt -45.61 -27.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.882 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.63 -61.68 1.85 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 63.130000000000003 110.842 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.771 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -70.29 -49.33 50.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 64.420000000000002 110.918 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.596 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.5 t80 -50.29 -47.0 55.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 110.926 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 30.4 t80 -55.88 -28.57 57.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 62.049999999999997 110.915 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -99.93 -4.59 29.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 70.049999999999997 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -73.11 -40.33 65.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.861 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.949 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -59.39 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 111.101 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.29 22.03 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 62.130000000000003 112.508 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.01 41.07 29.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 71.209999999999994 110.841 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.8 m-80 -114.11 169.12 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.863 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.408 ' HB2' ' CD1' ' A' ' 84' ' ' LEU . 96.5 p -70.28 -23.14 62.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 70.209999999999994 110.849 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -81.02 2.2 28.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.118 -0.492 . . . . 75.219999999999999 110.943 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.949 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -20.62 60.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 70.120000000000005 110.887 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.46 102.01 11.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 72.430000000000007 110.859 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.02 10.68 13.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 110.847 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.63 ' CD2' ' HE2' ' A' ' 62' ' ' MET . 2.7 m-30 -58.32 -68.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.917 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.62 178.01 3.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 61.009999999999998 110.897 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -2.2 2.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.119999999999997 110.9 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.544 ' HB ' HD12 ' A' ' 25' ' ' LEU . 65.4 p -92.15 -52.37 4.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 75.310000000000002 111.175 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.52 102.15 11.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.114 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 t -148.64 178.02 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 111.154 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 12' ' ' SER . 6.2 mp -65.57 127.2 30.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.874 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.04 167.76 9.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 71.219999999999999 111.179 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 87' ' ' THR . 11.3 m-80 -54.03 -168.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 74.329999999999998 110.884 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -44.99 173.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 111.17 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.7 t-20 -51.97 106.33 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.653 0.739 . . . . 73.329999999999998 110.87 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.78 -4.39 13.94 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.665 2.244 . . . . 61.329999999999998 112.353 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 p -52.02 112.44 0.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 54.32 110.81 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 94' ' ' CYS . 1.8 p90 -79.8 -16.62 55.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 110.926 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.85 -123.83 0.94 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.439999999999998 112.454 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -51.41 -35.35 38.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 43.039999999999999 111.08 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -76.35 104.16 6.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 62.140000000000001 110.882 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.0 129.24 45.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.329999999999998 110.919 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.545 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.1 m-85 -78.42 154.97 79.24 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.655 0.74 . . . . 72.409999999999997 110.876 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.75 108.08 2.0 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.647 2.231 . . . . 54.219999999999999 112.37 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 54.6 p -80.55 -10.78 59.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.842 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.66 37.89 27.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 73.409999999999997 112.505 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -157.97 141.95 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 74.219999999999999 110.849 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 110.851 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.817 0.342 . . . . 75.200000000000003 111.066 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.9 m -103.31 121.46 48.61 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.628 0.728 . . . . 74.430000000000007 111.143 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 164.52 34.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.69 2.26 . . . . 72.230000000000004 112.329 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.1 p -111.52 113.55 53.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.633 0.73 . . . . 74.140000000000001 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -171.18 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 71.299999999999997 112.331 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 7' ' ' PRO . 81.5 p -130.49 103.0 16.48 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.633 0.73 . . . . 72.5 111.107 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 6' ' ' THR . 53.9 Cg_endo -69.79 -167.57 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.675 2.25 . . . . 64.230000000000004 112.384 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.51 128.89 50.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 73.150000000000006 110.942 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.48 130.92 45.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 70.340000000000003 111.076 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.1 177.96 5.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 111.111 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 81.43 175.21 49.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 71.120000000000005 112.465 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.52 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -148.51 138.55 22.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.915 0.388 . . . . 73.510000000000005 110.836 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.594 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.0 m-90 -136.03 123.06 21.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.420000000000002 110.913 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 102.01 13.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 74.209999999999994 110.836 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.5 m -154.58 153.06 27.25 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 54.219999999999999 111.09 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 53.4 Cg_endo -69.82 129.34 17.37 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 71.019999999999996 112.383 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.95 118.12 11.29 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.522 0.677 . . . . 75.219999999999999 110.947 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 79.87 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.686 2.257 . . . . 73.140000000000001 112.324 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 170.58 -24.3 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 72.099999999999994 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.692 ' HB ' HD11 ' A' ' 25' ' ' LEU . 4.8 t -59.0 166.84 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.79 0.328 . . . . 71.450000000000003 111.164 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.779 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.01 107.3 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 52.119999999999997 110.849 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 54' ' ' VAL . 72.9 m-20 -33.36 -63.41 0.24 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.127 -0.488 . . . . 73.129999999999995 110.862 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.99 -39.74 13.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 75.150000000000006 110.862 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -58.34 -50.93 71.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 53.340000000000003 110.875 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.782 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -71.49 -29.65 65.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 71.510000000000005 110.883 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.434 ' OG1' HG11 ' A' ' 54' ' ' VAL . 97.1 m -52.13 -26.53 11.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 54.25 111.129 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.36 -24.77 72.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.759 . . . . 21.120000000000001 112.49 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.27 -51.4 63.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 65.439999999999998 110.864 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 55' ' ' LYS . 73.1 mt -62.53 -52.46 59.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 62.340000000000003 111.102 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -50.25 -43.63 53.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 75.5 110.871 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -73.16 -58.11 3.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 110.934 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.786 ' HB1' ' CG ' ' A' ' 38' ' ' ASP . . . -51.46 -31.65 24.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 63.210000000000001 111.125 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.7 t -56.91 -11.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 110.883 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 18.0 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 41.299999999999997 110.855 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -92.17 -52.1 4.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 73.219999999999999 110.887 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.38 -92.38 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.786 -0.721 . . . . 75.310000000000002 112.512 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.41 4.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.784 0.326 . . . . 75.439999999999998 111.138 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.88 ' HA ' HG21 ' A' ' 61' ' ' VAL . 2.5 m-20 -66.66 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.84 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -76.07 134.92 39.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 52.130000000000003 110.88 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.94 -72.3 0.33 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.719 -0.753 . . . . 61.0 112.463 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.78 6.47 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.674 2.25 . . . . 72.510000000000005 112.358 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.626 HD12 ' CG ' ' A' ' 57' ' ' HIS . 22.9 pt -82.44 18.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.450000000000003 111.141 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -80.16 123.75 83.14 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 75.030000000000001 110.895 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 163.32 38.74 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.678 2.252 . . . . 71.510000000000005 112.315 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.34 -32.99 1.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 62.109999999999999 112.514 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.49 -31.22 3.84 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.721 -0.752 . . . . 72.420000000000002 112.441 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.05 -68.13 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 111.126 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 49' ' ' PHE . 13.7 t -113.05 -13.77 13.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.430000000000007 110.926 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -34.46 -44.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 64.209999999999994 110.849 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -100.41 125.75 38.29 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 64.299999999999997 110.88 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.5 Cg_endo -69.75 151.89 91.82 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.726 -1.781 . . . . 44.140000000000001 112.317 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.38 120.02 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 63.100000000000001 110.875 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.76 168.59 16.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.178 -0.465 . . . . 71.030000000000001 111.115 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.631 HG21 ' HB3' ' A' ' 22' ' ' ASP . 91.8 t -65.79 -56.79 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 61.32 111.147 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HG3' ' CG ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -81.24 17.43 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 64.450000000000003 110.85 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.63 -42.29 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 64.5 111.061 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.626 ' CG ' HD12 ' A' ' 42' ' ' ILE . 67.5 m80 -52.28 -54.78 27.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.120000000000005 110.839 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.779 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -56.72 -37.74 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 62.310000000000002 111.105 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.14 -30.6 71.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 72.099999999999994 111.094 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.597 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 12.2 t80 -67.86 -66.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 110.902 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.88 HG21 ' HA ' ' A' ' 38' ' ' ASP . 7.5 p -55.24 -29.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 74.420000000000002 111.165 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 58' ' ' ALA . 1.6 mmt -45.53 -22.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.845 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -71.95 -56.61 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 110.903 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -76.14 -53.13 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 110.948 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.718 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.4 t80 -45.72 -48.2 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 63.100000000000001 110.953 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.606 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 33.8 t80 -58.51 -26.86 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 72.219999999999999 110.93 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -100.04 -2.78 33.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 74.319999999999993 110.91 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -40.09 52.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 71.099999999999994 110.839 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.898 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.71 -55.41 5.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 72.319999999999993 111.082 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.35 24.83 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.742 . . . . 54.530000000000001 112.496 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 49.2 31.98 3.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.802 0.334 . . . . 72.430000000000007 110.912 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.606 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 5.2 m-80 -102.81 168.59 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 65.040000000000006 110.864 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.8 p -70.93 -21.97 62.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.827 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.437 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.08 2.03 29.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.902 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.898 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.57 -18.94 61.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 72.140000000000001 110.898 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.54 102.05 11.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 71.450000000000003 110.87 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -118.04 8.93 12.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 64.120000000000005 110.886 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.779 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -58.51 -68.66 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 73.140000000000001 110.844 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -171.93 178.06 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.450000000000003 110.875 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -65.8 -0.99 2.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 65.540000000000006 110.895 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.735 HG21 ' CD1' ' A' ' 25' ' ' LEU . 62.3 p -92.84 -52.1 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 111.143 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.86 106.37 13.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 71.400000000000006 111.09 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.9 t -150.64 177.98 9.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.278 -0.419 . . . . 63.439999999999998 111.162 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 mp -66.03 149.85 49.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 110.947 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 t -133.77 168.55 18.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 72.319999999999993 111.156 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 87' ' ' THR . 14.4 m-20 -53.63 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.889 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.9 t -44.36 174.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 111.104 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.594 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -51.97 106.88 0.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.604 0.716 . . . . 72.239999999999995 110.877 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 88' ' ' ASN . 53.3 Cg_endo -69.85 -0.15 6.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.303 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.404 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 12.9 t -52.04 106.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 110.834 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.65 -16.33 59.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.918 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.74 -115.66 0.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 55.520000000000003 112.472 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.26 -39.34 69.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 62.039999999999999 111.108 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -76.37 102.03 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 52.219999999999999 110.886 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -99.97 137.95 37.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.150000000000006 110.903 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.26 146.52 32.05 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.637 0.732 . . . . 75.430000000000007 110.9 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.02 12.82 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.705 2.27 . . . . 73.400000000000006 112.334 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.454 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 2.0 p -113.7 0.25 14.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.099999999999994 110.806 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 62.4 -122.83 29.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 45.520000000000003 112.421 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -91.71 115.25 27.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 54.119999999999997 110.816 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 74.219999999999999 110.908 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.831 0.348 . . . . 52.130000000000003 111.081 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.5 p -144.76 148.37 39.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.558 0.694 . . . . 65.340000000000003 111.158 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 111.69 2.86 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.291 . . . . 75.120000000000005 112.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -79.7 114.33 44.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.578 0.704 . . . . 70.239999999999995 111.18 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 156.74 62.55 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 71.329999999999998 112.354 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -98.8 156.98 34.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.569 0.7 . . . . 73.450000000000003 111.147 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -173.89 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.676 2.251 . . . . 72.120000000000005 112.316 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -104.27 103.6 13.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 73.150000000000006 110.893 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 170.79 15.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 55.409999999999997 111.102 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.56 120.61 8.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 55.439999999999998 111.118 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.568 ' HA3' ' CH2' ' A' ' 13' ' ' TRP . . . 74.42 175.92 34.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 55.439999999999998 112.502 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.44 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 9.3 m -149.16 136.31 19.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 73.129999999999995 110.898 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.568 ' CH2' ' HA3' ' A' ' 11' ' ' GLY . 4.2 m-90 -135.67 109.65 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 72.25 110.905 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 102.17 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 72.230000000000004 110.832 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.7 m -155.66 152.43 24.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 73.120000000000005 111.131 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.71 123.55 10.23 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.686 2.257 . . . . 72.040000000000006 112.336 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -51.98 122.42 22.79 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.551 0.691 . . . . 74.030000000000001 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 88.06 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.693 2.262 . . . . 74.319999999999993 112.353 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.37 -20.79 0.21 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.752 . . . . 31.219999999999999 112.497 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.55 ' HB ' HD21 ' A' ' 25' ' ' LEU . 11.0 t -63.62 158.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 74.430000000000007 111.133 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 24' ' ' GLN . 1.8 m -52.09 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 71.040000000000006 110.817 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 21' ' ' SER . 85.9 m-20 -33.5 -68.1 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 75.230000000000004 110.873 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -39.4 -39.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 73.150000000000006 110.86 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 21' ' ' SER . 25.4 tt0 -58.11 -51.3 70.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 110.938 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.841 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.2 OUTLIER -70.96 -36.18 72.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 73.209999999999994 110.914 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.417 ' OG1' HG11 ' A' ' 54' ' ' VAL . 25.7 m -52.2 -15.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.98 -35.48 57.91 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 65.129999999999995 112.493 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -57.19 -68.3 0.24 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.818 0.342 . . . . 75.319999999999993 110.928 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 55' ' ' LYS . 73.6 mt -37.49 -47.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 70.400000000000006 111.121 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -54.42 -47.76 72.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 71.349999999999994 110.849 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -73.55 -56.1 5.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 44.450000000000003 110.942 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 31' ' ' TYR . . . -51.95 -35.7 46.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 54.109999999999999 111.102 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 43.5 t -56.39 -12.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 65.109999999999999 110.875 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -117.75 18.02 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 110.828 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.449 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -89.8 -52.82 4.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 72.349999999999994 110.899 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 165.19 -94.81 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 64.310000000000002 112.503 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.517 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -81.96 17.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 72.109999999999999 111.118 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.563 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -83.08 -59.95 2.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 64.519999999999996 110.902 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.28 122.31 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 71.5 110.902 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.14 -67.91 0.53 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 63.119999999999997 112.474 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 4.51 2.14 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.246 . . . . 73.109999999999999 112.339 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.604 HD12 ' CD2' ' A' ' 57' ' ' HIS . 19.4 pt -82.77 17.95 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 70.420000000000002 111.112 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -84.48 125.15 72.44 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.623 0.725 . . . . 75.439999999999998 110.899 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.525 ' CB ' ' CD1' ' A' ' 49' ' ' PHE . 53.7 Cg_endo -69.74 154.58 67.65 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.668 2.245 . . . . 64.129999999999995 112.293 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.88 -40.08 1.91 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.79 -0.719 . . . . 32.43 112.495 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.47 -23.51 3.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.747 -0.74 . . . . 61.210000000000001 112.494 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.06 -68.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 75.129999999999995 111.089 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.457 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -118.04 -11.28 10.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 54.509999999999998 110.873 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CD1' ' CB ' ' A' ' 44' ' ' PRO . 2.6 t80 -33.92 -52.59 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 71.120000000000005 110.897 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -99.57 127.97 32.73 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.623 0.725 . . . . 73.200000000000003 110.87 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.77 149.51 88.72 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.666 -1.806 . . . . 54.130000000000003 112.329 -0.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.98 152.75 24.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 63.149999999999999 110.891 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 56' ' ' ALA . 43.5 p -106.69 172.38 6.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 111.153 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.417 HG11 ' OG1' ' A' ' 26' ' ' THR . 98.0 t -66.21 -64.26 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.420000000000002 111.143 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.25 18.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.897 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -50.91 -38.9 52.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 44.420000000000002 111.054 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.604 ' CD2' HD12 ' A' ' 42' ' ' ILE . 60.2 m80 -54.08 -52.72 60.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 110.855 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.709 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -57.27 -37.53 72.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 72.329999999999998 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -35.34 74.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 44.100000000000001 111.131 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 3.0 t80 -68.45 -57.96 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.891 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.484 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 1.8 p -54.57 -37.44 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 71.439999999999998 111.164 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.661 ' HE2' ' CE2' ' A' ' 78' ' ' PHE . 9.7 mtt -49.09 -20.81 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.030000000000001 110.912 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.533 ' HB3' HD23 ' A' ' 64' ' ' LEU . 44.9 t30 -69.16 -62.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 110.896 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -74.93 -52.25 11.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 44.140000000000001 110.927 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.44 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 2.6 t80 -45.7 -49.55 14.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 71.519999999999996 110.87 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 2.8 t80 -58.42 -27.38 64.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.923 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.401 ' OE1' ' O ' ' A' ' 63' ' ' ASN . 29.0 mt-30 -101.11 -2.26 31.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.120000000000005 110.918 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -74.04 -41.43 61.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.864 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.733 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.15 -55.51 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 44.520000000000003 111.095 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.85 24.11 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.040000000000006 112.508 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 51.1 44.17 28.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 70.120000000000005 110.872 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.546 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.9 m-80 -109.89 172.44 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.913 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 m -74.22 -24.78 59.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 52.450000000000003 110.908 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -79.67 2.0 24.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 75.319999999999993 110.91 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.733 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.78 -23.26 59.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 73.329999999999998 110.912 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -82.37 101.96 10.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 54.329999999999998 110.902 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.0 10.1 12.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 74.150000000000006 110.847 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.709 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.0 m-30 -58.84 -68.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.84 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 t -172.0 178.01 3.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 62.399999999999999 110.836 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -65.51 -2.48 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 64.310000000000002 110.926 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.841 HG21 ' CD1' ' A' ' 25' ' ' LEU . 66.4 p -91.54 -50.57 5.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 63.539999999999999 111.149 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.479 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.71 102.09 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.108 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.5 t -148.81 178.01 9.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 61.43 111.11 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 mt -66.67 114.0 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 65.409999999999997 110.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -89.71 167.47 12.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 63.210000000000001 111.168 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -52.84 -169.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.222 -0.445 . . . . 62.409999999999997 110.905 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.24 172.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.549999999999997 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 9.5 t-20 -51.98 106.66 0.68 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.58 0.705 . . . . 63.520000000000003 110.907 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.19 3.74 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.743 2.295 . . . . 54.149999999999999 112.376 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.411 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 23.0 t -52.03 106.89 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 110.783 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -72.67 -17.04 61.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 54.299999999999997 110.941 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.44 -111.24 0.42 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.94 80.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 111.06 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -86.85 102.0 13.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 73.019999999999996 110.879 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -99.0 151.73 20.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 61.210000000000001 110.883 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.7 m-85 -92.35 154.07 42.84 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.669 0.747 . . . . 74.129999999999995 110.873 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 114.21 3.62 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 72.099999999999994 112.356 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.528 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 12.1 p -88.81 -11.71 44.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 65.219999999999999 110.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.71 -105.62 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 74.310000000000002 112.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.3 p -92.93 161.24 14.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.907 0.384 . . . . 62.130000000000003 110.861 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.120000000000005 110.839 -179.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.881 0.372 . . . . 54.009999999999998 111.122 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.1 p -107.19 143.29 26.86 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.526 0.679 . . . . 64.400000000000006 111.184 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 146.37 60.08 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.718 2.279 . . . . 70.019999999999996 112.338 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -119.54 111.46 36.31 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.608 0.718 . . . . 72.430000000000007 111.144 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 174.49 9.38 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.685 2.257 . . . . 74.439999999999998 112.347 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 36.7 p -99.16 121.34 55.8 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.109999999999999 111.118 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -173.6 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.688 2.259 . . . . 62.43 112.361 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.5 102.11 5.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 61.310000000000002 110.878 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.72 166.07 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 111.125 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.15 177.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 111.122 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.561 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 67.41 105.48 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 73.129999999999995 112.471 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.571 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -158.02 122.22 4.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.835 0.35 . . . . 71.209999999999994 110.846 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.583 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 3.5 m-90 -129.74 116.55 18.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 62.340000000000003 110.922 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.21 102.05 14.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 71.439999999999998 110.946 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.0 m -152.83 152.55 28.61 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 70.219999999999999 111.108 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 127.62 14.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.645 2.23 . . . . 72.140000000000001 112.327 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.06 118.15 11.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.602 0.715 . . . . 74.040000000000006 110.939 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 92.12 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.673 2.248 . . . . 63.32 112.334 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.78 -26.78 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 42.240000000000002 112.488 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.72 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.3 t -59.0 168.85 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 72.140000000000001 111.174 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.878 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -54.52 111.94 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 43.130000000000003 110.829 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD1' HG21 ' A' ' 54' ' ' VAL . 24.2 m-20 -38.94 -55.5 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 63.100000000000001 110.888 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -53.21 -33.98 55.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 110.846 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' SER . 6.6 tp60 -68.31 -46.48 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 75.340000000000003 110.868 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.878 HD22 ' O ' ' A' ' 21' ' ' SER . 0.8 OUTLIER -70.01 -54.06 14.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 72.299999999999997 110.955 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 27' ' ' GLY . 16.8 m -41.14 -48.35 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.400000000000006 111.169 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 26' ' ' THR . . . -34.91 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 23.219999999999999 112.502 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 31' ' ' TYR . 10.3 m-20 -59.5 -64.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 72.030000000000001 110.909 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.91 HG23 ' CG ' ' A' ' 57' ' ' HIS . 72.7 mt -36.58 -41.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 111.163 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -61.59 -45.6 93.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.908 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 28' ' ' ASN . 3.4 t80 -73.55 -58.28 3.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 75.140000000000001 110.887 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.947 ' HB1' ' CG ' ' A' ' 38' ' ' ASP . . . -48.1 -50.05 29.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 64.129999999999995 111.072 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.79 -22.49 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.929 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -80.52 13.33 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 70.430000000000007 110.861 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.498 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -97.96 -45.79 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 110.942 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.9 -43.91 1.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 71.400000000000006 112.5 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.658 HD13 ' N ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -101.54 2.29 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.346 . . . . 54.310000000000002 111.129 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.947 ' CG ' ' HB1' ' A' ' 32' ' ' ALA . 1.4 m-20 -74.99 -70.1 0.43 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 74.150000000000006 110.823 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.7 p -80.4 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 110.862 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.11 -68.78 0.46 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 74.319999999999993 112.466 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.61 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.4 Cg_endo -69.71 6.97 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 70.140000000000001 112.36 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.791 HD13 ' HB2' ' A' ' 57' ' ' HIS . 8.0 pt -82.14 17.04 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 74.409999999999997 111.136 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.25 121.69 85.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.628 0.728 . . . . 44.329999999999998 110.912 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -169.46 0.33 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 71.299999999999997 112.332 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.99 -28.74 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.779 -0.724 . . . . 73.540000000000006 112.5 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.08 -26.23 8.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 61.409999999999997 112.461 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -56.37 -68.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 72.5 111.138 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.92 13.8 14.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 60.049999999999997 110.843 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.578 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 10.9 t80 -47.88 -60.52 2.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.944 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.578 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 28.5 mt-10 -92.56 142.39 25.77 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.697 0.761 . . . . 74.409999999999997 110.844 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.7 Cg_endo -69.75 146.86 83.35 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 122.688 -1.796 . . . . 73.109999999999999 112.332 -0.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -99.91 142.21 31.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 54.140000000000001 110.901 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -97.86 160.06 14.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 64.200000000000003 111.184 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 ' OD1' ' A' ' 22' ' ' ASP . 40.9 t -65.87 -56.43 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 71.340000000000003 111.156 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.653 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.48 17.95 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 65.019999999999996 110.937 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -49.64 -55.29 14.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 72.239999999999995 111.112 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.91 ' CG ' HG23 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -35.23 -51.34 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 71.230000000000004 110.873 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.786 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -63.97 -42.14 97.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 72.200000000000003 111.126 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.46 -49.54 77.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 70.129999999999995 111.076 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.61 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.7 t80 -54.21 -63.42 1.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 73.209999999999994 110.932 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.796 HG11 ' OD1' ' A' ' 38' ' ' ASP . 3.5 p -54.85 -35.63 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 74.549999999999997 111.159 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.475 ' HE2' ' HA ' ' A' ' 62' ' ' MET . 0.0 OUTLIER -44.92 -21.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 64.420000000000002 110.872 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 61' ' ' VAL . 33.0 t-20 -72.56 -44.25 62.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 110.942 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -90.71 -49.06 6.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.954 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.732 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -47.0 -46.26 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 73.340000000000003 110.937 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.9 t80 -57.14 -30.71 64.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 110.904 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -97.25 -5.14 37.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 72.310000000000002 110.911 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.88 -40.96 62.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.847 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.991 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.38 -59.98 2.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.094 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -170.85 21.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.713 -0.756 . . . . 55.109999999999999 112.499 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 51.69 32.01 8.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 75.209999999999994 110.903 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.56 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.2 m-80 -105.55 167.1 9.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 72.299999999999997 110.901 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.8 p -68.73 -22.75 64.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 71.219999999999999 110.856 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.457 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.84 2.41 26.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.869 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.991 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.36 -16.89 61.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 73.439999999999998 110.894 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 0.8 OUTLIER -82.8 102.04 11.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 75.310000000000002 110.846 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -117.98 8.73 12.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.13 -0.486 . . . . 75.420000000000002 110.899 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.786 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.4 m-30 -58.98 -69.11 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 110.858 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -172.01 177.99 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.472 . . . . 45.350000000000001 110.885 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -2.56 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 63.409999999999997 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.598 HG21 HD13 ' A' ' 25' ' ' LEU . 70.4 p -91.62 -51.44 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 111.139 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -83.75 102.02 11.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 71.219999999999999 111.064 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.7 t -147.93 178.0 8.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 62.219999999999999 111.174 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.61 127.26 31.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 62.340000000000003 110.923 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -106.07 168.98 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 41.539999999999999 111.158 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 87' ' ' THR . 15.5 m120 -53.68 -168.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 110.894 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 86' ' ' ASN . 5.0 t -45.06 174.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 111.165 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.583 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.5 t-20 -51.99 107.24 0.79 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.656 0.741 . . . . 75.450000000000003 110.882 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.75 0.89 4.97 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.714 2.276 . . . . 61.109999999999999 112.324 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.412 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 21.8 t -52.06 108.72 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 54.310000000000002 110.854 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -72.18 -16.44 61.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.149 -0.478 . . . . 73.040000000000006 110.909 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.407 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 174.41 -109.16 0.29 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 64.209999999999994 112.511 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.45 -35.53 79.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 63.539999999999999 111.124 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 102.06 11.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 72.109999999999999 110.838 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.7 149.42 22.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 64.239999999999995 110.896 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.543 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -90.34 154.84 46.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.63 0.729 . . . . 65.219999999999999 110.932 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 114.66 3.78 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 71.409999999999997 112.35 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.482 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 83.7 p -91.31 -9.78 43.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.852 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.84 19.3 55.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 55.310000000000002 112.485 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.96 107.16 2.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 64.409999999999997 110.872 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 73.109999999999999 110.871 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.863 0.363 . . . . 73.140000000000001 111.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.487 HG23 ' HD2' ' A' ' 3' ' ' PRO . 99.3 m -119.85 134.77 23.96 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.569 0.699 . . . . 74.519999999999996 111.131 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HD2' HG23 ' A' ' 2' ' ' THR . 53.6 Cg_endo -69.7 106.82 1.72 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.729 2.286 . . . . 63.509999999999998 112.326 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.7 p -140.45 148.54 54.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.523 0.678 . . . . 70.219999999999999 111.188 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 139.72 40.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.705 2.27 . . . . 75.209999999999994 112.33 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -112.83 143.32 28.83 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.708 . . . . 63.350000000000001 111.147 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 4.87 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.651 2.234 . . . . 74.439999999999998 112.392 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -51.96 102.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 110.92 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.99 164.52 12.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 71.549999999999997 111.101 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 11' ' ' GLY . . . -80.06 138.51 37.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 54.310000000000002 111.097 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 35.71 91.91 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.778 -0.725 . . . . 71.340000000000003 112.458 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 3.0 m -157.99 127.47 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.843 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.589 ' CH2' ' HA2' ' A' ' 11' ' ' GLY . 3.8 m-90 -133.16 123.36 25.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 65.420000000000002 110.907 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -96.96 102.01 13.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 63.130000000000003 110.916 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.5 m -153.11 152.2 27.5 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.571 0.701 . . . . 75.349999999999994 111.191 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' CE ' ' A' ' 62' ' ' MET . 54.1 Cg_endo -69.76 129.92 18.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.637 2.225 . . . . 72.329999999999998 112.39 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -52.0 120.94 17.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 74.400000000000006 110.879 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 80.7 0.88 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.668 2.245 . . . . 75.319999999999993 112.281 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.43 -27.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.743 . . . . 74.209999999999994 112.516 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.656 ' HB ' HD11 ' A' ' 25' ' ' LEU . 19.7 t -59.15 164.38 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 65.239999999999995 111.158 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.89 ' O ' HD22 ' A' ' 25' ' ' LEU . 31.3 m -55.7 114.83 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 63.109999999999999 110.885 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.52 -67.56 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 74.129999999999995 110.894 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -39.59 -42.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 54.240000000000002 110.896 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.89 -48.7 80.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.941 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.89 HD22 ' O ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -71.11 -27.9 63.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.88 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.415 ' OG1' HG11 ' A' ' 54' ' ' VAL . 12.6 m -60.77 -41.46 95.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 73.319999999999993 111.109 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.94 -33.18 28.32 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 53.140000000000001 112.525 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -55.8 -44.94 78.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.762 0.315 . . . . 51.43 110.823 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.852 HG23 ' CG ' ' A' ' 57' ' ' HIS . 90.4 mt -60.1 -64.64 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.010000000000005 111.093 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -37.6 -41.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 63.109999999999999 110.886 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.483 ' CD2' ' N ' ' A' ' 32' ' ' ALA . 4.6 t80 -75.03 -68.61 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 74.329999999999998 110.946 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -47.95 -19.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.515 . . . . 71.219999999999999 111.107 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 4.4 t -70.52 1.59 4.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.549999999999997 110.914 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.36 17.9 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 71.519999999999996 110.862 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.72 -48.81 5.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.109999999999999 110.954 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 138.8 -61.47 0.57 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 33.119999999999997 112.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.486 HG12 HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -82.13 12.96 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 74.439999999999998 111.147 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.838 ' OD1' HG11 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -88.93 -63.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.450000000000003 110.883 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -80.02 119.37 22.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 62.299999999999997 110.879 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.4 -68.84 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.723 -0.751 . . . . 72.25 112.46 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.628 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.1 Cg_endo -69.75 6.3 1.36 Allowed 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.726 2.284 . . . . 54.310000000000002 112.316 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.1 pt -82.06 17.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 65.230000000000004 111.107 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -73.94 124.6 90.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.711 . . . . 65.209999999999994 110.905 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 53.9 Cg_endo -69.75 -179.37 2.86 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.723 2.282 . . . . 75.439999999999998 112.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.02 -36.15 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 63.43 112.486 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.1 -27.18 5.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 73.329999999999998 112.483 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.18 -68.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 63.509999999999998 111.146 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 41.3 t -117.86 -5.78 11.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 64.049999999999997 110.918 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 52' ' ' ASN . 2.6 t80 -40.69 -53.07 2.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.299999999999997 110.861 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.74 130.32 28.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.624 0.726 . . . . 70.120000000000005 110.94 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.8 151.83 91.88 Favored 'Cis proline' 0 C--N 1.341 0.146 0 C-N-CA 122.696 -1.793 . . . . 55.020000000000003 112.327 0.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 7.2 p-10 -101.69 144.32 30.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 70.200000000000003 110.907 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.9 p -94.97 160.3 14.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 72.040000000000006 111.143 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG11 ' OG1' ' A' ' 26' ' ' THR . 88.8 t -66.14 -52.98 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 62.020000000000003 111.128 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.617 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.97 17.97 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 74.510000000000005 110.881 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.34 -56.43 11.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 73.010000000000005 111.131 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.955 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -35.55 -49.77 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.818 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.688 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -65.01 -38.39 90.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 64.209999999999994 111.125 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.74 -53.96 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 63.0 111.101 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -54.49 -63.25 1.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 73.540000000000006 110.953 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 57' ' ' HIS . 1.6 p -53.73 -37.09 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 71.120000000000005 111.153 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.495 ' CE ' ' HD3' ' A' ' 16' ' ' PRO . 2.5 mtm -45.96 -21.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 61.43 110.888 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 10.3 t-20 -71.89 -54.53 9.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 74.540000000000006 110.866 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -79.0 -45.88 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 110.927 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.545 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -48.91 -49.63 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.883 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 20.6 t80 -55.32 -32.2 62.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.932 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.402 ' OE1' ' O ' ' A' ' 99' ' ' GLY . 35.2 mt-30 -96.12 -4.91 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.883 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.401 ' HB3' ' O ' ' A' ' 65' ' ' TYR . 7.3 t60 -74.79 -40.68 61.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 73.230000000000004 110.86 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.983 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.76 -61.57 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 54.340000000000003 111.135 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.18 20.94 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.677 -0.773 . . . . 75.209999999999994 112.484 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.94 33.3 11.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 63.350000000000001 110.94 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -106.57 167.71 9.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 63.409999999999997 110.878 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.469 ' CB ' HD11 ' A' ' 84' ' ' LEU . 75.4 p -69.09 -23.01 63.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 74.129999999999995 110.922 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -81.28 2.85 26.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.092 -0.504 . . . . 75.319999999999993 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.983 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.4 -24.37 60.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.540000000000006 110.881 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.95 102.0 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.200000000000003 110.901 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -118.0 11.36 13.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 74.299999999999997 110.848 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.688 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.8 m-30 -57.75 -68.19 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 75.299999999999997 110.876 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -171.9 178.01 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 73.040000000000006 110.872 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -65.61 -2.13 3.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 71.040000000000006 110.943 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 25' ' ' LEU . 72.4 p -91.76 -51.77 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 52.210000000000001 111.107 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -82.72 107.42 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 71.439999999999998 111.146 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -152.49 177.99 10.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 64.25 111.126 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 73' ' ' SER . 0.8 OUTLIER -66.36 153.73 41.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.926 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.454 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -133.69 167.27 20.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 63.030000000000001 111.148 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' THR . 6.5 m120 -53.66 -168.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 73.340000000000003 110.86 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.24 174.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 73.120000000000005 111.168 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.572 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.0 t-20 -52.06 107.0 0.73 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.632 0.73 . . . . 63.409999999999997 110.895 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -0.6 7.12 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.728 2.285 . . . . 75.019999999999996 112.369 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 5.3 t -52.0 105.99 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 42.530000000000001 110.827 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -79.71 -17.23 54.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.497 . . . . 75.409999999999997 110.914 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.421 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 177.58 -112.48 0.38 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 71.430000000000007 112.487 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -37.45 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.814 0.34 . . . . 75.510000000000005 111.127 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m -76.35 101.99 5.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 71.030000000000001 110.867 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.89 142.07 31.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 60.25 110.873 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.536 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 9.2 m-85 -93.05 140.88 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.716 0.77 . . . . 55.229999999999997 110.896 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 132.05 22.43 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.635 2.224 . . . . 64.430000000000007 112.368 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.498 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 3.1 t -117.95 -2.37 11.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 70.049999999999997 110.869 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' OE1' ' A' ' 67' ' ' GLN . . . 118.21 -36.86 3.46 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.767 -0.73 . . . . 32.130000000000003 112.506 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 106.96 4.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 51.039999999999999 110.855 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 72.25 110.873 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.874 0.369 . . . . 74.329999999999998 111.073 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.5 m -140.88 120.91 8.62 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.621 0.724 . . . . 74.219999999999999 111.077 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -177.99 2.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.669 2.246 . . . . 73.109999999999999 112.304 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -66.87 146.92 99.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.605 0.717 . . . . 31.309999999999999 111.133 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' O ' HG23 ' A' ' 6' ' ' THR . 53.2 Cg_endo -69.8 -50.8 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.651 2.234 . . . . 61.140000000000001 112.335 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 5' ' ' PRO . 29.1 p -156.79 154.04 25.74 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.569 0.7 . . . . 73.439999999999998 111.135 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 9.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.634 2.222 . . . . 75.400000000000006 112.341 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 6' ' ' THR . 6.6 ttmm -52.01 106.28 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.120000000000005 110.906 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.56 178.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 62.520000000000003 111.115 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.723 ' HB1' ' CZ2' ' A' ' 13' ' ' TRP . . . -159.12 174.74 14.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 63.409999999999997 111.117 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.584 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . 153.38 -29.23 0.78 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.713 -0.756 . . . . 61.130000000000003 112.496 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.488 ' HB3' ' CD2' ' A' ' 84' ' ' LEU . 7.0 m -143.97 139.95 29.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 73.340000000000003 110.839 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.723 ' CZ2' ' HB1' ' A' ' 10' ' ' ALA . 4.1 m-90 -134.82 124.97 25.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 71.209999999999994 110.912 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -100.48 102.05 13.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 75.030000000000001 110.883 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.492 ' CG1' ' HG2' ' A' ' 97' ' ' PRO . 2.9 m -150.65 153.87 34.48 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.67 0.748 . . . . 75.430000000000007 111.074 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.9 Cg_endo -69.74 126.3 13.17 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 70.150000000000006 112.376 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.08 113.42 4.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.591 0.71 . . . . 64.329999999999998 110.868 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 79.59 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 71.450000000000003 112.351 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.492 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 161.14 61.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.792 -0.718 . . . . 63.100000000000001 112.487 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.762 ' CG2' HD11 ' A' ' 25' ' ' LEU . 1.7 m -157.56 178.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 72.319999999999993 111.122 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' HD22 ' A' ' 25' ' ' LEU . 48.9 m -52.04 114.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 63.5 110.827 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.56 -53.67 5.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 75.140000000000001 110.841 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -50.73 -30.09 13.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.899 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -51.35 67.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 71.230000000000004 110.939 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.42 -32.06 67.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 62.100000000000001 110.905 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' THR . 11.9 m -66.72 -1.0 3.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 62.340000000000003 111.121 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.29 -38.13 6.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.474 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 3.3 p30 -57.68 -56.39 22.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 65.439999999999998 110.894 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' HB3' ' A' ' 57' ' ' HIS . 40.6 mt -43.52 -45.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 53.439999999999998 111.167 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.96 -50.88 33.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 71.129999999999995 110.877 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -74.77 -52.43 11.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.906 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 35' ' ' GLN . . . -46.55 -57.15 5.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 111.108 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.41 -20.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.864 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -81.41 12.55 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 70.530000000000001 110.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.16 5.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 71.230000000000004 110.901 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.38 -53.1 0.8 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.722 -0.751 . . . . 63.140000000000001 112.507 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.698 HD12 HD12 ' A' ' 64' ' ' LEU . 1.2 pt -82.06 5.87 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 73.430000000000007 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.799 ' OD1' HG21 ' A' ' 61' ' ' VAL . 6.9 m-20 -87.64 -56.71 3.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 72.530000000000001 110.878 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.2 OUTLIER -78.29 120.03 22.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.88 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.19 -67.69 0.5 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.75 -0.738 . . . . 64.129999999999995 112.492 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.62 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.72 4.81 1.96 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.722 2.281 . . . . 62.329999999999998 112.367 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.7 pt -82.41 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.112 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -73.29 125.73 90.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.635 0.731 . . . . 74.200000000000003 110.913 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.78 7.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.679 2.253 . . . . 75.109999999999999 112.344 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.37 -31.74 1.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 33.520000000000003 112.497 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.84 -31.91 5.17 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.72 . . . . 53.25 112.499 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.61 -68.25 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.351 . . . . 45.539999999999999 111.123 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.5 m -116.19 2.81 13.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 110.876 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.594 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.1 t80 -39.99 -58.84 1.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.914 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mm-40 -98.24 131.45 26.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.683 0.754 . . . . 64.230000000000004 110.866 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.4 Cg_endo -69.67 148.98 87.63 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 -1.795 . . . . 62.229999999999997 112.368 -0.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.98 134.27 46.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.9 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.428 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 43.3 p -79.92 155.57 27.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.152 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.07 -53.58 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.439 . . . . 61.210000000000001 111.136 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.636 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.61 18.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.849 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.4 -55.25 11.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 73.450000000000003 111.105 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.741 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -33.75 -53.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.869 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.784 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -66.23 -38.88 88.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 61.100000000000001 111.118 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -60.11 -42.45 94.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 73.329999999999998 111.086 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.1 t80 -66.32 -60.48 2.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.886 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.799 HG21 ' OD1' ' A' ' 38' ' ' ASP . 2.1 p -54.11 -34.77 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 72.409999999999997 111.086 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.6 ' HE2' ' CZ ' ' A' ' 78' ' ' PHE . 1.2 mmt -45.77 -25.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 53.109999999999999 110.885 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.45 ' C ' ' OD1' ' A' ' 63' ' ' ASN . 19.0 t-20 -65.6 -63.56 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 110.848 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.698 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -72.5 -53.18 12.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 74.400000000000006 110.961 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.675 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -39.22 -57.5 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 62.399999999999999 110.914 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.583 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 16.7 t80 -50.45 -38.1 41.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.143 -0.481 . . . . 64.120000000000005 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.44 ' OE1' ' C ' ' A' ' 99' ' ' GLY . 9.0 mt-30 -92.27 -4.22 54.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 75.099999999999994 110.929 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.539 ' CD2' HD13 ' A' ' 37' ' ' ILE . 2.3 t60 -74.88 -41.94 58.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 62.310000000000002 110.844 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.022 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.67 -63.17 1.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 72.340000000000003 111.099 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -165.03 18.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 71.219999999999999 112.538 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.94 35.7 16.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.858 0.361 . . . . 75.319999999999993 110.891 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.583 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.2 m-80 -107.31 167.84 9.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.953 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.504 ' CB ' HD11 ' A' ' 84' ' ' LEU . 72.1 p -68.98 -24.25 64.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 73.040000000000006 110.846 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -81.1 2.17 28.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 110.907 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 1.022 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -23.52 59.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 65.140000000000001 110.892 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.3 m -82.14 102.03 10.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 75.310000000000002 110.864 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -118.03 11.31 13.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 110.845 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.784 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.9 m-30 -57.96 -68.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.835 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.13 177.99 3.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 73.310000000000002 110.833 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -65.53 -1.61 2.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 72.019999999999996 110.95 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 69.8 p -92.79 -53.16 4.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 71.430000000000007 111.112 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.95 103.43 11.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 111.05 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.9 t -148.45 178.02 8.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 70.019999999999996 111.096 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD11 ' CB ' ' A' ' 73' ' ' SER . 1.3 mt -66.69 152.4 45.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 54.439999999999998 110.872 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -133.75 167.32 20.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 87' ' ' THR . 61.8 m-80 -53.53 -168.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 74.140000000000001 110.867 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 86' ' ' ASN . 7.2 t -45.23 175.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.200000000000003 111.155 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 7.8 t-20 -51.98 108.26 1.03 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 72.239999999999995 110.911 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.591 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.74 -2.89 10.93 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.709 2.273 . . . . 65.530000000000001 112.368 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.405 ' HB3' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.0 106.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.854 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -73.15 -15.85 61.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.915 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.2 -111.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 72.400000000000006 112.499 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.44 -31.56 67.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.827 0.346 . . . . 53.439999999999998 111.101 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 102.04 7.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 54.240000000000002 110.859 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.3 139.84 34.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 65.120000000000005 110.911 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.591 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 10.4 m-85 -85.84 157.63 57.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 71.409999999999997 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.492 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.81 106.26 1.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.647 2.231 . . . . 53.119999999999997 112.32 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.497 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 74.3 p -81.15 -11.48 59.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 62.520000000000003 110.866 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' C ' ' OE1' ' A' ' 67' ' ' GLN . . . 35.14 36.34 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 62.130000000000003 112.456 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.89 149.8 24.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.852 0.358 . . . . 74.040000000000006 110.879 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.898 0.38 . . . . 75.010000000000005 111.129 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.52 163.15 7.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.565 0.698 . . . . 70.129999999999995 111.174 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 3.09 2.97 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.744 2.296 . . . . 70.340000000000003 112.345 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.5 p -52.06 151.95 6.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.537 0.684 . . . . 63.020000000000003 111.188 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 136.4 33.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.683 2.255 . . . . 64.329999999999998 112.347 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.5 p -114.37 154.25 46.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.631 0.729 . . . . 70.239999999999995 111.1 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -172.05 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 73.099999999999994 112.35 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 126.03 42.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 74.019999999999996 110.872 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.25 127.8 33.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 73.25 111.069 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.1 136.9 52.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.140000000000001 111.069 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.58 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 91.64 63.45 1.17 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.721 . . . . 54.030000000000001 112.484 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' HD23 ' A' ' 84' ' ' LEU . 41.4 m -158.02 126.9 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.882 0.372 . . . . 73.319999999999993 110.857 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.58 ' CH2' ' HA2' ' A' ' 11' ' ' GLY . 5.7 m-90 -129.29 122.64 30.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.915 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 62' ' ' MET . 1.1 t -95.47 107.56 19.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 73.430000000000007 110.897 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 3.9 m -152.64 154.81 32.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 60.109999999999999 111.136 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.8 Cg_endo -69.74 131.37 21.13 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.701 2.267 . . . . 65.540000000000006 112.339 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 110.77 2.03 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.575 0.702 . . . . 74.230000000000004 110.929 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 96.79 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.677 2.252 . . . . 72.209999999999994 112.352 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.15 -32.31 2.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 43.399999999999999 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.853 HG22 ' H ' ' A' ' 21' ' ' SER . 3.6 p -58.67 -178.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.344 . . . . 54.450000000000003 111.127 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.853 ' H ' HG22 ' A' ' 20' ' ' VAL . 3.2 m -52.05 113.72 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 64.239999999999995 110.881 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.22 -56.71 18.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 63.140000000000001 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 26' ' ' THR . 0.4 OUTLIER -52.4 -15.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.906 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.31 -46.21 16.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 74.530000000000001 110.892 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.781 HD22 ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -70.41 -50.23 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.140000000000001 110.906 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 23' ' ' ASP . 12.3 t -36.89 -28.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 63.530000000000001 111.16 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 25' ' ' LEU . . . -66.34 -44.93 89.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.7 -0.762 . . . . 54.299999999999997 112.488 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' LEU . 14.5 m-20 -41.87 -48.82 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 74.450000000000003 110.883 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.805 HG23 ' CG ' ' A' ' 57' ' ' HIS . 82.1 mt -55.63 -42.46 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 75.340000000000003 111.133 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.32 -46.05 80.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 54.439999999999998 110.886 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -74.15 -61.5 1.83 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 54.119999999999997 110.93 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.708 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -50.06 -46.87 53.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 61.5 111.083 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 29' ' ' ILE . 40.4 t -50.33 -17.68 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 71.099999999999994 110.866 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -93.03 17.96 9.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 110.817 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.457 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -96.98 -48.95 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 64.230000000000004 110.935 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.7 -63.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 63.219999999999999 112.445 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.669 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.36 4.66 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 72.239999999999995 111.164 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.838 ' OD1' HG11 ' A' ' 61' ' ' VAL . 2.3 m-20 -78.08 -68.2 0.66 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 35.439999999999998 110.869 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.15 129.02 36.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 64.340000000000003 110.876 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.57 -72.69 0.39 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.738 -0.744 . . . . 71.349999999999994 112.496 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.75 8.29 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.675 2.25 . . . . 71.219999999999999 112.364 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.71 HD13 ' HD2' ' A' ' 57' ' ' HIS . 29.8 pt -82.12 17.63 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 53.450000000000003 111.106 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -76.06 125.27 88.22 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.559 0.695 . . . . 75.120000000000005 110.91 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 161.62 45.23 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.659 2.24 . . . . 53.100000000000001 112.327 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -109.4 -40.62 1.47 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.705 -0.76 . . . . 70.140000000000001 112.474 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.71 17.34 1.9 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 64.420000000000002 112.535 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.79 -68.42 0.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.356 . . . . 71.109999999999999 111.099 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -117.89 11.67 13.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 110.898 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.559 ' CD2' ' HG3' ' A' ' 50' ' ' GLU . 13.0 t80 -55.32 -52.42 63.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.109999999999999 110.881 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG3' ' CD2' ' A' ' 49' ' ' PHE . 83.1 mt-10 -98.31 129.17 31.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.696 0.76 . . . . 61.340000000000003 110.869 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.79 153.48 93.04 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.657 -1.81 . . . . 64.400000000000006 112.361 -0.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -99.41 141.55 32.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 55.310000000000002 110.85 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.489 ' CG2' ' HE2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -98.19 158.38 15.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 70.450000000000003 111.138 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.76 -55.17 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.319999999999993 111.146 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.599 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.07 18.0 0.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.519999999999996 110.903 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -48.9 -58.08 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 71.329999999999998 111.114 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.805 ' CG ' HG23 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -33.8 -48.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 60.32 110.842 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.688 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -64.53 -46.19 83.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 111.106 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -56.28 -46.96 79.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.150000000000006 111.093 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.6 t80 -59.77 -64.84 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 64.109999999999999 110.92 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.838 HG11 ' OD1' ' A' ' 38' ' ' ASP . 5.7 p -54.52 -36.21 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.492 . . . . 64.540000000000006 111.116 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.476 ' CE ' ' SG ' ' A' ' 76' ' ' CYS . 8.6 mtp -45.49 -21.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.859 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -71.85 -52.36 17.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 75.299999999999997 110.84 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.669 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -81.14 -45.13 16.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 65.430000000000007 110.943 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.634 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.3 t80 -50.79 -45.93 59.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.882 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 19.3 t80 -58.9 -32.2 69.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.499 . . . . 72.120000000000005 110.929 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' CD ' ' O ' ' A' ' 99' ' ' GLY . 27.2 mt-30 -95.95 -4.92 42.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 63.409999999999997 110.902 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -73.42 -41.81 62.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 110.884 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.992 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.19 -60.73 2.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 61.130000000000003 111.117 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.15 22.06 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.694 -0.765 . . . . 75.340000000000003 112.457 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.03 36.42 18.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 73.239999999999995 110.857 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.564 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 5.5 m-80 -108.81 165.55 11.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 74.219999999999999 110.842 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.413 ' HB3' HD21 ' A' ' 84' ' ' LEU . 11.5 p -68.34 -22.67 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.478 . . . . 74.530000000000001 110.841 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.471 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -80.78 2.16 27.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 73.25 110.902 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.992 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.68 -23.69 59.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 42.039999999999999 110.867 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' CE ' ' A' ' 62' ' ' MET . 4.1 m -82.48 102.01 11.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.887 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.03 12.89 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.868 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.688 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 4.2 m-30 -58.8 -68.26 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 110.87 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.73 177.99 3.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 53.229999999999997 110.86 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -1.94 3.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 110.921 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.622 HG21 ' CD1' ' A' ' 25' ' ' LEU . 68.2 p -92.01 -52.03 4.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.209999999999994 111.145 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.476 ' HB1' ' CE ' ' A' ' 62' ' ' MET . . . -82.51 101.98 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 53.310000000000002 111.087 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.5 t -148.86 178.08 8.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 111.156 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.683 ' H ' HD12 ' A' ' 84' ' ' LEU . 4.2 mp -66.89 154.15 41.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.450000000000003 110.871 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -133.92 169.22 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 111.169 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.06 -169.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 65.340000000000003 110.892 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.1 t -44.47 173.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.16 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.577 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 10.5 t-20 -52.04 106.55 0.67 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.596 0.712 . . . . 74.530000000000001 110.855 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.0 Cg_endo -69.76 0.59 5.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.641 2.228 . . . . 71.200000000000003 112.357 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.428 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 8.4 t -52.01 108.64 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 74.439999999999998 110.86 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 1.3 p90 -80.99 -16.29 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 74.310000000000002 110.963 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.26 -119.88 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 73.540000000000006 112.444 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.02 -30.63 71.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.873 0.368 . . . . 45.420000000000002 111.118 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.513 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.2 m -78.77 101.95 7.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.892 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -98.79 136.56 38.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 72.510000000000005 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.557 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 6.8 m-85 -85.27 147.22 46.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.72 . . . . 74.420000000000002 110.888 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 135.77 31.42 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.683 2.255 . . . . 73.120000000000005 112.335 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.481 ' HB2' ' NE1' ' A' ' 13' ' ' TRP . 10.6 t -115.83 -8.32 11.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 64.239999999999995 110.878 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' O ' ' CD ' ' A' ' 67' ' ' GLN . . . 78.31 39.39 22.81 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.749 -0.739 . . . . 71.409999999999997 112.482 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.8 t -93.06 135.71 33.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.892 0.377 . . . . 72.340000000000003 110.844 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 64.400000000000006 110.892 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.86 0.362 . . . . 40.409999999999997 111.069 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.1 p -141.48 146.26 41.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.549 0.69 . . . . 70.109999999999999 111.164 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 172.43 12.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.701 2.267 . . . . 61.009999999999998 112.339 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.9 p -143.92 123.39 7.36 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.722 . . . . 74.319999999999993 111.113 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.34 9.99 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 64.040000000000006 112.33 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.5 p -147.91 148.82 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.558 0.694 . . . . 72.140000000000001 111.17 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -171.89 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.682 2.254 . . . . 62.310000000000002 112.345 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.42 116.95 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 71.099999999999994 110.89 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.03 160.11 28.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 111.067 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 175.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 54.100000000000001 111.135 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.499 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 155.92 41.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 64.140000000000001 112.474 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.0 124.0 4.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.855 0.36 . . . . 74.030000000000001 110.854 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 4.8 m-90 -125.41 118.37 25.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.477 . . . . 73.25 110.926 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.559 ' SG ' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -94.06 102.05 14.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.447 . . . . 63.310000000000002 110.879 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' A' ' 16' ' ' PRO . 2.7 m -151.9 153.34 31.43 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.643 0.735 . . . . 73.329999999999998 111.095 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 81' ' ' THR . 53.5 Cg_endo -69.82 127.94 15.26 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.655 2.236 . . . . 71.430000000000007 112.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -51.96 114.71 5.65 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.583 0.706 . . . . 75.439999999999998 110.952 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HA ' ' NZ ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.76 15.3 0.23 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.694 2.263 . . . . 71.129999999999995 112.371 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 20' ' ' VAL . . . -131.65 62.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.709 -0.758 . . . . 54.329999999999998 112.499 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.633 ' CG2' HD11 ' A' ' 25' ' ' LEU . 2.2 m -158.49 178.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 75.510000000000005 111.077 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.604 ' O ' HD22 ' A' ' 25' ' ' LEU . 34.3 m -55.84 127.45 30.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.826 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.55 -49.4 67.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 73.319999999999993 110.833 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -28.03 36.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.839 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.03 -49.57 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 110.905 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -71.05 -41.33 70.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 72.329999999999998 110.917 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 m -46.29 -43.39 15.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 71.219999999999999 111.131 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -51.62 -29.57 25.36 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 71.439999999999998 112.513 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -59.97 -68.15 0.32 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.801 0.334 . . . . 44.219999999999999 110.946 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.643 HG23 ' CG ' ' A' ' 57' ' ' HIS . 97.2 mt -40.9 -68.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 74.409999999999997 111.123 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 29' ' ' ILE . 5.6 t30 -34.1 -44.37 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 110.838 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -75.72 -68.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 110.932 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.771 ' HB1' ' OD2' ' A' ' 38' ' ' ASP . . . -45.18 -21.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 73.409999999999997 111.082 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER -71.96 5.16 2.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.876 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 m -110.04 15.2 22.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 110.857 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -98.0 -47.2 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 51.43 110.866 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 131.19 -55.78 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 70.140000000000001 112.46 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.904 HG21 ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -82.21 9.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 51.5 111.141 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.771 ' OD2' ' HB1' ' A' ' 32' ' ' ALA . 1.6 m-20 -88.1 -63.77 1.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 110.868 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.12 114.93 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 63.130000000000003 110.88 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.77 -69.67 0.53 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 31.219999999999999 112.485 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.9 Cg_endo -69.8 7.5 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.692 2.261 . . . . 73.200000000000003 112.313 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 38' ' ' ASP . 29.3 pt -82.22 16.98 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 111.145 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -73.62 123.74 89.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 61.130000000000003 110.932 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 171.25 14.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.719 2.28 . . . . 73.420000000000002 112.316 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -123.83 -33.89 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 12.01 112.485 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.03 -18.09 5.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 63.32 112.498 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.32 -68.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 53.219999999999999 111.082 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.2 m -110.87 2.18 18.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 72.219999999999999 110.9 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 6.1 t80 -40.99 -60.07 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.409999999999997 110.877 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.14 134.12 22.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.731 . . . . 73.340000000000003 110.905 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.0 Cg_endo -69.71 150.67 90.38 Favored 'Cis proline' 0 C--N 1.341 0.145 0 C-N-CA 122.7 -1.792 . . . . 53.5 112.313 -0.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -100.47 122.22 42.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' NZ ' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -85.68 157.48 20.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 54.149999999999999 111.146 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.92 -49.33 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 111.105 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' NZ ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -81.28 18.07 1.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 65.340000000000003 110.882 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . -50.43 -54.18 23.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 62.450000000000003 111.076 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.946 ' O ' HG12 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -37.25 -50.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.861 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.812 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -65.3 -39.48 92.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 65.230000000000004 111.098 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -59.09 -55.85 29.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 62.200000000000003 111.105 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.3 t80 -52.6 -62.35 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 110.919 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.946 HG12 ' O ' ' A' ' 57' ' ' HIS . 1.5 p -54.38 -37.44 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 73.120000000000005 111.137 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.417 ' SD ' ' SG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -45.71 -21.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 110.875 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -71.37 -52.08 20.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 72.329999999999998 110.923 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.665 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -83.53 -46.39 12.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 110.899 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.626 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -46.33 -45.29 17.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 53.520000000000003 110.947 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.627 ' CE1' ' O ' ' A' ' 72' ' ' ASN . 58.7 t80 -60.45 -34.91 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 63.240000000000002 110.939 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.461 HE21 ' CA ' ' A' ' 99' ' ' GLY . 39.9 mt-30 -93.07 -4.22 52.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.103 -0.499 . . . . 64.349999999999994 110.96 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.904 ' CE1' HG21 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -70.83 -44.58 66.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 54.420000000000002 110.833 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.907 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.6 -59.53 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 65.099999999999994 111.064 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -174.79 24.64 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 74.420000000000002 112.466 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.01 32.43 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 110.846 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.627 ' O ' ' CE1' ' A' ' 66' ' ' TYR . 5.9 m-80 -100.71 163.63 12.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.400000000000006 110.891 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.523 ' CB ' HD11 ' A' ' 84' ' ' LEU . 83.8 p -67.55 -21.87 65.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.420000000000002 110.885 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.489 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.8 p90 -81.71 3.5 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 71.239999999999995 110.875 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.907 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -76.53 -26.71 55.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 72.439999999999998 110.873 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.417 ' SG ' ' SD ' ' A' ' 62' ' ' MET . 93.1 m -82.4 102.01 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.874 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -118.01 11.05 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 64.409999999999997 110.904 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.812 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.9 m-30 -57.72 -68.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 75.049999999999997 110.917 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.75 178.0 3.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.530000000000001 110.851 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -2.06 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 110.907 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.523 HG21 ' CD1' ' A' ' 25' ' ' LEU . 67.2 p -91.88 -53.58 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 60.210000000000001 111.104 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.49 102.01 11.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 63.030000000000001 111.107 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 14.3 t -152.88 178.03 10.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 73.209999999999994 111.141 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.559 HD23 ' SG ' ' A' ' 14' ' ' CYS . 18.8 mt -65.8 123.69 20.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 73.010000000000005 110.949 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.472 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.3 t -106.17 168.63 9.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.049999999999997 111.132 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.8 m120 -53.88 -167.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 110.895 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 86' ' ' ASN . 4.7 t -45.06 175.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 43.149999999999999 111.125 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.2 t-20 -51.95 107.09 0.75 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.701 . . . . 61.43 110.9 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.73 2.78 3.2 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 73.140000000000001 112.35 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.42 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 19.8 t -52.04 109.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 110.824 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -70.36 -16.86 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 74.209999999999994 110.967 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.455 ' N ' ' CD1' ' A' ' 91' ' ' TYR . . . 175.16 -110.54 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 63.229999999999997 112.474 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.81 73.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 62.409999999999997 111.085 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.32 104.66 14.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 62.340000000000003 110.886 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -98.64 149.86 22.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 65.129999999999995 110.93 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.534 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.4 m-85 -90.71 159.87 39.83 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.652 0.739 . . . . 74.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 104.35 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.261 . . . . 55.229999999999997 112.334 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.578 ' HA ' ' CD1' ' A' ' 13' ' ' TRP . 40.6 p -73.83 -15.96 61.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 64.230000000000004 110.89 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.461 ' CA ' HE21 ' A' ' 67' ' ' GLN . . . 45.0 52.78 7.82 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.666 -0.778 . . . . 52.219999999999999 112.516 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.59 167.0 19.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.908 0.385 . . . . 64.340000000000003 110.866 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 75.340000000000003 110.87 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.864 0.364 . . . . 62.509999999999998 111.081 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -52.43 141.56 32.87 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.541 0.686 . . . . 65.439999999999998 111.172 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 118.34 5.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.673 2.248 . . . . 73.439999999999998 112.34 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.48 HG23 ' HD2' ' A' ' 5' ' ' PRO . 21.6 m -79.26 136.94 56.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.578 0.704 . . . . 71.120000000000005 111.129 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 4' ' ' THR . 53.7 Cg_endo -69.81 84.33 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.631 2.22 . . . . 64.310000000000002 112.347 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.13 159.97 66.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.608 0.718 . . . . 72.120000000000005 111.112 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -173.86 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.71 2.274 . . . . 73.549999999999997 112.335 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' HZ2' ' HA ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -130.59 122.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.140000000000001 110.892 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.82 155.03 33.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.420000000000002 111.093 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 132.91 54.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 54.210000000000001 111.096 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA2' ' CH2' ' A' ' 13' ' ' TRP . . . 108.09 83.77 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 72.230000000000004 112.439 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.71 ' HB3' HD22 ' A' ' 84' ' ' LEU . 58.1 m -157.77 138.4 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 53.299999999999997 110.84 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.684 ' HB2' HG22 ' A' ' 85' ' ' THR . 10.9 m-90 -145.56 113.24 6.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 75.120000000000005 110.932 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.435 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -83.64 108.45 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 72.209999999999994 110.896 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.53 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.4 m -158.63 153.99 22.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 70.109999999999999 111.118 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.522 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.77 122.85 9.52 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.707 2.272 . . . . 60.43 112.36 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -51.92 116.97 8.99 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.609 0.718 . . . . 74.530000000000001 110.927 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 86.85 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 65.25 112.324 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 -27.5 0.62 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.782 -0.723 . . . . 70.409999999999997 112.487 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 21' ' ' SER . 2.6 t -59.03 170.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 52.340000000000003 111.12 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.885 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -52.97 118.37 3.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 53.240000000000002 110.826 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -42.98 -66.05 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 71.209999999999994 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -41.23 -40.62 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -58.01 -50.4 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 52.100000000000001 110.904 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.885 HD22 ' O ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -71.31 -31.17 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 54.149999999999999 110.947 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.2 m -64.66 -30.03 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 111.189 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.72 -23.3 70.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.752 -0.737 . . . . 71.129999999999995 112.466 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 57.5 m-20 -63.83 -58.64 6.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 72.239999999999995 110.912 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 55' ' ' LYS . 95.9 mt -47.14 -47.86 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 72.329999999999998 111.11 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -51.65 -44.24 62.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 72.439999999999998 110.865 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.12 -56.56 4.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.881 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . . . -47.85 -43.84 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 74.519999999999996 111.089 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.1 -28.31 4.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 110.891 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -81.46 15.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 70.200000000000003 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.597 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.95 -46.8 5.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 61.210000000000001 110.932 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.19 -62.43 0.64 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 54.399999999999999 112.512 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.79 ' CG1' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -83.07 11.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.806 0.336 . . . . 73.430000000000007 111.094 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.863 ' O ' HG23 ' A' ' 42' ' ' ILE . 1.6 t70 -86.98 -56.6 3.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.897 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.452 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.3 m -74.85 120.59 20.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.873 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.33 -69.44 0.43 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.724 -0.75 . . . . 75.530000000000001 112.477 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.81 1.28 4.61 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.686 2.257 . . . . 63.329999999999998 112.337 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 38' ' ' ASP . 33.3 pt -83.2 18.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 111.109 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -86.75 135.69 35.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.638 0.733 . . . . 72.200000000000003 110.907 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 174.12 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.281 . . . . 63.439999999999998 112.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.09 -33.73 0.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 73.239999999999995 112.463 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.18 -21.4 6.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 72.519999999999996 112.478 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.44 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 60.200000000000003 111.078 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 49' ' ' PHE . 1.2 m -117.91 -2.27 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.400000000000006 110.914 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 6.3 t80 -36.42 -51.9 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.867 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.582 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 19.1 mm-40 -99.72 129.56 28.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.59 0.71 . . . . 64.530000000000001 110.901 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.77 147.85 85.51 Favored 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.69 -1.796 . . . . 60.299999999999997 112.366 0.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.531 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 6.4 p30 -104.17 133.4 49.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 70.530000000000001 110.934 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.51 166.4 12.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 70.329999999999998 111.131 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.35 -56.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 111.095 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.08 14.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 75.140000000000001 110.877 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.38 53.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 41.020000000000003 111.109 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.733 ' CD2' HD12 ' A' ' 42' ' ' ILE . 64.8 m80 -51.95 -52.3 51.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 71.409999999999997 110.864 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.571 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -55.35 -43.02 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 111.108 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.73 -35.73 68.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.08 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.9 t80 -68.38 -64.71 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 70.430000000000007 110.927 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.592 HG22 ' HB2' ' A' ' 65' ' ' TYR . 7.1 p -55.5 -33.7 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 73.25 111.136 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.514 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -45.85 -27.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 65.319999999999993 110.843 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -66.16 -60.51 2.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 63.399999999999999 110.835 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.79 HD12 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -71.4 -47.85 53.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.932 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.597 ' CE2' ' CG ' ' A' ' 35' ' ' GLN . 3.0 t80 -45.55 -48.24 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 110.955 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.4 t80 -62.37 -31.89 72.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 71.230000000000004 110.943 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -95.64 -4.64 44.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.491 . . . . 71.439999999999998 110.919 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -71.29 -42.89 68.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 70.530000000000001 110.869 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.904 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.45 -60.61 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 71.420000000000002 111.098 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.19 23.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 72.239999999999995 112.494 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 7.7 mtp180 52.07 43.18 30.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 74.439999999999998 110.856 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.562 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.3 m-80 -109.19 166.95 10.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 40.520000000000003 110.941 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.475 ' HB2' HD11 ' A' ' 84' ' ' LEU . 32.6 p -71.15 -24.93 62.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 41.43 110.819 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -78.52 -1.1 32.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 64.409999999999997 110.907 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.904 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.82 -22.07 59.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 72.549999999999997 110.879 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -82.78 102.05 11.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 73.510000000000005 110.855 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -117.98 6.88 12.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.868 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.655 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.3 m-30 -58.96 -71.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 64.209999999999994 110.89 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.16 178.01 2.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.807 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -2.78 3.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 63.200000000000003 110.904 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.643 HG21 ' CD1' ' A' ' 25' ' ' LEU . 29.1 p -97.99 -46.68 5.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 75.349999999999994 111.148 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.655 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -80.97 24.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 61.130000000000003 111.062 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -84.47 -178.18 6.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 62.149999999999999 111.141 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 12' ' ' SER . 1.6 mt -66.89 134.91 52.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 55.229999999999997 110.906 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.684 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.2 t -106.2 169.06 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 111.164 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 87' ' ' THR . 13.1 m-80 -53.25 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 70.019999999999996 110.886 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -45.08 173.84 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 75.140000000000001 111.159 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.573 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 6.6 t-20 -52.07 106.24 0.63 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.608 0.718 . . . . 74.109999999999999 110.889 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HG2' ' CD1' ' A' ' 96' ' ' PHE . 53.9 Cg_endo -69.72 -13.21 34.44 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 60.219999999999999 112.378 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 t -52.06 105.52 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 62.420000000000002 110.847 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.2 -16.7 52.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.310000000000002 110.908 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.56 -115.35 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.769 -0.729 . . . . 63.229999999999997 112.504 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.27 86.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 111.082 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.25 101.99 5.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 110.918 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.57 139.18 36.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 61.049999999999997 110.892 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 89' ' ' PRO . 20.0 m-85 -93.01 141.18 23.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 74.120000000000005 110.879 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 129.02 16.81 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.682 2.255 . . . . 74.310000000000002 112.331 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 36.8 p -110.03 -6.4 15.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.519999999999996 110.898 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 46.43 30.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.708 -0.758 . . . . 12.33 112.478 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.6 p -155.69 125.24 6.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.92 0.39 . . . . 65.230000000000004 110.83 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 6.5 t30 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 65.439999999999998 110.864 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.872 0.368 . . . . 73.109999999999999 111.119 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.4 p -88.01 137.97 31.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.587 0.708 . . . . 64.519999999999996 111.128 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 165.35 31.21 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.68 2.253 . . . . 71.129999999999995 112.369 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.2 p -142.15 127.36 10.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 111.153 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 157.73 59.33 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.669 2.246 . . . . 74.420000000000002 112.353 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.73 HG22 ' HB2' ' A' ' 8' ' ' LYS . 3.1 m -142.74 101.95 5.41 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.599 0.714 . . . . 64.420000000000002 111.161 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 6' ' ' THR . 53.6 Cg_endo -69.71 3.47 2.73 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.656 2.237 . . . . 73.200000000000003 112.397 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.73 ' HB2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -52.12 102.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 74.310000000000002 110.894 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.75 168.56 17.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 42.149999999999999 111.151 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.63 177.98 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.510000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -125.77 -8.69 5.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 63.020000000000003 112.469 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB3' HD22 ' A' ' 84' ' ' LEU . 3.7 m -141.9 148.23 38.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 64.230000000000004 110.867 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.558 ' CZ2' ' HB2' ' A' ' 88' ' ' ASN . 9.2 m-90 -142.85 115.16 8.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 71.310000000000002 110.893 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.79 108.62 17.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 62.109999999999999 110.885 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG21 ' CD2' ' A' ' 96' ' ' PHE . 3.2 m -158.56 154.16 22.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.674 0.749 . . . . 72.519999999999996 111.124 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.542 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.78 120.75 7.48 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 75.049999999999997 112.334 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.01 117.7 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.617 0.722 . . . . 74.340000000000003 110.877 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 85.23 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.723 2.282 . . . . 50.219999999999999 112.338 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.06 -21.95 0.51 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 65.549999999999997 112.409 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.826 ' HB ' HD11 ' A' ' 25' ' ' LEU . 2.3 t -59.07 164.94 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 65.030000000000001 111.155 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.769 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.0 m -53.63 111.76 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 53.310000000000002 110.854 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.7 m-20 -33.78 -64.54 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 61.130000000000003 110.884 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.24 -40.73 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.871 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 21' ' ' SER . 2.4 tp-100 -58.33 -50.44 73.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 70.019999999999996 110.896 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.926 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -70.9 -29.28 65.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.901 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 m -66.53 -0.24 2.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 111.168 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.92 -38.5 5.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.721 -0.752 . . . . 45.340000000000003 112.498 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.4 p30 -53.6 -43.1 68.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.829 0.347 . . . . 62.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.595 HD11 ' HA ' ' A' ' 55' ' ' LYS . 64.1 mt -59.11 -46.94 91.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 70.040000000000006 111.137 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -44.31 38.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 63.43 110.884 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -73.7 -49.03 27.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.92 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.451 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . . . -51.7 -45.13 63.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 73.299999999999997 111.093 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' CA ' ' OD2' ' A' ' 38' ' ' ASP . 9.0 t -57.44 -12.16 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 51.109999999999999 110.863 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.13 6.69 47.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 64.019999999999996 110.831 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.468 ' CG ' ' CE2' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -97.96 -43.09 7.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 110.957 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.96 -47.09 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 64.230000000000004 112.428 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.583 HD12 HD12 ' A' ' 64' ' ' LEU . 1.5 pt -89.74 8.21 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 73.049999999999997 111.132 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.774 ' O ' HG23 ' A' ' 42' ' ' ILE . 9.3 t70 -86.87 -61.75 1.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 70.430000000000007 110.871 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 3.8 m -75.95 124.62 27.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.812 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.28 -74.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 64.099999999999994 112.433 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' C ' ' A' ' 39' ' ' CYS . 53.3 Cg_endo -69.81 4.14 2.39 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.647 2.231 . . . . 74.109999999999999 112.325 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 38' ' ' ASP . 5.9 pt -82.93 17.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 111.111 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -79.16 144.33 62.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.608 0.718 . . . . 64.150000000000006 110.891 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.595 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 54.2 Cg_endo -69.74 148.13 64.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.684 2.256 . . . . 64.519999999999996 112.388 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.64 -39.28 3.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.5 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.69 15.18 2.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.74 . . . . 72.239999999999995 112.52 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.89 -68.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 60.219999999999999 111.149 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' PHE . 21.1 t -117.93 -6.73 10.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 61.310000000000002 110.888 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 44' ' ' PRO . 3.0 t80 -34.34 -56.35 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 71.109999999999999 110.878 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 9.7 mm-40 -99.6 125.84 39.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 61.25 110.913 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.6 Cg_endo -69.82 150.71 90.73 Favored 'Cis proline' 0 C--N 1.342 0.204 0 C-N-CA 122.648 -1.813 . . . . 72.319999999999993 112.337 0.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -111.29 133.52 53.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 72.230000000000004 110.852 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.81 176.63 6.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 64.420000000000002 111.098 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -65.32 -54.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 73.120000000000005 111.114 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.595 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.71 17.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.862 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -51.34 -39.28 56.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 73.150000000000006 111.101 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.719 ' CG ' HD12 ' A' ' 42' ' ' ILE . 26.8 m170 -57.25 -57.77 11.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 72.140000000000001 110.893 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.667 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -50.02 -36.52 29.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 74.040000000000006 111.086 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.18 -44.31 92.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 111.059 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 5.7 t80 -68.01 -59.09 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 74.219999999999999 110.904 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 65' ' ' TYR . 7.5 p -55.1 -35.97 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 73.150000000000006 111.152 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.633 ' HE3' ' HA ' ' A' ' 62' ' ' MET . 0.3 OUTLIER -46.46 -29.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.892 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.38 -65.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.935 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.53 -47.87 74.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.902 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.527 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.2 t80 -49.71 -47.6 50.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.929 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.563 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.1 t80 -60.6 -30.62 69.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.129999999999995 110.882 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -98.87 3.34 47.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 73.310000000000002 110.881 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.535 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -75.41 -48.8 21.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.878 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -70.16 -54.55 12.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.240000000000002 111.065 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.67 26.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.738 -0.744 . . . . 62.240000000000002 112.489 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.97 47.96 23.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 72.409999999999997 110.847 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.563 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 4.1 m-80 -114.19 162.07 17.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 62.119999999999997 110.928 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.577 ' HB2' HD11 ' A' ' 84' ' ' LEU . 59.5 p -67.96 -24.43 65.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 62.109999999999999 110.818 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -80.04 1.19 28.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.142 -0.481 . . . . 75.400000000000006 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.667 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -77.46 -19.79 55.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.919 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -83.54 102.08 11.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 41.229999999999997 110.833 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -118.04 7.56 12.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 72.239999999999995 110.898 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.667 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.3 m-30 -59.27 -71.07 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 110.913 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.71 177.97 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.883 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -65.5 -1.99 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 72.409999999999997 110.931 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.926 HG21 ' CD1' ' A' ' 25' ' ' LEU . 26.9 p -97.92 -47.48 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 53.310000000000002 111.157 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.03 26.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 44.130000000000003 111.088 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.6 t -86.75 -177.83 6.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 63.329999999999998 111.158 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' A' ' 73' ' ' SER . 14.5 mt -67.04 130.51 43.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.442 . . . . 64.519999999999996 110.899 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.5 t -106.02 169.51 8.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 64.519999999999996 111.139 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' THR . 34.0 m120 -53.15 -169.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 61.310000000000002 110.883 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' ASN . 2.5 t -44.66 172.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 61.130000000000003 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.558 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 15.7 t-20 -52.09 106.79 0.7 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.662 0.744 . . . . 75.209999999999994 110.869 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.555 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.8 Cg_endo -69.74 -3.7 12.52 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 73.439999999999998 112.353 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 1.9 t -52.02 104.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 61.100000000000001 110.889 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -17.83 25.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.899 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.08 -117.7 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 51.130000000000003 112.519 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.8 -26.79 65.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 72.329999999999998 111.07 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 t -76.13 102.02 5.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 53.549999999999997 110.87 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.77 127.94 45.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 73.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.555 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 25.6 m-85 -92.45 141.15 24.43 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 63.229999999999997 110.836 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 133.24 25.17 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.688 2.259 . . . . 75.530000000000001 112.361 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 99' ' ' GLY . 18.4 p -106.1 -14.34 15.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 61.520000000000003 110.859 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 98' ' ' SER . . . 35.49 38.77 0.19 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 63.049999999999997 112.472 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.1 p -151.71 150.44 30.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 71.140000000000001 110.826 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 73.530000000000001 110.877 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.857 0.361 . . . . 54.310000000000002 111.087 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.0 p -94.48 132.99 27.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.638 0.733 . . . . 75.209999999999994 111.141 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -176.28 1.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 71.439999999999998 112.346 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.7 p -156.44 147.45 16.51 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.604 0.716 . . . . 74.040000000000006 111.105 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 176.42 6.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.707 2.271 . . . . 61.229999999999997 112.356 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.0 p -100.34 143.55 26.74 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.589 0.709 . . . . 72.439999999999998 111.153 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -172.85 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.687 2.258 . . . . 63.32 112.372 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' HD3' ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -114.52 126.67 55.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 71.25 110.904 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' N ' ' HD3' ' A' ' 8' ' ' LYS . . . -56.01 113.32 1.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 64.340000000000003 111.093 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.53 177.96 7.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 111.088 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.569 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -59.78 -177.15 1.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 74.409999999999997 112.44 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.656 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 1.0 OUTLIER -146.3 153.92 41.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 71.430000000000007 110.856 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.656 ' CE3' ' C ' ' A' ' 12' ' ' SER . 8.6 m-90 -153.4 112.2 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 75.310000000000002 110.908 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -79.41 110.76 15.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 110.927 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.505 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 5.6 m -159.96 155.88 22.92 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.668 0.747 . . . . 74.439999999999998 111.078 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 53.4 Cg_endo -69.77 122.9 9.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 74.439999999999998 112.331 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -52.02 114.53 5.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.525 0.678 . . . . 71.400000000000006 110.918 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 99.89 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.679 2.253 . . . . 74.010000000000005 112.312 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.63 -28.28 2.66 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 72.530000000000001 112.474 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.882 HG11 HD11 ' A' ' 25' ' ' LEU . 5.8 p -58.89 173.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 42.450000000000003 111.155 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.701 ' H ' HG22 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -52.0 109.08 0.33 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.853 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -42.77 -68.29 0.21 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 50.340000000000003 110.861 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -41.22 -27.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 65.340000000000003 110.894 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.491 ' CB ' ' O ' ' A' ' 21' ' ' SER . 6.1 tm0? -63.99 -51.49 64.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 73.299999999999997 110.915 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.882 HD11 HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -70.24 -33.41 71.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 43.100000000000001 110.915 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.9 m -51.01 -18.84 0.87 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 62.009999999999998 111.144 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.97 -27.65 49.12 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 71.420000000000002 112.493 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 25' ' ' LEU . 78.7 m-20 -59.81 -46.51 88.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 51.43 110.917 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.499 ' CD1' ' O ' ' A' ' 54' ' ' VAL . 65.2 mt -62.96 -53.24 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.479 . . . . 62.030000000000001 111.117 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -52.43 -47.21 66.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 72.239999999999995 110.873 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -69.37 -59.62 2.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 63.140000000000001 110.904 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' CG ' ' A' ' 38' ' ' ASP . . . -51.69 -33.36 33.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 63.0 111.081 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 29' ' ' ILE . 43.8 t -57.27 -11.3 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 63.539999999999999 110.859 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 17.99 14.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 70.030000000000001 110.863 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 3.1 mm100 -90.84 -51.83 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 62.43 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 168.02 -97.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.741 . . . . 73.109999999999999 112.471 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.796 HG12 HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -81.99 18.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 64.530000000000001 111.121 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -75.09 -62.45 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 65.439999999999998 110.89 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -75.37 126.14 30.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 51.240000000000002 110.83 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.13 -70.06 0.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.698 -0.763 . . . . 63.25 112.467 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' CG ' ' O ' ' A' ' 37' ' ' ILE . 53.7 Cg_endo -69.81 6.0 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.683 2.255 . . . . 64.129999999999995 112.325 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.653 HD12 ' CG ' ' A' ' 57' ' ' HIS . 22.6 pt -82.63 18.0 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 111.135 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -79.89 129.51 70.31 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.922 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 170.1 17.46 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.678 2.252 . . . . 75.0 112.299 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.6 -41.06 0.81 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 61.439999999999998 112.48 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.35 -17.49 5.33 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 61.149999999999999 112.505 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.14 -68.64 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.337 . . . . 72.209999999999994 111.132 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.05 6.29 12.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 64.329999999999998 110.859 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.573 ' CE2' ' HG3' ' A' ' 50' ' ' GLU . 3.7 t80 -40.87 -68.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 45.32 110.885 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HG3' ' CE2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -93.24 137.74 23.45 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.617 0.722 . . . . 73.109999999999999 110.913 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.555 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 54.2 Cg_endo -69.75 139.87 57.18 Favored 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.712 -1.786 . . . . 74.25 112.317 -0.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.73 133.66 52.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.438 ' HB ' ' NZ ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -86.93 174.24 8.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.479 . . . . 74.129999999999995 111.129 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.499 ' O ' ' CD1' ' A' ' 29' ' ' ILE . 56.4 t -65.76 -55.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 111.162 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HZ2' ' N ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -78.42 13.64 1.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 110.904 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.579 ' N ' ' HZ2' ' A' ' 55' ' ' LYS . . . -51.15 -48.89 61.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 41.530000000000001 111.112 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.653 ' CG ' HD12 ' A' ' 42' ' ' ILE . 65.5 m80 -49.04 -48.13 44.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 74.340000000000003 110.847 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.485 ' HB1' ' HE2' ' A' ' 78' ' ' PHE . . . -57.66 -38.06 74.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 61.439999999999998 111.116 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.54 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.422 . . . . 34.43 111.119 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.607 ' CE1' HD21 ' A' ' 64' ' ' LEU . 3.4 t80 -68.53 -59.14 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 63.439999999999998 110.905 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' A' ' 38' ' ' ASP . 2.0 p -54.71 -39.19 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 73.219999999999999 111.125 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.706 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 5.0 mtm -45.96 -32.62 2.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 71.129999999999995 110.858 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -66.59 0.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 62.340000000000003 110.862 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.796 HD12 HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.69 -59.5 4.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 71.329999999999998 110.911 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.436 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 4.4 t80 -39.65 -43.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.901 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 4.0 t80 -61.15 -41.34 96.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.505 . . . . 63.439999999999998 110.927 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 99' ' ' GLY . 29.2 mt-30 -91.62 -3.82 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 64.209999999999994 110.931 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.3 t60 -75.26 -40.68 58.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 74.140000000000001 110.89 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.998 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -75.76 -60.6 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 111.081 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -168.62 20.04 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 72.510000000000005 112.51 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 mtt180 51.96 33.91 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 72.530000000000001 110.887 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.551 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.9 m-80 -102.98 167.24 9.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.109999999999999 110.897 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.655 ' HB2' HD11 ' A' ' 84' ' ' LEU . 93.7 p -71.26 -24.3 62.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 71.319999999999993 110.858 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.436 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -78.19 0.52 24.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 75.129999999999995 110.927 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.998 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -6.17 45.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.925 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -94.28 102.21 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.319999999999993 110.85 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.03 5.29 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 44.119999999999997 110.819 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.0 m-30 -59.31 -71.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 62.329999999999998 110.879 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.37 177.99 2.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 75.109999999999999 110.86 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.37 -2.84 3.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.936 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.49 HG21 ' CD1' ' A' ' 25' ' ' LEU . 27.5 p -98.04 -47.25 5.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 111.103 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.706 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -81.44 24.0 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 64.030000000000001 111.06 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 t -85.05 -177.29 6.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 70.439999999999998 111.173 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 73' ' ' SER . 15.4 mt -66.86 125.28 25.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.140000000000001 110.875 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.7 t -98.01 169.39 9.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 73.140000000000001 111.161 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 85' ' ' THR . 51.8 m-80 -52.95 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 110.901 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 1.6 t -44.39 170.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 63.039999999999999 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.563 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.3 t-20 -52.01 106.29 0.64 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.643 0.735 . . . . 62.240000000000002 110.902 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.563 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.7 Cg_endo -69.73 -3.09 11.28 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.699 2.266 . . . . 71.450000000000003 112.323 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.449 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 3.5 t -51.97 107.02 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.450000000000003 110.857 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -17.88 45.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 110.913 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 176.56 -113.59 0.44 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 72.510000000000005 112.471 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.18 -38.16 90.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 61.439999999999998 111.103 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 101.99 5.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 110.905 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.51 144.97 28.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 55.299999999999997 110.906 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.563 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 8.6 m-85 -92.45 150.35 39.83 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.657 0.741 . . . . 74.010000000000005 110.924 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 115.97 4.34 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.687 2.258 . . . . 72.209999999999994 112.333 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 8.5 p -109.42 16.58 22.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.437 . . . . 53.030000000000001 110.876 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.465 ' O ' ' NE2' ' A' ' 67' ' ' GLN . . . 68.04 -80.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 75.219999999999999 112.509 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.43 106.69 15.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 71.349999999999994 110.852 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 63.109999999999999 110.86 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.874 0.369 . . . . 64.439999999999998 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.7 m -98.03 119.66 61.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.558 0.694 . . . . 73.150000000000006 111.154 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 161.9 44.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 44.340000000000003 112.359 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.8 p -80.32 115.91 58.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 64.329999999999998 111.157 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 177.91 5.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 54.25 112.356 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 p -97.81 102.69 14.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.597 0.713 . . . . 64.209999999999994 111.11 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -173.85 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.643 2.229 . . . . 65.219999999999999 112.327 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -88.07 123.97 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 62.020000000000003 110.871 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.55 163.56 2.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 72.109999999999999 111.063 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -160.47 177.43 10.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 111.09 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.99 -134.66 3.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 73.140000000000001 112.51 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.571 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -154.71 154.57 33.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 73.319999999999993 110.836 -179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.574 ' CD1' ' HB3' ' A' ' 98' ' ' SER . 7.6 m-90 -146.7 105.24 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 63.119999999999997 110.929 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.428 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -72.28 105.34 4.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 53.43 110.867 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.519 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.2 m -158.77 153.62 21.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.622 0.725 . . . . 63.130000000000003 111.098 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.76 120.27 7.08 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.651 2.234 . . . . 50.25 112.371 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.0 119.37 14.03 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.572 0.701 . . . . 75.239999999999995 110.904 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 85.3 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.725 2.283 . . . . 62.100000000000001 112.355 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.42 -22.43 0.29 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.757 . . . . 70.439999999999998 112.457 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 21' ' ' SER . 24.4 t -65.81 164.13 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.848 0.356 . . . . 62.039999999999999 111.123 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.582 ' N ' HG12 ' A' ' 20' ' ' VAL . 5.4 m -54.0 103.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 62.020000000000003 110.88 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 21' ' ' SER . 34.8 m-20 -34.06 -65.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 110.876 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 22' ' ' ASP . 35.2 m-20 -36.21 -41.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.895 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -62.62 -46.91 86.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 64.209999999999994 110.911 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.794 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.1 OUTLIER -70.27 -33.54 71.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.299999999999997 110.93 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.6 m -56.6 -35.0 67.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 32.420000000000002 111.145 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -61.9 -26.63 67.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 73.099999999999994 112.509 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -63.46 -43.2 98.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 73.109999999999999 110.919 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 57' ' ' HIS . 24.9 mt -62.38 -51.63 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 75.010000000000005 111.102 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -54.07 -45.41 71.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.881 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -68.95 -58.07 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 110.895 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.894 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -49.94 -47.03 52.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 75.310000000000002 111.127 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -50.77 -17.43 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 54.25 110.863 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 t -88.0 13.58 10.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 52.340000000000003 110.897 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -98.03 -46.06 6.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 72.0 110.918 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 136.53 -55.57 0.7 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.714 -0.755 . . . . 55.32 112.457 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 65' ' ' TYR . 1.3 pt -88.13 4.1 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.853 0.359 . . . . 60.100000000000001 111.135 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.894 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 1.9 m-20 -80.6 -58.98 2.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 75.510000000000005 110.857 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.456 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -75.37 127.31 32.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 75.25 110.874 -179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 118.17 -73.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.737 . . . . 40.409999999999997 112.483 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.602 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 53.6 Cg_endo -69.8 3.61 2.69 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.686 2.257 . . . . 62.450000000000003 112.336 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.815 HG23 ' O ' ' A' ' 38' ' ' ASP . 12.7 pt -83.1 17.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 54.240000000000002 111.08 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.52 135.54 53.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 64.420000000000002 110.905 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 176.56 6.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.695 2.263 . . . . 71.0 112.381 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -112.95 -35.43 1.67 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.728 -0.749 . . . . 71.439999999999998 112.466 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.1 -25.86 9.12 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 53.340000000000003 112.471 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.78 -68.14 0.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 63.240000000000002 111.108 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -107.09 -8.96 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.219999999999999 110.866 -179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 2.0 t80 -37.49 -48.44 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 75.519999999999996 110.842 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -98.32 126.97 37.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.652 0.739 . . . . 74.519999999999996 110.858 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.8 Cg_endo -69.72 148.26 86.26 Favored 'Cis proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 -1.789 . . . . 61.439999999999998 112.335 -0.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 8.7 t-20 -103.14 150.63 23.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 53.030000000000001 110.848 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.4 ' CB ' ' HE2' ' A' ' 55' ' ' LYS . 27.9 p -106.46 163.82 12.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 71.319999999999993 111.119 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.8 -56.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 53.509999999999998 111.122 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.609 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -80.49 16.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.864 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 59' ' ' ALA . . . -51.24 -47.89 62.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 71.0 111.127 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.724 ' CD2' HD12 ' A' ' 42' ' ' ILE . 68.2 m80 -45.34 -58.97 2.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 110.84 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.696 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -51.46 -38.81 55.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.096 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 56' ' ' ALA . . . -55.89 -40.42 72.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 74.200000000000003 111.111 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.602 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 9.4 t80 -68.13 -63.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 74.040000000000006 110.923 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.881 HG11 ' OD1' ' A' ' 38' ' ' ASP . 7.4 p -55.12 -33.56 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.478 . . . . 73.129999999999995 111.129 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.686 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 mmt -46.13 -29.66 1.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 110.885 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -64.37 -65.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 64.310000000000002 110.858 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.569 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -65.87 -51.03 62.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 62.530000000000001 110.901 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.561 ' HB2' HG22 ' A' ' 61' ' ' VAL . 2.8 t80 -44.64 -43.71 8.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 74.030000000000001 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.549 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 3.7 t80 -64.08 -30.71 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.936 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -98.21 -2.33 39.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 74.329999999999998 110.928 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -72.99 -48.18 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 75.109999999999999 110.85 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.937 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -68.82 -57.06 6.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 111.136 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.7 24.35 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.7 -0.762 . . . . 74.109999999999999 112.482 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 52.0 35.61 16.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 70.230000000000004 110.839 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 2.7 m-80 -103.14 166.3 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 35.399999999999999 110.846 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -71.3 -23.24 61.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 65.530000000000001 110.81 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.44 ' CZ2' ' CG ' ' A' ' 72' ' ' ASN . 1.7 p90 -79.29 0.26 29.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.169 -0.468 . . . . 74.340000000000003 110.936 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.937 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.74 -23.19 59.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.299999999999997 110.891 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -84.11 102.11 12.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 61.009999999999998 110.846 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -118.08 8.44 12.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.828 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.696 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 3.5 m-30 -59.46 -70.55 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.876 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.75 177.98 2.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 74.129999999999995 110.803 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -65.33 -2.35 3.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 71.400000000000006 110.903 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.794 HG21 ' CD1' ' A' ' 25' ' ' LEU . 29.0 p -97.96 -46.46 5.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 111.17 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.67 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.66 25.4 0.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 111.077 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.8 t -86.56 -177.6 6.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 74.519999999999996 111.18 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.538 HD22 ' HB3' ' A' ' 12' ' ' SER . 16.7 mt -66.89 106.9 2.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 53.130000000000003 110.915 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 13' ' ' TRP . 1.2 t -77.98 167.55 21.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 64.099999999999994 111.152 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 87' ' ' THR . 17.2 m-20 -53.27 -168.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 110.862 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.3 t -44.65 173.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 73.400000000000006 111.099 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 21.5 t-20 -52.0 106.0 0.6 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.647 0.737 . . . . 54.520000000000003 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.2 Cg_endo -69.74 -23.03 31.33 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.707 2.272 . . . . 70.299999999999997 112.298 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.1 t -52.0 106.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 71.219999999999999 110.832 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -80.03 -15.3 57.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 73.129999999999995 110.917 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 173.01 -124.96 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 74.329999999999998 112.474 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -37.86 -43.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 73.450000000000003 111.088 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.29 102.01 5.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 62.219999999999999 110.852 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.84 133.83 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 110.907 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.546 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 23.8 m-85 -92.71 146.48 32.32 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.678 0.751 . . . . 74.5 110.869 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 117.13 4.89 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.674 2.249 . . . . 70.129999999999995 112.345 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.574 ' HB3' ' CD1' ' A' ' 13' ' ' TRP . 91.9 p -102.6 -1.36 30.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 63.299999999999997 110.87 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.87 -88.04 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 43.020000000000003 112.509 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -77.47 124.11 27.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 70.120000000000005 110.895 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 43.420000000000002 110.894 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.897 0.38 . . . . 64.030000000000001 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.9 p -118.0 143.5 32.84 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 75.209999999999994 111.175 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -47.05 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.249 . . . . 73.409999999999997 112.343 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 77.0 p -103.26 145.11 29.99 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.699 . . . . 72.420000000000002 111.148 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -175.5 1.18 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.234 . . . . 73.329999999999998 112.353 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 p -90.64 119.75 68.98 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.693 . . . . 74.219999999999999 111.176 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -173.05 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 71.5 112.333 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.31 124.93 19.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 110.884 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -160.67 160.25 31.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 71.530000000000001 111.123 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.85 168.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 73.010000000000005 111.153 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.45 36.65 1.29 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.781 -0.724 . . . . 64.010000000000005 112.544 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.665 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 58.8 m -159.79 152.05 20.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 71.5 110.836 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.665 ' CE3' ' C ' ' A' ' 12' ' ' SER . 9.2 m-90 -152.8 123.19 7.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 75.299999999999997 110.909 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.48 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.1 OUTLIER -90.7 111.72 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 71.120000000000005 110.886 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.488 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.2 m -160.09 154.89 20.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 71.450000000000003 111.133 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HD3' ' HE1' ' A' ' 62' ' ' MET . 53.5 Cg_endo -69.75 125.59 12.33 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.717 2.278 . . . . 63.32 112.35 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 110.13 1.73 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.512 0.672 . . . . 71.299999999999997 110.882 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 97.58 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.688 2.259 . . . . 74.310000000000002 112.29 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.83 -33.73 2.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.754 -0.736 . . . . 54.229999999999997 112.483 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 21' ' ' SER . 2.8 p -58.98 178.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 64.040000000000006 111.136 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.775 ' H ' HG22 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -52.0 128.46 24.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.838 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 24' ' ' GLN . 72.9 m-20 -58.26 -67.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.854 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' HA ' HG22 ' A' ' 26' ' ' THR . 1.1 m-20 -41.81 -23.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 70.510000000000005 110.834 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 22' ' ' ASP . 1.0 OUTLIER -67.7 -48.32 66.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 53.450000000000003 110.904 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.654 HD11 ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -70.89 -56.67 5.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.898 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 23' ' ' ASP . 12.0 t -44.9 -20.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 70.310000000000002 111.108 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 25' ' ' LEU . . . -69.15 -37.93 82.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 73.200000000000003 112.48 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.88 -56.24 23.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.782 0.325 . . . . 74.510000000000005 110.916 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 57' ' ' HIS . 23.4 mt -46.44 -41.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 62.109999999999999 111.128 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -56.66 -48.08 78.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 74.120000000000005 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.13 -56.18 5.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 62.539999999999999 110.967 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.878 ' HB1' ' OD1' ' A' ' 38' ' ' ASP . . . -51.05 -43.47 60.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 75.219999999999999 111.099 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 38' ' ' ASP . 37.4 t -52.75 -15.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 74.510000000000005 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.32 15.87 16.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 60.020000000000003 110.886 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.445 ' HA ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -97.98 -48.04 5.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 73.230000000000004 110.922 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.73 -64.14 0.51 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.748 . . . . 34.200000000000003 112.486 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.115 HD12 HD12 ' A' ' 64' ' ' LEU . 3.4 pt -82.3 14.45 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.808 0.337 . . . . 71.349999999999994 111.121 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.878 ' OD1' ' HB1' ' A' ' 32' ' ' ALA . 3.2 m-20 -89.5 -65.68 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 73.519999999999996 110.846 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 41' ' ' PRO . 1.4 m -76.08 124.49 27.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.858 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.45 -74.58 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 71.239999999999995 112.499 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD2' ' C ' ' A' ' 39' ' ' CYS . 53.5 Cg_endo -69.78 5.73 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.692 2.261 . . . . 62.25 112.322 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.678 HG23 ' O ' ' A' ' 38' ' ' ASP . 5.1 pt -85.23 17.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 70.019999999999996 111.105 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -76.69 135.49 68.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.617 0.722 . . . . 75.409999999999997 110.93 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 170.66 16.09 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.625 2.216 . . . . 74.099999999999994 112.318 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.78 -38.83 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 71.329999999999998 112.444 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.57 -26.16 4.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.75 -0.738 . . . . 45.299999999999997 112.434 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.83 -68.72 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.809 0.338 . . . . 63.420000000000002 111.093 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.96 14.43 14.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 44.100000000000001 110.897 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE1' ' HB2' ' A' ' 52' ' ' ASN . 3.1 t80 -56.48 -50.9 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.899 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -97.52 128.33 34.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.699 0.762 . . . . 72.430000000000007 110.853 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 150.84 90.87 Favored 'Cis proline' 0 C--N 1.342 0.197 0 C-N-CA 122.68 -1.8 . . . . 74.540000000000006 112.37 -0.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.553 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . 4.1 t30 -99.74 131.62 45.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 72.329999999999998 110.86 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.545 ' HB ' ' HZ3' ' A' ' 55' ' ' LYS . 65.7 p -90.9 167.31 12.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 52.119999999999997 111.193 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.2 -59.52 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 71.400000000000006 111.141 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -81.49 17.97 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 110.929 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' HB2' ' OG1' ' A' ' 53' ' ' THR . . . -48.55 -41.12 29.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 71.400000000000006 111.043 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.596 ' CD2' HD12 ' A' ' 42' ' ' ILE . 47.2 m80 -54.76 -55.26 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 74.140000000000001 110.874 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.497 ' HA ' ' CG1' ' A' ' 61' ' ' VAL . . . -50.57 -41.93 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 34.399999999999999 111.106 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' HA ' ' HE3' ' A' ' 62' ' ' MET . . . -57.43 -40.23 77.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 111.101 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 6.3 t80 -68.92 -57.0 6.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 73.329999999999998 110.972 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.513 HG21 ' OD1' ' A' ' 38' ' ' ASP . 3.3 p -54.39 -43.79 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 72.319999999999993 111.134 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.563 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 2.8 ttm -45.76 -29.08 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 75.400000000000006 110.863 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.502 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 32.8 t30 -59.3 -62.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 64.540000000000006 110.855 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.115 HD12 HD12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.58 -46.22 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 73.319999999999993 110.93 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.538 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 3.4 t80 -47.43 -54.59 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 72.329999999999998 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.599 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 3.0 t80 -55.59 -30.55 61.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 74.120000000000005 110.905 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 63' ' ' ASN . 49.4 mt-30 -95.41 -4.51 45.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 73.409999999999997 110.895 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -68.4 -44.14 75.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 54.399999999999999 110.905 179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.978 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -76.42 -60.23 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 111.085 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.82 23.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.736 . . . . 32.509999999999998 112.475 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.563 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.02 37.24 20.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.0 110.858 -179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.599 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 2.4 m-80 -100.97 164.76 11.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 74.230000000000004 110.913 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.0 p -68.38 -25.57 65.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 110.825 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -79.55 1.78 24.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 71.319999999999993 110.951 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.978 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -79.92 -3.93 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 43.420000000000002 110.868 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -101.57 102.01 12.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 44.039999999999999 110.888 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -117.96 9.54 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.904 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.638 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.6 m-30 -58.33 -70.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.929 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.78 178.01 2.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 61.100000000000001 110.868 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -3.07 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 74.420000000000002 110.937 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.543 HG21 ' CD1' ' A' ' 25' ' ' LEU . 26.5 p -97.95 -49.01 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 44.340000000000003 111.146 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -81.73 25.64 0.53 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.139 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 t -86.3 -178.5 6.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 71.430000000000007 111.16 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 12' ' ' SER . 2.9 mm? -66.91 130.89 44.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.434 . . . . 63.539999999999999 110.899 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.05 167.85 9.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 73.019999999999996 111.149 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 87' ' ' THR . 2.9 m-20 -53.71 -168.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 71.310000000000002 110.878 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 89' ' ' PRO . 0.2 OUTLIER -44.53 171.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 111.163 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.557 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 13.6 t-20 -51.95 105.94 0.59 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 73.329999999999998 110.878 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.79 -1.27 8.21 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.253 . . . . 72.439999999999998 112.347 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.456 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 4.9 t -51.98 110.3 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.450000000000003 110.874 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -86.98 -18.06 31.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 64.230000000000004 110.918 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.44 -120.72 0.65 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 64.430000000000007 112.452 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.862 0.363 . . . . 74.140000000000001 111.119 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.42 101.98 5.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 72.349999999999994 110.854 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.03 140.32 33.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 110.891 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.5 m-85 -92.11 146.03 31.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.729 . . . . 74.430000000000007 110.865 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 122.83 9.49 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.666 2.244 . . . . 74.200000000000003 112.37 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.441 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 25.7 p -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 74.420000000000002 110.866 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.1 -57.0 2.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.75 . . . . 50.530000000000001 112.495 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 t -88.99 176.17 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 53.210000000000001 110.86 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 65.030000000000001 110.885 -179.974 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.9 0.381 . . . . 54.329999999999998 111.048 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.673 HG23 ' HD2' ' A' ' 3' ' ' PRO . 95.6 m -68.39 139.03 91.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.565 0.698 . . . . 74.310000000000002 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.673 ' HD2' HG23 ' A' ' 2' ' ' THR . 54.0 Cg_endo -69.73 -177.28 1.79 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.656 2.237 . . . . 53.340000000000003 112.376 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.6 p -53.93 129.54 57.05 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.624 0.726 . . . . 75.209999999999994 111.112 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -179.45 2.94 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.647 2.231 . . . . 73.420000000000002 112.326 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 p -53.92 156.07 5.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 74.230000000000004 111.149 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -174.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.687 2.258 . . . . 73.420000000000002 112.324 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.97 121.0 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 52.149999999999999 110.902 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.23 171.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 73.430000000000007 111.109 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 125.46 23.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 111.129 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.563 ' C ' ' CZ3' ' A' ' 13' ' ' TRP . . . -41.12 121.37 2.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.692 -0.766 . . . . 70.010000000000005 112.539 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.651 ' N ' ' CZ3' ' A' ' 13' ' ' TRP . 2.7 m -157.92 129.68 6.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.833 0.349 . . . . 73.400000000000006 110.874 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.651 ' CZ3' ' N ' ' A' ' 12' ' ' SER . 6.4 m-90 -141.07 114.14 8.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 63.409999999999997 110.916 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -84.0 110.67 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 74.200000000000003 110.861 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.51 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 m -159.59 154.34 21.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.626 0.727 . . . . 75.0 111.121 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 54.1 Cg_endo -69.8 123.28 9.94 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 63.119999999999997 112.326 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.98 114.3 5.18 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 74.420000000000002 110.871 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 92.37 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.715 2.277 . . . . 72.140000000000001 112.37 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.74 -24.45 1.32 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.747 -0.74 . . . . 52.200000000000003 112.512 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.636 ' HB ' HD21 ' A' ' 25' ' ' LEU . 44.3 t -59.05 165.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 64.340000000000003 111.142 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.632 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.2 m -52.08 108.58 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 72.450000000000003 110.877 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 21' ' ' SER . 5.5 m-20 -32.99 -65.27 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.140000000000001 110.853 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.02 -40.68 2.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.905 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -60.26 -49.17 78.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 73.25 110.907 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' A' ' 81' ' ' THR . 0.3 OUTLIER -71.22 -29.04 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 61.520000000000003 110.945 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.778 ' OG1' HG11 ' A' ' 54' ' ' VAL . 17.3 m -67.11 0.07 2.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 73.519999999999996 111.166 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.92 -40.34 5.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 65.129999999999995 112.506 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 25' ' ' LEU . 5.3 p30 -50.47 -44.3 55.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.87 0.367 . . . . 74.25 110.883 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 55' ' ' LYS . 61.6 mt -58.21 -49.05 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 74.049999999999997 111.142 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.19 -41.07 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.9 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -74.15 -52.68 11.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 110.967 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.726 ' HB1' ' HB2' ' A' ' 38' ' ' ASP . . . -52.82 -41.6 64.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 70.299999999999997 111.099 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 7.0 t -60.42 -9.69 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 60.509999999999998 110.9 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.19 3.89 40.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.019999999999996 110.848 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.18 -36.48 6.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 110.923 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.64 -31.18 7.01 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 34.130000000000003 112.506 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.728 ' CD1' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -83.22 -11.41 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 74.430000000000007 111.168 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.726 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.65 -63.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.876 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 38' ' ' ASP . 62.9 m -75.83 129.57 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 41.210000000000001 110.834 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.7 -85.3 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.759 -0.734 . . . . 54.310000000000002 112.51 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 7.02 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.662 2.242 . . . . 74.340000000000003 112.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.697 HD12 ' CG ' ' A' ' 57' ' ' HIS . 5.1 pt -82.62 17.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.540000000000006 111.16 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -79.53 132.85 60.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.601 0.715 . . . . 64.430000000000007 110.916 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 171.52 14.33 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.686 2.258 . . . . 61.530000000000001 112.323 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -118.34 -41.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 63.130000000000003 112.492 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.36 -25.72 3.6 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.689 -0.767 . . . . 71.349999999999994 112.449 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.41 -68.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.784 0.326 . . . . 61.039999999999999 111.12 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.95 14.88 14.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 51.420000000000002 110.907 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.591 ' CE2' ' HG2' ' A' ' 50' ' ' GLU . 2.9 t80 -51.66 -56.55 13.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 71.109999999999999 110.847 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.591 ' HG2' ' CE2' ' A' ' 49' ' ' PHE . 1.3 mm-40 -96.41 133.18 25.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.656 0.741 . . . . 65.450000000000003 110.879 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.79 157.04 92.57 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.705 -1.79 . . . . 65.299999999999997 112.33 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -117.24 142.22 47.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 60.149999999999999 110.912 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.0 p -106.84 172.82 6.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 111.118 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.778 HG11 ' OG1' ' A' ' 26' ' ' THR . 43.9 t -65.73 -54.73 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 71.430000000000007 111.153 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HA ' HD11 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -79.7 17.23 0.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.893 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.3 -45.44 65.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 70.340000000000003 111.115 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.697 ' CG ' HD12 ' A' ' 42' ' ' ILE . 32.9 m170 -53.79 -60.18 3.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 71.549999999999997 110.843 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.497 ' C ' ' HE2' ' A' ' 62' ' ' MET . . . -43.97 -47.21 8.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 44.310000000000002 111.1 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.89 -38.35 49.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 75.140000000000001 111.134 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 8.9 t80 -69.33 -65.01 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.25 110.947 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.664 HG23 HG12 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -54.42 -26.63 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 75.019999999999996 111.127 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.723 ' SD ' ' HB1' ' A' ' 82' ' ' ALA . 1.5 mtm -52.26 -20.38 2.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.889 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.07 -65.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 61.340000000000003 110.877 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.728 HD12 ' CD1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -63.74 -41.77 97.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.908 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' C ' ' CD1' ' A' ' 65' ' ' TYR . 3.4 t80 -58.51 -45.11 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.916 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.561 ' CE2' ' O ' ' A' ' 72' ' ' ASN . 4.6 t80 -65.21 -30.43 71.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.409999999999997 110.926 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -96.21 -3.71 43.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 71.010000000000005 110.949 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -45.74 74.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 71.530000000000001 110.83 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.686 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -75.82 -57.75 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 111.071 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.11 25.95 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 71.299999999999997 112.463 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 0.5 OUTLIER 52.04 47.09 25.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 72.010000000000005 110.897 -179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.561 ' O ' ' CE2' ' A' ' 66' ' ' TYR . 3.6 m-80 -110.27 165.6 11.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 71.230000000000004 110.886 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.694 ' HB2' HD11 ' A' ' 84' ' ' LEU . 30.4 p -70.74 -25.84 63.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 65.209999999999994 110.841 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -77.74 0.3 24.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.946 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.686 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -77.54 -14.42 59.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 75.530000000000001 110.886 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.415 ' SG ' ' O ' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -91.39 102.03 14.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 75.239999999999995 110.864 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.06 7.75 12.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 54.43 110.877 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 3.3 m-30 -59.03 -70.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 70.150000000000006 110.853 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.85 178.03 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.487 . . . . 75.540000000000006 110.884 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -1.84 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 110.908 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.889 HG21 ' CD1' ' A' ' 25' ' ' LEU . 37.3 p -95.0 -50.33 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 111.147 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.723 ' HB1' ' SD ' ' A' ' 62' ' ' MET . . . -80.66 29.77 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 71.400000000000006 111.106 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -87.01 -179.52 6.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 111.148 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.694 HD11 ' HB2' ' A' ' 73' ' ' SER . 2.5 mt -67.36 131.51 45.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 64.209999999999994 110.938 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -106.08 168.43 9.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 73.540000000000006 111.129 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -53.25 -169.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 55.409999999999997 110.867 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -44.22 172.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 74.329999999999998 111.127 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 14.4 t-20 -52.01 106.78 0.7 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.636 0.731 . . . . 74.109999999999999 110.89 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.547 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 53.6 Cg_endo -69.7 -4.03 13.17 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.678 2.252 . . . . 74.150000000000006 112.34 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 88' ' ' ASN . 2.5 t -51.98 110.83 0.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 54.229999999999997 110.838 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -15.69 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 72.329999999999998 110.921 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.89 -128.92 1.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 62.100000000000001 112.52 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.1 -33.59 65.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 74.519999999999996 111.142 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.49 101.98 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 53.219999999999999 110.902 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -99.75 141.29 32.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 75.450000000000003 110.939 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.547 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 15.9 m-85 -93.14 147.76 34.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.611 0.72 . . . . 75.299999999999997 110.896 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 115.4 4.08 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 72.239999999999995 112.289 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.47 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 27.9 p -95.08 -6.8 41.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 75.310000000000002 110.878 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.39 -83.37 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.709 -0.757 . . . . 71.430000000000007 112.488 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.59 120.76 34.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 73.129999999999995 110.853 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 74.219999999999999 110.827 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 41.229999999999997 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.2 p -116.12 145.88 35.91 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.641 0.734 . . . . 53.43 111.099 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 107.09 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 75.129999999999995 112.318 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 p -95.96 144.22 27.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.711 . . . . 54.25 111.138 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -166.38 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.728 2.285 . . . . 74.030000000000001 112.357 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -74.46 141.97 77.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.611 0.72 . . . . 61.100000000000001 111.118 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -173.81 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.726 2.284 . . . . 60.140000000000001 112.343 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.73 124.19 39.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.85 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.02 140.58 42.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 111.079 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.32 25.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 65.319999999999993 111.139 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.52 -145.36 8.24 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 64.230000000000004 112.515 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.662 ' C ' ' CE3' ' A' ' 13' ' ' TRP . 70.8 m -150.32 161.52 42.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 75.219999999999999 110.825 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.662 ' CE3' ' C ' ' A' ' 12' ' ' SER . 7.2 m-90 -152.94 107.06 3.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.956 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' O ' ' CG1' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -72.87 105.59 4.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 65.230000000000004 110.853 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.556 ' C ' ' HA ' ' A' ' 82' ' ' ALA . 3.8 m -158.88 154.82 23.37 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.647 0.736 . . . . 73.209999999999994 111.139 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' CB ' ' HG3' ' A' ' 55' ' ' LYS . 53.3 Cg_endo -69.78 118.43 5.68 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.71 2.273 . . . . 72.140000000000001 112.329 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.98 110.16 1.74 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.598 0.714 . . . . 71.420000000000002 110.89 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 79.65 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.705 2.27 . . . . 42.439999999999998 112.356 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 159.41 58.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 41.009999999999998 112.484 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.839 ' CG2' HD11 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -158.26 177.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 60.310000000000002 111.105 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 2.4 m -51.97 116.07 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 52.32 110.878 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -40.94 -66.22 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 110.887 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.33 -27.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.824 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' SER . 21.8 tt0 -63.54 -52.45 61.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 110.908 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.839 HD11 ' CG2' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -71.65 -51.14 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 64.109999999999999 110.903 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.597 ' OG1' HG11 ' A' ' 54' ' ' VAL . 25.7 m -45.5 -43.86 12.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 72.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -44.4 -30.49 2.05 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.701 -0.762 . . . . 72.239999999999995 112.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -64.37 -66.68 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 110.876 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.541 HD13 ' HB2' ' A' ' 57' ' ' HIS . 37.1 mt -38.21 -49.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.178 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.442 ' OD1' ' C ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -52.14 -44.84 64.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 75.030000000000001 110.873 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -74.05 -54.6 7.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 110.937 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -51.57 -38.89 56.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 44.009999999999998 111.088 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.17 -12.66 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.299999999999997 110.874 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -115.2 18.04 16.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 110.844 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.464 ' HB2' ' CG ' ' A' ' 38' ' ' ASP . 1.8 mm100 -93.02 -52.02 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.918 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . 161.72 -91.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.725 -0.75 . . . . 65.129999999999995 112.482 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.451 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -81.55 17.91 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 53.009999999999998 111.132 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.643 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -85.41 -60.68 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 71.150000000000006 110.869 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.88 110.06 8.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 63.520000000000003 110.924 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.65 -70.99 0.46 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 63.420000000000002 112.486 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.558 ' O ' ' CE1' ' A' ' 60' ' ' TYR . 54.0 Cg_endo -69.75 8.1 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.691 2.26 . . . . 71.099999999999994 112.309 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.682 HD12 ' CD2' ' A' ' 57' ' ' HIS . 20.2 pt -82.32 18.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 64.150000000000006 111.142 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -82.85 122.56 78.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 65.329999999999998 110.926 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 168.53 21.36 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 71.430000000000007 112.303 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.56 -35.45 1.08 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.765 -0.731 . . . . 44.340000000000003 112.503 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.57 -19.42 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 42.420000000000002 112.519 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.27 -68.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 74.209999999999994 111.089 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.9 t -117.98 12.75 13.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 75.209999999999994 110.914 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.524 ' CE1' ' CB ' ' A' ' 52' ' ' ASN . 2.1 t80 -56.97 -47.37 80.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 110.863 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' HA ' ' C ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -96.57 129.12 33.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.652 0.739 . . . . 74.239999999999995 110.909 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 50' ' ' GLU . 53.9 Cg_endo -69.76 150.54 90.33 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.68 -1.8 . . . . 61.299999999999997 112.367 0.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.524 ' CB ' ' CE1' ' A' ' 49' ' ' PHE . 0.6 OUTLIER -114.5 118.2 33.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 74.010000000000005 110.936 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.82 170.18 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 72.409999999999997 111.156 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.597 HG11 ' OG1' ' A' ' 26' ' ' THR . 50.3 t -64.4 -52.83 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.230000000000004 111.134 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.527 ' HG3' ' CB ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -77.73 13.63 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 65.310000000000002 110.873 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -50.99 -43.06 60.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 71.349999999999994 111.098 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.682 ' CD2' HD12 ' A' ' 42' ' ' ILE . 61.8 m80 -55.2 -46.97 75.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.426 . . . . 72.319999999999993 110.834 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.592 ' HB1' ' CE2' ' A' ' 78' ' ' PHE . . . -59.67 -37.53 79.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 52.310000000000002 111.098 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.67 -36.34 80.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 54.340000000000003 111.12 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.558 ' CE1' ' O ' ' A' ' 41' ' ' PRO . 3.2 t80 -68.74 -61.19 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 74.120000000000005 110.915 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 57' ' ' HIS . 0.8 OUTLIER -54.79 -45.36 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 75.109999999999999 111.145 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -46.07 -21.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 65.310000000000002 110.876 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' HB3' HD23 ' A' ' 64' ' ' LEU . 10.9 t30 -69.41 -59.52 2.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.510000000000005 110.906 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -76.74 -47.18 22.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 72.120000000000005 110.938 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t80 -46.52 -40.11 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.929 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 72' ' ' ASN . 6.3 t80 -60.47 -31.07 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 110.956 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -96.3 -4.32 42.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 72.109999999999999 110.888 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -50.4 45.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.430000000000007 110.863 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.812 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . . . -68.01 -57.84 5.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 22.350000000000001 111.09 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.14 25.09 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 73.450000000000003 112.501 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.01 35.82 17.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 70.439999999999998 110.888 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.476 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 3.2 m-80 -102.84 169.69 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.9 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.562 ' HB2' HD11 ' A' ' 84' ' ' LEU . 56.5 p -71.72 -22.49 61.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 61.329999999999998 110.83 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 72' ' ' ASN . 1.7 p90 -80.66 0.82 32.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.138 -0.483 . . . . 74.109999999999999 110.892 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.812 ' OD1' ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -73.71 -10.28 59.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 65.230000000000004 110.906 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HE1' ' A' ' 62' ' ' MET . 0.5 OUTLIER -90.66 103.33 16.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.049999999999997 110.917 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -118.03 2.23 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.879 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.592 ' CE2' ' HB1' ' A' ' 58' ' ' ALA . 2.8 m-85 -58.94 -71.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 110.924 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.35 177.97 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 63.229999999999997 110.895 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -65.41 -2.48 3.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 73.540000000000006 110.922 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.1 p -98.02 -48.43 5.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 61.219999999999999 111.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.565 ' HB3' ' HB2' ' A' ' 78' ' ' PHE . . . -80.42 23.66 0.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 111.137 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -84.98 -176.69 6.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.229999999999997 111.209 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 73' ' ' SER . 2.0 mt -66.21 107.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 64.219999999999999 110.901 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 86' ' ' ASN . 1.4 t -78.14 168.97 19.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.349999999999994 111.147 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' THR . 75.3 m-20 -53.54 -168.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 110.907 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' ASN . 10.2 t -44.46 171.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 55.210000000000001 111.145 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.565 ' HB2' ' CZ2' ' A' ' 13' ' ' TRP . 8.7 t-20 -52.01 106.27 0.63 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.636 0.732 . . . . 73.239999999999995 110.872 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.571 ' HG2' ' CG ' ' A' ' 96' ' ' PHE . 54.3 Cg_endo -69.72 -1.6 8.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.701 2.268 . . . . 75.040000000000006 112.385 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -52.01 108.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.901 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.579 ' CE1' ' HB2' ' A' ' 94' ' ' CYS . 4.1 p90 -82.82 -18.14 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 62.140000000000001 110.914 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.59 -114.48 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 65.209999999999994 112.5 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.45 -36.92 85.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 73.349999999999994 111.049 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.579 ' HB2' ' CE1' ' A' ' 91' ' ' TYR . 1.8 m -79.41 101.98 8.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.91 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -100.08 147.82 25.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 62.329999999999998 110.908 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CG ' ' HG2' ' A' ' 89' ' ' PRO . 7.6 m-85 -93.1 156.41 40.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.619 0.723 . . . . 75.340000000000003 110.904 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 125.95 12.69 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.692 2.262 . . . . 74.109999999999999 112.291 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.483 ' HB3' ' NE1' ' A' ' 13' ' ' TRP . 1.2 p -117.57 5.24 12.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.510000000000005 110.843 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.88 -142.68 25.74 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.724 -0.751 . . . . 71.109999999999999 112.53 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 m -81.56 113.71 19.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 70.430000000000007 110.866 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.089 -0.505 . . . . 73.239999999999995 110.905 -179.96 . . . . . . . . 0 0 . 1 stop_ save_